diff --git "a/kg/node/pathway.csv" "b/kg/node/pathway.csv"
new file mode 100644--- /dev/null
+++ "b/kg/node/pathway.csv"
@@ -0,0 +1,2752 @@
+,Unnamed: 0.6,Unnamed: 0.5,Unnamed: 0.4,Unnamed: 0.3,Unnamed: 0.2,Unnamed: 0.1,Unnamed: 0,id,name,source,type,Inter_ID
+0,0,0,0,0,0,0,0,R-HSA-3781865,Diseases of glycosylation,REACTOME,pathway,PATHWAY_0
+1,1,1,1,1,1,1,1,R-HSA-211976,Endogenous sterols,REACTOME,pathway,PATHWAY_1
+2,2,2,2,2,2,2,2,R-HSA-9670621,Defective Inhibition of DNA Recombination at Telomere,REACTOME,pathway,PATHWAY_2
+3,3,3,3,3,3,3,3,R-HSA-975577,N-Glycan antennae elongation,REACTOME,pathway,PATHWAY_3
+4,4,4,4,4,4,4,4,R-HSA-1482922,Acyl chain remodelling of PI,REACTOME,pathway,PATHWAY_4
+5,5,5,5,5,5,5,5,R-HSA-434313,Intracellular metabolism of fatty acids regulates insulin secretion,REACTOME,pathway,PATHWAY_5
+6,6,6,6,6,6,6,6,R-HSA-9018681,Biosynthesis of protectins,REACTOME,pathway,PATHWAY_6
+7,7,7,7,7,7,7,7,R-HSA-5099900,WNT5A-dependent internalization of FZD4,REACTOME,pathway,PATHWAY_7
+8,8,8,8,8,8,8,8,R-HSA-156842,Eukaryotic Translation Elongation,REACTOME,pathway,PATHWAY_8
+9,9,9,9,9,9,9,9,R-HSA-9793380,Formation of paraxial mesoderm,REACTOME,pathway,PATHWAY_9
+10,10,10,10,10,10,10,10,R-HSA-2142688,Synthesis of 5-eicosatetraenoic acids,REACTOME,pathway,PATHWAY_10
+11,11,11,11,11,11,11,11,R-HSA-2559584,Formation of Senescence-Associated Heterochromatin Foci (SAHF),REACTOME,pathway,PATHWAY_11
+12,12,12,12,12,12,12,12,R-HSA-5625886,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,REACTOME,pathway,PATHWAY_12
+13,13,13,13,13,13,13,13,R-HSA-9026395,Biosynthesis of DHA-derived sulfido conjugates,REACTOME,pathway,PATHWAY_13
+14,14,14,14,14,14,14,14,R-HSA-168333,NEP/NS2 Interacts with the Cellular Export Machinery,REACTOME,pathway,PATHWAY_14
+15,15,15,15,15,15,15,15,R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,REACTOME,pathway,PATHWAY_15
+16,16,16,16,16,16,16,16,R-HSA-111452,Activation and oligomerization of BAK protein,REACTOME,pathway,PATHWAY_16
+17,17,17,17,17,17,17,17,R-HSA-9845323,Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs),REACTOME,pathway,PATHWAY_17
+18,18,18,18,18,18,18,18,R-HSA-209931,Serotonin and melatonin biosynthesis,REACTOME,pathway,PATHWAY_18
+19,19,19,19,19,19,19,19,R-HSA-8949664,Processing of SMDT1,REACTOME,pathway,PATHWAY_19
+20,20,20,20,20,20,20,20,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,REACTOME,pathway,PATHWAY_20
+21,21,21,21,21,21,21,21,R-HSA-2995383,Initiation of Nuclear Envelope (NE) Reformation,REACTOME,pathway,PATHWAY_21
+22,22,22,22,22,22,22,22,R-HSA-8964038,LDL clearance,REACTOME,pathway,PATHWAY_22
+23,23,23,23,23,23,23,23,R-HSA-159740,Gamma-carboxylation of protein precursors,REACTOME,pathway,PATHWAY_23
+24,24,24,24,24,24,24,24,R-HSA-428359,Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,REACTOME,pathway,PATHWAY_24
+25,25,25,25,25,25,25,25,R-HSA-5660883,Defective SLC7A9 causes cystinuria (CSNU),REACTOME,pathway,PATHWAY_25
+26,26,26,26,26,26,26,26,R-HSA-9028335,Activated NTRK2 signals through PI3K,REACTOME,pathway,PATHWAY_26
+27,27,27,27,27,27,27,27,R-HSA-3359463,Defective CUBN causes MGA1,REACTOME,pathway,PATHWAY_27
+28,28,28,28,28,28,28,28,R-HSA-5638303,Inhibition of Signaling by Overexpressed EGFR,REACTOME,pathway,PATHWAY_28
+29,29,29,29,29,29,29,29,R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,REACTOME,pathway,PATHWAY_29
+30,30,30,30,30,30,30,30,R-HSA-437239,Recycling pathway of L1,REACTOME,pathway,PATHWAY_30
+31,31,31,31,31,31,31,31,R-HSA-5668599,RHO GTPases Activate NADPH Oxidases,REACTOME,pathway,PATHWAY_31
+32,32,32,32,32,32,32,32,R-HSA-9926550,"Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition",REACTOME,pathway,PATHWAY_32
+33,33,33,33,33,33,33,33,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,REACTOME,pathway,PATHWAY_33
+34,34,34,34,34,34,34,34,R-HSA-5083625,Defective GALNT3 causes HFTC,REACTOME,pathway,PATHWAY_34
+35,35,35,35,35,35,35,35,R-HSA-9632693,Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects,REACTOME,pathway,PATHWAY_35
+36,36,36,36,36,36,36,36,R-HSA-5668914,Diseases of metabolism,REACTOME,pathway,PATHWAY_36
+37,37,37,37,37,37,37,37,R-HSA-5358747,CTNNB1 S33 mutants aren't phosphorylated,REACTOME,pathway,PATHWAY_37
+38,38,38,38,38,38,38,38,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,REACTOME,pathway,PATHWAY_38
+39,39,39,39,39,39,39,39,R-HSA-9022537,Loss of MECP2 binding ability to the NCoR/SMRT complex,REACTOME,pathway,PATHWAY_39
+40,40,40,40,40,40,40,40,R-HSA-9694682,SARS-CoV-2 Genome Replication and Transcription,REACTOME,pathway,PATHWAY_40
+41,41,41,41,41,41,41,41,R-HSA-8964043,Plasma lipoprotein clearance,REACTOME,pathway,PATHWAY_41
+42,42,42,42,42,42,42,42,R-HSA-9860931,Response of endothelial cells to shear stress,REACTOME,pathway,PATHWAY_42
+43,43,43,43,43,43,43,43,R-HSA-162594,Early Phase of HIV Life Cycle,REACTOME,pathway,PATHWAY_43
+44,44,44,44,44,44,44,44,R-HSA-4719377,Defective DPM2 causes DPM2-CDG,REACTOME,pathway,PATHWAY_44
+45,45,45,45,45,45,45,45,R-HSA-4043911,Defective PMM2 causes PMM2-CDG,REACTOME,pathway,PATHWAY_45
+46,46,46,46,46,46,46,46,R-HSA-2691230,Signaling by NOTCH1 HD Domain Mutants in Cancer,REACTOME,pathway,PATHWAY_46
+47,47,47,47,47,47,47,47,R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs,REACTOME,pathway,PATHWAY_47
+48,48,48,48,48,48,48,48,R-HSA-109582,Hemostasis,REACTOME,pathway,PATHWAY_48
+49,49,49,49,49,49,49,49,R-HSA-8949613,Cristae formation,REACTOME,pathway,PATHWAY_49
+50,50,50,50,50,50,50,50,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),REACTOME,pathway,PATHWAY_50
+51,51,51,51,51,51,51,51,R-HSA-9706369,Negative regulation of FLT3,REACTOME,pathway,PATHWAY_51
+52,52,52,52,52,52,52,52,R-HSA-9619483,Activation of AMPK downstream of NMDARs,REACTOME,pathway,PATHWAY_52
+53,53,53,53,53,53,53,53,R-HSA-73728,RNA Polymerase I Promoter Opening,REACTOME,pathway,PATHWAY_53
+54,54,54,54,54,54,54,54,R-HSA-9762293,Regulation of CDH11 gene transcription,REACTOME,pathway,PATHWAY_54
+55,55,55,55,55,55,55,55,R-HSA-2161522,Abacavir ADME,REACTOME,pathway,PATHWAY_55
+56,56,56,56,56,56,56,56,R-HSA-9865125,Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD,REACTOME,pathway,PATHWAY_56
+57,57,57,57,57,57,57,57,R-HSA-72766,Translation,REACTOME,pathway,PATHWAY_57
+58,58,58,58,58,58,58,58,R-HSA-5173214,O-glycosylation of TSR domain-containing proteins,REACTOME,pathway,PATHWAY_58
+59,59,59,59,59,59,59,59,R-HSA-9034015,Signaling by NTRK3 (TRKC),REACTOME,pathway,PATHWAY_59
+60,60,60,60,60,60,60,60,R-HSA-1839128,FGFR4 mutant receptor activation,REACTOME,pathway,PATHWAY_60
+61,61,61,61,61,61,61,61,R-HSA-375280,Amine ligand-binding receptors,REACTOME,pathway,PATHWAY_61
+62,62,62,62,62,62,62,62,R-HSA-9027307,Biosynthesis of maresin-like SPMs,REACTOME,pathway,PATHWAY_62
+63,63,63,63,63,63,63,63,R-HSA-937072,TRAF6-mediated induction of TAK1 complex within TLR4 complex,REACTOME,pathway,PATHWAY_63
+64,64,64,64,64,64,64,64,R-HSA-1660524,PIPs transport between plasma and early endosome membranes,REACTOME,pathway,PATHWAY_64
+65,65,65,65,65,65,65,65,R-HSA-445989,TAK1-dependent IKK and NF-kappa-B activation  ,REACTOME,pathway,PATHWAY_65
+66,66,66,66,66,66,66,66,R-HSA-5250955,Toxicity of botulinum toxin type D (botD),REACTOME,pathway,PATHWAY_66
+67,67,67,67,67,67,67,67,R-HSA-110314,Recognition of DNA damage by PCNA-containing replication complex,REACTOME,pathway,PATHWAY_67
+68,68,68,68,68,68,68,68,R-HSA-9013422,RHOBTB1 GTPase cycle,REACTOME,pathway,PATHWAY_68
+69,69,69,69,69,69,69,69,R-HSA-9637687,Suppression of phagosomal maturation,REACTOME,pathway,PATHWAY_69
+70,70,70,70,70,70,70,70,R-HSA-4720454,Defective ALG9 causes CDG-1l,REACTOME,pathway,PATHWAY_70
+71,71,71,71,71,71,71,71,R-HSA-9692914,SARS-CoV-1-host interactions,REACTOME,pathway,PATHWAY_71
+72,72,72,72,72,72,72,72,R-HSA-445355,Smooth Muscle Contraction,REACTOME,pathway,PATHWAY_72
+73,73,73,73,73,73,73,73,R-HSA-193368,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,REACTOME,pathway,PATHWAY_73
+74,74,74,74,74,74,74,74,R-HSA-9634597,GPER1 signaling,REACTOME,pathway,PATHWAY_74
+75,75,75,75,75,75,75,75,R-HSA-163358,PKA-mediated phosphorylation of key metabolic factors,REACTOME,pathway,PATHWAY_75
+76,76,76,76,76,76,76,76,R-HSA-5083632,Defective C1GALT1C1 causes TNPS,REACTOME,pathway,PATHWAY_76
+77,77,77,77,77,77,77,77,R-HSA-9657688,Defective factor XII causes hereditary angioedema,REACTOME,pathway,PATHWAY_77
+78,78,78,78,78,78,78,78,R-HSA-933543,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,REACTOME,pathway,PATHWAY_78
+79,79,79,79,79,79,79,79,R-HSA-9759785,Diseases of propionyl-CoA catabolism,REACTOME,pathway,PATHWAY_79
+80,80,80,80,80,80,80,80,R-HSA-5656121,Translesion synthesis by POLI,REACTOME,pathway,PATHWAY_80
+81,81,81,81,81,81,81,81,R-HSA-167243,Tat-mediated HIV elongation arrest and recovery,REACTOME,pathway,PATHWAY_81
+82,82,82,82,82,82,82,82,R-HSA-73894,DNA Repair,REACTOME,pathway,PATHWAY_82
+83,83,83,83,83,83,83,83,R-HSA-69202,Cyclin E associated events during G1/S transition ,REACTOME,pathway,PATHWAY_83
+84,84,84,84,84,84,84,84,R-HSA-210745,Regulation of gene expression in beta cells,REACTOME,pathway,PATHWAY_84
+85,85,85,85,85,85,85,85,R-HSA-9748784,Drug ADME,REACTOME,pathway,PATHWAY_85
+86,86,86,86,86,86,86,86,R-HSA-9637690,Response of Mtb to phagocytosis,REACTOME,pathway,PATHWAY_86
+87,87,87,87,87,87,87,87,R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,REACTOME,pathway,PATHWAY_87
+88,88,88,88,88,88,88,88,R-HSA-9018679,Biosynthesis of EPA-derived SPMs,REACTOME,pathway,PATHWAY_88
+89,89,89,89,89,89,89,89,R-HSA-73621,Pyrimidine catabolism,REACTOME,pathway,PATHWAY_89
+90,90,90,90,90,90,90,90,R-HSA-72649,Translation initiation complex formation,REACTOME,pathway,PATHWAY_90
+91,91,91,91,91,91,91,91,R-HSA-5250924,B-WICH complex positively regulates rRNA expression,REACTOME,pathway,PATHWAY_91
+92,92,92,92,92,92,92,92,R-HSA-9675151,Disorders of Developmental Biology,REACTOME,pathway,PATHWAY_92
+93,93,93,93,93,93,93,93,R-HSA-4724325,Defective ALG8 causes CDG-1h,REACTOME,pathway,PATHWAY_93
+94,94,94,94,94,94,94,94,R-HSA-2871796,FCERI mediated MAPK activation,REACTOME,pathway,PATHWAY_94
+95,95,95,95,95,95,95,95,R-HSA-6803211,TP53 Regulates Transcription of Death Receptors and Ligands,REACTOME,pathway,PATHWAY_95
+96,96,96,96,96,96,96,96,R-HSA-163754,Insulin effects increased synthesis of Xylulose-5-Phosphate,REACTOME,pathway,PATHWAY_96
+97,97,97,97,97,97,97,97,R-HSA-9703648,Signaling by FLT3 ITD and TKD mutants,REACTOME,pathway,PATHWAY_97
+98,98,98,98,98,98,98,98,R-HSA-9020933,Interleukin-23 signaling,REACTOME,pathway,PATHWAY_98
+99,99,99,99,99,99,99,99,R-HSA-1280215,Cytokine Signaling in Immune system,REACTOME,pathway,PATHWAY_99
+100,100,100,100,100,100,100,100,R-HSA-1474228,Degradation of the extracellular matrix,REACTOME,pathway,PATHWAY_100
+101,101,101,101,101,101,101,101,R-HSA-111933,Calmodulin induced events,REACTOME,pathway,PATHWAY_101
+102,102,102,102,102,102,102,102,R-HSA-5632684,Hedgehog 'on' state,REACTOME,pathway,PATHWAY_102
+103,103,103,103,103,103,103,103,R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,REACTOME,pathway,PATHWAY_103
+104,104,104,104,104,104,104,104,R-HSA-1482839,Acyl chain remodelling of PE,REACTOME,pathway,PATHWAY_104
+105,105,105,105,105,105,105,105,R-HSA-2660825,Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,REACTOME,pathway,PATHWAY_105
+106,106,106,106,106,106,106,106,R-HSA-8982491,Glycogen metabolism,REACTOME,pathway,PATHWAY_106
+107,107,107,107,107,107,107,107,R-HSA-8949275,RUNX3 Regulates Immune Response and Cell Migration,REACTOME,pathway,PATHWAY_107
+108,108,108,108,108,108,108,108,R-HSA-975574,Reactions specific to the hybrid N-glycan synthesis pathway,REACTOME,pathway,PATHWAY_108
+109,109,109,109,109,109,109,109,R-HSA-9702605,pexidartinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_109
+110,110,110,110,110,110,110,110,R-HSA-456926,Thrombin signalling through proteinase activated receptors (PARs),REACTOME,pathway,PATHWAY_110
+111,111,111,111,111,111,111,111,R-HSA-2022928,HS-GAG biosynthesis,REACTOME,pathway,PATHWAY_111
+112,112,112,112,112,112,112,112,R-HSA-8983711,OAS antiviral response,REACTOME,pathway,PATHWAY_112
+113,113,113,113,113,113,113,113,R-HSA-350054,Notch-HLH transcription pathway,REACTOME,pathway,PATHWAY_113
+114,114,114,114,114,114,114,114,R-HSA-9820960,Respiratory syncytial virus (RSV) attachment and entry,REACTOME,pathway,PATHWAY_114
+115,115,115,115,115,115,115,115,R-HSA-5660489,MTF1 activates gene expression,REACTOME,pathway,PATHWAY_115
+116,116,116,116,116,116,116,116,R-HSA-8853333,Signaling by FGFR2 fusions,REACTOME,pathway,PATHWAY_116
+117,117,117,117,117,117,117,117,R-HSA-427589,Type II Na+/Pi cotransporters,REACTOME,pathway,PATHWAY_117
+118,118,118,118,118,118,118,118,R-HSA-444821,Relaxin receptors,REACTOME,pathway,PATHWAY_118
+119,119,119,119,119,119,119,119,R-HSA-1643713,Signaling by EGFR in Cancer,REACTOME,pathway,PATHWAY_119
+120,120,120,120,120,120,120,120,R-HSA-141424,Amplification of signal from the kinetochores,REACTOME,pathway,PATHWAY_120
+121,121,121,121,121,121,121,121,R-HSA-372790,Signaling by GPCR,REACTOME,pathway,PATHWAY_121
+122,122,122,122,122,122,122,122,R-HSA-9614085,FOXO-mediated transcription,REACTOME,pathway,PATHWAY_122
+123,123,123,123,123,123,123,123,R-HSA-9717329,lorlatinib-resistant ALK mutants,REACTOME,pathway,PATHWAY_123
+124,124,124,124,124,124,124,124,R-HSA-73864,RNA Polymerase I Transcription,REACTOME,pathway,PATHWAY_124
+125,125,125,125,125,125,125,125,R-HSA-1236974,ER-Phagosome pathway,REACTOME,pathway,PATHWAY_125
+126,126,126,126,126,126,126,126,R-HSA-69615,G1/S DNA Damage Checkpoints,REACTOME,pathway,PATHWAY_126
+127,127,127,127,127,127,127,127,R-HSA-74713,IRS activation,REACTOME,pathway,PATHWAY_127
+128,128,128,128,128,128,128,128,R-HSA-446199,Synthesis of Dolichyl-phosphate,REACTOME,pathway,PATHWAY_128
+129,129,129,129,129,129,129,129,R-HSA-212718,EGFR interacts with phospholipase C-gamma,REACTOME,pathway,PATHWAY_129
+130,130,130,130,130,130,130,130,R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,REACTOME,pathway,PATHWAY_130
+131,131,131,131,131,131,131,131,R-HSA-5663205,Infectious disease,REACTOME,pathway,PATHWAY_131
+132,132,132,132,132,132,132,132,R-HSA-3642278,Loss of Function of TGFBR2 in Cancer,REACTOME,pathway,PATHWAY_132
+133,133,133,133,133,133,133,133,R-HSA-556833,Metabolism of lipids,REACTOME,pathway,PATHWAY_133
+134,134,134,134,134,134,134,134,R-HSA-9613354,Lipophagy,REACTOME,pathway,PATHWAY_134
+135,135,135,135,135,135,135,135,R-HSA-9759194,Nuclear events mediated by NFE2L2,REACTOME,pathway,PATHWAY_135
+136,136,136,136,136,136,136,136,R-HSA-9842640,Signaling by LTK in cancer,REACTOME,pathway,PATHWAY_136
+137,137,137,137,137,137,137,137,R-HSA-9702632,sunitinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_137
+138,138,138,138,138,138,138,138,R-HSA-5669034,TNFs bind their physiological receptors,REACTOME,pathway,PATHWAY_138
+139,139,139,139,139,139,139,139,R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,REACTOME,pathway,PATHWAY_139
+140,140,140,140,140,140,140,140,R-HSA-9637628,Modulation by Mtb of host immune system,REACTOME,pathway,PATHWAY_140
+141,141,141,141,141,141,141,141,R-HSA-390650,Histamine receptors,REACTOME,pathway,PATHWAY_141
+142,142,142,142,142,142,142,142,R-HSA-1169091,Activation of NF-kappaB in B cells,REACTOME,pathway,PATHWAY_142
+143,143,143,143,143,143,143,143,R-HSA-1358803,Downregulation of ERBB2:ERBB3 signaling,REACTOME,pathway,PATHWAY_143
+144,144,144,144,144,144,144,144,R-HSA-9013408,RHOG GTPase cycle,REACTOME,pathway,PATHWAY_144
+145,145,145,145,145,145,145,145,R-HSA-2453864,Retinoid cycle disease events,REACTOME,pathway,PATHWAY_145
+146,146,146,146,146,146,146,146,R-HSA-400451,Free fatty acids regulate insulin secretion,REACTOME,pathway,PATHWAY_146
+147,147,147,147,147,147,147,147,R-HSA-1566948,Elastic fibre formation,REACTOME,pathway,PATHWAY_147
+148,148,148,148,148,148,148,148,R-HSA-3656237,Defective EXT2 causes exostoses 2,REACTOME,pathway,PATHWAY_148
+149,149,149,149,149,149,149,149,R-HSA-936964,"Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)",REACTOME,pathway,PATHWAY_149
+150,150,150,150,150,150,150,150,R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,REACTOME,pathway,PATHWAY_150
+151,151,151,151,151,151,151,151,R-HSA-389887,Beta-oxidation of pristanoyl-CoA,REACTOME,pathway,PATHWAY_151
+152,152,152,152,152,152,152,152,R-HSA-162710,Synthesis of glycosylphosphatidylinositol (GPI),REACTOME,pathway,PATHWAY_152
+153,153,153,153,153,153,153,153,R-HSA-1538133,G0 and Early G1,REACTOME,pathway,PATHWAY_153
+154,154,154,154,154,154,154,154,R-HSA-977606,Regulation of Complement cascade,REACTOME,pathway,PATHWAY_154
+155,155,155,155,155,155,155,155,R-HSA-5689603,UCH proteinases,REACTOME,pathway,PATHWAY_155
+156,156,156,156,156,156,156,156,R-HSA-159236,Transport of Mature mRNA derived from an Intron-Containing Transcript,REACTOME,pathway,PATHWAY_156
+157,157,157,157,157,157,157,157,R-HSA-3858494,Beta-catenin independent WNT signaling,REACTOME,pathway,PATHWAY_157
+158,158,158,158,158,158,158,158,R-HSA-5365859,RA biosynthesis pathway,REACTOME,pathway,PATHWAY_158
+159,159,159,159,159,159,159,159,R-HSA-1912420,Pre-NOTCH Processing in Golgi,REACTOME,pathway,PATHWAY_159
+160,160,160,160,160,160,160,160,R-HSA-5357769,Caspase activation via extrinsic apoptotic signalling pathway,REACTOME,pathway,PATHWAY_160
+161,161,161,161,161,161,161,161,R-HSA-8980692,RHOA GTPase cycle,REACTOME,pathway,PATHWAY_161
+162,162,162,162,162,162,162,162,R-HSA-9630750,Evasion of Oncogene Induced Senescence Due to p16INK4A Defects,REACTOME,pathway,PATHWAY_162
+163,163,163,163,163,163,163,163,R-HSA-174577,Activation of C3 and C5,REACTOME,pathway,PATHWAY_163
+164,164,164,164,164,164,164,164,R-HSA-4549356,"Defective DPAGT1 causes CDG-1j, CMSTA2",REACTOME,pathway,PATHWAY_164
+165,165,165,165,165,165,165,165,R-HSA-9825892,Regulation of MITF-M-dependent genes involved in cell cycle and proliferation,REACTOME,pathway,PATHWAY_165
+166,166,166,166,166,166,166,166,R-HSA-9927353,Co-inhibition by BTLA,REACTOME,pathway,PATHWAY_166
+167,167,167,167,167,167,167,167,R-HSA-73863,RNA Polymerase I Transcription Termination,REACTOME,pathway,PATHWAY_167
+168,168,168,168,168,168,168,168,R-HSA-1169092,Activation of RAS in B cells,REACTOME,pathway,PATHWAY_168
+169,169,169,169,169,169,169,169,R-HSA-8849469,PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,REACTOME,pathway,PATHWAY_169
+170,170,170,170,170,170,170,170,R-HSA-9694516,SARS-CoV-2 Infection,REACTOME,pathway,PATHWAY_170
+171,171,171,171,171,171,171,171,R-HSA-8849932,Synaptic adhesion-like molecules,REACTOME,pathway,PATHWAY_171
+172,172,172,172,172,172,172,172,R-HSA-8878171,Transcriptional regulation by RUNX1,REACTOME,pathway,PATHWAY_172
+173,173,173,173,173,173,173,173,R-HSA-3645790,TGFBR2 Kinase Domain Mutants in Cancer,REACTOME,pathway,PATHWAY_173
+174,174,174,174,174,174,174,174,R-HSA-4086400,PCP/CE pathway,REACTOME,pathway,PATHWAY_174
+175,175,175,175,175,175,175,175,R-HSA-3359454,Defective TCN2 causes TCN2 deficiency,REACTOME,pathway,PATHWAY_175
+176,176,176,176,176,176,176,176,R-HSA-68949,Orc1 removal from chromatin,REACTOME,pathway,PATHWAY_176
+177,177,177,177,177,177,177,177,R-HSA-6794361,Neurexins and neuroligins,REACTOME,pathway,PATHWAY_177
+178,178,178,178,178,178,178,178,R-HSA-5655799,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum),REACTOME,pathway,PATHWAY_178
+179,179,179,179,179,179,179,179,R-HSA-5696400,Dual Incision in GG-NER,REACTOME,pathway,PATHWAY_179
+180,180,180,180,180,180,180,180,R-HSA-69478,G2/M DNA replication checkpoint,REACTOME,pathway,PATHWAY_180
+181,181,181,181,181,181,181,181,R-HSA-166663,Initial triggering of complement,REACTOME,pathway,PATHWAY_181
+182,182,182,182,182,182,182,182,R-HSA-1368082,RORA activates gene expression,REACTOME,pathway,PATHWAY_182
+183,183,183,183,183,183,183,183,R-HSA-977225,Amyloid fiber formation,REACTOME,pathway,PATHWAY_183
+184,184,184,184,184,184,184,184,R-HSA-193648,NRAGE signals death through JNK,REACTOME,pathway,PATHWAY_184
+185,185,185,185,185,185,185,185,R-HSA-186712,Regulation of beta-cell development,REACTOME,pathway,PATHWAY_185
+186,186,186,186,186,186,186,186,R-HSA-947581,Molybdenum cofactor biosynthesis,REACTOME,pathway,PATHWAY_186
+187,187,187,187,187,187,187,187,R-HSA-5683177,Defective ABCC8 can cause hypo- and hyper-glycemias,REACTOME,pathway,PATHWAY_187
+188,188,188,188,188,188,188,188,R-HSA-9669917,Imatinib-resistant KIT mutants,REACTOME,pathway,PATHWAY_188
+189,189,189,189,189,189,189,189,R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,REACTOME,pathway,PATHWAY_189
+190,190,190,190,190,190,190,190,R-HSA-8853383,Lysosomal oligosaccharide catabolism,REACTOME,pathway,PATHWAY_190
+191,191,191,191,191,191,191,191,R-HSA-6803157,Antimicrobial peptides,REACTOME,pathway,PATHWAY_191
+192,192,192,192,192,192,192,192,R-HSA-71032,Propionyl-CoA catabolism,REACTOME,pathway,PATHWAY_192
+193,193,193,193,193,193,193,193,R-HSA-163765,ChREBP activates metabolic gene expression,REACTOME,pathway,PATHWAY_193
+194,194,194,194,194,194,194,194,R-HSA-9828721,Translation of respiratory syncytial virus mRNAs,REACTOME,pathway,PATHWAY_194
+195,195,195,195,195,195,195,195,R-HSA-5619047,Defective SLC2A9 causes hypouricemia renal 2 (RHUC2),REACTOME,pathway,PATHWAY_195
+196,196,196,196,196,196,196,196,R-HSA-879518,Transport of organic anions,REACTOME,pathway,PATHWAY_196
+197,197,197,197,197,197,197,197,R-HSA-72187,mRNA 3'-end processing,REACTOME,pathway,PATHWAY_197
+198,198,198,198,198,198,198,198,R-HSA-182971,EGFR downregulation,REACTOME,pathway,PATHWAY_198
+199,199,199,199,199,199,199,199,R-HSA-68881,Mitotic Metaphase/Anaphase Transition,REACTOME,pathway,PATHWAY_199
+200,200,200,200,200,200,200,200,R-HSA-9692912,SARS-CoV-1 targets PDZ proteins in cell-cell junction,REACTOME,pathway,PATHWAY_200
+201,201,201,201,201,201,201,201,R-HSA-6806834,Signaling by MET,REACTOME,pathway,PATHWAY_201
+202,202,202,202,202,202,202,202,R-HSA-5358751,CTNNB1 S45 mutants aren't phosphorylated,REACTOME,pathway,PATHWAY_202
+203,203,203,203,203,203,203,203,R-HSA-9759811,Regulation of CDH11 mRNA translation by microRNAs,REACTOME,pathway,PATHWAY_203
+204,204,204,204,204,204,204,204,R-HSA-6782861,Synthesis of wybutosine at G37 of tRNA(Phe),REACTOME,pathway,PATHWAY_204
+205,205,205,205,205,205,205,205,R-HSA-1368071,NR1D1 (REV-ERBA) represses gene expression,REACTOME,pathway,PATHWAY_205
+206,206,206,206,206,206,206,206,R-HSA-72086,mRNA Capping,REACTOME,pathway,PATHWAY_206
+207,207,207,207,207,207,207,207,R-HSA-176407,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,REACTOME,pathway,PATHWAY_207
+208,208,208,208,208,208,208,208,R-HSA-5654743,Signaling by FGFR4,REACTOME,pathway,PATHWAY_208
+209,209,209,209,209,209,209,209,R-HSA-2206291,MPS IIIC - Sanfilippo syndrome C,REACTOME,pathway,PATHWAY_209
+210,210,210,210,210,210,210,210,R-HSA-5675482,Regulation of necroptotic cell death,REACTOME,pathway,PATHWAY_210
+211,211,211,211,211,211,211,211,R-HSA-2029485,Role of phospholipids in phagocytosis,REACTOME,pathway,PATHWAY_211
+212,212,212,212,212,212,212,212,R-HSA-174490,Membrane binding and targetting of GAG proteins,REACTOME,pathway,PATHWAY_212
+213,213,213,213,213,213,213,213,R-HSA-9709570,Impaired BRCA2 binding to RAD51,REACTOME,pathway,PATHWAY_213
+214,214,214,214,214,214,214,214,R-HSA-73929,"Base-Excision Repair, AP Site Formation",REACTOME,pathway,PATHWAY_214
+215,215,215,215,215,215,215,215,R-HSA-1483226,Synthesis of PI,REACTOME,pathway,PATHWAY_215
+216,216,216,216,216,216,216,216,R-HSA-8963743,Digestion and absorption,REACTOME,pathway,PATHWAY_216
+217,217,217,217,217,217,217,217,R-HSA-9605308,Diseases of Base Excision Repair,REACTOME,pathway,PATHWAY_217
+218,218,218,218,218,218,218,218,R-HSA-9702509,FLT3 mutants bind TKIs,REACTOME,pathway,PATHWAY_218
+219,219,219,219,219,219,219,219,R-HSA-139910,Activation of BMF and translocation to mitochondria,REACTOME,pathway,PATHWAY_219
+220,220,220,220,220,220,220,220,R-HSA-425561,Sodium/Calcium exchangers,REACTOME,pathway,PATHWAY_220
+221,221,221,221,221,221,221,221,R-HSA-9857492,Protein lipoylation,REACTOME,pathway,PATHWAY_221
+222,222,222,222,222,222,222,222,R-HSA-9840310,Glycosphingolipid catabolism,REACTOME,pathway,PATHWAY_222
+223,223,223,223,223,223,223,223,R-HSA-1483115,Hydrolysis of LPC,REACTOME,pathway,PATHWAY_223
+224,224,224,224,224,224,224,224,R-HSA-5693606,DNA Double Strand Break Response,REACTOME,pathway,PATHWAY_224
+225,225,225,225,225,225,225,225,R-HSA-9672396,Defective cofactor function of FVIIIa variant,REACTOME,pathway,PATHWAY_225
+226,226,226,226,226,226,226,226,R-HSA-8866376,Reelin signalling pathway,REACTOME,pathway,PATHWAY_226
+227,227,227,227,227,227,227,227,R-HSA-9026519,Activated NTRK2 signals through RAS,REACTOME,pathway,PATHWAY_227
+228,228,228,228,228,228,228,228,R-HSA-9013406,RHOQ GTPase cycle,REACTOME,pathway,PATHWAY_228
+229,229,229,229,229,229,229,229,R-HSA-351906,Apoptotic cleavage of cell adhesion  proteins,REACTOME,pathway,PATHWAY_229
+230,230,230,230,230,230,230,230,R-HSA-9013507,NOTCH3 Activation and Transmission of Signal to the Nucleus,REACTOME,pathway,PATHWAY_230
+231,231,231,231,231,231,231,231,R-HSA-844455,The NLRP1 inflammasome,REACTOME,pathway,PATHWAY_231
+232,232,232,232,232,232,232,232,R-HSA-9854311,Maturation of TCA enzymes and regulation of TCA cycle,REACTOME,pathway,PATHWAY_232
+233,233,233,233,233,233,233,233,R-HSA-9013973,TICAM1-dependent activation of IRF3/IRF7,REACTOME,pathway,PATHWAY_233
+234,234,234,234,234,234,234,234,R-HSA-9682706,Replication of the SARS-CoV-1 genome,REACTOME,pathway,PATHWAY_234
+235,235,235,235,235,235,235,235,R-HSA-3359473,Defective MMADHC causes MMAHCD,REACTOME,pathway,PATHWAY_235
+236,236,236,236,236,236,236,236,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,REACTOME,pathway,PATHWAY_236
+237,237,237,237,237,237,237,237,R-HSA-8853334,Signaling by FGFR3 fusions in cancer,REACTOME,pathway,PATHWAY_237
+238,238,238,238,238,238,238,238,R-HSA-9665233,Resistance of ERBB2 KD mutants to trastuzumab,REACTOME,pathway,PATHWAY_238
+239,239,239,239,239,239,239,239,R-HSA-2142691,Synthesis of Leukotrienes (LT) and Eoxins (EX),REACTOME,pathway,PATHWAY_239
+240,240,240,240,240,240,240,240,R-HSA-9629232,Defective Base Excision Repair Associated with NEIL3,REACTOME,pathway,PATHWAY_240
+241,241,241,241,241,241,241,241,R-HSA-5083630,Defective LFNG causes SCDO3,REACTOME,pathway,PATHWAY_241
+242,242,242,242,242,242,242,242,R-HSA-936837,Ion transport by P-type ATPases,REACTOME,pathway,PATHWAY_242
+243,243,243,243,243,243,243,243,R-HSA-69239,Synthesis of DNA,REACTOME,pathway,PATHWAY_243
+244,244,244,244,244,244,244,244,R-HSA-5658208,Defective SLC5A2 causes renal glucosuria (GLYS1),REACTOME,pathway,PATHWAY_244
+245,245,245,245,245,245,245,245,R-HSA-446205,Synthesis of GDP-mannose,REACTOME,pathway,PATHWAY_245
+246,246,246,246,246,246,246,246,R-HSA-1500620,Meiosis,REACTOME,pathway,PATHWAY_246
+247,247,247,247,247,247,247,247,R-HSA-391903,Eicosanoid ligand-binding receptors,REACTOME,pathway,PATHWAY_247
+248,248,248,248,248,248,248,248,R-HSA-390651,Dopamine receptors,REACTOME,pathway,PATHWAY_248
+249,249,249,249,249,249,249,249,R-HSA-5223345,Miscellaneous transport and binding events,REACTOME,pathway,PATHWAY_249
+250,250,250,250,250,250,250,250,R-HSA-5619066,Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1),REACTOME,pathway,PATHWAY_250
+251,251,251,251,251,251,251,251,R-HSA-5250982,Toxicity of tetanus toxin (tetX),REACTOME,pathway,PATHWAY_251
+252,252,252,252,252,252,252,252,R-HSA-9918443,Defective visual phototransduction due to OPN1SW loss of function,REACTOME,pathway,PATHWAY_252
+253,253,253,253,253,253,253,253,R-HSA-2129379,Molecules associated with elastic fibres,REACTOME,pathway,PATHWAY_253
+254,254,254,254,254,254,254,254,R-HSA-417973,Adenosine P1 receptors,REACTOME,pathway,PATHWAY_254
+255,255,255,255,255,255,255,255,R-HSA-196071,Metabolism of steroid hormones,REACTOME,pathway,PATHWAY_255
+256,256,256,256,256,256,256,256,R-HSA-9723905,Loss of function of TP53 in cancer due to loss of tetramerization ability,REACTOME,pathway,PATHWAY_256
+257,257,257,257,257,257,257,257,R-HSA-2466712,"Biosynthesis of A2E, implicated in retinal degradation",REACTOME,pathway,PATHWAY_257
+258,258,258,258,258,258,258,258,R-HSA-9754189,Germ layer formation at gastrulation,REACTOME,pathway,PATHWAY_258
+259,259,259,259,259,259,259,259,R-HSA-203641,NOSTRIN mediated eNOS trafficking,REACTOME,pathway,PATHWAY_259
+260,260,260,260,260,260,260,260,R-HSA-5660862,Defective SLC7A7 causes lysinuric protein intolerance (LPI),REACTOME,pathway,PATHWAY_260
+261,261,261,261,261,261,261,261,R-HSA-5602358,Diseases associated with the TLR signaling cascade,REACTOME,pathway,PATHWAY_261
+262,262,262,262,262,262,262,262,R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,REACTOME,pathway,PATHWAY_262
+263,263,263,263,263,263,263,263,R-HSA-5657562,Essential fructosuria,REACTOME,pathway,PATHWAY_263
+264,264,264,264,264,264,264,264,R-HSA-162587,HIV Life Cycle,REACTOME,pathway,PATHWAY_264
+265,265,265,265,265,265,265,265,R-HSA-83936,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,REACTOME,pathway,PATHWAY_265
+266,266,266,266,266,266,266,266,R-HSA-73886,Chromosome Maintenance,REACTOME,pathway,PATHWAY_266
+267,267,267,267,267,267,267,267,R-HSA-1170546,Prolactin receptor signaling,REACTOME,pathway,PATHWAY_267
+268,268,268,268,268,268,268,268,R-HSA-196843,Vitamin B2 (riboflavin) metabolism,REACTOME,pathway,PATHWAY_268
+269,269,269,269,269,269,269,269,R-HSA-211897,Cytochrome P450 - arranged by substrate type,REACTOME,pathway,PATHWAY_269
+270,270,270,270,270,270,270,270,R-HSA-5619048,"Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)",REACTOME,pathway,PATHWAY_270
+271,271,271,271,271,271,271,271,R-HSA-211916,Vitamins,REACTOME,pathway,PATHWAY_271
+272,272,272,272,272,272,272,272,R-HSA-2025928,Calcineurin activates NFAT,REACTOME,pathway,PATHWAY_272
+273,273,273,273,273,273,273,273,R-HSA-2022854,Keratan sulfate biosynthesis,REACTOME,pathway,PATHWAY_273
+274,274,274,274,274,274,274,274,R-HSA-191650,Regulation of gap junction activity,REACTOME,pathway,PATHWAY_274
+275,275,275,275,275,275,275,275,R-HSA-2160916,Hyaluronan uptake and degradation,REACTOME,pathway,PATHWAY_275
+276,276,276,276,276,276,276,276,R-HSA-426496,Post-transcriptional silencing by small RNAs,REACTOME,pathway,PATHWAY_276
+277,277,277,277,277,277,277,277,R-HSA-5578996,Defective CYP27A1 causes CTX,REACTOME,pathway,PATHWAY_277
+278,278,278,278,278,278,278,278,R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,REACTOME,pathway,PATHWAY_278
+279,279,279,279,279,279,279,279,R-HSA-389948,Co-inhibition by PD-1,REACTOME,pathway,PATHWAY_279
+280,280,280,280,280,280,280,280,R-HSA-5659729,Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,REACTOME,pathway,PATHWAY_280
+281,281,281,281,281,281,281,281,R-HSA-1839130,Signaling by activated point mutants of FGFR3,REACTOME,pathway,PATHWAY_281
+282,282,282,282,282,282,282,282,R-HSA-6785470,tRNA processing in the mitochondrion,REACTOME,pathway,PATHWAY_282
+283,283,283,283,283,283,283,283,R-HSA-380320,Recruitment of NuMA to mitotic centrosomes,REACTOME,pathway,PATHWAY_283
+284,284,284,284,284,284,284,284,R-HSA-432047,Passive transport by Aquaporins,REACTOME,pathway,PATHWAY_284
+285,285,285,285,285,285,285,285,R-HSA-9694631,Maturation of nucleoprotein,REACTOME,pathway,PATHWAY_285
+286,286,286,286,286,286,286,286,R-HSA-9673766,Signaling by cytosolic PDGFRA and PDGFRB fusion proteins,REACTOME,pathway,PATHWAY_286
+287,287,287,287,287,287,287,287,R-HSA-5619055,Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI),REACTOME,pathway,PATHWAY_287
+288,288,288,288,288,288,288,288,R-HSA-9734195,Defective APRT disrupts adenine salvage,REACTOME,pathway,PATHWAY_288
+289,289,289,289,289,289,289,289,R-HSA-140180,COX reactions,REACTOME,pathway,PATHWAY_289
+290,290,290,290,290,290,290,290,R-HSA-392154,Nitric oxide stimulates guanylate cyclase,REACTOME,pathway,PATHWAY_290
+291,291,291,291,291,291,291,291,R-HSA-400685,Sema4D in semaphorin signaling,REACTOME,pathway,PATHWAY_291
+292,292,292,292,292,292,292,292,R-HSA-9018676,Biosynthesis of D-series resolvins,REACTOME,pathway,PATHWAY_292
+293,293,293,293,293,293,293,293,R-HSA-2206296,MPS II - Hunter syndrome,REACTOME,pathway,PATHWAY_293
+294,294,294,294,294,294,294,294,R-HSA-5662853,Essential pentosuria,REACTOME,pathway,PATHWAY_294
+295,295,295,295,295,295,295,295,R-HSA-211994,Sterols are 12-hydroxylated by CYP8B1,REACTOME,pathway,PATHWAY_295
+296,296,296,296,296,296,296,296,R-HSA-2046105,Linoleic acid (LA) metabolism,REACTOME,pathway,PATHWAY_296
+297,297,297,297,297,297,297,297,R-HSA-75064,mRNA Editing: A to I Conversion,REACTOME,pathway,PATHWAY_297
+298,298,298,298,298,298,298,298,R-HSA-2214320,Anchoring fibril formation,REACTOME,pathway,PATHWAY_298
+299,299,299,299,299,299,299,299,R-HSA-5619052,Defective SLC9A9 causes autism 16 (AUTS16),REACTOME,pathway,PATHWAY_299
+300,300,300,300,300,300,300,300,R-HSA-9861559,PDH complex synthesizes acetyl-CoA from PYR,REACTOME,pathway,PATHWAY_300
+301,301,301,301,301,301,301,301,R-HSA-428542,Regulation of commissural axon pathfinding by SLIT and ROBO,REACTOME,pathway,PATHWAY_301
+302,302,302,302,302,302,302,302,R-HSA-167826,The fatty acid cycling model,REACTOME,pathway,PATHWAY_302
+303,303,303,303,303,303,303,303,R-HSA-350562,Regulation of ornithine decarboxylase (ODC),REACTOME,pathway,PATHWAY_303
+304,304,304,304,304,304,304,304,R-HSA-9614399,Regulation of localization of FOXO transcription factors,REACTOME,pathway,PATHWAY_304
+305,305,305,305,305,305,305,305,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,REACTOME,pathway,PATHWAY_305
+306,306,306,306,306,306,306,306,R-HSA-9010642,ROBO receptors bind AKAP5,REACTOME,pathway,PATHWAY_306
+307,307,307,307,307,307,307,307,R-HSA-1482883,Acyl chain remodeling of DAG and TAG,REACTOME,pathway,PATHWAY_307
+308,308,308,308,308,308,308,308,R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,REACTOME,pathway,PATHWAY_308
+309,309,309,309,309,309,309,309,R-HSA-2428924,IGF1R signaling cascade,REACTOME,pathway,PATHWAY_309
+310,310,310,310,310,310,310,310,R-HSA-912526,Interleukin receptor SHC signaling,REACTOME,pathway,PATHWAY_310
+311,311,311,311,311,311,311,311,R-HSA-170660,Adenylate cyclase activating pathway,REACTOME,pathway,PATHWAY_311
+312,312,312,312,312,312,312,312,R-HSA-177243,Interactions of Rev with host cellular proteins,REACTOME,pathway,PATHWAY_312
+313,313,313,313,313,313,313,313,R-HSA-156582,Acetylation,REACTOME,pathway,PATHWAY_313
+314,314,314,314,314,314,314,314,R-HSA-8941855,RUNX3 regulates CDKN1A transcription,REACTOME,pathway,PATHWAY_314
+315,315,315,315,315,315,315,315,R-HSA-933541,TRAF6 mediated IRF7 activation,REACTOME,pathway,PATHWAY_315
+316,316,316,316,316,316,316,316,R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,REACTOME,pathway,PATHWAY_316
+317,317,317,317,317,317,317,317,R-HSA-75944,Transcription from mitochondrial promoters,REACTOME,pathway,PATHWAY_317
+318,318,318,318,318,318,318,318,R-HSA-5625900,RHO GTPases activate CIT,REACTOME,pathway,PATHWAY_318
+319,319,319,319,319,319,319,319,R-HSA-163560,Triglyceride catabolism,REACTOME,pathway,PATHWAY_319
+320,320,320,320,320,320,320,320,R-HSA-210455,Astrocytic Glutamate-Glutamine Uptake And Metabolism,REACTOME,pathway,PATHWAY_320
+321,321,321,321,321,321,321,321,R-HSA-8874211,CREB3 factors activate genes,REACTOME,pathway,PATHWAY_321
+322,322,322,322,322,322,322,322,R-HSA-114452,Activation of BH3-only proteins,REACTOME,pathway,PATHWAY_322
+323,323,323,323,323,323,323,323,R-HSA-5339716,Signaling by GSK3beta mutants,REACTOME,pathway,PATHWAY_323
+324,324,324,324,324,324,324,324,R-HSA-3065676,SUMO is conjugated to E1 (UBA2:SAE1),REACTOME,pathway,PATHWAY_324
+325,325,325,325,325,325,325,325,R-HSA-3315487,SMAD2/3 MH2 Domain Mutants in Cancer,REACTOME,pathway,PATHWAY_325
+326,326,326,326,326,326,326,326,R-HSA-9717301,NVP-TAE684-resistant ALK mutants,REACTOME,pathway,PATHWAY_326
+327,327,327,327,327,327,327,327,R-HSA-9614657,FOXO-mediated transcription of cell death genes,REACTOME,pathway,PATHWAY_327
+328,328,328,328,328,328,328,328,R-HSA-5619110,"Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",REACTOME,pathway,PATHWAY_328
+329,329,329,329,329,329,329,329,R-HSA-5688354,Defective pro-SFTPC causes SMDP2 and RDS,REACTOME,pathway,PATHWAY_329
+330,330,330,330,330,330,330,330,R-HSA-1592389,Activation of Matrix Metalloproteinases,REACTOME,pathway,PATHWAY_330
+331,331,331,331,331,331,331,331,R-HSA-8949215,Mitochondrial calcium ion transport,REACTOME,pathway,PATHWAY_331
+332,332,332,332,332,332,332,332,R-HSA-2022923,Dermatan sulfate biosynthesis,REACTOME,pathway,PATHWAY_332
+333,333,333,333,333,333,333,333,R-HSA-3295583,TRP channels,REACTOME,pathway,PATHWAY_333
+334,334,334,334,334,334,334,334,R-HSA-5362768,Hh mutants are degraded by ERAD,REACTOME,pathway,PATHWAY_334
+335,335,335,335,335,335,335,335,R-HSA-9035034,RHOF GTPase cycle,REACTOME,pathway,PATHWAY_335
+336,336,336,336,336,336,336,336,R-HSA-8981607,Intracellular oxygen transport,REACTOME,pathway,PATHWAY_336
+337,337,337,337,337,337,337,337,R-HSA-176187,Activation of ATR in response to replication stress,REACTOME,pathway,PATHWAY_337
+338,338,338,338,338,338,338,338,R-HSA-9856530,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,REACTOME,pathway,PATHWAY_338
+339,339,339,339,339,339,339,339,R-HSA-164938,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,REACTOME,pathway,PATHWAY_339
+340,340,340,340,340,340,340,340,R-HSA-9652169,Signaling by MAP2K mutants,REACTOME,pathway,PATHWAY_340
+341,341,341,341,341,341,341,341,R-HSA-196791,Vitamin D (calciferol) metabolism,REACTOME,pathway,PATHWAY_341
+342,342,342,342,342,342,342,342,R-HSA-3928665,EPH-ephrin mediated repulsion of cells,REACTOME,pathway,PATHWAY_342
+343,343,343,343,343,343,343,343,R-HSA-1306955,GRB7 events in ERBB2 signaling,REACTOME,pathway,PATHWAY_343
+344,344,344,344,344,344,344,344,R-HSA-9675143,Diseases of the neuronal system,REACTOME,pathway,PATHWAY_344
+345,345,345,345,345,345,345,345,R-HSA-983695,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,REACTOME,pathway,PATHWAY_345
+346,346,346,346,346,346,346,346,R-HSA-380259,Loss of Nlp from mitotic centrosomes,REACTOME,pathway,PATHWAY_346
+347,347,347,347,347,347,347,347,R-HSA-380284,Loss of proteins required for interphase microtubule organization from the centrosome,REACTOME,pathway,PATHWAY_347
+348,348,348,348,348,348,348,348,R-HSA-177929,Signaling by EGFR,REACTOME,pathway,PATHWAY_348
+349,349,349,349,349,349,349,349,R-HSA-5679090,Defective ABCG8 causes GBD4 and sitosterolemia,REACTOME,pathway,PATHWAY_349
+350,350,350,350,350,350,350,350,R-HSA-9031628,NGF-stimulated transcription,REACTOME,pathway,PATHWAY_350
+351,351,351,351,351,351,351,351,R-HSA-9918450,Defective visual phototransduction due to OPN1LW loss of function,REACTOME,pathway,PATHWAY_351
+352,352,352,352,352,352,352,352,R-HSA-427601,Multifunctional anion exchangers,REACTOME,pathway,PATHWAY_352
+353,353,353,353,353,353,353,353,R-HSA-111463,SMAC (DIABLO) binds to IAPs ,REACTOME,pathway,PATHWAY_353
+354,354,354,354,354,354,354,354,R-HSA-211957,Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,REACTOME,pathway,PATHWAY_354
+355,355,355,355,355,355,355,355,R-HSA-3359469,Defective MTR causes HMAG,REACTOME,pathway,PATHWAY_355
+356,356,356,356,356,356,356,356,R-HSA-9860276,SLC15A4:TASL-dependent IRF5 activation,REACTOME,pathway,PATHWAY_356
+357,357,357,357,357,357,357,357,R-HSA-389397,Orexin and neuropeptides FF and QRFP bind to their respective receptors,REACTOME,pathway,PATHWAY_357
+358,358,358,358,358,358,358,358,R-HSA-1059683,Interleukin-6 signaling,REACTOME,pathway,PATHWAY_358
+359,359,359,359,359,359,359,359,R-HSA-73772,RNA Polymerase I Promoter Escape,REACTOME,pathway,PATHWAY_359
+360,360,360,360,360,360,360,360,R-HSA-500792,GPCR ligand binding,REACTOME,pathway,PATHWAY_360
+361,361,361,361,361,361,361,361,R-HSA-525793,Myogenesis,REACTOME,pathway,PATHWAY_361
+362,362,362,362,362,362,362,362,R-HSA-167169,HIV Transcription Elongation,REACTOME,pathway,PATHWAY_362
+363,363,363,363,363,363,363,363,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,REACTOME,pathway,PATHWAY_363
+364,364,364,364,364,364,364,364,R-HSA-9013405,RHOD GTPase cycle,REACTOME,pathway,PATHWAY_364
+365,365,365,365,365,365,365,365,R-HSA-927802,Nonsense-Mediated Decay (NMD),REACTOME,pathway,PATHWAY_365
+366,366,366,366,366,366,366,366,R-HSA-5633007,Regulation of TP53 Activity,REACTOME,pathway,PATHWAY_366
+367,367,367,367,367,367,367,367,R-HSA-9018683,Biosynthesis of DPA-derived SPMs,REACTOME,pathway,PATHWAY_367
+368,368,368,368,368,368,368,368,R-HSA-1296052,Ca2+ activated K+ channels,REACTOME,pathway,PATHWAY_368
+369,369,369,369,369,369,369,369,R-HSA-2473224,Antagonism of Activin by Follistatin,REACTOME,pathway,PATHWAY_369
+370,370,370,370,370,370,370,370,R-HSA-9639288,Amino acids regulate mTORC1,REACTOME,pathway,PATHWAY_370
+371,371,371,371,371,371,371,371,R-HSA-416476,G alpha (q) signalling events,REACTOME,pathway,PATHWAY_371
+372,372,372,372,372,372,372,372,R-HSA-201688,WNT mediated activation of DVL,REACTOME,pathway,PATHWAY_372
+373,373,373,373,373,373,373,373,R-HSA-1226099,Signaling by FGFR in disease,REACTOME,pathway,PATHWAY_373
+374,374,374,374,374,374,374,374,R-HSA-189085,Digestion of dietary carbohydrate,REACTOME,pathway,PATHWAY_374
+375,375,375,375,375,375,375,375,R-HSA-9839397,TGFBR3 regulates FGF2 signaling,REACTOME,pathway,PATHWAY_375
+376,376,376,376,376,376,376,376,R-HSA-1489509,DAG and IP3 signaling,REACTOME,pathway,PATHWAY_376
+377,377,377,377,377,377,377,377,R-HSA-5688890,Defective CSF2RA causes SMDP4,REACTOME,pathway,PATHWAY_377
+378,378,378,378,378,378,378,378,R-HSA-9757110,Prednisone ADME,REACTOME,pathway,PATHWAY_378
+379,379,379,379,379,379,379,379,R-HSA-1614558,Degradation of cysteine and homocysteine,REACTOME,pathway,PATHWAY_379
+380,380,380,380,380,380,380,380,R-HSA-400206,Regulation of lipid metabolism by PPARalpha,REACTOME,pathway,PATHWAY_380
+381,381,381,381,381,381,381,381,R-HSA-1855191,Synthesis of IPs in the nucleus,REACTOME,pathway,PATHWAY_381
+382,382,382,382,382,382,382,382,R-HSA-6783589,Interleukin-6 family signaling,REACTOME,pathway,PATHWAY_382
+383,383,383,383,383,383,383,383,R-HSA-3247509,Chromatin modifying enzymes,REACTOME,pathway,PATHWAY_383
+384,384,384,384,384,384,384,384,R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,REACTOME,pathway,PATHWAY_384
+385,385,385,385,385,385,385,385,R-HSA-209560,NF-kB is activated and signals survival,REACTOME,pathway,PATHWAY_385
+386,386,386,386,386,386,386,386,R-HSA-4724289,Defective ALG6 causes CDG-1c,REACTOME,pathway,PATHWAY_386
+387,387,387,387,387,387,387,387,R-HSA-264642,Acetylcholine Neurotransmitter Release Cycle,REACTOME,pathway,PATHWAY_387
+388,388,388,388,388,388,388,388,R-HSA-1221632,Meiotic synapsis,REACTOME,pathway,PATHWAY_388
+389,389,389,389,389,389,389,389,R-HSA-8985801,Regulation of cortical dendrite branching,REACTOME,pathway,PATHWAY_389
+390,390,390,390,390,390,390,390,R-HSA-5655332,Signaling by FGFR3 in disease,REACTOME,pathway,PATHWAY_390
+391,391,391,391,391,391,391,391,R-HSA-1362300,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,REACTOME,pathway,PATHWAY_391
+392,392,392,392,392,392,392,392,R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,REACTOME,pathway,PATHWAY_392
+393,393,393,393,393,393,393,393,R-HSA-4719360,Defective DPM3 causes DPM3-CDG,REACTOME,pathway,PATHWAY_393
+394,394,394,394,394,394,394,394,R-HSA-1295596,Spry regulation of FGF signaling,REACTOME,pathway,PATHWAY_394
+395,395,395,395,395,395,395,395,R-HSA-9694719,Maturation of protein 3a,REACTOME,pathway,PATHWAY_395
+396,396,396,396,396,396,396,396,R-HSA-9851151,MDK and PTN in ALK signaling,REACTOME,pathway,PATHWAY_396
+397,397,397,397,397,397,397,397,R-HSA-159230,Transport of the SLBP Dependant Mature mRNA,REACTOME,pathway,PATHWAY_397
+398,398,398,398,398,398,398,398,R-HSA-5579019,Defective FMO3 causes TMAU,REACTOME,pathway,PATHWAY_398
+399,399,399,399,399,399,399,399,R-HSA-168256,Immune System,REACTOME,pathway,PATHWAY_399
+400,400,400,400,400,400,400,400,R-HSA-177128,Conjugation of salicylate with glycine,REACTOME,pathway,PATHWAY_400
+401,401,401,401,401,401,401,401,R-HSA-9675126,Diseases of mitotic cell cycle,REACTOME,pathway,PATHWAY_401
+402,402,402,402,402,402,402,402,R-HSA-426486,Small interfering RNA (siRNA) biogenesis,REACTOME,pathway,PATHWAY_402
+403,403,403,403,403,403,403,403,R-HSA-194313,VEGF ligand-receptor interactions,REACTOME,pathway,PATHWAY_403
+404,404,404,404,404,404,404,404,R-HSA-5610780,Degradation of GLI1 by the proteasome,REACTOME,pathway,PATHWAY_404
+405,405,405,405,405,405,405,405,R-HSA-9604323,Negative regulation of NOTCH4 signaling,REACTOME,pathway,PATHWAY_405
+406,406,406,406,406,406,406,406,R-HSA-9008059,Interleukin-37 signaling,REACTOME,pathway,PATHWAY_406
+407,407,407,407,407,407,407,407,R-HSA-9793242,SUMOylation of nuclear envelope proteins,REACTOME,pathway,PATHWAY_407
+408,408,408,408,408,408,408,408,R-HSA-69560,Transcriptional activation of p53 responsive genes  ,REACTOME,pathway,PATHWAY_408
+409,409,409,409,409,409,409,409,R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),REACTOME,pathway,PATHWAY_409
+410,410,410,410,410,410,410,410,R-HSA-429958,mRNA decay by 3' to 5' exoribonuclease,REACTOME,pathway,PATHWAY_410
+411,411,411,411,411,411,411,411,R-HSA-430039,mRNA decay by 5' to 3' exoribonuclease,REACTOME,pathway,PATHWAY_411
+412,412,412,412,412,412,412,412,R-HSA-5660526,Response to metal ions,REACTOME,pathway,PATHWAY_412
+413,413,413,413,413,413,413,413,R-HSA-113510,E2F mediated regulation of DNA replication,REACTOME,pathway,PATHWAY_413
+414,414,414,414,414,414,414,414,R-HSA-77352,Beta oxidation of butanoyl-CoA to acetyl-CoA,REACTOME,pathway,PATHWAY_414
+415,415,415,415,415,415,415,415,R-HSA-9820865,Z-decay: degradation of maternal mRNAs by zygotically expressed factors,REACTOME,pathway,PATHWAY_415
+416,416,416,416,416,416,416,416,R-HSA-418889,Caspase activation via Dependence Receptors in the absence of ligand,REACTOME,pathway,PATHWAY_416
+417,417,417,417,417,417,417,417,R-HSA-381070,IRE1alpha activates chaperones,REACTOME,pathway,PATHWAY_417
+418,418,418,418,418,418,418,418,R-HSA-421270,Cell-cell junction organization,REACTOME,pathway,PATHWAY_418
+419,419,419,419,419,419,419,419,R-HSA-9022927,MECP2 regulates transcription of genes involved in GABA signaling,REACTOME,pathway,PATHWAY_419
+420,420,420,420,420,420,420,420,R-HSA-9909505,Modulation of host responses by IFN-stimulated genes,REACTOME,pathway,PATHWAY_420
+421,421,421,421,421,421,421,421,R-HSA-432720,Lysosome Vesicle Biogenesis,REACTOME,pathway,PATHWAY_421
+422,422,422,422,422,422,422,422,R-HSA-8935964,RUNX1 regulates expression of components of tight junctions,REACTOME,pathway,PATHWAY_422
+423,423,423,423,423,423,423,423,R-HSA-8951430,RUNX3 regulates WNT signaling,REACTOME,pathway,PATHWAY_423
+424,424,424,424,424,424,424,424,R-HSA-1266738,Developmental Biology,REACTOME,pathway,PATHWAY_424
+425,425,425,425,425,425,425,425,R-HSA-389661,Glyoxylate metabolism and glycine degradation,REACTOME,pathway,PATHWAY_425
+426,426,426,426,426,426,426,426,R-HSA-170670,Adenylate cyclase inhibitory pathway,REACTOME,pathway,PATHWAY_426
+427,427,427,427,427,427,427,427,R-HSA-166658,Complement cascade,REACTOME,pathway,PATHWAY_427
+428,428,428,428,428,428,428,428,R-HSA-1483248,Synthesis of PIPs at the ER membrane,REACTOME,pathway,PATHWAY_428
+429,429,429,429,429,429,429,429,R-HSA-8931987,RUNX1 regulates estrogen receptor mediated transcription,REACTOME,pathway,PATHWAY_429
+430,430,430,430,430,430,430,430,R-HSA-5619044,Defective SLC6A19 causes Hartnup disorder (HND),REACTOME,pathway,PATHWAY_430
+431,431,431,431,431,431,431,431,R-HSA-187042,TRKA activation by NGF,REACTOME,pathway,PATHWAY_431
+432,432,432,432,432,432,432,432,R-HSA-422475,Axon guidance,REACTOME,pathway,PATHWAY_432
+433,433,433,433,433,433,433,433,R-HSA-392451,G beta:gamma signalling through PI3Kgamma,REACTOME,pathway,PATHWAY_433
+434,434,434,434,434,434,434,434,R-HSA-196807,Nicotinate metabolism,REACTOME,pathway,PATHWAY_434
+435,435,435,435,435,435,435,435,R-HSA-380270,Recruitment of mitotic centrosome proteins and complexes,REACTOME,pathway,PATHWAY_435
+436,436,436,436,436,436,436,436,R-HSA-4420332,Defective B3GALT6 causes EDSP2 and SEMDJL1,REACTOME,pathway,PATHWAY_436
+437,437,437,437,437,437,437,437,R-HSA-9664433,Leishmania parasite growth and survival,REACTOME,pathway,PATHWAY_437
+438,438,438,438,438,438,438,438,R-HSA-163841,"Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation",REACTOME,pathway,PATHWAY_438
+439,439,439,439,439,439,439,439,R-HSA-1257604,PIP3 activates AKT signaling,REACTOME,pathway,PATHWAY_439
+440,440,440,440,440,440,440,440,R-HSA-5579021,Defective CYP21A2 causes AH3,REACTOME,pathway,PATHWAY_440
+441,441,441,441,441,441,441,441,R-HSA-5250968,Toxicity of botulinum toxin type A (botA),REACTOME,pathway,PATHWAY_441
+442,442,442,442,442,442,442,442,R-HSA-1483076,Synthesis of CL,REACTOME,pathway,PATHWAY_442
+443,443,443,443,443,443,443,443,R-HSA-194441,Metabolism of non-coding RNA,REACTOME,pathway,PATHWAY_443
+444,444,444,444,444,444,444,444,R-HSA-8878166,Transcriptional regulation by RUNX2,REACTOME,pathway,PATHWAY_444
+445,445,445,445,445,445,445,445,R-HSA-5210891,Uptake and function of anthrax toxins,REACTOME,pathway,PATHWAY_445
+446,446,446,446,446,446,446,446,R-HSA-9759774,Diseases of mitochondrial beta oxidation,REACTOME,pathway,PATHWAY_446
+447,447,447,447,447,447,447,447,R-HSA-9692913,SARS-CoV-1-mediated effects on programmed cell death,REACTOME,pathway,PATHWAY_447
+448,448,448,448,448,448,448,448,R-HSA-1500931,Cell-Cell communication,REACTOME,pathway,PATHWAY_448
+449,449,449,449,449,449,449,449,R-HSA-9694301,Maturation of replicase proteins,REACTOME,pathway,PATHWAY_449
+450,450,450,450,450,450,450,450,R-HSA-9820841,M-decay: degradation of maternal mRNAs by maternally stored factors,REACTOME,pathway,PATHWAY_450
+451,451,451,451,451,451,451,451,R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,REACTOME,pathway,PATHWAY_451
+452,452,452,452,452,452,452,452,R-HSA-202430,Translocation of ZAP-70 to Immunological synapse,REACTOME,pathway,PATHWAY_452
+453,453,453,453,453,453,453,453,R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,REACTOME,pathway,PATHWAY_453
+454,454,454,454,454,454,454,454,R-HSA-140179,Amine Oxidase reactions,REACTOME,pathway,PATHWAY_454
+455,455,455,455,455,455,455,455,R-HSA-113418,Formation of the Early Elongation Complex,REACTOME,pathway,PATHWAY_455
+456,456,456,456,456,456,456,456,R-HSA-199418,Negative regulation of the PI3K/AKT network,REACTOME,pathway,PATHWAY_456
+457,457,457,457,457,457,457,457,R-HSA-9865118,Diseases of branched-chain amino acid catabolism,REACTOME,pathway,PATHWAY_457
+458,458,458,458,458,458,458,458,R-HSA-75158,TRAIL  signaling,REACTOME,pathway,PATHWAY_458
+459,459,459,459,459,459,459,459,R-HSA-5659735,Defective SLC6A19 causes Hartnup disorder (HND),REACTOME,pathway,PATHWAY_459
+460,460,460,460,460,460,460,460,R-HSA-9636569,Suppression of autophagy,REACTOME,pathway,PATHWAY_460
+461,461,461,461,461,461,461,461,R-HSA-427413,NoRC negatively regulates rRNA expression,REACTOME,pathway,PATHWAY_461
+462,462,462,462,462,462,462,462,R-HSA-159782,Removal of aminoterminal propeptides from gamma-carboxylated proteins,REACTOME,pathway,PATHWAY_462
+463,463,463,463,463,463,463,463,R-HSA-162585,Uncoating of the HIV Virion,REACTOME,pathway,PATHWAY_463
+464,464,464,464,464,464,464,464,R-HSA-5654693,FRS-mediated FGFR1 signaling,REACTOME,pathway,PATHWAY_464
+465,465,465,465,465,465,465,465,R-HSA-195721,Signaling by WNT,REACTOME,pathway,PATHWAY_465
+466,466,466,466,466,466,466,466,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,REACTOME,pathway,PATHWAY_466
+467,467,467,467,467,467,467,467,R-HSA-5684996,MAPK1/MAPK3 signaling,REACTOME,pathway,PATHWAY_467
+468,468,468,468,468,468,468,468,R-HSA-8984722,Interleukin-35 Signalling,REACTOME,pathway,PATHWAY_468
+469,469,469,469,469,469,469,469,R-HSA-417957,P2Y receptors,REACTOME,pathway,PATHWAY_469
+470,470,470,470,470,470,470,470,R-HSA-5619099,"Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)",REACTOME,pathway,PATHWAY_470
+471,471,471,471,471,471,471,471,R-HSA-209776,Metabolism of amine-derived hormones,REACTOME,pathway,PATHWAY_471
+472,472,472,472,472,472,472,472,R-HSA-373760,L1CAM interactions,REACTOME,pathway,PATHWAY_472
+473,473,473,473,473,473,473,473,R-HSA-429593,Inositol transporters,REACTOME,pathway,PATHWAY_473
+474,474,474,474,474,474,474,474,R-HSA-70688,Proline catabolism,REACTOME,pathway,PATHWAY_474
+475,475,475,475,475,475,475,475,R-HSA-9702614,ponatinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_475
+476,476,476,476,476,476,476,476,R-HSA-5683678,Defective ABCA3 causes SMDP3,REACTOME,pathway,PATHWAY_476
+477,477,477,477,477,477,477,477,R-HSA-73762,RNA Polymerase I Transcription Initiation,REACTOME,pathway,PATHWAY_477
+478,478,478,478,478,478,478,478,R-HSA-9918440,Defective visual phototransduction due to RDH12 loss of function,REACTOME,pathway,PATHWAY_478
+479,479,479,479,479,479,479,479,R-HSA-9853506,OGDH complex synthesizes succinyl-CoA from 2-OG,REACTOME,pathway,PATHWAY_479
+480,480,480,480,480,480,480,480,R-HSA-75109,Triglyceride biosynthesis,REACTOME,pathway,PATHWAY_480
+481,481,481,481,481,481,481,481,R-HSA-5576891,Cardiac conduction,REACTOME,pathway,PATHWAY_481
+482,482,482,482,482,482,482,482,R-HSA-5620971,Pyroptosis,REACTOME,pathway,PATHWAY_482
+483,483,483,483,483,483,483,483,R-HSA-140834,Extrinsic Pathway of Fibrin Clot Formation,REACTOME,pathway,PATHWAY_483
+484,484,484,484,484,484,484,484,R-HSA-6804759,Regulation of TP53 Activity through Association with Co-factors,REACTOME,pathway,PATHWAY_484
+485,485,485,485,485,485,485,485,R-HSA-1482925,Acyl chain remodelling of PG,REACTOME,pathway,PATHWAY_485
+486,486,486,486,486,486,486,486,R-HSA-5679001,Defective ABCC2 causes DJS,REACTOME,pathway,PATHWAY_486
+487,487,487,487,487,487,487,487,R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),REACTOME,pathway,PATHWAY_487
+488,488,488,488,488,488,488,488,R-HSA-3000484,Scavenging by Class F Receptors,REACTOME,pathway,PATHWAY_488
+489,489,489,489,489,489,489,489,R-HSA-165054,Rev-mediated nuclear export of HIV RNA,REACTOME,pathway,PATHWAY_489
+490,490,490,490,490,490,490,490,R-HSA-3000480,Scavenging by Class A Receptors,REACTOME,pathway,PATHWAY_490
+491,491,491,491,491,491,491,491,R-HSA-9824439,Bacterial Infection Pathways,REACTOME,pathway,PATHWAY_491
+492,492,492,492,492,492,492,492,R-HSA-450341,Activation of the AP-1 family of transcription factors,REACTOME,pathway,PATHWAY_492
+493,493,493,493,493,493,493,493,R-HSA-379398,Enzymatic degradation of Dopamine by monoamine oxidase,REACTOME,pathway,PATHWAY_493
+494,494,494,494,494,494,494,494,R-HSA-9701898,STAT3 nuclear events downstream of ALK signaling,REACTOME,pathway,PATHWAY_494
+495,495,495,495,495,495,495,495,R-HSA-72731,Recycling of eIF2:GDP,REACTOME,pathway,PATHWAY_495
+496,496,496,496,496,496,496,496,R-HSA-447043,Neurofascin interactions,REACTOME,pathway,PATHWAY_496
+497,497,497,497,497,497,497,497,R-HSA-70268,Pyruvate metabolism,REACTOME,pathway,PATHWAY_497
+498,498,498,498,498,498,498,498,R-HSA-162582,Signal Transduction,REACTOME,pathway,PATHWAY_498
+499,499,499,499,499,499,499,499,R-HSA-5423646,Aflatoxin activation and detoxification,REACTOME,pathway,PATHWAY_499
+500,500,500,500,500,500,500,500,R-HSA-157579,Telomere Maintenance,REACTOME,pathway,PATHWAY_500
+501,501,501,501,501,501,501,501,R-HSA-201556,Signaling by ALK,REACTOME,pathway,PATHWAY_501
+502,502,502,502,502,502,502,502,R-HSA-9820962,Assembly and release of respiratory syncytial virus (RSV) virions,REACTOME,pathway,PATHWAY_502
+503,503,503,503,503,503,503,503,R-HSA-9729555,Sensory perception of sour taste,REACTOME,pathway,PATHWAY_503
+504,504,504,504,504,504,504,504,R-HSA-444411,Rhesus glycoproteins mediate ammonium transport,REACTOME,pathway,PATHWAY_504
+505,505,505,505,505,505,505,505,R-HSA-5576893,Phase 2 - plateau phase,REACTOME,pathway,PATHWAY_505
+506,506,506,506,506,506,506,506,R-HSA-9702624,sorafenib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_506
+507,507,507,507,507,507,507,507,R-HSA-192456,Digestion of dietary lipid,REACTOME,pathway,PATHWAY_507
+508,508,508,508,508,508,508,508,R-HSA-169911,Regulation of Apoptosis,REACTOME,pathway,PATHWAY_508
+509,509,509,509,509,509,509,509,R-HSA-77111,Synthesis of Ketone Bodies,REACTOME,pathway,PATHWAY_509
+510,510,510,510,510,510,510,510,R-HSA-168315,Inhibition of Host mRNA Processing and RNA Silencing,REACTOME,pathway,PATHWAY_510
+511,511,511,511,511,511,511,511,R-HSA-352238,Breakdown of the nuclear lamina,REACTOME,pathway,PATHWAY_511
+512,512,512,512,512,512,512,512,R-HSA-168305,Inhibition of Interferon Synthesis,REACTOME,pathway,PATHWAY_512
+513,513,513,513,513,513,513,513,R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,REACTOME,pathway,PATHWAY_513
+514,514,514,514,514,514,514,514,R-HSA-2142845,Hyaluronan metabolism,REACTOME,pathway,PATHWAY_514
+515,515,515,515,515,515,515,515,R-HSA-2187338,Visual phototransduction,REACTOME,pathway,PATHWAY_515
+516,516,516,516,516,516,516,516,R-HSA-9845622,Defective VWF binding to collagen type I ,REACTOME,pathway,PATHWAY_516
+517,517,517,517,517,517,517,517,R-HSA-2206282,MPS IIIB - Sanfilippo syndrome B,REACTOME,pathway,PATHWAY_517
+518,518,518,518,518,518,518,518,R-HSA-204626,Hypusine synthesis from eIF5A-lysine,REACTOME,pathway,PATHWAY_518
+519,519,519,519,519,519,519,519,R-HSA-5621480,Dectin-2 family,REACTOME,pathway,PATHWAY_519
+520,520,520,520,520,520,520,520,R-HSA-9670615,Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations,REACTOME,pathway,PATHWAY_520
+521,521,521,521,521,521,521,521,R-HSA-9022534,Loss of MECP2 binding ability to 5hmC-DNA,REACTOME,pathway,PATHWAY_521
+522,522,522,522,522,522,522,522,R-HSA-9675108,Nervous system development,REACTOME,pathway,PATHWAY_522
+523,523,523,523,523,523,523,523,R-HSA-8851805,MET activates RAS signaling,REACTOME,pathway,PATHWAY_523
+524,524,524,524,524,524,524,524,R-HSA-8875878,MET promotes cell motility,REACTOME,pathway,PATHWAY_524
+525,525,525,525,525,525,525,525,R-HSA-9009391,Extra-nuclear estrogen signaling,REACTOME,pathway,PATHWAY_525
+526,526,526,526,526,526,526,526,R-HSA-8866907,Activation of the TFAP2 (AP-2) family of transcription factors,REACTOME,pathway,PATHWAY_526
+527,527,527,527,527,527,527,527,R-HSA-2132295,MHC class II antigen presentation,REACTOME,pathway,PATHWAY_527
+528,528,528,528,528,528,528,528,R-HSA-5423599,Diseases of Mismatch Repair (MMR),REACTOME,pathway,PATHWAY_528
+529,529,529,529,529,529,529,529,R-HSA-5693616,Presynaptic phase of homologous DNA pairing and strand exchange,REACTOME,pathway,PATHWAY_529
+530,530,530,530,530,530,530,530,R-HSA-5601884,PIWI-interacting RNA (piRNA) biogenesis,REACTOME,pathway,PATHWAY_530
+531,531,531,531,531,531,531,531,R-HSA-3322077,Glycogen synthesis,REACTOME,pathway,PATHWAY_531
+532,532,532,532,532,532,532,532,R-HSA-174437,Removal of the Flap Intermediate from the C-strand,REACTOME,pathway,PATHWAY_532
+533,533,533,533,533,533,533,533,R-HSA-2644605,FBXW7 Mutants and NOTCH1 in Cancer,REACTOME,pathway,PATHWAY_533
+534,534,534,534,534,534,534,534,R-HSA-5619098,Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS),REACTOME,pathway,PATHWAY_534
+535,535,535,535,535,535,535,535,R-HSA-9851695,Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes,REACTOME,pathway,PATHWAY_535
+536,536,536,536,536,536,536,536,R-HSA-3000497,Scavenging by Class H Receptors,REACTOME,pathway,PATHWAY_536
+537,537,537,537,537,537,537,537,R-HSA-446388,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,REACTOME,pathway,PATHWAY_537
+538,538,538,538,538,538,538,538,R-HSA-8951664,Neddylation,REACTOME,pathway,PATHWAY_538
+539,539,539,539,539,539,539,539,R-HSA-419771,Opsins,REACTOME,pathway,PATHWAY_539
+540,540,540,540,540,540,540,540,R-HSA-2562578,TRIF-mediated programmed cell death,REACTOME,pathway,PATHWAY_540
+541,541,541,541,541,541,541,541,R-HSA-4641265,Repression of WNT target genes,REACTOME,pathway,PATHWAY_541
+542,542,542,542,542,542,542,542,R-HSA-9034793,Activated NTRK3 signals through PLCG1,REACTOME,pathway,PATHWAY_542
+543,543,543,543,543,543,543,543,R-HSA-8934903,Receptor Mediated Mitophagy,REACTOME,pathway,PATHWAY_543
+544,544,544,544,544,544,544,544,R-HSA-9761174,Formation of intermediate mesoderm,REACTOME,pathway,PATHWAY_544
+545,545,545,545,545,545,545,545,R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,REACTOME,pathway,PATHWAY_545
+546,546,546,546,546,546,546,546,R-HSA-1592230,Mitochondrial biogenesis,REACTOME,pathway,PATHWAY_546
+547,547,547,547,547,547,547,547,R-HSA-1299287,Tandem pore domain halothane-inhibited K+ channel (THIK),REACTOME,pathway,PATHWAY_547
+548,548,548,548,548,548,548,548,R-HSA-5619071,Defective SLC22A12 causes renal hypouricemia 1 (RHUC1),REACTOME,pathway,PATHWAY_548
+549,549,549,549,549,549,549,549,R-HSA-9616222,Transcriptional regulation of granulopoiesis,REACTOME,pathway,PATHWAY_549
+550,550,550,550,550,550,550,550,R-HSA-390696,Adrenoceptors,REACTOME,pathway,PATHWAY_550
+551,551,551,551,551,551,551,551,R-HSA-5579005,Defective CYP4F22 causes ARCI5,REACTOME,pathway,PATHWAY_551
+552,552,552,552,552,552,552,552,R-HSA-8875656,MET receptor recycling,REACTOME,pathway,PATHWAY_552
+553,553,553,553,553,553,553,553,R-HSA-8874177,ATF6B (ATF6-beta) activates chaperones,REACTOME,pathway,PATHWAY_553
+554,554,554,554,554,554,554,554,R-HSA-629594,Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,REACTOME,pathway,PATHWAY_554
+555,555,555,555,555,555,555,555,R-HSA-9864848,Complex IV assembly,REACTOME,pathway,PATHWAY_555
+556,556,556,556,556,556,556,556,R-HSA-9616333,Defective Base Excision Repair Associated with NTHL1,REACTOME,pathway,PATHWAY_556
+557,557,557,557,557,557,557,557,R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,REACTOME,pathway,PATHWAY_557
+558,558,558,558,558,558,558,558,R-HSA-445717,Aquaporin-mediated transport,REACTOME,pathway,PATHWAY_558
+559,559,559,559,559,559,559,559,R-HSA-5637810,Constitutive Signaling by EGFRvIII,REACTOME,pathway,PATHWAY_559
+560,560,560,560,560,560,560,560,R-HSA-168249,Innate Immune System,REACTOME,pathway,PATHWAY_560
+561,561,561,561,561,561,561,561,R-HSA-2197563,NOTCH2 intracellular domain regulates transcription,REACTOME,pathway,PATHWAY_561
+562,562,562,562,562,562,562,562,R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,REACTOME,pathway,PATHWAY_562
+563,563,563,563,563,563,563,563,R-HSA-3214858,RMTs methylate histone arginines,REACTOME,pathway,PATHWAY_563
+564,564,564,564,564,564,564,564,R-HSA-9830674,Formation of the ureteric bud,REACTOME,pathway,PATHWAY_564
+565,565,565,565,565,565,565,565,R-HSA-1187000,Fertilization,REACTOME,pathway,PATHWAY_565
+566,566,566,566,566,566,566,566,R-HSA-156587,Amino Acid conjugation,REACTOME,pathway,PATHWAY_566
+567,567,567,567,567,567,567,567,R-HSA-1660537,PIPs transport between early endosome and Golgi membranes,REACTOME,pathway,PATHWAY_567
+568,568,568,568,568,568,568,568,R-HSA-9659379,Sensory processing of sound,REACTOME,pathway,PATHWAY_568
+569,569,569,569,569,569,569,569,R-HSA-8854518,AURKA Activation by TPX2,REACTOME,pathway,PATHWAY_569
+570,570,570,570,570,570,570,570,R-HSA-9734735,Defective ADA disrupts (deoxy)adenosine deamination,REACTOME,pathway,PATHWAY_570
+571,571,571,571,571,571,571,571,R-HSA-168270,Fusion and Uncoating of the Influenza Virion,REACTOME,pathway,PATHWAY_571
+572,572,572,572,572,572,572,572,R-HSA-1483171,Synthesis of BMP,REACTOME,pathway,PATHWAY_572
+573,573,573,573,573,573,573,573,R-HSA-163767,PP2A-mediated dephosphorylation of key metabolic factors,REACTOME,pathway,PATHWAY_573
+574,574,574,574,574,574,574,574,R-HSA-70635,Urea cycle,REACTOME,pathway,PATHWAY_574
+575,575,575,575,575,575,575,575,R-HSA-1362409,Mitochondrial iron-sulfur cluster biogenesis,REACTOME,pathway,PATHWAY_575
+576,576,576,576,576,576,576,576,R-HSA-376176,Signaling by ROBO receptors,REACTOME,pathway,PATHWAY_576
+577,577,577,577,577,577,577,577,R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,REACTOME,pathway,PATHWAY_577
+578,578,578,578,578,578,578,578,R-HSA-9702620,quizartinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_578
+579,579,579,579,579,579,579,579,R-HSA-1483101,Synthesis of PS,REACTOME,pathway,PATHWAY_579
+580,580,580,580,580,580,580,580,R-HSA-9609507,Protein localization,REACTOME,pathway,PATHWAY_580
+581,581,581,581,581,581,581,581,R-HSA-170822,Regulation of Glucokinase by Glucokinase Regulatory Protein,REACTOME,pathway,PATHWAY_581
+582,582,582,582,582,582,582,582,R-HSA-8940973,RUNX2 regulates osteoblast differentiation,REACTOME,pathway,PATHWAY_582
+583,583,583,583,583,583,583,583,R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",REACTOME,pathway,PATHWAY_583
+584,584,584,584,584,584,584,584,R-HSA-9836573,Mitochondrial RNA degradation,REACTOME,pathway,PATHWAY_584
+585,585,585,585,585,585,585,585,R-HSA-9636003,NEIL3-mediated resolution of ICLs,REACTOME,pathway,PATHWAY_585
+586,586,586,586,586,586,586,586,R-HSA-5609976,Defective GALK1 causes GALCT2,REACTOME,pathway,PATHWAY_586
+587,587,587,587,587,587,587,587,R-HSA-1855192,IPs transport between nucleus and ER lumen,REACTOME,pathway,PATHWAY_587
+588,588,588,588,588,588,588,588,R-HSA-9674555,Signaling by CSF3 (G-CSF),REACTOME,pathway,PATHWAY_588
+589,589,589,589,589,589,589,589,R-HSA-9842663,Signaling by LTK,REACTOME,pathway,PATHWAY_589
+590,590,590,590,590,590,590,590,R-HSA-5654719,SHC-mediated cascade:FGFR4,REACTOME,pathway,PATHWAY_590
+591,591,591,591,591,591,591,591,R-HSA-8941284,RUNX2 regulates chondrocyte maturation,REACTOME,pathway,PATHWAY_591
+592,592,592,592,592,592,592,592,R-HSA-198753,ERK/MAPK targets,REACTOME,pathway,PATHWAY_592
+593,593,593,593,593,593,593,593,R-HSA-193681,Ceramide signalling,REACTOME,pathway,PATHWAY_593
+594,594,594,594,594,594,594,594,R-HSA-9665250,Resistance of ERBB2 KD mutants to AEE788,REACTOME,pathway,PATHWAY_594
+595,595,595,595,595,595,595,595,R-HSA-880009,Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,REACTOME,pathway,PATHWAY_595
+596,596,596,596,596,596,596,596,R-HSA-264870,Caspase-mediated cleavage of cytoskeletal proteins,REACTOME,pathway,PATHWAY_596
+597,597,597,597,597,597,597,597,R-HSA-9026403,Biosynthesis of DPAn-3-derived 13-series resolvins,REACTOME,pathway,PATHWAY_597
+598,598,598,598,598,598,598,598,R-HSA-9013418,RHOBTB2 GTPase cycle,REACTOME,pathway,PATHWAY_598
+599,599,599,599,599,599,599,599,R-HSA-8941413,Events associated with phagocytolytic activity of PMN cells,REACTOME,pathway,PATHWAY_599
+600,600,600,600,600,600,600,600,R-HSA-111469,"SMAC, XIAP-regulated apoptotic response",REACTOME,pathway,PATHWAY_600
+601,601,601,601,601,601,601,601,R-HSA-5658623,FGFRL1 modulation of FGFR1 signaling,REACTOME,pathway,PATHWAY_601
+602,602,602,602,602,602,602,602,R-HSA-9914355,Isovaleric acidemia,REACTOME,pathway,PATHWAY_602
+603,603,603,603,603,603,603,603,R-HSA-373080,Class B/2 (Secretin family receptors),REACTOME,pathway,PATHWAY_603
+604,604,604,604,604,604,604,604,R-HSA-9753510,Signaling by RAS GAP mutants,REACTOME,pathway,PATHWAY_604
+605,605,605,605,605,605,605,605,R-HSA-8878159,Transcriptional regulation by RUNX3,REACTOME,pathway,PATHWAY_605
+606,606,606,606,606,606,606,606,R-HSA-9717323,ceritinib-resistant ALK mutants,REACTOME,pathway,PATHWAY_606
+607,607,607,607,607,607,607,607,R-HSA-1852241,Organelle biogenesis and maintenance,REACTOME,pathway,PATHWAY_607
+608,608,608,608,608,608,608,608,R-HSA-352230,Amino acid transport across the plasma membrane,REACTOME,pathway,PATHWAY_608
+609,609,609,609,609,609,609,609,R-HSA-500657,Presynaptic function of Kainate receptors,REACTOME,pathway,PATHWAY_609
+610,610,610,610,610,610,610,610,R-HSA-975163,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,REACTOME,pathway,PATHWAY_610
+611,611,611,611,611,611,611,611,R-HSA-3304356,SMAD2/3 Phosphorylation Motif Mutants in Cancer,REACTOME,pathway,PATHWAY_611
+612,612,612,612,612,612,612,612,R-HSA-111459,Activation of caspases through apoptosome-mediated cleavage,REACTOME,pathway,PATHWAY_612
+613,613,613,613,613,613,613,613,R-HSA-9033807,ABO blood group biosynthesis,REACTOME,pathway,PATHWAY_613
+614,614,614,614,614,614,614,614,R-HSA-111885,Opioid Signalling,REACTOME,pathway,PATHWAY_614
+615,615,615,615,615,615,615,615,R-HSA-390648,Muscarinic acetylcholine receptors,REACTOME,pathway,PATHWAY_615
+616,616,616,616,616,616,616,616,R-HSA-190322,FGFR4 ligand binding and activation,REACTOME,pathway,PATHWAY_616
+617,617,617,617,617,617,617,617,R-HSA-4551295,Defective ALG11 causes CDG-1p,REACTOME,pathway,PATHWAY_617
+618,618,618,618,618,618,618,618,R-HSA-9925561,Developmental Lineage of Pancreatic Acinar Cells,REACTOME,pathway,PATHWAY_618
+619,619,619,619,619,619,619,619,R-HSA-2206305,MPS IIID - Sanfilippo syndrome D,REACTOME,pathway,PATHWAY_619
+620,620,620,620,620,620,620,620,R-HSA-5626978,TNFR1-mediated ceramide production,REACTOME,pathway,PATHWAY_620
+621,621,621,621,621,621,621,621,R-HSA-72312,rRNA processing,REACTOME,pathway,PATHWAY_621
+622,622,622,622,622,622,622,622,R-HSA-75105,Fatty acyl-CoA biosynthesis,REACTOME,pathway,PATHWAY_622
+623,623,623,623,623,623,623,623,R-HSA-5619056,Defective HK1 causes hexokinase deficiency (HK deficiency),REACTOME,pathway,PATHWAY_623
+624,624,624,624,624,624,624,624,R-HSA-8939243,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,REACTOME,pathway,PATHWAY_624
+625,625,625,625,625,625,625,625,R-HSA-9735871,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,REACTOME,pathway,PATHWAY_625
+626,626,626,626,626,626,626,626,R-HSA-69273,Cyclin A/B1/B2 associated events during G2/M transition,REACTOME,pathway,PATHWAY_626
+627,627,627,627,627,627,627,627,R-HSA-1963640,GRB2 events in ERBB2 signaling,REACTOME,pathway,PATHWAY_627
+628,628,628,628,628,628,628,628,R-HSA-382551,Transport of small molecules,REACTOME,pathway,PATHWAY_628
+629,629,629,629,629,629,629,629,R-HSA-190861,Gap junction assembly,REACTOME,pathway,PATHWAY_629
+630,630,630,630,630,630,630,630,R-HSA-9686347,Microbial modulation of RIPK1-mediated regulated necrosis,REACTOME,pathway,PATHWAY_630
+631,631,631,631,631,631,631,631,R-HSA-9706574,RHOBTB GTPase Cycle,REACTOME,pathway,PATHWAY_631
+632,632,632,632,632,632,632,632,R-HSA-9735869,SARS-CoV-1 modulates host translation machinery,REACTOME,pathway,PATHWAY_632
+633,633,633,633,633,633,633,633,R-HSA-170984,ARMS-mediated activation,REACTOME,pathway,PATHWAY_633
+634,634,634,634,634,634,634,634,R-HSA-112308,Presynaptic depolarization and calcium channel opening,REACTOME,pathway,PATHWAY_634
+635,635,635,635,635,635,635,635,R-HSA-1483206,Glycerophospholipid biosynthesis,REACTOME,pathway,PATHWAY_635
+636,636,636,636,636,636,636,636,R-HSA-9702577,semaxanib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_636
+637,637,637,637,637,637,637,637,R-HSA-451308,Activation of Ca-permeable Kainate Receptor,REACTOME,pathway,PATHWAY_637
+638,638,638,638,638,638,638,638,R-HSA-190372,FGFR3c ligand binding and activation,REACTOME,pathway,PATHWAY_638
+639,639,639,639,639,639,639,639,R-HSA-9701192,Defective homologous recombination repair (HRR) due to BRCA1 loss of function,REACTOME,pathway,PATHWAY_639
+640,640,640,640,640,640,640,640,R-HSA-844456,The NLRP3 inflammasome,REACTOME,pathway,PATHWAY_640
+641,641,641,641,641,641,641,641,R-HSA-168273,Influenza Viral RNA Transcription and Replication,REACTOME,pathway,PATHWAY_641
+642,642,642,642,642,642,642,642,R-HSA-8847453,Synthesis of PIPs in the nucleus,REACTOME,pathway,PATHWAY_642
+643,643,643,643,643,643,643,643,R-HSA-446343,Localization of the PINCH-ILK-PARVIN complex to focal adhesions,REACTOME,pathway,PATHWAY_643
+644,644,644,644,644,644,644,644,R-HSA-9669924,Masitinib-resistant KIT mutants,REACTOME,pathway,PATHWAY_644
+645,645,645,645,645,645,645,645,R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,REACTOME,pathway,PATHWAY_645
+646,646,646,646,646,646,646,646,R-HSA-194315,Signaling by Rho GTPases,REACTOME,pathway,PATHWAY_646
+647,647,647,647,647,647,647,647,R-HSA-8866427,VLDLR internalisation and degradation,REACTOME,pathway,PATHWAY_647
+648,648,648,648,648,648,648,648,R-HSA-453276,Regulation of mitotic cell cycle,REACTOME,pathway,PATHWAY_648
+649,649,649,649,649,649,649,649,R-HSA-174414,Processive synthesis on the C-strand of the telomere,REACTOME,pathway,PATHWAY_649
+650,650,650,650,650,650,650,650,R-HSA-2428928,IRS-related events triggered by IGF1R,REACTOME,pathway,PATHWAY_650
+651,651,651,651,651,651,651,651,R-HSA-114294,"Activation, translocation and oligomerization of BAX",REACTOME,pathway,PATHWAY_651
+652,652,652,652,652,652,652,652,R-HSA-4839743,Signaling by CTNNB1 phospho-site mutants,REACTOME,pathway,PATHWAY_652
+653,653,653,653,653,653,653,653,R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,REACTOME,pathway,PATHWAY_653
+654,654,654,654,654,654,654,654,R-HSA-1433559,Regulation of KIT signaling,REACTOME,pathway,PATHWAY_654
+655,655,655,655,655,655,655,655,R-HSA-9768777,Regulation of NPAS4 gene transcription,REACTOME,pathway,PATHWAY_655
+656,656,656,656,656,656,656,656,R-HSA-1660510,PIPs transport between Golgi and plasma membranes,REACTOME,pathway,PATHWAY_656
+657,657,657,657,657,657,657,657,R-HSA-9702569,KW2449-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_657
+658,658,658,658,658,658,658,658,R-HSA-428540,Activation of RAC1,REACTOME,pathway,PATHWAY_658
+659,659,659,659,659,659,659,659,R-HSA-9017802,Noncanonical activation of NOTCH3,REACTOME,pathway,PATHWAY_659
+660,660,660,660,660,660,660,660,R-HSA-1236394,Signaling by ERBB4,REACTOME,pathway,PATHWAY_660
+661,661,661,661,661,661,661,661,R-HSA-196836,Vitamin C (ascorbate) metabolism,REACTOME,pathway,PATHWAY_661
+662,662,662,662,662,662,662,662,R-HSA-3299685,Detoxification of Reactive Oxygen Species,REACTOME,pathway,PATHWAY_662
+663,663,663,663,663,663,663,663,R-HSA-8852135,Protein ubiquitination,REACTOME,pathway,PATHWAY_663
+664,664,664,664,664,664,664,664,R-HSA-1834941,STING mediated induction of host immune responses,REACTOME,pathway,PATHWAY_664
+665,665,665,665,665,665,665,665,R-HSA-9758919,Epithelial-Mesenchymal Transition (EMT) during gastrulation,REACTOME,pathway,PATHWAY_665
+666,666,666,666,666,666,666,666,R-HSA-1236973,Cross-presentation of particulate exogenous antigens (phagosomes),REACTOME,pathway,PATHWAY_666
+667,667,667,667,667,667,667,667,R-HSA-5083633,"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",REACTOME,pathway,PATHWAY_667
+668,668,668,668,668,668,668,668,R-HSA-9024909,BDNF activates NTRK2 (TRKB) signaling,REACTOME,pathway,PATHWAY_668
+669,669,669,669,669,669,669,669,R-HSA-74259,Purine catabolism,REACTOME,pathway,PATHWAY_669
+670,670,670,670,670,670,670,670,R-HSA-5654228,Phospholipase C-mediated cascade; FGFR4,REACTOME,pathway,PATHWAY_670
+671,671,671,671,671,671,671,671,R-HSA-9013419,RHOT2 GTPase cycle,REACTOME,pathway,PATHWAY_671
+672,672,672,672,672,672,672,672,R-HSA-190375,FGFR2c ligand binding and activation,REACTOME,pathway,PATHWAY_672
+673,673,673,673,673,673,673,673,R-HSA-6798695,Neutrophil degranulation,REACTOME,pathway,PATHWAY_673
+674,674,674,674,674,674,674,674,R-HSA-9754706,Atorvastatin ADME,REACTOME,pathway,PATHWAY_674
+675,675,675,675,675,675,675,675,R-HSA-9759476,Regulation of Homotypic Cell-Cell Adhesion,REACTOME,pathway,PATHWAY_675
+676,676,676,676,676,676,676,676,R-HSA-5693554,Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),REACTOME,pathway,PATHWAY_676
+677,677,677,677,677,677,677,677,R-HSA-69416,Dimerization of procaspase-8,REACTOME,pathway,PATHWAY_677
+678,678,678,678,678,678,678,678,R-HSA-5619081,Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),REACTOME,pathway,PATHWAY_678
+679,679,679,679,679,679,679,679,R-HSA-77288,mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,REACTOME,pathway,PATHWAY_679
+680,680,680,680,680,680,680,680,R-HSA-174411,Polymerase switching on the C-strand of the telomere,REACTOME,pathway,PATHWAY_680
+681,681,681,681,681,681,681,681,R-HSA-1250342,PI3K events in ERBB4 signaling,REACTOME,pathway,PATHWAY_681
+682,682,682,682,682,682,682,682,R-HSA-9014826,Interleukin-36 pathway,REACTOME,pathway,PATHWAY_682
+683,683,683,683,683,683,683,683,R-HSA-418038,Nucleotide-like (purinergic) receptors,REACTOME,pathway,PATHWAY_683
+684,684,684,684,684,684,684,684,R-HSA-5674404,PTEN Loss of Function in Cancer,REACTOME,pathway,PATHWAY_684
+685,685,685,685,685,685,685,685,R-HSA-375276,Peptide ligand-binding receptors,REACTOME,pathway,PATHWAY_685
+686,686,686,686,686,686,686,686,R-HSA-2514856,The phototransduction cascade,REACTOME,pathway,PATHWAY_686
+687,687,687,687,687,687,687,687,R-HSA-1236975,Antigen processing-Cross presentation,REACTOME,pathway,PATHWAY_687
+688,688,688,688,688,688,688,688,R-HSA-6807878,COPI-mediated anterograde transport,REACTOME,pathway,PATHWAY_688
+689,689,689,689,689,689,689,689,R-HSA-168303,Packaging of Eight RNA Segments,REACTOME,pathway,PATHWAY_689
+690,690,690,690,690,690,690,690,R-HSA-194002,Glucocorticoid biosynthesis,REACTOME,pathway,PATHWAY_690
+691,691,691,691,691,691,691,691,R-HSA-168276,NS1 Mediated Effects on Host Pathways,REACTOME,pathway,PATHWAY_691
+692,692,692,692,692,692,692,692,R-HSA-351143,Agmatine biosynthesis,REACTOME,pathway,PATHWAY_692
+693,693,693,693,693,693,693,693,R-HSA-389599,Alpha-oxidation of phytanate,REACTOME,pathway,PATHWAY_693
+694,694,694,694,694,694,694,694,R-HSA-110362,POLB-Dependent Long Patch Base Excision Repair,REACTOME,pathway,PATHWAY_694
+695,695,695,695,695,695,695,695,R-HSA-9909438,3-Methylcrotonyl-CoA carboxylase deficiency,REACTOME,pathway,PATHWAY_695
+696,696,696,696,696,696,696,696,R-HSA-8853884,Transcriptional Regulation by VENTX,REACTOME,pathway,PATHWAY_696
+697,697,697,697,697,697,697,697,R-HSA-180024,DARPP-32 events,REACTOME,pathway,PATHWAY_697
+698,698,698,698,698,698,698,698,R-HSA-1679131,Trafficking and processing of endosomal TLR,REACTOME,pathway,PATHWAY_698
+699,699,699,699,699,699,699,699,R-HSA-170968,Frs2-mediated activation,REACTOME,pathway,PATHWAY_699
+700,700,700,700,700,700,700,700,R-HSA-9669921,KIT mutants bind TKIs,REACTOME,pathway,PATHWAY_700
+701,701,701,701,701,701,701,701,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,REACTOME,pathway,PATHWAY_701
+702,702,702,702,702,702,702,702,R-HSA-3274531,Glycogen storage disease type Ia (G6PC),REACTOME,pathway,PATHWAY_702
+703,703,703,703,703,703,703,703,R-HSA-5619035,Defective SLC17A5 causes Salla disease (SD) and ISSD,REACTOME,pathway,PATHWAY_703
+704,704,704,704,704,704,704,704,R-HSA-9665244,Resistance of ERBB2 KD mutants to sapitinib,REACTOME,pathway,PATHWAY_704
+705,705,705,705,705,705,705,705,R-HSA-9012999,RHO GTPase cycle,REACTOME,pathway,PATHWAY_705
+706,706,706,706,706,706,706,706,R-HSA-9671555,Signaling by PDGFR in disease,REACTOME,pathway,PATHWAY_706
+707,707,707,707,707,707,707,707,R-HSA-9018677,Biosynthesis of DHA-derived SPMs,REACTOME,pathway,PATHWAY_707
+708,708,708,708,708,708,708,708,R-HSA-392518,Signal amplification,REACTOME,pathway,PATHWAY_708
+709,709,709,709,709,709,709,709,R-HSA-6804757,Regulation of TP53 Degradation,REACTOME,pathway,PATHWAY_709
+710,710,710,710,710,710,710,710,R-HSA-5619036,Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6),REACTOME,pathway,PATHWAY_710
+711,711,711,711,711,711,711,711,R-HSA-5654696,Downstream signaling of activated FGFR2,REACTOME,pathway,PATHWAY_711
+712,712,712,712,712,712,712,712,R-HSA-9701190,Defective homologous recombination repair (HRR) due to BRCA2 loss of function,REACTOME,pathway,PATHWAY_712
+713,713,713,713,713,713,713,713,R-HSA-2990846,SUMOylation,REACTOME,pathway,PATHWAY_713
+714,714,714,714,714,714,714,714,R-HSA-9665251,Resistance of ERBB2 KD mutants to lapatinib,REACTOME,pathway,PATHWAY_714
+715,715,715,715,715,715,715,715,R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,REACTOME,pathway,PATHWAY_715
+716,716,716,716,716,716,716,716,R-HSA-174048,APC/C:Cdc20 mediated degradation of Cyclin B,REACTOME,pathway,PATHWAY_716
+717,717,717,717,717,717,717,717,R-HSA-5621481,C-type lectin receptors (CLRs),REACTOME,pathway,PATHWAY_717
+718,718,718,718,718,718,718,718,R-HSA-549127,Organic cation transport,REACTOME,pathway,PATHWAY_718
+719,719,719,719,719,719,719,719,R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,REACTOME,pathway,PATHWAY_719
+720,720,720,720,720,720,720,720,R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,REACTOME,pathway,PATHWAY_720
+721,721,721,721,721,721,721,721,R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",REACTOME,pathway,PATHWAY_721
+722,722,722,722,722,722,722,722,R-HSA-2453902,The canonical retinoid cycle in rods (twilight vision),REACTOME,pathway,PATHWAY_722
+723,723,723,723,723,723,723,723,R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,REACTOME,pathway,PATHWAY_723
+724,724,724,724,724,724,724,724,R-HSA-9828642,Respiratory syncytial virus genome transcription,REACTOME,pathway,PATHWAY_724
+725,725,725,725,725,725,725,725,R-HSA-5688031,Defective pro-SFTPB causes SMDP1 and RDS,REACTOME,pathway,PATHWAY_725
+726,726,726,726,726,726,726,726,R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,REACTOME,pathway,PATHWAY_726
+727,727,727,727,727,727,727,727,R-HSA-9609736,Assembly and cell surface presentation of NMDA receptors,REACTOME,pathway,PATHWAY_727
+728,728,728,728,728,728,728,728,R-HSA-9735804,Diseases of nucleotide metabolism,REACTOME,pathway,PATHWAY_728
+729,729,729,729,729,729,729,729,R-HSA-5467348,Truncations of AMER1 destabilize the destruction complex,REACTOME,pathway,PATHWAY_729
+730,730,730,730,730,730,730,730,R-HSA-442720,CREB1 phosphorylation through the activation of Adenylate Cyclase,REACTOME,pathway,PATHWAY_730
+731,731,731,731,731,731,731,731,R-HSA-5579020,Defective SLC35D1 causes SCHBCKD,REACTOME,pathway,PATHWAY_731
+732,732,732,732,732,732,732,732,R-HSA-9664422,FCGR3A-mediated phagocytosis,REACTOME,pathway,PATHWAY_732
+733,733,733,733,733,733,733,733,R-HSA-1640170,Cell Cycle,REACTOME,pathway,PATHWAY_733
+734,734,734,734,734,734,734,734,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,REACTOME,pathway,PATHWAY_734
+735,735,735,735,735,735,735,735,R-HSA-205017,NFG and proNGF binds to p75NTR,REACTOME,pathway,PATHWAY_735
+736,736,736,736,736,736,736,736,R-HSA-5602636,IKBKB deficiency causes SCID,REACTOME,pathway,PATHWAY_736
+737,737,737,737,737,737,737,737,R-HSA-5579016,Defective UGT1A4 causes hyperbilirubinemia,REACTOME,pathway,PATHWAY_737
+738,738,738,738,738,738,738,738,R-HSA-198323,AKT phosphorylates targets in the cytosol,REACTOME,pathway,PATHWAY_738
+739,739,739,739,739,739,739,739,R-HSA-389357,CD28 dependent PI3K/Akt signaling,REACTOME,pathway,PATHWAY_739
+740,740,740,740,740,740,740,740,R-HSA-5651801,PCNA-Dependent Long Patch Base Excision Repair,REACTOME,pathway,PATHWAY_740
+741,741,741,741,741,741,741,741,R-HSA-1296053,Classical Kir channels,REACTOME,pathway,PATHWAY_741
+742,742,742,742,742,742,742,742,R-HSA-449836,Other interleukin signaling,REACTOME,pathway,PATHWAY_742
+743,743,743,743,743,743,743,743,R-HSA-5467340,AXIN missense mutants destabilize the destruction complex,REACTOME,pathway,PATHWAY_743
+744,744,744,744,744,744,744,744,R-HSA-4570464,SUMOylation of RNA binding proteins,REACTOME,pathway,PATHWAY_744
+745,745,745,745,745,745,745,745,R-HSA-390450,Folding of actin by CCT/TriC,REACTOME,pathway,PATHWAY_745
+746,746,746,746,746,746,746,746,R-HSA-2122948,Activated NOTCH1 Transmits Signal to the Nucleus,REACTOME,pathway,PATHWAY_746
+747,747,747,747,747,747,747,747,R-HSA-3229121,Glycogen storage diseases,REACTOME,pathway,PATHWAY_747
+748,748,748,748,748,748,748,748,R-HSA-190827,Transport of connexins along the secretory pathway,REACTOME,pathway,PATHWAY_748
+749,749,749,749,749,749,749,749,R-HSA-9013404,RAC2 GTPase cycle,REACTOME,pathway,PATHWAY_749
+750,750,750,750,750,750,750,750,R-HSA-9858328,OADH complex synthesizes glutaryl-CoA from 2-OA,REACTOME,pathway,PATHWAY_750
+751,751,751,751,751,751,751,751,R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),REACTOME,pathway,PATHWAY_751
+752,752,752,752,752,752,752,752,R-HSA-9652817,Signaling by MAPK mutants,REACTOME,pathway,PATHWAY_752
+753,753,753,753,753,753,753,753,R-HSA-2559585,Oncogene Induced Senescence,REACTOME,pathway,PATHWAY_753
+754,754,754,754,754,754,754,754,R-HSA-109704,PI3K Cascade,REACTOME,pathway,PATHWAY_754
+755,755,755,755,755,755,755,755,R-HSA-2219528,PI3K/AKT Signaling in Cancer,REACTOME,pathway,PATHWAY_755
+756,756,756,756,756,756,756,756,R-HSA-428643,Organic anion transporters,REACTOME,pathway,PATHWAY_756
+757,757,757,757,757,757,757,757,R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,REACTOME,pathway,PATHWAY_757
+758,758,758,758,758,758,758,758,R-HSA-8875791,MET activates STAT3,REACTOME,pathway,PATHWAY_758
+759,759,759,759,759,759,759,759,R-HSA-77348,Beta oxidation of octanoyl-CoA to hexanoyl-CoA,REACTOME,pathway,PATHWAY_759
+760,760,760,760,760,760,760,760,R-HSA-9694548,Maturation of spike protein,REACTOME,pathway,PATHWAY_760
+761,761,761,761,761,761,761,761,R-HSA-159234,Transport of Mature mRNAs Derived from Intronless Transcripts,REACTOME,pathway,PATHWAY_761
+762,762,762,762,762,762,762,762,R-HSA-68689,CDC6 association with the ORC:origin complex,REACTOME,pathway,PATHWAY_762
+763,763,763,763,763,763,763,763,R-HSA-9729902,Reversible DNA damage induced by alkylating chemotherapeutic drugs,REACTOME,pathway,PATHWAY_763
+764,764,764,764,764,764,764,764,R-HSA-112126,ALKBH3 mediated reversal of alkylation damage,REACTOME,pathway,PATHWAY_764
+765,765,765,765,765,765,765,765,R-HSA-159227,Transport of the SLBP independent Mature mRNA,REACTOME,pathway,PATHWAY_765
+766,766,766,766,766,766,766,766,R-HSA-9856872,Malate-aspartate shuttle,REACTOME,pathway,PATHWAY_766
+767,767,767,767,767,767,767,767,R-HSA-1912422,Pre-NOTCH Expression and Processing,REACTOME,pathway,PATHWAY_767
+768,768,768,768,768,768,768,768,R-HSA-373752,Netrin-1 signaling,REACTOME,pathway,PATHWAY_768
+769,769,769,769,769,769,769,769,R-HSA-5678771,"Defective ABCB4 causes PFIC3, ICP3 and GBD1",REACTOME,pathway,PATHWAY_769
+770,770,770,770,770,770,770,770,R-HSA-15869,Metabolism of nucleotides,REACTOME,pathway,PATHWAY_770
+771,771,771,771,771,771,771,771,R-HSA-975634,Retinoid metabolism and transport,REACTOME,pathway,PATHWAY_771
+772,772,772,772,772,772,772,772,R-HSA-9717316,alectinib-resistant ALK mutants,REACTOME,pathway,PATHWAY_772
+773,773,773,773,773,773,773,773,R-HSA-9824272,Somitogenesis,REACTOME,pathway,PATHWAY_773
+774,774,774,774,774,774,774,774,R-HSA-6785631,ERBB2 Regulates Cell Motility,REACTOME,pathway,PATHWAY_774
+775,775,775,775,775,775,775,775,R-HSA-8848021,Signaling by PTK6,REACTOME,pathway,PATHWAY_775
+776,776,776,776,776,776,776,776,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,REACTOME,pathway,PATHWAY_776
+777,777,777,777,777,777,777,777,R-HSA-1296059,G protein gated Potassium channels,REACTOME,pathway,PATHWAY_777
+778,778,778,778,778,778,778,778,R-HSA-173599,"Formation of the active cofactor, UDP-glucuronate",REACTOME,pathway,PATHWAY_778
+779,779,779,779,779,779,779,779,R-HSA-2408557,Selenocysteine synthesis,REACTOME,pathway,PATHWAY_779
+780,780,780,780,780,780,780,780,R-HSA-9025046,NTF3 activates NTRK2 (TRKB) signaling,REACTOME,pathway,PATHWAY_780
+781,781,781,781,781,781,781,781,R-HSA-9013420,RHOU GTPase cycle,REACTOME,pathway,PATHWAY_781
+782,782,782,782,782,782,782,782,R-HSA-804914,Transport of fatty acids,REACTOME,pathway,PATHWAY_782
+783,783,783,783,783,783,783,783,R-HSA-2046106,alpha-linolenic acid (ALA) metabolism,REACTOME,pathway,PATHWAY_783
+784,784,784,784,784,784,784,784,R-HSA-9818027,NFE2L2 regulating anti-oxidant/detoxification enzymes,REACTOME,pathway,PATHWAY_784
+785,785,785,785,785,785,785,785,R-HSA-6791461,RPIA deficiency: failed conversion of RU5P to R5P,REACTOME,pathway,PATHWAY_785
+786,786,786,786,786,786,786,786,R-HSA-5576886,Phase 4 - resting membrane potential,REACTOME,pathway,PATHWAY_786
+787,787,787,787,787,787,787,787,R-HSA-75108,"Activation, myristolyation of BID and translocation to mitochondria",REACTOME,pathway,PATHWAY_787
+788,788,788,788,788,788,788,788,R-HSA-3229133,Glycogen storage disease type Ib (SLC37A4),REACTOME,pathway,PATHWAY_788
+789,789,789,789,789,789,789,789,R-HSA-5579002,Defective UGT1A1 causes hyperbilirubinemia,REACTOME,pathway,PATHWAY_789
+790,790,790,790,790,790,790,790,R-HSA-69052,Switching of origins to a post-replicative state,REACTOME,pathway,PATHWAY_790
+791,791,791,791,791,791,791,791,R-HSA-9860927,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",REACTOME,pathway,PATHWAY_791
+792,792,792,792,792,792,792,792,R-HSA-162791,Attachment of GPI anchor to uPAR,REACTOME,pathway,PATHWAY_792
+793,793,793,793,793,793,793,793,R-HSA-879415,Advanced glycosylation endproduct receptor signaling,REACTOME,pathway,PATHWAY_793
+794,794,794,794,794,794,794,794,R-HSA-2428933,SHC-related events triggered by IGF1R,REACTOME,pathway,PATHWAY_794
+795,795,795,795,795,795,795,795,R-HSA-5685938,HDR through Single Strand Annealing (SSA),REACTOME,pathway,PATHWAY_795
+796,796,796,796,796,796,796,796,R-HSA-9715370,Miro GTPase Cycle,REACTOME,pathway,PATHWAY_796
+797,797,797,797,797,797,797,797,R-HSA-8964539,Glutamate and glutamine metabolism,REACTOME,pathway,PATHWAY_797
+798,798,798,798,798,798,798,798,R-HSA-9845619,Enhanced cleavage of VWF variant by ADAMTS13,REACTOME,pathway,PATHWAY_798
+799,799,799,799,799,799,799,799,R-HSA-167287,HIV elongation arrest and recovery,REACTOME,pathway,PATHWAY_799
+800,800,800,800,800,800,800,800,R-HSA-5687868,Defective SFTPA2 causes IPF,REACTOME,pathway,PATHWAY_800
+801,801,801,801,801,801,801,801,R-HSA-937042,IRAK2 mediated activation of TAK1 complex,REACTOME,pathway,PATHWAY_801
+802,802,802,802,802,802,802,802,R-HSA-2408522,Selenoamino acid metabolism,REACTOME,pathway,PATHWAY_802
+803,803,803,803,803,803,803,803,R-HSA-2142696,Synthesis of Hepoxilins (HX) and Trioxilins (TrX),REACTOME,pathway,PATHWAY_803
+804,804,804,804,804,804,804,804,R-HSA-9754560,SARS-CoV-2 modulates autophagy,REACTOME,pathway,PATHWAY_804
+805,805,805,805,805,805,805,805,R-HSA-209905,Catecholamine biosynthesis,REACTOME,pathway,PATHWAY_805
+806,806,806,806,806,806,806,806,R-HSA-211979,Eicosanoids,REACTOME,pathway,PATHWAY_806
+807,807,807,807,807,807,807,807,R-HSA-8964046,VLDL clearance,REACTOME,pathway,PATHWAY_807
+808,808,808,808,808,808,808,808,R-HSA-3371511,HSF1 activation,REACTOME,pathway,PATHWAY_808
+809,809,809,809,809,809,809,809,R-HSA-5358351,Signaling by Hedgehog,REACTOME,pathway,PATHWAY_809
+810,810,810,810,810,810,810,810,R-HSA-73942,DNA Damage Reversal,REACTOME,pathway,PATHWAY_810
+811,811,811,811,811,811,811,811,R-HSA-69236,G1 Phase,REACTOME,pathway,PATHWAY_811
+812,812,812,812,812,812,812,812,R-HSA-4570571,Defective RFT1 causes CDG-1n,REACTOME,pathway,PATHWAY_812
+813,813,813,813,813,813,813,813,R-HSA-629597,Highly calcium permeable nicotinic acetylcholine receptors,REACTOME,pathway,PATHWAY_813
+814,814,814,814,814,814,814,814,R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum  stress,REACTOME,pathway,PATHWAY_814
+815,815,815,815,815,815,815,815,R-HSA-164378,PKA activation in glucagon signalling,REACTOME,pathway,PATHWAY_815
+816,816,816,816,816,816,816,816,R-HSA-379397,Enzymatic degradation of dopamine by COMT,REACTOME,pathway,PATHWAY_816
+817,817,817,817,817,817,817,817,R-HSA-9818032,NFE2L2 regulating MDR associated enzymes,REACTOME,pathway,PATHWAY_817
+818,818,818,818,818,818,818,818,R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,REACTOME,pathway,PATHWAY_818
+819,819,819,819,819,819,819,819,R-HSA-442660,Na+/Cl- dependent neurotransmitter transporters,REACTOME,pathway,PATHWAY_819
+820,820,820,820,820,820,820,820,R-HSA-3304347,Loss of Function of SMAD4 in Cancer,REACTOME,pathway,PATHWAY_820
+821,821,821,821,821,821,821,821,R-HSA-68882,Mitotic Anaphase,REACTOME,pathway,PATHWAY_821
+822,822,822,822,822,822,822,822,R-HSA-5250913,Positive epigenetic regulation of rRNA expression,REACTOME,pathway,PATHWAY_822
+823,823,823,823,823,823,823,823,R-HSA-74158,RNA Polymerase III Transcription,REACTOME,pathway,PATHWAY_823
+824,824,824,824,824,824,824,824,R-HSA-8849474,PTK6 Activates STAT3,REACTOME,pathway,PATHWAY_824
+825,825,825,825,825,825,825,825,R-HSA-74752,Signaling by Insulin receptor,REACTOME,pathway,PATHWAY_825
+826,826,826,826,826,826,826,826,R-HSA-4755609,Defective DHDDS causes RP59,REACTOME,pathway,PATHWAY_826
+827,827,827,827,827,827,827,827,R-HSA-5659898,Intestinal saccharidase deficiencies,REACTOME,pathway,PATHWAY_827
+828,828,828,828,828,828,828,828,R-HSA-9006821,Alternative Lengthening of Telomeres (ALT),REACTOME,pathway,PATHWAY_828
+829,829,829,829,829,829,829,829,R-HSA-9607240,FLT3 Signaling,REACTOME,pathway,PATHWAY_829
+830,830,830,830,830,830,830,830,R-HSA-418597,G alpha (z) signalling events,REACTOME,pathway,PATHWAY_830
+831,831,831,831,831,831,831,831,R-HSA-8981373,Intestinal hexose absorption,REACTOME,pathway,PATHWAY_831
+832,832,832,832,832,832,832,832,R-HSA-2514853,Condensation of Prometaphase Chromosomes,REACTOME,pathway,PATHWAY_832
+833,833,833,833,833,833,833,833,R-HSA-8948216,Collagen chain trimerization,REACTOME,pathway,PATHWAY_833
+834,834,834,834,834,834,834,834,R-HSA-192823,Viral mRNA Translation,REACTOME,pathway,PATHWAY_834
+835,835,835,835,835,835,835,835,R-HSA-8952158,RUNX3 regulates BCL2L11 (BIM) transcription,REACTOME,pathway,PATHWAY_835
+836,836,836,836,836,836,836,836,R-HSA-9696264,RND3 GTPase cycle,REACTOME,pathway,PATHWAY_836
+837,837,837,837,837,837,837,837,R-HSA-2514859,"Inactivation, recovery and regulation of the phototransduction cascade",REACTOME,pathway,PATHWAY_837
+838,838,838,838,838,838,838,838,R-HSA-5652227,Fructose biosynthesis,REACTOME,pathway,PATHWAY_838
+839,839,839,839,839,839,839,839,R-HSA-167162,RNA Polymerase II HIV Promoter Escape,REACTOME,pathway,PATHWAY_839
+840,840,840,840,840,840,840,840,R-HSA-190239,FGFR3 ligand binding and activation,REACTOME,pathway,PATHWAY_840
+841,841,841,841,841,841,841,841,R-HSA-1368108,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",REACTOME,pathway,PATHWAY_841
+842,842,842,842,842,842,842,842,R-HSA-8953897,Cellular responses to stimuli,REACTOME,pathway,PATHWAY_842
+843,843,843,843,843,843,843,843,R-HSA-5619076,Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25),REACTOME,pathway,PATHWAY_843
+844,844,844,844,844,844,844,844,R-HSA-9665247,Resistance of ERBB2 KD mutants to osimertinib,REACTOME,pathway,PATHWAY_844
+845,845,845,845,845,845,845,845,R-HSA-180585,Vif-mediated degradation of APOBEC3G,REACTOME,pathway,PATHWAY_845
+846,846,846,846,846,846,846,846,R-HSA-202040,G-protein activation,REACTOME,pathway,PATHWAY_846
+847,847,847,847,847,847,847,847,R-HSA-435368,Zinc efflux and compartmentalization by the SLC30 family,REACTOME,pathway,PATHWAY_847
+848,848,848,848,848,848,848,848,R-HSA-9678108,SARS-CoV-1 Infection,REACTOME,pathway,PATHWAY_848
+849,849,849,849,849,849,849,849,R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA ,REACTOME,pathway,PATHWAY_849
+850,850,850,850,850,850,850,850,R-HSA-500753,Pyrimidine biosynthesis,REACTOME,pathway,PATHWAY_850
+851,851,851,851,851,851,851,851,R-HSA-9818030,NFE2L2 regulating tumorigenic genes,REACTOME,pathway,PATHWAY_851
+852,852,852,852,852,852,852,852,R-HSA-9664407,Parasite infection,REACTOME,pathway,PATHWAY_852
+853,853,853,853,853,853,853,853,R-HSA-111367,SLBP independent Processing of Histone Pre-mRNAs,REACTOME,pathway,PATHWAY_853
+854,854,854,854,854,854,854,854,R-HSA-901032,ER Quality Control Compartment (ERQC),REACTOME,pathway,PATHWAY_854
+855,855,855,855,855,855,855,855,R-HSA-69275,G2/M Transition,REACTOME,pathway,PATHWAY_855
+856,856,856,856,856,856,856,856,R-HSA-5609975,Diseases associated with glycosylation precursor biosynthesis,REACTOME,pathway,PATHWAY_856
+857,857,857,857,857,857,857,857,R-HSA-140534,Caspase activation via Death Receptors in the presence of ligand,REACTOME,pathway,PATHWAY_857
+858,858,858,858,858,858,858,858,R-HSA-442729,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,REACTOME,pathway,PATHWAY_858
+859,859,859,859,859,859,859,859,R-HSA-9683612,Maturation of protein M,REACTOME,pathway,PATHWAY_859
+860,860,860,860,860,860,860,860,R-HSA-5250989,Toxicity of botulinum toxin type G (botG),REACTOME,pathway,PATHWAY_860
+861,861,861,861,861,861,861,861,R-HSA-428890,Role of ABL in ROBO-SLIT signaling,REACTOME,pathway,PATHWAY_861
+862,862,862,862,862,862,862,862,R-HSA-5620922,BBSome-mediated cargo-targeting to cilium,REACTOME,pathway,PATHWAY_862
+863,863,863,863,863,863,863,863,R-HSA-888593,Reuptake of GABA,REACTOME,pathway,PATHWAY_863
+864,864,864,864,864,864,864,864,R-HSA-9603505,NTRK3 as a dependence receptor,REACTOME,pathway,PATHWAY_864
+865,865,865,865,865,865,865,865,R-HSA-9672393,Defective F8 binding to von Willebrand factor,REACTOME,pathway,PATHWAY_865
+866,866,866,866,866,866,866,866,R-HSA-9859138,"BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV",REACTOME,pathway,PATHWAY_866
+867,867,867,867,867,867,867,867,R-HSA-5602410,TLR3 deficiency - HSE,REACTOME,pathway,PATHWAY_867
+868,868,868,868,868,868,868,868,R-HSA-9615710,Late endosomal microautophagy,REACTOME,pathway,PATHWAY_868
+869,869,869,869,869,869,869,869,R-HSA-3371571,HSF1-dependent transactivation,REACTOME,pathway,PATHWAY_869
+870,870,870,870,870,870,870,870,R-HSA-2467813,Separation of Sister Chromatids,REACTOME,pathway,PATHWAY_870
+871,871,871,871,871,871,871,871,R-HSA-9843743,Transcriptional regulation of brown and beige adipocyte differentiation,REACTOME,pathway,PATHWAY_871
+872,872,872,872,872,872,872,872,R-HSA-5625970,RHO GTPases activate KTN1,REACTOME,pathway,PATHWAY_872
+873,873,873,873,873,873,873,873,R-HSA-5610787,Hedgehog 'off' state,REACTOME,pathway,PATHWAY_873
+874,874,874,874,874,874,874,874,R-HSA-9035968,Defective GGT1 in aflatoxin detoxification causes GLUTH,REACTOME,pathway,PATHWAY_874
+875,875,875,875,875,875,875,875,R-HSA-190873,Gap junction degradation,REACTOME,pathway,PATHWAY_875
+876,876,876,876,876,876,876,876,R-HSA-9664535,LTC4-CYSLTR mediated IL4 production,REACTOME,pathway,PATHWAY_876
+877,877,877,877,877,877,877,877,R-HSA-174495,"Synthesis And Processing Of GAG, GAGPOL Polyproteins",REACTOME,pathway,PATHWAY_877
+878,878,878,878,878,878,878,878,R-HSA-1227990,Signaling by ERBB2 in Cancer,REACTOME,pathway,PATHWAY_878
+879,879,879,879,879,879,879,879,R-HSA-5673001,RAF/MAP kinase cascade,REACTOME,pathway,PATHWAY_879
+880,880,880,880,880,880,880,880,R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,REACTOME,pathway,PATHWAY_880
+881,881,881,881,881,881,881,881,R-HSA-175567,Integration of viral DNA into host genomic DNA,REACTOME,pathway,PATHWAY_881
+882,882,882,882,882,882,882,882,R-HSA-3304349,Loss of Function of SMAD2/3 in Cancer,REACTOME,pathway,PATHWAY_882
+883,883,883,883,883,883,883,883,R-HSA-2691232,Constitutive Signaling by NOTCH1 HD Domain Mutants,REACTOME,pathway,PATHWAY_883
+884,884,884,884,884,884,884,884,R-HSA-428157,Sphingolipid metabolism,REACTOME,pathway,PATHWAY_884
+885,885,885,885,885,885,885,885,R-HSA-438066,"Unblocking of NMDA receptors, glutamate binding and activation",REACTOME,pathway,PATHWAY_885
+886,886,886,886,886,886,886,886,R-HSA-9702600,midostaurin-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_886
+887,887,887,887,887,887,887,887,R-HSA-68877,Mitotic Prometaphase,REACTOME,pathway,PATHWAY_887
+888,888,888,888,888,888,888,888,R-HSA-1483166,Synthesis of PA,REACTOME,pathway,PATHWAY_888
+889,889,889,889,889,889,889,889,R-HSA-165160,PDE3B signalling,REACTOME,pathway,PATHWAY_889
+890,890,890,890,890,890,890,890,R-HSA-9830369,Kidney development,REACTOME,pathway,PATHWAY_890
+891,891,891,891,891,891,891,891,R-HSA-166662,Lectin pathway of complement activation,REACTOME,pathway,PATHWAY_891
+892,892,892,892,892,892,892,892,R-HSA-9717189,Sensory perception of taste,REACTOME,pathway,PATHWAY_892
+893,893,893,893,893,893,893,893,R-HSA-73928,Depyrimidination,REACTOME,pathway,PATHWAY_893
+894,894,894,894,894,894,894,894,R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),REACTOME,pathway,PATHWAY_894
+895,895,895,895,895,895,895,895,R-HSA-9734009,Defective Intrinsic Pathway for Apoptosis,REACTOME,pathway,PATHWAY_895
+896,896,896,896,896,896,896,896,R-HSA-9656256,Defective OGG1 Substrate Processing,REACTOME,pathway,PATHWAY_896
+897,897,897,897,897,897,897,897,R-HSA-5357609,Glycogen storage disease type II (GAA),REACTOME,pathway,PATHWAY_897
+898,898,898,898,898,898,898,898,R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,REACTOME,pathway,PATHWAY_898
+899,899,899,899,899,899,899,899,R-HSA-9022699,MECP2 regulates neuronal receptors and channels,REACTOME,pathway,PATHWAY_899
+900,900,900,900,900,900,900,900,R-HSA-9673218,Defective F9 secretion,REACTOME,pathway,PATHWAY_900
+901,901,901,901,901,901,901,901,R-HSA-171286,Synthesis and processing of ENV and VPU,REACTOME,pathway,PATHWAY_901
+902,902,902,902,902,902,902,902,R-HSA-180534,Vpu mediated degradation of CD4,REACTOME,pathway,PATHWAY_902
+903,903,903,903,903,903,903,903,R-HSA-5654712,FRS-mediated FGFR4 signaling,REACTOME,pathway,PATHWAY_903
+904,904,904,904,904,904,904,904,R-HSA-111931,PKA-mediated phosphorylation of CREB,REACTOME,pathway,PATHWAY_904
+905,905,905,905,905,905,905,905,R-HSA-1474244,Extracellular matrix organization,REACTOME,pathway,PATHWAY_905
+906,906,906,906,906,906,906,906,R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,REACTOME,pathway,PATHWAY_906
+907,907,907,907,907,907,907,907,R-HSA-9694614,Attachment and Entry,REACTOME,pathway,PATHWAY_907
+908,908,908,908,908,908,908,908,R-HSA-419812,Calcitonin-like ligand receptors,REACTOME,pathway,PATHWAY_908
+909,909,909,909,909,909,909,909,R-HSA-8957322,Metabolism of steroids,REACTOME,pathway,PATHWAY_909
+910,910,910,910,910,910,910,910,R-HSA-8868773,rRNA processing in the nucleus and cytosol,REACTOME,pathway,PATHWAY_910
+911,911,911,911,911,911,911,911,R-HSA-9818035,NFE2L2 regulating ER-stress associated genes,REACTOME,pathway,PATHWAY_911
+912,912,912,912,912,912,912,912,R-HSA-5579013,Defective CYP7B1 causes SPG5A and CBAS3,REACTOME,pathway,PATHWAY_912
+913,913,913,913,913,913,913,913,R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,REACTOME,pathway,PATHWAY_913
+914,914,914,914,914,914,914,914,R-HSA-4086398,Ca2+ pathway,REACTOME,pathway,PATHWAY_914
+915,915,915,915,915,915,915,915,R-HSA-1433557,Signaling by SCF-KIT,REACTOME,pathway,PATHWAY_915
+916,916,916,916,916,916,916,916,R-HSA-5218921,VEGFR2 mediated cell proliferation,REACTOME,pathway,PATHWAY_916
+917,917,917,917,917,917,917,917,R-HSA-110056,MAPK3 (ERK1) activation,REACTOME,pathway,PATHWAY_917
+918,918,918,918,918,918,918,918,R-HSA-174403,Glutathione synthesis and recycling,REACTOME,pathway,PATHWAY_918
+919,919,919,919,919,919,919,919,R-HSA-6793080,rRNA modification in the mitochondrion,REACTOME,pathway,PATHWAY_919
+920,920,920,920,920,920,920,920,R-HSA-196741,"Cobalamin (Cbl, vitamin B12) transport and metabolism",REACTOME,pathway,PATHWAY_920
+921,921,921,921,921,921,921,921,R-HSA-9033500,TYSND1 cleaves peroxisomal proteins,REACTOME,pathway,PATHWAY_921
+922,922,922,922,922,922,922,922,R-HSA-159424,Conjugation of carboxylic acids,REACTOME,pathway,PATHWAY_922
+923,923,923,923,923,923,923,923,R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,REACTOME,pathway,PATHWAY_923
+924,924,924,924,924,924,924,924,R-HSA-9662001,Defective factor VIII causes hemophilia A,REACTOME,pathway,PATHWAY_924
+925,925,925,925,925,925,925,925,R-HSA-5678895,Defective CFTR causes cystic fibrosis,REACTOME,pathway,PATHWAY_925
+926,926,926,926,926,926,926,926,R-HSA-9707616,Heme signaling,REACTOME,pathway,PATHWAY_926
+927,927,927,927,927,927,927,927,R-HSA-1483152,Hydrolysis of LPE,REACTOME,pathway,PATHWAY_927
+928,928,928,928,928,928,928,928,R-HSA-111457,Release of apoptotic factors from the mitochondria,REACTOME,pathway,PATHWAY_928
+929,929,929,929,929,929,929,929,R-HSA-1266695,Interleukin-7 signaling,REACTOME,pathway,PATHWAY_929
+930,930,930,930,930,930,930,930,R-HSA-1855196,IP3 and IP4 transport between cytosol and nucleus,REACTOME,pathway,PATHWAY_930
+931,931,931,931,931,931,931,931,R-HSA-112412,SOS-mediated signalling,REACTOME,pathway,PATHWAY_931
+932,932,932,932,932,932,932,932,R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,REACTOME,pathway,PATHWAY_932
+933,933,933,933,933,933,933,933,R-HSA-168927,"TICAM1, RIP1-mediated IKK complex recruitment",REACTOME,pathway,PATHWAY_933
+934,934,934,934,934,934,934,934,R-HSA-448424,Interleukin-17 signaling,REACTOME,pathway,PATHWAY_934
+935,935,935,935,935,935,935,935,R-HSA-77289,Mitochondrial Fatty Acid Beta-Oxidation,REACTOME,pathway,PATHWAY_935
+936,936,936,936,936,936,936,936,R-HSA-9702581,crenolanib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_936
+937,937,937,937,937,937,937,937,R-HSA-1855231,Synthesis of IPs in the ER lumen,REACTOME,pathway,PATHWAY_937
+938,938,938,938,938,938,938,938,R-HSA-193692,Regulated proteolysis of p75NTR,REACTOME,pathway,PATHWAY_938
+939,939,939,939,939,939,939,939,R-HSA-9856532,Mechanical load activates signaling by PIEZO1 and integrins in osteocytes,REACTOME,pathway,PATHWAY_939
+940,940,940,940,940,940,940,940,R-HSA-175474,Assembly Of The HIV Virion,REACTOME,pathway,PATHWAY_940
+941,941,941,941,941,941,941,941,R-HSA-8941856,RUNX3 regulates NOTCH signaling,REACTOME,pathway,PATHWAY_941
+942,942,942,942,942,942,942,942,R-HSA-3371599,Defective HLCS causes multiple carboxylase deficiency,REACTOME,pathway,PATHWAY_942
+943,943,943,943,943,943,943,943,R-HSA-8856688,Golgi-to-ER retrograde transport,REACTOME,pathway,PATHWAY_943
+944,944,944,944,944,944,944,944,R-HSA-8941237,Invadopodia formation,REACTOME,pathway,PATHWAY_944
+945,945,945,945,945,945,945,945,R-HSA-674695,RNA Polymerase II Pre-transcription Events,REACTOME,pathway,PATHWAY_945
+946,946,946,946,946,946,946,946,R-HSA-69618,Mitotic Spindle Checkpoint,REACTOME,pathway,PATHWAY_946
+947,947,947,947,947,947,947,947,R-HSA-420499,Class C/3 (Metabotropic glutamate/pheromone receptors),REACTOME,pathway,PATHWAY_947
+948,948,948,948,948,948,948,948,R-HSA-1307965,betaKlotho-mediated ligand binding,REACTOME,pathway,PATHWAY_948
+949,949,949,949,949,949,949,949,R-HSA-1222449,Mtb iron assimilation by chelation,REACTOME,pathway,PATHWAY_949
+950,950,950,950,950,950,950,950,R-HSA-9013106,RHOC GTPase cycle,REACTOME,pathway,PATHWAY_950
+951,951,951,951,951,951,951,951,R-HSA-1660516,Synthesis of PIPs at the early endosome membrane,REACTOME,pathway,PATHWAY_951
+952,952,952,952,952,952,952,952,R-HSA-69206,G1/S Transition,REACTOME,pathway,PATHWAY_952
+953,953,953,953,953,953,953,953,R-HSA-597592,Post-translational protein modification,REACTOME,pathway,PATHWAY_953
+954,954,954,954,954,954,954,954,R-HSA-204998,"Cell death signalling via NRAGE, NRIF and NADE",REACTOME,pathway,PATHWAY_954
+955,955,955,955,955,955,955,955,R-HSA-5690338,Defective ABCC6 causes PXE,REACTOME,pathway,PATHWAY_955
+956,956,956,956,956,956,956,956,R-HSA-189445,Metabolism of porphyrins,REACTOME,pathway,PATHWAY_956
+957,957,957,957,957,957,957,957,R-HSA-176417,Phosphorylation of Emi1,REACTOME,pathway,PATHWAY_957
+958,958,958,958,958,958,958,958,R-HSA-5358565,Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),REACTOME,pathway,PATHWAY_958
+959,959,959,959,959,959,959,959,R-HSA-168275,Entry of Influenza Virion into Host Cell via Endocytosis,REACTOME,pathway,PATHWAY_959
+960,960,960,960,960,960,960,960,R-HSA-71288,Creatine metabolism,REACTOME,pathway,PATHWAY_960
+961,961,961,961,961,961,961,961,R-HSA-9824594,Regulation of MITF-M-dependent genes involved in apoptosis,REACTOME,pathway,PATHWAY_961
+962,962,962,962,962,962,962,962,R-HSA-8956319,Nucleotide catabolism,REACTOME,pathway,PATHWAY_962
+963,963,963,963,963,963,963,963,R-HSA-193670,p75NTR negatively regulates cell cycle via SC1,REACTOME,pathway,PATHWAY_963
+964,964,964,964,964,964,964,964,R-HSA-425397,"Transport of vitamins, nucleosides, and related molecules",REACTOME,pathway,PATHWAY_964
+965,965,965,965,965,965,965,965,R-HSA-5619095,"Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)",REACTOME,pathway,PATHWAY_965
+966,966,966,966,966,966,966,966,R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),REACTOME,pathway,PATHWAY_966
+967,967,967,967,967,967,967,967,R-HSA-202131,Metabolism of nitric oxide: NOS3 activation and regulation,REACTOME,pathway,PATHWAY_967
+968,968,968,968,968,968,968,968,R-HSA-165159,MTOR signalling,REACTOME,pathway,PATHWAY_968
+969,969,969,969,969,969,969,969,R-HSA-8957275,Post-translational protein phosphorylation,REACTOME,pathway,PATHWAY_969
+970,970,970,970,970,970,970,970,R-HSA-9033658,Blood group systems biosynthesis,REACTOME,pathway,PATHWAY_970
+971,971,971,971,971,971,971,971,R-HSA-382556,ABC-family proteins mediated transport,REACTOME,pathway,PATHWAY_971
+972,972,972,972,972,972,972,972,R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,REACTOME,pathway,PATHWAY_972
+973,973,973,973,973,973,973,973,R-HSA-2142816,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),REACTOME,pathway,PATHWAY_973
+974,974,974,974,974,974,974,974,R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),REACTOME,pathway,PATHWAY_974
+975,975,975,975,975,975,975,975,R-HSA-71737,Pyrophosphate hydrolysis,REACTOME,pathway,PATHWAY_975
+976,976,976,976,976,976,976,976,R-HSA-5339562,Uptake and actions of bacterial toxins,REACTOME,pathway,PATHWAY_976
+977,977,977,977,977,977,977,977,R-HSA-168888,Inhibition of IFN-beta,REACTOME,pathway,PATHWAY_977
+978,978,978,978,978,978,978,978,R-HSA-418359,Reduction of cytosolic Ca++ levels,REACTOME,pathway,PATHWAY_978
+979,979,979,979,979,979,979,979,R-HSA-8876384,Listeria monocytogenes entry into host cells,REACTOME,pathway,PATHWAY_979
+980,980,980,980,980,980,980,980,R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,REACTOME,pathway,PATHWAY_980
+981,981,981,981,981,981,981,981,R-HSA-8939247,RUNX1 regulates transcription of genes involved in interleukin signaling,REACTOME,pathway,PATHWAY_981
+982,982,982,982,982,982,982,982,R-HSA-8935690,Digestion,REACTOME,pathway,PATHWAY_982
+983,983,983,983,983,983,983,983,R-HSA-9696273,RND1 GTPase cycle,REACTOME,pathway,PATHWAY_983
+984,984,984,984,984,984,984,984,R-HSA-5654733,Negative regulation of FGFR4 signaling,REACTOME,pathway,PATHWAY_984
+985,985,985,985,985,985,985,985,R-HSA-9759475,Regulation of CDH11 Expression and Function,REACTOME,pathway,PATHWAY_985
+986,986,986,986,986,986,986,986,R-HSA-1236977,Endosomal/Vacuolar pathway,REACTOME,pathway,PATHWAY_986
+987,987,987,987,987,987,987,987,R-HSA-450513,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",REACTOME,pathway,PATHWAY_987
+988,988,988,988,988,988,988,988,R-HSA-168799,Neurotoxicity of clostridium toxins,REACTOME,pathway,PATHWAY_988
+989,989,989,989,989,989,989,989,R-HSA-9673767,"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",REACTOME,pathway,PATHWAY_989
+990,990,990,990,990,990,990,990,R-HSA-9669933,Signaling by kinase domain mutants of KIT,REACTOME,pathway,PATHWAY_990
+991,991,991,991,991,991,991,991,R-HSA-606279,Deposition of new CENPA-containing nucleosomes at the centromere,REACTOME,pathway,PATHWAY_991
+992,992,992,992,992,992,992,992,R-HSA-73943,Reversal of alkylation damage by DNA dioxygenases,REACTOME,pathway,PATHWAY_992
+993,993,993,993,993,993,993,993,R-HSA-9733458,Induction of Cell-Cell Fusion,REACTOME,pathway,PATHWAY_993
+994,994,994,994,994,994,994,994,R-HSA-8853336,Signaling by plasma membrane FGFR1 fusions,REACTOME,pathway,PATHWAY_994
+995,995,995,995,995,995,995,995,R-HSA-418457,cGMP effects,REACTOME,pathway,PATHWAY_995
+996,996,996,996,996,996,996,996,R-HSA-982772,Growth hormone receptor signaling,REACTOME,pathway,PATHWAY_996
+997,997,997,997,997,997,997,997,R-HSA-8866906,TFAP2 (AP-2) family regulates transcription of other transcription factors,REACTOME,pathway,PATHWAY_997
+998,998,998,998,998,998,998,998,R-HSA-9640463,Wax biosynthesis,REACTOME,pathway,PATHWAY_998
+999,999,999,999,999,999,999,999,R-HSA-9032845,Activated NTRK2 signals through CDK5,REACTOME,pathway,PATHWAY_999
+1000,1000,1000,1000,1000,1000,1000,1000,R-HSA-6787450,tRNA modification in the mitochondrion,REACTOME,pathway,PATHWAY_1000
+1001,1001,1001,1001,1001,1001,1001,1001,R-HSA-977443,GABA receptor activation,REACTOME,pathway,PATHWAY_1001
+1002,1002,1002,1002,1002,1002,1002,1002,R-HSA-9026290,Biosynthesis of DPAn-3-derived maresins,REACTOME,pathway,PATHWAY_1002
+1003,1003,1003,1003,1003,1003,1003,1003,R-HSA-8849473,PTK6 Expression,REACTOME,pathway,PATHWAY_1003
+1004,1004,1004,1004,1004,1004,1004,1004,R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,REACTOME,pathway,PATHWAY_1004
+1005,1005,1005,1005,1005,1005,1005,1005,R-HSA-4755510,SUMOylation of immune response proteins,REACTOME,pathway,PATHWAY_1005
+1006,1006,1006,1006,1006,1006,1006,1006,R-HSA-8857538,PTK6 promotes HIF1A stabilization,REACTOME,pathway,PATHWAY_1006
+1007,1007,1007,1007,1007,1007,1007,1007,R-HSA-69091,Polymerase switching,REACTOME,pathway,PATHWAY_1007
+1008,1008,1008,1008,1008,1008,1008,1008,R-HSA-373076,Class A/1 (Rhodopsin-like receptors),REACTOME,pathway,PATHWAY_1008
+1009,1009,1009,1009,1009,1009,1009,1009,R-HSA-3560801,Defective B3GAT3 causes JDSSDHD,REACTOME,pathway,PATHWAY_1009
+1010,1010,1010,1010,1010,1010,1010,1010,R-HSA-6802952,Signaling by BRAF and RAF1 fusions,REACTOME,pathway,PATHWAY_1010
+1011,1011,1011,1011,1011,1011,1011,1011,R-HSA-9793528,Ciprofloxacin ADME,REACTOME,pathway,PATHWAY_1011
+1012,1012,1012,1012,1012,1012,1012,1012,R-HSA-111957,Cam-PDE 1 activation,REACTOME,pathway,PATHWAY_1012
+1013,1013,1013,1013,1013,1013,1013,1013,R-HSA-179812,GRB2 events in EGFR signaling,REACTOME,pathway,PATHWAY_1013
+1014,1014,1014,1014,1014,1014,1014,1014,R-HSA-199220,Vitamin B5 (pantothenate) metabolism,REACTOME,pathway,PATHWAY_1014
+1015,1015,1015,1015,1015,1015,1015,1015,R-HSA-2500257,Resolution of Sister Chromatid Cohesion,REACTOME,pathway,PATHWAY_1015
+1016,1016,1016,1016,1016,1016,1016,1016,R-HSA-449147,Signaling by Interleukins,REACTOME,pathway,PATHWAY_1016
+1017,1017,1017,1017,1017,1017,1017,1017,R-HSA-8866911,TFAP2 (AP-2) family regulates transcription of cell cycle factors,REACTOME,pathway,PATHWAY_1017
+1018,1018,1018,1018,1018,1018,1018,1018,R-HSA-9032500,Activated NTRK2 signals through FYN,REACTOME,pathway,PATHWAY_1018
+1019,1019,1019,1019,1019,1019,1019,1019,R-HSA-9014843,Interleukin-33 signaling,REACTOME,pathway,PATHWAY_1019
+1020,1020,1020,1020,1020,1020,1020,1020,R-HSA-9841922,MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis,REACTOME,pathway,PATHWAY_1020
+1021,1021,1021,1021,1021,1021,1021,1021,R-HSA-1227986,Signaling by ERBB2,REACTOME,pathway,PATHWAY_1021
+1022,1022,1022,1022,1022,1022,1022,1022,R-HSA-5655862,Translesion synthesis by POLK,REACTOME,pathway,PATHWAY_1022
+1023,1023,1023,1023,1023,1023,1023,1023,R-HSA-9013700,NOTCH4 Activation and Transmission of Signal to the Nucleus,REACTOME,pathway,PATHWAY_1023
+1024,1024,1024,1024,1024,1024,1024,1024,R-HSA-5696398,Nucleotide Excision Repair,REACTOME,pathway,PATHWAY_1024
+1025,1025,1025,1025,1025,1025,1025,1025,R-HSA-73893,DNA Damage Bypass,REACTOME,pathway,PATHWAY_1025
+1026,1026,1026,1026,1026,1026,1026,1026,R-HSA-181431,Acetylcholine binding and downstream events,REACTOME,pathway,PATHWAY_1026
+1027,1027,1027,1027,1027,1027,1027,1027,R-HSA-622323,Presynaptic nicotinic acetylcholine receptors,REACTOME,pathway,PATHWAY_1027
+1028,1028,1028,1028,1028,1028,1028,1028,R-HSA-3656535,TGFBR1 LBD Mutants in Cancer,REACTOME,pathway,PATHWAY_1028
+1029,1029,1029,1029,1029,1029,1029,1029,R-HSA-114608,Platelet degranulation ,REACTOME,pathway,PATHWAY_1029
+1030,1030,1030,1030,1030,1030,1030,1030,R-HSA-4839726,Chromatin organization,REACTOME,pathway,PATHWAY_1030
+1031,1031,1031,1031,1031,1031,1031,1031,R-HSA-5679096,Defective ABCG5 causes sitosterolemia,REACTOME,pathway,PATHWAY_1031
+1032,1032,1032,1032,1032,1032,1032,1032,R-HSA-9620244,Long-term potentiation,REACTOME,pathway,PATHWAY_1032
+1033,1033,1033,1033,1033,1033,1033,1033,R-HSA-9755511,KEAP1-NFE2L2 pathway,REACTOME,pathway,PATHWAY_1033
+1034,1034,1034,1034,1034,1034,1034,1034,R-HSA-5687613,Diseases associated with surfactant metabolism,REACTOME,pathway,PATHWAY_1034
+1035,1035,1035,1035,1035,1035,1035,1035,R-HSA-163680,AMPK inhibits chREBP transcriptional activation activity,REACTOME,pathway,PATHWAY_1035
+1036,1036,1036,1036,1036,1036,1036,1036,R-HSA-2046104,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,REACTOME,pathway,PATHWAY_1036
+1037,1037,1037,1037,1037,1037,1037,1037,R-HSA-9675135,Diseases of DNA repair,REACTOME,pathway,PATHWAY_1037
+1038,1038,1038,1038,1038,1038,1038,1038,R-HSA-5654720,PI-3K cascade:FGFR4,REACTOME,pathway,PATHWAY_1038
+1039,1039,1039,1039,1039,1039,1039,1039,R-HSA-4641258,Degradation of DVL,REACTOME,pathway,PATHWAY_1039
+1040,1040,1040,1040,1040,1040,1040,1040,R-HSA-379401,Dopamine clearance from the synaptic cleft,REACTOME,pathway,PATHWAY_1040
+1041,1041,1041,1041,1041,1041,1041,1041,R-HSA-549132,Organic cation/anion/zwitterion transport,REACTOME,pathway,PATHWAY_1041
+1042,1042,1042,1042,1042,1042,1042,1042,R-HSA-418885,DCC mediated attractive signaling,REACTOME,pathway,PATHWAY_1042
+1043,1043,1043,1043,1043,1043,1043,1043,R-HSA-3359467,Defective MTRR causes HMAE,REACTOME,pathway,PATHWAY_1043
+1044,1044,1044,1044,1044,1044,1044,1044,R-HSA-9669929,Regorafenib-resistant KIT mutants,REACTOME,pathway,PATHWAY_1044
+1045,1045,1045,1045,1045,1045,1045,1045,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,REACTOME,pathway,PATHWAY_1045
+1046,1046,1046,1046,1046,1046,1046,1046,R-HSA-168255,Influenza Infection,REACTOME,pathway,PATHWAY_1046
+1047,1047,1047,1047,1047,1047,1047,1047,R-HSA-9683439,Assembly of the SARS-CoV-1 Replication-Transcription Complex (RTC),REACTOME,pathway,PATHWAY_1047
+1048,1048,1048,1048,1048,1048,1048,1048,R-HSA-6803204,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,REACTOME,pathway,PATHWAY_1048
+1049,1049,1049,1049,1049,1049,1049,1049,R-HSA-5619041,Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG),REACTOME,pathway,PATHWAY_1049
+1050,1050,1050,1050,1050,1050,1050,1050,R-HSA-6811440,Retrograde transport at the Trans-Golgi-Network,REACTOME,pathway,PATHWAY_1050
+1051,1051,1051,1051,1051,1051,1051,1051,R-HSA-9013148,CDC42 GTPase cycle,REACTOME,pathway,PATHWAY_1051
+1052,1052,1052,1052,1052,1052,1052,1052,R-HSA-162699,Synthesis of dolichyl-phosphate mannose,REACTOME,pathway,PATHWAY_1052
+1053,1053,1053,1053,1053,1053,1053,1053,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,REACTOME,pathway,PATHWAY_1053
+1054,1054,1054,1054,1054,1054,1054,1054,R-HSA-9704331,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,REACTOME,pathway,PATHWAY_1054
+1055,1055,1055,1055,1055,1055,1055,1055,R-HSA-111996,Ca-dependent events,REACTOME,pathway,PATHWAY_1055
+1056,1056,1056,1056,1056,1056,1056,1056,R-HSA-69186,Lagging Strand Synthesis,REACTOME,pathway,PATHWAY_1056
+1057,1057,1057,1057,1057,1057,1057,1057,R-HSA-1300642,Sperm Motility And Taxes,REACTOME,pathway,PATHWAY_1057
+1058,1058,1058,1058,1058,1058,1058,1058,R-HSA-6807047,Cholesterol biosynthesis via desmosterol,REACTOME,pathway,PATHWAY_1058
+1059,1059,1059,1059,1059,1059,1059,1059,R-HSA-9707564,Cytoprotection by HMOX1,REACTOME,pathway,PATHWAY_1059
+1060,1060,1060,1060,1060,1060,1060,1060,R-HSA-5579014,Defective CYP27B1 causes VDDR1A,REACTOME,pathway,PATHWAY_1060
+1061,1061,1061,1061,1061,1061,1061,1061,R-HSA-69473,G2/M DNA damage checkpoint,REACTOME,pathway,PATHWAY_1061
+1062,1062,1062,1062,1062,1062,1062,1062,R-HSA-426048,Arachidonate production from DAG,REACTOME,pathway,PATHWAY_1062
+1063,1063,1063,1063,1063,1063,1063,1063,R-HSA-3359462,Defective AMN causes MGA1,REACTOME,pathway,PATHWAY_1063
+1064,1064,1064,1064,1064,1064,1064,1064,R-HSA-2995410,Nuclear Envelope (NE) Reassembly,REACTOME,pathway,PATHWAY_1064
+1065,1065,1065,1065,1065,1065,1065,1065,R-HSA-844623,The IPAF inflammasome,REACTOME,pathway,PATHWAY_1065
+1066,1066,1066,1066,1066,1066,1066,1066,R-HSA-77346,Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,REACTOME,pathway,PATHWAY_1066
+1067,1067,1067,1067,1067,1067,1067,1067,R-HSA-72689,Formation of a pool of free 40S subunits,REACTOME,pathway,PATHWAY_1067
+1068,1068,1068,1068,1068,1068,1068,1068,R-HSA-1237112,Methionine salvage pathway,REACTOME,pathway,PATHWAY_1068
+1069,1069,1069,1069,1069,1069,1069,1069,R-HSA-192105,Synthesis of bile acids and bile salts,REACTOME,pathway,PATHWAY_1069
+1070,1070,1070,1070,1070,1070,1070,1070,R-HSA-6806664,Metabolism of vitamin K,REACTOME,pathway,PATHWAY_1070
+1071,1071,1071,1071,1071,1071,1071,1071,R-HSA-1614517,Sulfide oxidation to sulfate,REACTOME,pathway,PATHWAY_1071
+1072,1072,1072,1072,1072,1072,1072,1072,R-HSA-70350,Fructose catabolism,REACTOME,pathway,PATHWAY_1072
+1073,1073,1073,1073,1073,1073,1073,1073,R-HSA-6794362,Protein-protein interactions at synapses,REACTOME,pathway,PATHWAY_1073
+1074,1074,1074,1074,1074,1074,1074,1074,R-HSA-3595177,Defective CHSY1 causes TPBS,REACTOME,pathway,PATHWAY_1074
+1075,1075,1075,1075,1075,1075,1075,1075,R-HSA-165181,Inhibition of TSC complex formation by PKB,REACTOME,pathway,PATHWAY_1075
+1076,1076,1076,1076,1076,1076,1076,1076,R-HSA-5654708,Downstream signaling of activated FGFR3,REACTOME,pathway,PATHWAY_1076
+1077,1077,1077,1077,1077,1077,1077,1077,R-HSA-110330,Recognition and association of DNA glycosylase with site containing an affected purine,REACTOME,pathway,PATHWAY_1077
+1078,1078,1078,1078,1078,1078,1078,1078,R-HSA-9843745,Adipogenesis,REACTOME,pathway,PATHWAY_1078
+1079,1079,1079,1079,1079,1079,1079,1079,R-HSA-5340588,Signaling by RNF43 mutants,REACTOME,pathway,PATHWAY_1079
+1080,1080,1080,1080,1080,1080,1080,1080,R-HSA-9854909,Regulation of MITF-M dependent genes involved in invasion,REACTOME,pathway,PATHWAY_1080
+1081,1081,1081,1081,1081,1081,1081,1081,R-HSA-5357801,Programmed Cell Death,REACTOME,pathway,PATHWAY_1081
+1082,1082,1082,1082,1082,1082,1082,1082,R-HSA-75072,mRNA Editing,REACTOME,pathway,PATHWAY_1082
+1083,1083,1083,1083,1083,1083,1083,1083,R-HSA-168898,Toll-like Receptor Cascades,REACTOME,pathway,PATHWAY_1083
+1084,1084,1084,1084,1084,1084,1084,1084,R-HSA-5693571,Nonhomologous End-Joining (NHEJ),REACTOME,pathway,PATHWAY_1084
+1085,1085,1085,1085,1085,1085,1085,1085,R-HSA-5579004,Defective CYP26C1 causes FFDD4,REACTOME,pathway,PATHWAY_1085
+1086,1086,1086,1086,1086,1086,1086,1086,R-HSA-6803207,TP53 Regulates Transcription of Caspase Activators and Caspases,REACTOME,pathway,PATHWAY_1086
+1087,1087,1087,1087,1087,1087,1087,1087,R-HSA-69231,Cyclin D associated events in G1,REACTOME,pathway,PATHWAY_1087
+1088,1088,1088,1088,1088,1088,1088,1088,R-HSA-114508,Effects of PIP2 hydrolysis,REACTOME,pathway,PATHWAY_1088
+1089,1089,1089,1089,1089,1089,1089,1089,R-HSA-1855204,Synthesis of IP3 and IP4 in the cytosol,REACTOME,pathway,PATHWAY_1089
+1090,1090,1090,1090,1090,1090,1090,1090,R-HSA-5683057,MAPK family signaling cascades,REACTOME,pathway,PATHWAY_1090
+1091,1091,1091,1091,1091,1091,1091,1091,R-HSA-8875555,MET activates RAP1 and RAC1,REACTOME,pathway,PATHWAY_1091
+1092,1092,1092,1092,1092,1092,1092,1092,R-HSA-9694676,Translation of Replicase and Assembly of the Replication Transcription Complex,REACTOME,pathway,PATHWAY_1092
+1093,1093,1093,1093,1093,1093,1093,1093,R-HSA-1461957,Beta defensins,REACTOME,pathway,PATHWAY_1093
+1094,1094,1094,1094,1094,1094,1094,1094,R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,REACTOME,pathway,PATHWAY_1094
+1095,1095,1095,1095,1095,1095,1095,1095,R-HSA-844615,The AIM2 inflammasome,REACTOME,pathway,PATHWAY_1095
+1096,1096,1096,1096,1096,1096,1096,1096,R-HSA-68884,Mitotic Telophase/Cytokinesis,REACTOME,pathway,PATHWAY_1096
+1097,1097,1097,1097,1097,1097,1097,1097,R-HSA-1251932,PLCG1 events in ERBB2 signaling,REACTOME,pathway,PATHWAY_1097
+1098,1098,1098,1098,1098,1098,1098,1098,R-HSA-186763,Downstream signal transduction,REACTOME,pathway,PATHWAY_1098
+1099,1099,1099,1099,1099,1099,1099,1099,R-HSA-5682113,Defective ABCA1 causes TGD,REACTOME,pathway,PATHWAY_1099
+1100,1100,1100,1100,1100,1100,1100,1100,R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,REACTOME,pathway,PATHWAY_1100
+1101,1101,1101,1101,1101,1101,1101,1101,R-HSA-8849175,Threonine catabolism,REACTOME,pathway,PATHWAY_1101
+1102,1102,1102,1102,1102,1102,1102,1102,R-HSA-948021,Transport to the Golgi and subsequent modification,REACTOME,pathway,PATHWAY_1102
+1103,1103,1103,1103,1103,1103,1103,1103,R-HSA-110312,Translesion synthesis by REV1,REACTOME,pathway,PATHWAY_1103
+1104,1104,1104,1104,1104,1104,1104,1104,R-HSA-163282,Mitochondrial transcription initiation,REACTOME,pathway,PATHWAY_1104
+1105,1105,1105,1105,1105,1105,1105,1105,R-HSA-9694686,Replication of the SARS-CoV-2 genome,REACTOME,pathway,PATHWAY_1105
+1106,1106,1106,1106,1106,1106,1106,1106,R-HSA-159418,Recycling of bile acids and salts,REACTOME,pathway,PATHWAY_1106
+1107,1107,1107,1107,1107,1107,1107,1107,R-HSA-451306,Ionotropic activity of kainate receptors,REACTOME,pathway,PATHWAY_1107
+1108,1108,1108,1108,1108,1108,1108,1108,R-HSA-9672391,Defective F8 cleavage by thrombin,REACTOME,pathway,PATHWAY_1108
+1109,1109,1109,1109,1109,1109,1109,1109,R-HSA-1475029,Reversible hydration of carbon dioxide,REACTOME,pathway,PATHWAY_1109
+1110,1110,1110,1110,1110,1110,1110,1110,R-HSA-9636249,Inhibition of nitric oxide production,REACTOME,pathway,PATHWAY_1110
+1111,1111,1111,1111,1111,1111,1111,1111,R-HSA-192869,cRNA Synthesis,REACTOME,pathway,PATHWAY_1111
+1112,1112,1112,1112,1112,1112,1112,1112,R-HSA-5693568,Resolution of D-loop Structures through Holliday Junction Intermediates,REACTOME,pathway,PATHWAY_1112
+1113,1113,1113,1113,1113,1113,1113,1113,R-HSA-2644607,Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,REACTOME,pathway,PATHWAY_1113
+1114,1114,1114,1114,1114,1114,1114,1114,R-HSA-9912481,Branched-chain ketoacid dehydrogenase kinase deficiency,REACTOME,pathway,PATHWAY_1114
+1115,1115,1115,1115,1115,1115,1115,1115,R-HSA-5619062,Defective SLC1A3 causes episodic ataxia 6 (EA6),REACTOME,pathway,PATHWAY_1115
+1116,1116,1116,1116,1116,1116,1116,1116,R-HSA-5688849,Defective CSF2RB causes SMDP5,REACTOME,pathway,PATHWAY_1116
+1117,1117,1117,1117,1117,1117,1117,1117,R-HSA-6804115,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,REACTOME,pathway,PATHWAY_1117
+1118,1118,1118,1118,1118,1118,1118,1118,R-HSA-9708530,Regulation of BACH1 activity,REACTOME,pathway,PATHWAY_1118
+1119,1119,1119,1119,1119,1119,1119,1119,R-HSA-193634,Axonal growth inhibition (RHOA activation),REACTOME,pathway,PATHWAY_1119
+1120,1120,1120,1120,1120,1120,1120,1120,R-HSA-9841251,Mitochondrial unfolded protein response (UPRmt),REACTOME,pathway,PATHWAY_1120
+1121,1121,1121,1121,1121,1121,1121,1121,R-HSA-9911233,Expression of NOTCH2NL genes,REACTOME,pathway,PATHWAY_1121
+1122,1122,1122,1122,1122,1122,1122,1122,R-HSA-9646304,Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects,REACTOME,pathway,PATHWAY_1122
+1123,1123,1123,1123,1123,1123,1123,1123,R-HSA-4641257,Degradation of AXIN,REACTOME,pathway,PATHWAY_1123
+1124,1124,1124,1124,1124,1124,1124,1124,R-HSA-4085023,Defective GFPT1 causes CMSTA1,REACTOME,pathway,PATHWAY_1124
+1125,1125,1125,1125,1125,1125,1125,1125,R-HSA-1660508,PIPs transport between late endosome and Golgi membranes,REACTOME,pathway,PATHWAY_1125
+1126,1126,1126,1126,1126,1126,1126,1126,R-HSA-110373,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,REACTOME,pathway,PATHWAY_1126
+1127,1127,1127,1127,1127,1127,1127,1127,R-HSA-6804114,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,REACTOME,pathway,PATHWAY_1127
+1128,1128,1128,1128,1128,1128,1128,1128,R-HSA-9006925,Intracellular signaling by second messengers,REACTOME,pathway,PATHWAY_1128
+1129,1129,1129,1129,1129,1129,1129,1129,R-HSA-933542,TRAF6 mediated NF-kB activation,REACTOME,pathway,PATHWAY_1129
+1130,1130,1130,1130,1130,1130,1130,1130,R-HSA-6791465,Pentose phosphate pathway disease,REACTOME,pathway,PATHWAY_1130
+1131,1131,1131,1131,1131,1131,1131,1131,R-HSA-9709603,Impaired BRCA2 binding to PALB2,REACTOME,pathway,PATHWAY_1131
+1132,1132,1132,1132,1132,1132,1132,1132,R-HSA-9673324,WNT5:FZD7-mediated leishmania damping,REACTOME,pathway,PATHWAY_1132
+1133,1133,1133,1133,1133,1133,1133,1133,R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,REACTOME,pathway,PATHWAY_1133
+1134,1134,1134,1134,1134,1134,1134,1134,R-HSA-9843940,Regulation of endogenous retroelements by KRAB-ZFP proteins,REACTOME,pathway,PATHWAY_1134
+1135,1135,1135,1135,1135,1135,1135,1135,R-HSA-198765,Signalling to ERK5,REACTOME,pathway,PATHWAY_1135
+1136,1136,1136,1136,1136,1136,1136,1136,R-HSA-77075,RNA Pol II CTD phosphorylation and interaction with CE,REACTOME,pathway,PATHWAY_1136
+1137,1137,1137,1137,1137,1137,1137,1137,R-HSA-73780,RNA Polymerase III Chain Elongation,REACTOME,pathway,PATHWAY_1137
+1138,1138,1138,1138,1138,1138,1138,1138,R-HSA-8963678,Intestinal lipid absorption,REACTOME,pathway,PATHWAY_1138
+1139,1139,1139,1139,1139,1139,1139,1139,R-HSA-3656225,Defective CHST6 causes MCDC1,REACTOME,pathway,PATHWAY_1139
+1140,1140,1140,1140,1140,1140,1140,1140,R-HSA-9750126,Drug-induced formation of DNA interstrand crosslinks,REACTOME,pathway,PATHWAY_1140
+1141,1141,1141,1141,1141,1141,1141,1141,R-HSA-5340573,LGK974 inhibits PORCN,REACTOME,pathway,PATHWAY_1141
+1142,1142,1142,1142,1142,1142,1142,1142,R-HSA-9670095,Inhibition of DNA recombination at telomere,REACTOME,pathway,PATHWAY_1142
+1143,1143,1143,1143,1143,1143,1143,1143,R-HSA-5579026,Defective CYP11A1 causes AICSR,REACTOME,pathway,PATHWAY_1143
+1144,1144,1144,1144,1144,1144,1144,1144,R-HSA-5576894,Phase 1 - inactivation of fast Na+ channels,REACTOME,pathway,PATHWAY_1144
+1145,1145,1145,1145,1145,1145,1145,1145,R-HSA-190377,FGFR2b ligand binding and activation,REACTOME,pathway,PATHWAY_1145
+1146,1146,1146,1146,1146,1146,1146,1146,R-HSA-180746,Nuclear import of Rev protein,REACTOME,pathway,PATHWAY_1146
+1147,1147,1147,1147,1147,1147,1147,1147,R-HSA-2206292,MPS VII - Sly syndrome,REACTOME,pathway,PATHWAY_1147
+1148,1148,1148,1148,1148,1148,1148,1148,R-HSA-1483148,Synthesis of PG,REACTOME,pathway,PATHWAY_1148
+1149,1149,1149,1149,1149,1149,1149,1149,R-HSA-5578995,Defective TPMT causes TPMT deficiency,REACTOME,pathway,PATHWAY_1149
+1150,1150,1150,1150,1150,1150,1150,1150,R-HSA-9727281,Translation of Accessory Proteins,REACTOME,pathway,PATHWAY_1150
+1151,1151,1151,1151,1151,1151,1151,1151,R-HSA-167158,Formation of the HIV-1 Early Elongation Complex,REACTOME,pathway,PATHWAY_1151
+1152,1152,1152,1152,1152,1152,1152,1152,R-HSA-163359,Glucagon signaling in metabolic regulation,REACTOME,pathway,PATHWAY_1152
+1153,1153,1153,1153,1153,1153,1153,1153,R-HSA-1963642,PI3K events in ERBB2 signaling,REACTOME,pathway,PATHWAY_1153
+1154,1154,1154,1154,1154,1154,1154,1154,R-HSA-9818749,Regulation of NFE2L2 gene expression,REACTOME,pathway,PATHWAY_1154
+1155,1155,1155,1155,1155,1155,1155,1155,R-HSA-110329,Cleavage of the damaged pyrimidine ,REACTOME,pathway,PATHWAY_1155
+1156,1156,1156,1156,1156,1156,1156,1156,R-HSA-9635644,Inhibition of membrane repair,REACTOME,pathway,PATHWAY_1156
+1157,1157,1157,1157,1157,1157,1157,1157,R-HSA-9694493,Maturation of protein E,REACTOME,pathway,PATHWAY_1157
+1158,1158,1158,1158,1158,1158,1158,1158,R-HSA-9029569,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,REACTOME,pathway,PATHWAY_1158
+1159,1159,1159,1159,1159,1159,1159,1159,R-HSA-8963889,Assembly of active LPL and LIPC lipase complexes,REACTOME,pathway,PATHWAY_1159
+1160,1160,1160,1160,1160,1160,1160,1160,R-HSA-9748787,Azathioprine ADME,REACTOME,pathway,PATHWAY_1160
+1161,1161,1161,1161,1161,1161,1161,1161,R-HSA-9680350,Signaling by CSF1 (M-CSF) in myeloid cells,REACTOME,pathway,PATHWAY_1161
+1162,1162,1162,1162,1162,1162,1162,1162,R-HSA-209563,Axonal growth stimulation,REACTOME,pathway,PATHWAY_1162
+1163,1163,1163,1163,1163,1163,1163,1163,R-HSA-428543,Inactivation of CDC42 and RAC1,REACTOME,pathway,PATHWAY_1163
+1164,1164,1164,1164,1164,1164,1164,1164,R-HSA-75205,Dissolution of Fibrin Clot,REACTOME,pathway,PATHWAY_1164
+1165,1165,1165,1165,1165,1165,1165,1165,R-HSA-399956,CRMPs in Sema3A signaling,REACTOME,pathway,PATHWAY_1165
+1166,1166,1166,1166,1166,1166,1166,1166,R-HSA-9027283,Erythropoietin activates STAT5,REACTOME,pathway,PATHWAY_1166
+1167,1167,1167,1167,1167,1167,1167,1167,R-HSA-9665230,Drug resistance in ERBB2 KD mutants,REACTOME,pathway,PATHWAY_1167
+1168,1168,1168,1168,1168,1168,1168,1168,R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,REACTOME,pathway,PATHWAY_1168
+1169,1169,1169,1169,1169,1169,1169,1169,R-HSA-5661231,Metallothioneins bind metals,REACTOME,pathway,PATHWAY_1169
+1170,1170,1170,1170,1170,1170,1170,1170,R-HSA-264876,Insulin processing,REACTOME,pathway,PATHWAY_1170
+1171,1171,1171,1171,1171,1171,1171,1171,R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,REACTOME,pathway,PATHWAY_1171
+1172,1172,1172,1172,1172,1172,1172,1172,R-HSA-8941858,Regulation of RUNX3 expression and activity,REACTOME,pathway,PATHWAY_1172
+1173,1173,1173,1173,1173,1173,1173,1173,R-HSA-9700206,Signaling by ALK in cancer,REACTOME,pathway,PATHWAY_1173
+1174,1174,1174,1174,1174,1174,1174,1174,R-HSA-2564830,Cytosolic iron-sulfur cluster assembly,REACTOME,pathway,PATHWAY_1174
+1175,1175,1175,1175,1175,1175,1175,1175,R-HSA-173623,Classical antibody-mediated complement activation,REACTOME,pathway,PATHWAY_1175
+1176,1176,1176,1176,1176,1176,1176,1176,R-HSA-167290,Pausing and recovery of HIV elongation,REACTOME,pathway,PATHWAY_1176
+1177,1177,1177,1177,1177,1177,1177,1177,R-HSA-2033519,Activated point mutants of FGFR2,REACTOME,pathway,PATHWAY_1177
+1178,1178,1178,1178,1178,1178,1178,1178,R-HSA-444209,Free fatty acid receptors,REACTOME,pathway,PATHWAY_1178
+1179,1179,1179,1179,1179,1179,1179,1179,R-HSA-76009,Platelet Aggregation (Plug Formation),REACTOME,pathway,PATHWAY_1179
+1180,1180,1180,1180,1180,1180,1180,1180,R-HSA-9824856,Defective regulation of TLR7 by endogenous ligand,REACTOME,pathway,PATHWAY_1180
+1181,1181,1181,1181,1181,1181,1181,1181,R-HSA-75892,Platelet Adhesion to exposed collagen,REACTOME,pathway,PATHWAY_1181
+1182,1182,1182,1182,1182,1182,1182,1182,R-HSA-187015,Activation of TRKA receptors,REACTOME,pathway,PATHWAY_1182
+1183,1183,1183,1183,1183,1183,1183,1183,R-HSA-9022538,Loss of MECP2 binding ability to 5mC-DNA,REACTOME,pathway,PATHWAY_1183
+1184,1184,1184,1184,1184,1184,1184,1184,R-HSA-202424,Downstream TCR signaling,REACTOME,pathway,PATHWAY_1184
+1185,1185,1185,1185,1185,1185,1185,1185,R-HSA-4793954,Defective MOGS causes CDG-2b,REACTOME,pathway,PATHWAY_1185
+1186,1186,1186,1186,1186,1186,1186,1186,R-HSA-1839126,FGFR2 mutant receptor activation,REACTOME,pathway,PATHWAY_1186
+1187,1187,1187,1187,1187,1187,1187,1187,R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,REACTOME,pathway,PATHWAY_1187
+1188,1188,1188,1188,1188,1188,1188,1188,R-HSA-9916720,Mitochondrial short-chain enoyl-CoA hydratase deficiency 1,REACTOME,pathway,PATHWAY_1188
+1189,1189,1189,1189,1189,1189,1189,1189,R-HSA-9682708,Transcription of SARS-CoV-1 sgRNAs,REACTOME,pathway,PATHWAY_1189
+1190,1190,1190,1190,1190,1190,1190,1190,R-HSA-139915,Activation of PUMA and translocation to mitochondria,REACTOME,pathway,PATHWAY_1190
+1191,1191,1191,1191,1191,1191,1191,1191,R-HSA-9753281,Paracetamol ADME,REACTOME,pathway,PATHWAY_1191
+1192,1192,1192,1192,1192,1192,1192,1192,R-HSA-5579017,Defective CYP11B1 causes AH4,REACTOME,pathway,PATHWAY_1192
+1193,1193,1193,1193,1193,1193,1193,1193,R-HSA-9772755,Formation of WDR5-containing histone-modifying complexes,REACTOME,pathway,PATHWAY_1193
+1194,1194,1194,1194,1194,1194,1194,1194,R-HSA-5368286,Mitochondrial translation initiation,REACTOME,pathway,PATHWAY_1194
+1195,1195,1195,1195,1195,1195,1195,1195,R-HSA-3134973,LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,REACTOME,pathway,PATHWAY_1195
+1196,1196,1196,1196,1196,1196,1196,1196,R-HSA-177504,Retrograde neurotrophin signalling,REACTOME,pathway,PATHWAY_1196
+1197,1197,1197,1197,1197,1197,1197,1197,R-HSA-427975,Proton/oligopeptide cotransporters,REACTOME,pathway,PATHWAY_1197
+1198,1198,1198,1198,1198,1198,1198,1198,R-HSA-450385,Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,REACTOME,pathway,PATHWAY_1198
+1199,1199,1199,1199,1199,1199,1199,1199,R-HSA-5467343,Deletions in the AMER1 gene destabilize the destruction complex,REACTOME,pathway,PATHWAY_1199
+1200,1200,1200,1200,1200,1200,1200,1200,R-HSA-193775,Synthesis of bile acids and bile salts via 24-hydroxycholesterol,REACTOME,pathway,PATHWAY_1200
+1201,1201,1201,1201,1201,1201,1201,1201,R-HSA-5250981,Toxicity of botulinum toxin type F (botF),REACTOME,pathway,PATHWAY_1201
+1202,1202,1202,1202,1202,1202,1202,1202,R-HSA-2168880,Scavenging of heme from plasma,REACTOME,pathway,PATHWAY_1202
+1203,1203,1203,1203,1203,1203,1203,1203,R-HSA-6804756,Regulation of TP53 Activity through Phosphorylation,REACTOME,pathway,PATHWAY_1203
+1204,1204,1204,1204,1204,1204,1204,1204,R-HSA-8964026,Chylomicron clearance,REACTOME,pathway,PATHWAY_1204
+1205,1205,1205,1205,1205,1205,1205,1205,R-HSA-390471,Association of TriC/CCT with target proteins during biosynthesis,REACTOME,pathway,PATHWAY_1205
+1206,1206,1206,1206,1206,1206,1206,1206,R-HSA-3304351,Signaling by TGF-beta Receptor Complex in Cancer,REACTOME,pathway,PATHWAY_1206
+1207,1207,1207,1207,1207,1207,1207,1207,R-HSA-452723,Transcriptional regulation of pluripotent stem cells,REACTOME,pathway,PATHWAY_1207
+1208,1208,1208,1208,1208,1208,1208,1208,R-HSA-429914,Deadenylation-dependent mRNA decay,REACTOME,pathway,PATHWAY_1208
+1209,1209,1209,1209,1209,1209,1209,1209,R-HSA-202403,TCR signaling,REACTOME,pathway,PATHWAY_1209
+1210,1210,1210,1210,1210,1210,1210,1210,R-HSA-350864,Regulation of thyroid hormone activity,REACTOME,pathway,PATHWAY_1210
+1211,1211,1211,1211,1211,1211,1211,1211,R-HSA-5603037,IRAK4 deficiency (TLR5),REACTOME,pathway,PATHWAY_1211
+1212,1212,1212,1212,1212,1212,1212,1212,R-HSA-5663020,Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),REACTOME,pathway,PATHWAY_1212
+1213,1213,1213,1213,1213,1213,1213,1213,R-HSA-9818028,NFE2L2 regulates pentose phosphate pathway genes,REACTOME,pathway,PATHWAY_1213
+1214,1214,1214,1214,1214,1214,1214,1214,R-HSA-1638074,Keratan sulfate/keratin metabolism,REACTOME,pathway,PATHWAY_1214
+1215,1215,1215,1215,1215,1215,1215,1215,R-HSA-5140745,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",REACTOME,pathway,PATHWAY_1215
+1216,1216,1216,1216,1216,1216,1216,1216,R-HSA-9013508,NOTCH3 Intracellular Domain Regulates Transcription,REACTOME,pathway,PATHWAY_1216
+1217,1217,1217,1217,1217,1217,1217,1217,R-HSA-399997,Acetylcholine regulates insulin secretion,REACTOME,pathway,PATHWAY_1217
+1218,1218,1218,1218,1218,1218,1218,1218,R-HSA-4411364,Binding of TCF/LEF:CTNNB1 to target gene promoters,REACTOME,pathway,PATHWAY_1218
+1219,1219,1219,1219,1219,1219,1219,1219,R-HSA-392517,Rap1 signalling,REACTOME,pathway,PATHWAY_1219
+1220,1220,1220,1220,1220,1220,1220,1220,R-HSA-5389840,Mitochondrial translation elongation,REACTOME,pathway,PATHWAY_1220
+1221,1221,1221,1221,1221,1221,1221,1221,R-HSA-71336,Pentose phosphate pathway,REACTOME,pathway,PATHWAY_1221
+1222,1222,1222,1222,1222,1222,1222,1222,R-HSA-200425,Carnitine shuttle,REACTOME,pathway,PATHWAY_1222
+1223,1223,1223,1223,1223,1223,1223,1223,R-HSA-9674404,Sorafenib-resistant PDGFR mutants,REACTOME,pathway,PATHWAY_1223
+1224,1224,1224,1224,1224,1224,1224,1224,R-HSA-3249367,STAT6-mediated induction of chemokines,REACTOME,pathway,PATHWAY_1224
+1225,1225,1225,1225,1225,1225,1225,1225,R-HSA-9674403,Regorafenib-resistant PDGFR mutants,REACTOME,pathway,PATHWAY_1225
+1226,1226,1226,1226,1226,1226,1226,1226,R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,REACTOME,pathway,PATHWAY_1226
+1227,1227,1227,1227,1227,1227,1227,1227,R-HSA-198693,AKT phosphorylates targets in the nucleus,REACTOME,pathway,PATHWAY_1227
+1228,1228,1228,1228,1228,1228,1228,1228,R-HSA-5696394,DNA Damage Recognition in GG-NER,REACTOME,pathway,PATHWAY_1228
+1229,1229,1229,1229,1229,1229,1229,1229,R-HSA-917729,Endosomal Sorting Complex Required For Transport (ESCRT),REACTOME,pathway,PATHWAY_1229
+1230,1230,1230,1230,1230,1230,1230,1230,R-HSA-5689896,Ovarian tumor domain proteases,REACTOME,pathway,PATHWAY_1230
+1231,1231,1231,1231,1231,1231,1231,1231,R-HSA-9768919,NPAS4 regulates expression of target genes,REACTOME,pathway,PATHWAY_1231
+1232,1232,1232,1232,1232,1232,1232,1232,R-HSA-9617324,Negative regulation of NMDA receptor-mediated neuronal transmission,REACTOME,pathway,PATHWAY_1232
+1233,1233,1233,1233,1233,1233,1233,1233,R-HSA-913531,Interferon Signaling,REACTOME,pathway,PATHWAY_1233
+1234,1234,1234,1234,1234,1234,1234,1234,R-HSA-167238,Pausing and recovery of Tat-mediated HIV elongation,REACTOME,pathway,PATHWAY_1234
+1235,1235,1235,1235,1235,1235,1235,1235,R-HSA-5619046,Defective SLC26A4 causes Pendred syndrome (PDS),REACTOME,pathway,PATHWAY_1235
+1236,1236,1236,1236,1236,1236,1236,1236,R-HSA-194068,Bile acid and bile salt metabolism,REACTOME,pathway,PATHWAY_1236
+1237,1237,1237,1237,1237,1237,1237,1237,R-HSA-390466,Chaperonin-mediated protein folding,REACTOME,pathway,PATHWAY_1237
+1238,1238,1238,1238,1238,1238,1238,1238,R-HSA-937061,TRIF (TICAM1)-mediated TLR4 signaling ,REACTOME,pathway,PATHWAY_1238
+1239,1239,1239,1239,1239,1239,1239,1239,R-HSA-8986944,Transcriptional Regulation by MECP2,REACTOME,pathway,PATHWAY_1239
+1240,1240,1240,1240,1240,1240,1240,1240,R-HSA-9616334,Defective Base Excision Repair Associated with NEIL1,REACTOME,pathway,PATHWAY_1240
+1241,1241,1241,1241,1241,1241,1241,1241,R-HSA-5578999,Defective GCLC causes HAGGSD,REACTOME,pathway,PATHWAY_1241
+1242,1242,1242,1242,1242,1242,1242,1242,R-HSA-211000,Gene Silencing by RNA,REACTOME,pathway,PATHWAY_1242
+1243,1243,1243,1243,1243,1243,1243,1243,R-HSA-2173789,TGF-beta receptor signaling activates SMADs,REACTOME,pathway,PATHWAY_1243
+1244,1244,1244,1244,1244,1244,1244,1244,R-HSA-9702596,lestaurtinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_1244
+1245,1245,1245,1245,1245,1245,1245,1245,R-HSA-5654687,Downstream signaling of activated FGFR1,REACTOME,pathway,PATHWAY_1245
+1246,1246,1246,1246,1246,1246,1246,1246,R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,REACTOME,pathway,PATHWAY_1246
+1247,1247,1247,1247,1247,1247,1247,1247,R-HSA-983712,Ion channel transport,REACTOME,pathway,PATHWAY_1247
+1248,1248,1248,1248,1248,1248,1248,1248,R-HSA-72737,Cap-dependent Translation Initiation,REACTOME,pathway,PATHWAY_1248
+1249,1249,1249,1249,1249,1249,1249,1249,R-HSA-9705677,SARS-CoV-2 targets PDZ proteins in cell-cell junction,REACTOME,pathway,PATHWAY_1249
+1250,1250,1250,1250,1250,1250,1250,1250,R-HSA-9861718,Regulation of pyruvate metabolism,REACTOME,pathway,PATHWAY_1250
+1251,1251,1251,1251,1251,1251,1251,1251,R-HSA-5339717,Signaling by LRP5 mutants ,REACTOME,pathway,PATHWAY_1251
+1252,1252,1252,1252,1252,1252,1252,1252,R-HSA-9022702,MECP2 regulates transcription of neuronal ligands,REACTOME,pathway,PATHWAY_1252
+1253,1253,1253,1253,1253,1253,1253,1253,R-HSA-379716,Cytosolic tRNA aminoacylation,REACTOME,pathway,PATHWAY_1253
+1254,1254,1254,1254,1254,1254,1254,1254,R-HSA-426117,Cation-coupled Chloride cotransporters,REACTOME,pathway,PATHWAY_1254
+1255,1255,1255,1255,1255,1255,1255,1255,R-HSA-6811438,Intra-Golgi traffic,REACTOME,pathway,PATHWAY_1255
+1256,1256,1256,1256,1256,1256,1256,1256,R-HSA-6802957,Oncogenic MAPK signaling,REACTOME,pathway,PATHWAY_1256
+1257,1257,1257,1257,1257,1257,1257,1257,R-HSA-446353,Cell-extracellular matrix interactions,REACTOME,pathway,PATHWAY_1257
+1258,1258,1258,1258,1258,1258,1258,1258,R-HSA-167044,Signalling to RAS,REACTOME,pathway,PATHWAY_1258
+1259,1259,1259,1259,1259,1259,1259,1259,R-HSA-69109,Leading Strand Synthesis,REACTOME,pathway,PATHWAY_1259
+1260,1260,1260,1260,1260,1260,1260,1260,R-HSA-166786,Creation of C4 and C2 activators,REACTOME,pathway,PATHWAY_1260
+1261,1261,1261,1261,1261,1261,1261,1261,R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,REACTOME,pathway,PATHWAY_1261
+1262,1262,1262,1262,1262,1262,1262,1262,R-HSA-9816359,Maternal to zygotic transition (MZT),REACTOME,pathway,PATHWAY_1262
+1263,1263,1263,1263,1263,1263,1263,1263,R-HSA-3928663,EPHA-mediated growth cone collapse,REACTOME,pathway,PATHWAY_1263
+1264,1264,1264,1264,1264,1264,1264,1264,R-HSA-9664424,Cell recruitment (pro-inflammatory response),REACTOME,pathway,PATHWAY_1264
+1265,1265,1265,1265,1265,1265,1265,1265,R-HSA-211736,Stimulation of the cell death response by PAK-2p34,REACTOME,pathway,PATHWAY_1265
+1266,1266,1266,1266,1266,1266,1266,1266,R-HSA-202433,Generation of second messenger molecules,REACTOME,pathway,PATHWAY_1266
+1267,1267,1267,1267,1267,1267,1267,1267,R-HSA-5368287,Mitochondrial translation,REACTOME,pathway,PATHWAY_1267
+1268,1268,1268,1268,1268,1268,1268,1268,R-HSA-9026527,Activated NTRK2 signals through PLCG1,REACTOME,pathway,PATHWAY_1268
+1269,1269,1269,1269,1269,1269,1269,1269,R-HSA-9027276,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),REACTOME,pathway,PATHWAY_1269
+1270,1270,1270,1270,1270,1270,1270,1270,R-HSA-5619050,"Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)",REACTOME,pathway,PATHWAY_1270
+1271,1271,1271,1271,1271,1271,1271,1271,R-HSA-9022535,Loss of phosphorylation of MECP2 at T308,REACTOME,pathway,PATHWAY_1271
+1272,1272,1272,1272,1272,1272,1272,1272,R-HSA-5336415,Uptake and function of diphtheria toxin,REACTOME,pathway,PATHWAY_1272
+1273,1273,1273,1273,1273,1273,1273,1273,R-HSA-418990,Adherens junctions interactions,REACTOME,pathway,PATHWAY_1273
+1274,1274,1274,1274,1274,1274,1274,1274,R-HSA-1250347,SHC1 events in ERBB4 signaling,REACTOME,pathway,PATHWAY_1274
+1275,1275,1275,1275,1275,1275,1275,1275,R-HSA-6802953,RAS signaling downstream of NF1 loss-of-function variants,REACTOME,pathway,PATHWAY_1275
+1276,1276,1276,1276,1276,1276,1276,1276,R-HSA-9667769,Acetylcholine inhibits contraction of outer hair cells,REACTOME,pathway,PATHWAY_1276
+1277,1277,1277,1277,1277,1277,1277,1277,R-HSA-198725,Nuclear Events (kinase and transcription factor activation),REACTOME,pathway,PATHWAY_1277
+1278,1278,1278,1278,1278,1278,1278,1278,R-HSA-9612973,Autophagy,REACTOME,pathway,PATHWAY_1278
+1279,1279,1279,1279,1279,1279,1279,1279,R-HSA-5625740,RHO GTPases activate PKNs,REACTOME,pathway,PATHWAY_1279
+1280,1280,1280,1280,1280,1280,1280,1280,R-HSA-1299316,TWIK-releated acid-sensitive K+ channel (TASK),REACTOME,pathway,PATHWAY_1280
+1281,1281,1281,1281,1281,1281,1281,1281,R-HSA-4090294,SUMOylation of intracellular receptors,REACTOME,pathway,PATHWAY_1281
+1282,1282,1282,1282,1282,1282,1282,1282,R-HSA-212676,Dopamine Neurotransmitter Release Cycle,REACTOME,pathway,PATHWAY_1282
+1283,1283,1283,1283,1283,1283,1283,1283,R-HSA-2559583,Cellular Senescence,REACTOME,pathway,PATHWAY_1283
+1284,1284,1284,1284,1284,1284,1284,1284,R-HSA-71403,Citric acid cycle (TCA cycle),REACTOME,pathway,PATHWAY_1284
+1285,1285,1285,1285,1285,1285,1285,1285,R-HSA-5467337,APC truncation mutants have impaired AXIN binding,REACTOME,pathway,PATHWAY_1285
+1286,1286,1286,1286,1286,1286,1286,1286,R-HSA-8876493,InlA-mediated entry of Listeria monocytogenes into host cells,REACTOME,pathway,PATHWAY_1286
+1287,1287,1287,1287,1287,1287,1287,1287,R-HSA-983189,Kinesins,REACTOME,pathway,PATHWAY_1287
+1288,1288,1288,1288,1288,1288,1288,1288,R-HSA-3134963,DEx/H-box helicases activate type I IFN and inflammatory cytokines production ,REACTOME,pathway,PATHWAY_1288
+1289,1289,1289,1289,1289,1289,1289,1289,R-HSA-9020558,Interleukin-2 signaling,REACTOME,pathway,PATHWAY_1289
+1290,1290,1290,1290,1290,1290,1290,1290,R-HSA-9656255,Defective OGG1 Substrate Binding,REACTOME,pathway,PATHWAY_1290
+1291,1291,1291,1291,1291,1291,1291,1291,R-HSA-1442490,Collagen degradation,REACTOME,pathway,PATHWAY_1291
+1292,1292,1292,1292,1292,1292,1292,1292,R-HSA-1247673,Erythrocytes take up oxygen and release carbon dioxide,REACTOME,pathway,PATHWAY_1292
+1293,1293,1293,1293,1293,1293,1293,1293,R-HSA-2980766,Nuclear Envelope Breakdown,REACTOME,pathway,PATHWAY_1293
+1294,1294,1294,1294,1294,1294,1294,1294,R-HSA-73817,Purine ribonucleoside monophosphate biosynthesis,REACTOME,pathway,PATHWAY_1294
+1295,1295,1295,1295,1295,1295,1295,1295,R-HSA-2206307,MPS IIIA - Sanfilippo syndrome A,REACTOME,pathway,PATHWAY_1295
+1296,1296,1296,1296,1296,1296,1296,1296,R-HSA-73779,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,REACTOME,pathway,PATHWAY_1296
+1297,1297,1297,1297,1297,1297,1297,1297,R-HSA-5357905,Regulation of TNFR1 signaling,REACTOME,pathway,PATHWAY_1297
+1298,1298,1298,1298,1298,1298,1298,1298,R-HSA-112043,PLC beta mediated events,REACTOME,pathway,PATHWAY_1298
+1299,1299,1299,1299,1299,1299,1299,1299,R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,REACTOME,pathway,PATHWAY_1299
+1300,1300,1300,1300,1300,1300,1300,1300,R-HSA-111447,Activation of BAD and translocation to mitochondria ,REACTOME,pathway,PATHWAY_1300
+1301,1301,1301,1301,1301,1301,1301,1301,R-HSA-446652,Interleukin-1 family signaling,REACTOME,pathway,PATHWAY_1301
+1302,1302,1302,1302,1302,1302,1302,1302,R-HSA-72306,tRNA processing,REACTOME,pathway,PATHWAY_1302
+1303,1303,1303,1303,1303,1303,1303,1303,R-HSA-9632700,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,REACTOME,pathway,PATHWAY_1303
+1304,1304,1304,1304,1304,1304,1304,1304,R-HSA-399721,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",REACTOME,pathway,PATHWAY_1304
+1305,1305,1305,1305,1305,1305,1305,1305,R-HSA-2029481,FCGR activation,REACTOME,pathway,PATHWAY_1305
+1306,1306,1306,1306,1306,1306,1306,1306,R-HSA-379724,tRNA Aminoacylation,REACTOME,pathway,PATHWAY_1306
+1307,1307,1307,1307,1307,1307,1307,1307,R-HSA-73856,RNA Polymerase II Transcription Termination,REACTOME,pathway,PATHWAY_1307
+1308,1308,1308,1308,1308,1308,1308,1308,R-HSA-205043,NRIF signals cell death from the nucleus,REACTOME,pathway,PATHWAY_1308
+1309,1309,1309,1309,1309,1309,1309,1309,R-HSA-389513,Co-inhibition by CTLA4,REACTOME,pathway,PATHWAY_1309
+1310,1310,1310,1310,1310,1310,1310,1310,R-HSA-112313,Neurotransmitter uptake and metabolism In glial cells,REACTOME,pathway,PATHWAY_1310
+1311,1311,1311,1311,1311,1311,1311,1311,R-HSA-8951911,RUNX3 regulates RUNX1-mediated transcription,REACTOME,pathway,PATHWAY_1311
+1312,1312,1312,1312,1312,1312,1312,1312,R-HSA-5609978,Defective GALT can cause GALCT,REACTOME,pathway,PATHWAY_1312
+1313,1313,1313,1313,1313,1313,1313,1313,R-HSA-1855183,"Synthesis of IP2, IP, and Ins in the cytosol",REACTOME,pathway,PATHWAY_1313
+1314,1314,1314,1314,1314,1314,1314,1314,R-HSA-6782135,Dual incision in TC-NER,REACTOME,pathway,PATHWAY_1314
+1315,1315,1315,1315,1315,1315,1315,1315,R-HSA-5607764,CLEC7A (Dectin-1) signaling,REACTOME,pathway,PATHWAY_1315
+1316,1316,1316,1316,1316,1316,1316,1316,R-HSA-1989781,PPARA activates gene expression,REACTOME,pathway,PATHWAY_1316
+1317,1317,1317,1317,1317,1317,1317,1317,R-HSA-5649702,APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,REACTOME,pathway,PATHWAY_1317
+1318,1318,1318,1318,1318,1318,1318,1318,R-HSA-5678520,Defective ABCB11 causes PFIC2 and BRIC2,REACTOME,pathway,PATHWAY_1318
+1319,1319,1319,1319,1319,1319,1319,1319,R-HSA-9630222,Defective NTHL1 substrate binding,REACTOME,pathway,PATHWAY_1319
+1320,1320,1320,1320,1320,1320,1320,1320,R-HSA-8964616,G beta:gamma signalling through CDC42,REACTOME,pathway,PATHWAY_1320
+1321,1321,1321,1321,1321,1321,1321,1321,R-HSA-3656534,Loss of Function of TGFBR1 in Cancer,REACTOME,pathway,PATHWAY_1321
+1322,1322,1322,1322,1322,1322,1322,1322,R-HSA-1660499,Synthesis of PIPs at the plasma membrane,REACTOME,pathway,PATHWAY_1322
+1323,1323,1323,1323,1323,1323,1323,1323,R-HSA-3311021,SMAD4 MH2 Domain Mutants in Cancer,REACTOME,pathway,PATHWAY_1323
+1324,1324,1324,1324,1324,1324,1324,1324,R-HSA-9827857,Specification of primordial germ cells,REACTOME,pathway,PATHWAY_1324
+1325,1325,1325,1325,1325,1325,1325,1325,R-HSA-1502540,Signaling by Activin,REACTOME,pathway,PATHWAY_1325
+1326,1326,1326,1326,1326,1326,1326,1326,R-HSA-1234158,Regulation of gene expression by Hypoxia-inducible Factor,REACTOME,pathway,PATHWAY_1326
+1327,1327,1327,1327,1327,1327,1327,1327,R-HSA-5619079,Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,REACTOME,pathway,PATHWAY_1327
+1328,1328,1328,1328,1328,1328,1328,1328,R-HSA-74182,Ketone body metabolism,REACTOME,pathway,PATHWAY_1328
+1329,1329,1329,1329,1329,1329,1329,1329,R-HSA-8849472,PTK6 Down-Regulation,REACTOME,pathway,PATHWAY_1329
+1330,1330,1330,1330,1330,1330,1330,1330,R-HSA-425410,Metal ion SLC transporters,REACTOME,pathway,PATHWAY_1330
+1331,1331,1331,1331,1331,1331,1331,1331,R-HSA-9646303,Evasion of Oncogene Induced Senescence Due to p14ARF Defects,REACTOME,pathway,PATHWAY_1331
+1332,1332,1332,1332,1332,1332,1332,1332,R-HSA-3828062,Glycogen storage disease type 0 (muscle GYS1),REACTOME,pathway,PATHWAY_1332
+1333,1333,1333,1333,1333,1333,1333,1333,R-HSA-9645722,Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function,REACTOME,pathway,PATHWAY_1333
+1334,1334,1334,1334,1334,1334,1334,1334,R-HSA-9839394,TGFBR3 expression,REACTOME,pathway,PATHWAY_1334
+1335,1335,1335,1335,1335,1335,1335,1335,R-HSA-9635465,Suppression of apoptosis,REACTOME,pathway,PATHWAY_1335
+1336,1336,1336,1336,1336,1336,1336,1336,R-HSA-6799990,Metal sequestration by antimicrobial proteins,REACTOME,pathway,PATHWAY_1336
+1337,1337,1337,1337,1337,1337,1337,1337,R-HSA-9694786,Transcription of SARS-CoV-2 sgRNAs,REACTOME,pathway,PATHWAY_1337
+1338,1338,1338,1338,1338,1338,1338,1338,R-HSA-2871837,FCERI mediated NF-kB activation,REACTOME,pathway,PATHWAY_1338
+1339,1339,1339,1339,1339,1339,1339,1339,R-HSA-3700989,Transcriptional Regulation by TP53,REACTOME,pathway,PATHWAY_1339
+1340,1340,1340,1340,1340,1340,1340,1340,R-HSA-9749641,Aspirin ADME,REACTOME,pathway,PATHWAY_1340
+1341,1341,1341,1341,1341,1341,1341,1341,R-HSA-622312,Inflammasomes,REACTOME,pathway,PATHWAY_1341
+1342,1342,1342,1342,1342,1342,1342,1342,R-HSA-75157,FasL/ CD95L signaling,REACTOME,pathway,PATHWAY_1342
+1343,1343,1343,1343,1343,1343,1343,1343,R-HSA-9833482,PKR-mediated signaling,REACTOME,pathway,PATHWAY_1343
+1344,1344,1344,1344,1344,1344,1344,1344,R-HSA-9833109,Evasion by RSV of host interferon responses,REACTOME,pathway,PATHWAY_1344
+1345,1345,1345,1345,1345,1345,1345,1345,R-HSA-3781860,Diseases associated with N-glycosylation of proteins,REACTOME,pathway,PATHWAY_1345
+1346,1346,1346,1346,1346,1346,1346,1346,R-HSA-5358752,CTNNB1 T41 mutants aren't phosphorylated,REACTOME,pathway,PATHWAY_1346
+1347,1347,1347,1347,1347,1347,1347,1347,R-HSA-9839406,TGFBR3 regulates activin signaling,REACTOME,pathway,PATHWAY_1347
+1348,1348,1348,1348,1348,1348,1348,1348,R-HSA-1971475,A tetrasaccharide linker sequence is required for GAG synthesis,REACTOME,pathway,PATHWAY_1348
+1349,1349,1349,1349,1349,1349,1349,1349,R-HSA-9669914,Dasatinib-resistant KIT mutants,REACTOME,pathway,PATHWAY_1349
+1350,1350,1350,1350,1350,1350,1350,1350,R-HSA-168277,Influenza Virus Induced Apoptosis,REACTOME,pathway,PATHWAY_1350
+1351,1351,1351,1351,1351,1351,1351,1351,R-HSA-162658,Golgi Cisternae Pericentriolar Stack Reorganization,REACTOME,pathway,PATHWAY_1351
+1352,1352,1352,1352,1352,1352,1352,1352,R-HSA-75955,RNA Polymerase II Transcription Elongation,REACTOME,pathway,PATHWAY_1352
+1353,1353,1353,1353,1353,1353,1353,1353,R-HSA-5358493,Synthesis of diphthamide-EEF2,REACTOME,pathway,PATHWAY_1353
+1354,1354,1354,1354,1354,1354,1354,1354,R-HSA-399955,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,REACTOME,pathway,PATHWAY_1354
+1355,1355,1355,1355,1355,1355,1355,1355,R-HSA-2408499,Formation of selenosugars for excretion,REACTOME,pathway,PATHWAY_1355
+1356,1356,1356,1356,1356,1356,1356,1356,R-HSA-2179392,EGFR Transactivation by Gastrin,REACTOME,pathway,PATHWAY_1356
+1357,1357,1357,1357,1357,1357,1357,1357,R-HSA-5635851,GLI proteins bind promoters of Hh responsive genes to promote transcription,REACTOME,pathway,PATHWAY_1357
+1358,1358,1358,1358,1358,1358,1358,1358,R-HSA-109703,PKB-mediated events,REACTOME,pathway,PATHWAY_1358
+1359,1359,1359,1359,1359,1359,1359,1359,R-HSA-8948700,Competing endogenous RNAs (ceRNAs) regulate PTEN translation,REACTOME,pathway,PATHWAY_1359
+1360,1360,1360,1360,1360,1360,1360,1360,R-HSA-9034013,NTF3 activates NTRK3 signaling,REACTOME,pathway,PATHWAY_1360
+1361,1361,1361,1361,1361,1361,1361,1361,R-HSA-9694594,Maturation of protein M,REACTOME,pathway,PATHWAY_1361
+1362,1362,1362,1362,1362,1362,1362,1362,R-HSA-9603381,Activated NTRK3 signals through PI3K,REACTOME,pathway,PATHWAY_1362
+1363,1363,1363,1363,1363,1363,1363,1363,R-HSA-5620920,Cargo trafficking to the periciliary membrane,REACTOME,pathway,PATHWAY_1363
+1364,1364,1364,1364,1364,1364,1364,1364,R-HSA-1606322,ZBP1(DAI) mediated induction of type I IFNs,REACTOME,pathway,PATHWAY_1364
+1365,1365,1365,1365,1365,1365,1365,1365,R-HSA-5682910,LGI-ADAM interactions,REACTOME,pathway,PATHWAY_1365
+1366,1366,1366,1366,1366,1366,1366,1366,R-HSA-177539,Autointegration results in viral DNA circles,REACTOME,pathway,PATHWAY_1366
+1367,1367,1367,1367,1367,1367,1367,1367,R-HSA-9036092,Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI),REACTOME,pathway,PATHWAY_1367
+1368,1368,1368,1368,1368,1368,1368,1368,R-HSA-5619107,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),REACTOME,pathway,PATHWAY_1368
+1369,1369,1369,1369,1369,1369,1369,1369,R-HSA-9630794,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,REACTOME,pathway,PATHWAY_1369
+1370,1370,1370,1370,1370,1370,1370,1370,R-HSA-3814836,Glycogen storage disease type XV (GYG1),REACTOME,pathway,PATHWAY_1370
+1371,1371,1371,1371,1371,1371,1371,1371,R-HSA-2172127,DAP12 interactions,REACTOME,pathway,PATHWAY_1371
+1372,1372,1372,1372,1372,1372,1372,1372,R-HSA-70370,Galactose catabolism,REACTOME,pathway,PATHWAY_1372
+1373,1373,1373,1373,1373,1373,1373,1373,R-HSA-168325,Viral Messenger RNA Synthesis,REACTOME,pathway,PATHWAY_1373
+1374,1374,1374,1374,1374,1374,1374,1374,R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,REACTOME,pathway,PATHWAY_1374
+1375,1375,1375,1375,1375,1375,1375,1375,R-HSA-2161517,Abacavir transmembrane transport,REACTOME,pathway,PATHWAY_1375
+1376,1376,1376,1376,1376,1376,1376,1376,R-HSA-4839735,Signaling by AXIN mutants,REACTOME,pathway,PATHWAY_1376
+1377,1377,1377,1377,1377,1377,1377,1377,R-HSA-447041,CHL1 interactions,REACTOME,pathway,PATHWAY_1377
+1378,1378,1378,1378,1378,1378,1378,1378,R-HSA-201451,Signaling by BMP,REACTOME,pathway,PATHWAY_1378
+1379,1379,1379,1379,1379,1379,1379,1379,R-HSA-9828211,"Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation",REACTOME,pathway,PATHWAY_1379
+1380,1380,1380,1380,1380,1380,1380,1380,R-HSA-442742,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,REACTOME,pathway,PATHWAY_1380
+1381,1381,1381,1381,1381,1381,1381,1381,R-HSA-1614603,Cysteine formation from homocysteine,REACTOME,pathway,PATHWAY_1381
+1382,1382,1382,1382,1382,1382,1382,1382,R-HSA-156711,Polo-like kinase mediated events,REACTOME,pathway,PATHWAY_1382
+1383,1383,1383,1383,1383,1383,1383,1383,R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,REACTOME,pathway,PATHWAY_1383
+1384,1384,1384,1384,1384,1384,1384,1384,R-HSA-9865113,Loss-of-function mutations in DBT cause MSUD2,REACTOME,pathway,PATHWAY_1384
+1385,1385,1385,1385,1385,1385,1385,1385,R-HSA-5656169,Termination of translesion DNA synthesis,REACTOME,pathway,PATHWAY_1385
+1386,1386,1386,1386,1386,1386,1386,1386,R-HSA-6811555,PI5P Regulates TP53 Acetylation,REACTOME,pathway,PATHWAY_1386
+1387,1387,1387,1387,1387,1387,1387,1387,R-HSA-5620916,VxPx cargo-targeting to cilium,REACTOME,pathway,PATHWAY_1387
+1388,1388,1388,1388,1388,1388,1388,1388,R-HSA-1222556,ROS and RNS production in phagocytes,REACTOME,pathway,PATHWAY_1388
+1389,1389,1389,1389,1389,1389,1389,1389,R-HSA-8865999,MET activates PTPN11,REACTOME,pathway,PATHWAY_1389
+1390,1390,1390,1390,1390,1390,1390,1390,R-HSA-8963888,Chylomicron assembly,REACTOME,pathway,PATHWAY_1390
+1391,1391,1391,1391,1391,1391,1391,1391,R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,REACTOME,pathway,PATHWAY_1391
+1392,1392,1392,1392,1392,1392,1392,1392,R-HSA-8875360,InlB-mediated entry of Listeria monocytogenes into host cell,REACTOME,pathway,PATHWAY_1392
+1393,1393,1393,1393,1393,1393,1393,1393,R-HSA-3359457,Defective CBLIF causes IFD,REACTOME,pathway,PATHWAY_1393
+1394,1394,1394,1394,1394,1394,1394,1394,R-HSA-73884,Base Excision Repair,REACTOME,pathway,PATHWAY_1394
+1395,1395,1395,1395,1395,1395,1395,1395,R-HSA-9022707,MECP2 regulates transcription factors,REACTOME,pathway,PATHWAY_1395
+1396,1396,1396,1396,1396,1396,1396,1396,R-HSA-380287,Centrosome maturation,REACTOME,pathway,PATHWAY_1396
+1397,1397,1397,1397,1397,1397,1397,1397,R-HSA-6802949,Signaling by RAS mutants,REACTOME,pathway,PATHWAY_1397
+1398,1398,1398,1398,1398,1398,1398,1398,R-HSA-8847993,ERBB2 Activates PTK6 Signaling,REACTOME,pathway,PATHWAY_1398
+1399,1399,1399,1399,1399,1399,1399,1399,R-HSA-9006936,Signaling by TGFB family members,REACTOME,pathway,PATHWAY_1399
+1400,1400,1400,1400,1400,1400,1400,1400,R-HSA-1855215,IPs transport between ER lumen and cytosol,REACTOME,pathway,PATHWAY_1400
+1401,1401,1401,1401,1401,1401,1401,1401,R-HSA-5387390,Hh mutants abrogate ligand secretion,REACTOME,pathway,PATHWAY_1401
+1402,1402,1402,1402,1402,1402,1402,1402,R-HSA-5619039,"Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)",REACTOME,pathway,PATHWAY_1402
+1403,1403,1403,1403,1403,1403,1403,1403,R-HSA-5579006,Defective GSS causes GSS deficiency,REACTOME,pathway,PATHWAY_1403
+1404,1404,1404,1404,1404,1404,1404,1404,R-HSA-1362277,Transcription of E2F targets under negative control by DREAM complex,REACTOME,pathway,PATHWAY_1404
+1405,1405,1405,1405,1405,1405,1405,1405,R-HSA-5610783,Degradation of GLI2 by the proteasome,REACTOME,pathway,PATHWAY_1405
+1406,1406,1406,1406,1406,1406,1406,1406,R-HSA-112316,Neuronal System,REACTOME,pathway,PATHWAY_1406
+1407,1407,1407,1407,1407,1407,1407,1407,R-HSA-9702506,Drug resistance of FLT3 mutants,REACTOME,pathway,PATHWAY_1407
+1408,1408,1408,1408,1408,1408,1408,1408,R-HSA-9914274,3-methylglutaconic aciduria,REACTOME,pathway,PATHWAY_1408
+1409,1409,1409,1409,1409,1409,1409,1409,R-HSA-141405,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,REACTOME,pathway,PATHWAY_1409
+1410,1410,1410,1410,1410,1410,1410,1410,R-HSA-3232118,SUMOylation of transcription factors,REACTOME,pathway,PATHWAY_1410
+1411,1411,1411,1411,1411,1411,1411,1411,R-HSA-5686938,Regulation of TLR by endogenous ligand,REACTOME,pathway,PATHWAY_1411
+1412,1412,1412,1412,1412,1412,1412,1412,R-HSA-4551638,SUMOylation of chromatin organization proteins,REACTOME,pathway,PATHWAY_1412
+1413,1413,1413,1413,1413,1413,1413,1413,R-HSA-400511,"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",REACTOME,pathway,PATHWAY_1413
+1414,1414,1414,1414,1414,1414,1414,1414,R-HSA-2980736,Peptide hormone metabolism,REACTOME,pathway,PATHWAY_1414
+1415,1415,1415,1415,1415,1415,1415,1415,R-HSA-6798163,Choline catabolism,REACTOME,pathway,PATHWAY_1415
+1416,1416,1416,1416,1416,1416,1416,1416,R-HSA-111471,Apoptotic factor-mediated response,REACTOME,pathway,PATHWAY_1416
+1417,1417,1417,1417,1417,1417,1417,1417,R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",REACTOME,pathway,PATHWAY_1417
+1418,1418,1418,1418,1418,1418,1418,1418,R-HSA-881907,Gastrin-CREB signalling pathway via PKC and MAPK,REACTOME,pathway,PATHWAY_1418
+1419,1419,1419,1419,1419,1419,1419,1419,R-HSA-164843,2-LTR circle formation,REACTOME,pathway,PATHWAY_1419
+1420,1420,1420,1420,1420,1420,1420,1420,R-HSA-111446,Activation of BIM and translocation to mitochondria ,REACTOME,pathway,PATHWAY_1420
+1421,1421,1421,1421,1421,1421,1421,1421,R-HSA-114604,GPVI-mediated activation cascade,REACTOME,pathway,PATHWAY_1421
+1422,1422,1422,1422,1422,1422,1422,1422,R-HSA-199992,trans-Golgi Network Vesicle Budding,REACTOME,pathway,PATHWAY_1422
+1423,1423,1423,1423,1423,1423,1423,1423,R-HSA-5619060,Defective CP causes aceruloplasminemia (ACERULOP),REACTOME,pathway,PATHWAY_1423
+1424,1424,1424,1424,1424,1424,1424,1424,R-HSA-9854907,Regulation of MITF-M dependent genes involved in metabolism,REACTOME,pathway,PATHWAY_1424
+1425,1425,1425,1425,1425,1425,1425,1425,R-HSA-210500,Glutamate Neurotransmitter Release Cycle,REACTOME,pathway,PATHWAY_1425
+1426,1426,1426,1426,1426,1426,1426,1426,R-HSA-210747,Regulation of gene expression in early pancreatic precursor cells,REACTOME,pathway,PATHWAY_1426
+1427,1427,1427,1427,1427,1427,1427,1427,R-HSA-5619043,Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1),REACTOME,pathway,PATHWAY_1427
+1428,1428,1428,1428,1428,1428,1428,1428,R-HSA-5579028,Defective CYP17A1 causes AH5,REACTOME,pathway,PATHWAY_1428
+1429,1429,1429,1429,1429,1429,1429,1429,R-HSA-9013694,Signaling by NOTCH4,REACTOME,pathway,PATHWAY_1429
+1430,1430,1430,1430,1430,1430,1430,1430,R-HSA-111932,CaMK IV-mediated phosphorylation of CREB,REACTOME,pathway,PATHWAY_1430
+1431,1431,1431,1431,1431,1431,1431,1431,R-HSA-1643685,Disease,REACTOME,pathway,PATHWAY_1431
+1432,1432,1432,1432,1432,1432,1432,1432,R-HSA-1222541,Cell redox homeostasis,REACTOME,pathway,PATHWAY_1432
+1433,1433,1433,1433,1433,1433,1433,1433,R-HSA-419408,Lysosphingolipid and LPA receptors,REACTOME,pathway,PATHWAY_1433
+1434,1434,1434,1434,1434,1434,1434,1434,R-HSA-5693538,Homology Directed Repair,REACTOME,pathway,PATHWAY_1434
+1435,1435,1435,1435,1435,1435,1435,1435,R-HSA-918233,TRAF3-dependent IRF activation pathway,REACTOME,pathway,PATHWAY_1435
+1436,1436,1436,1436,1436,1436,1436,1436,R-HSA-3214847,HATs acetylate histones,REACTOME,pathway,PATHWAY_1436
+1437,1437,1437,1437,1437,1437,1437,1437,R-HSA-112382,Formation of RNA Pol II elongation complex ,REACTOME,pathway,PATHWAY_1437
+1438,1438,1438,1438,1438,1438,1438,1438,R-HSA-8877330,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),REACTOME,pathway,PATHWAY_1438
+1439,1439,1439,1439,1439,1439,1439,1439,R-HSA-211163,AKT-mediated inactivation of FOXO1A,REACTOME,pathway,PATHWAY_1439
+1440,1440,1440,1440,1440,1440,1440,1440,R-HSA-9825895,"Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence",REACTOME,pathway,PATHWAY_1440
+1441,1441,1441,1441,1441,1441,1441,1441,R-HSA-390522,Striated Muscle Contraction,REACTOME,pathway,PATHWAY_1441
+1442,1442,1442,1442,1442,1442,1442,1442,R-HSA-196780,Biotin transport and metabolism,REACTOME,pathway,PATHWAY_1442
+1443,1443,1443,1443,1443,1443,1443,1443,R-HSA-73927,Depurination,REACTOME,pathway,PATHWAY_1443
+1444,1444,1444,1444,1444,1444,1444,1444,R-HSA-210991,Basigin interactions,REACTOME,pathway,PATHWAY_1444
+1445,1445,1445,1445,1445,1445,1445,1445,R-HSA-9764302,Regulation of CDH19 Expression and Function,REACTOME,pathway,PATHWAY_1445
+1446,1446,1446,1446,1446,1446,1446,1446,R-HSA-432030,Transport of glycerol from adipocytes to the liver by Aquaporins,REACTOME,pathway,PATHWAY_1446
+1447,1447,1447,1447,1447,1447,1447,1447,R-HSA-418592,ADP signalling through P2Y purinoceptor 1,REACTOME,pathway,PATHWAY_1447
+1448,1448,1448,1448,1448,1448,1448,1448,R-HSA-9012852,Signaling by NOTCH3,REACTOME,pathway,PATHWAY_1448
+1449,1449,1449,1449,1449,1449,1449,1449,R-HSA-3371556,Cellular response to heat stress,REACTOME,pathway,PATHWAY_1449
+1450,1450,1450,1450,1450,1450,1450,1450,R-HSA-112310,Neurotransmitter release cycle,REACTOME,pathway,PATHWAY_1450
+1451,1451,1451,1451,1451,1451,1451,1451,R-HSA-74751,Insulin receptor signalling cascade,REACTOME,pathway,PATHWAY_1451
+1452,1452,1452,1452,1452,1452,1452,1452,R-HSA-9828806,Maturation of hRSV A proteins,REACTOME,pathway,PATHWAY_1452
+1453,1453,1453,1453,1453,1453,1453,1453,R-HSA-76061,RNA Polymerase III Transcription Initiation From Type 1 Promoter,REACTOME,pathway,PATHWAY_1453
+1454,1454,1454,1454,1454,1454,1454,1454,R-HSA-72662,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",REACTOME,pathway,PATHWAY_1454
+1455,1455,1455,1455,1455,1455,1455,1455,R-HSA-1280218,Adaptive Immune System,REACTOME,pathway,PATHWAY_1455
+1456,1456,1456,1456,1456,1456,1456,1456,R-HSA-167161,HIV Transcription Initiation,REACTOME,pathway,PATHWAY_1456
+1457,1457,1457,1457,1457,1457,1457,1457,R-HSA-6804754,Regulation of TP53 Expression,REACTOME,pathway,PATHWAY_1457
+1458,1458,1458,1458,1458,1458,1458,1458,R-HSA-9634600,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",REACTOME,pathway,PATHWAY_1458
+1459,1459,1459,1459,1459,1459,1459,1459,R-HSA-5334118,DNA methylation,REACTOME,pathway,PATHWAY_1459
+1460,1460,1460,1460,1460,1460,1460,1460,R-HSA-9629569,Protein hydroxylation,REACTOME,pathway,PATHWAY_1460
+1461,1461,1461,1461,1461,1461,1461,1461,R-HSA-77387,Insulin receptor recycling,REACTOME,pathway,PATHWAY_1461
+1462,1462,1462,1462,1462,1462,1462,1462,R-HSA-388844,Receptor-type tyrosine-protein phosphatases,REACTOME,pathway,PATHWAY_1462
+1463,1463,1463,1463,1463,1463,1463,1463,R-HSA-9665246,Resistance of ERBB2 KD mutants to neratinib,REACTOME,pathway,PATHWAY_1463
+1464,1464,1464,1464,1464,1464,1464,1464,R-HSA-1482788,Acyl chain remodelling of PC,REACTOME,pathway,PATHWAY_1464
+1465,1465,1465,1465,1465,1465,1465,1465,R-HSA-71262,Carnitine synthesis,REACTOME,pathway,PATHWAY_1465
+1466,1466,1466,1466,1466,1466,1466,1466,R-HSA-442380,Zinc influx into cells by the SLC39 gene family,REACTOME,pathway,PATHWAY_1466
+1467,1467,1467,1467,1467,1467,1467,1467,R-HSA-5602566,TICAM1 deficiency - HSE,REACTOME,pathway,PATHWAY_1467
+1468,1468,1468,1468,1468,1468,1468,1468,R-HSA-9669938,Signaling by KIT in disease,REACTOME,pathway,PATHWAY_1468
+1469,1469,1469,1469,1469,1469,1469,1469,R-HSA-9730628,Sensory perception of salty taste,REACTOME,pathway,PATHWAY_1469
+1470,1470,1470,1470,1470,1470,1470,1470,R-HSA-9014325,"TICAM1,TRAF6-dependent induction of TAK1 complex",REACTOME,pathway,PATHWAY_1470
+1471,1471,1471,1471,1471,1471,1471,1471,R-HSA-4043916,Defective MPI causes MPI-CDG,REACTOME,pathway,PATHWAY_1471
+1472,1472,1472,1472,1472,1472,1472,1472,R-HSA-5685942,HDR through Homologous Recombination (HRR),REACTOME,pathway,PATHWAY_1472
+1473,1473,1473,1473,1473,1473,1473,1473,R-HSA-9702636,tandutinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_1473
+1474,1474,1474,1474,1474,1474,1474,1474,R-HSA-110331,Cleavage of the damaged purine,REACTOME,pathway,PATHWAY_1474
+1475,1475,1475,1475,1475,1475,1475,1475,R-HSA-3296197,Hydroxycarboxylic acid-binding receptors,REACTOME,pathway,PATHWAY_1475
+1476,1476,1476,1476,1476,1476,1476,1476,R-HSA-197264,Nicotinamide salvaging,REACTOME,pathway,PATHWAY_1476
+1477,1477,1477,1477,1477,1477,1477,1477,R-HSA-190242,FGFR1 ligand binding and activation,REACTOME,pathway,PATHWAY_1477
+1478,1478,1478,1478,1478,1478,1478,1478,R-HSA-9818026,NFE2L2 regulating inflammation associated genes,REACTOME,pathway,PATHWAY_1478
+1479,1479,1479,1479,1479,1479,1479,1479,R-HSA-450302,activated TAK1 mediates p38 MAPK activation,REACTOME,pathway,PATHWAY_1479
+1480,1480,1480,1480,1480,1480,1480,1480,R-HSA-392170,ADP signalling through P2Y purinoceptor 12,REACTOME,pathway,PATHWAY_1480
+1481,1481,1481,1481,1481,1481,1481,1481,R-HSA-9026766,Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),REACTOME,pathway,PATHWAY_1481
+1482,1482,1482,1482,1482,1482,1482,1482,R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,REACTOME,pathway,PATHWAY_1482
+1483,1483,1483,1483,1483,1483,1483,1483,R-HSA-9037629,Lewis blood group biosynthesis,REACTOME,pathway,PATHWAY_1483
+1484,1484,1484,1484,1484,1484,1484,1484,R-HSA-3232142,SUMOylation of ubiquitinylation proteins,REACTOME,pathway,PATHWAY_1484
+1485,1485,1485,1485,1485,1485,1485,1485,R-HSA-5250971,Toxicity of botulinum toxin type C (botC),REACTOME,pathway,PATHWAY_1485
+1486,1486,1486,1486,1486,1486,1486,1486,R-HSA-3296482,Defects in vitamin and cofactor metabolism,REACTOME,pathway,PATHWAY_1486
+1487,1487,1487,1487,1487,1487,1487,1487,R-HSA-69481,G2/M Checkpoints,REACTOME,pathway,PATHWAY_1487
+1488,1488,1488,1488,1488,1488,1488,1488,R-HSA-418346,Platelet homeostasis,REACTOME,pathway,PATHWAY_1488
+1489,1489,1489,1489,1489,1489,1489,1489,R-HSA-2187335,The retinoid cycle in cones (daylight vision),REACTOME,pathway,PATHWAY_1489
+1490,1490,1490,1490,1490,1490,1490,1490,R-HSA-8854214,TBC/RABGAPs,REACTOME,pathway,PATHWAY_1490
+1491,1491,1491,1491,1491,1491,1491,1491,R-HSA-9668328,Sealing of the nuclear envelope (NE) by ESCRT-III,REACTOME,pathway,PATHWAY_1491
+1492,1492,1492,1492,1492,1492,1492,1492,R-HSA-480985,Synthesis of dolichyl-phosphate-glucose,REACTOME,pathway,PATHWAY_1492
+1493,1493,1493,1493,1493,1493,1493,1493,R-HSA-9673240,Defective gamma-carboxylation of F9,REACTOME,pathway,PATHWAY_1493
+1494,1494,1494,1494,1494,1494,1494,1494,R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,REACTOME,pathway,PATHWAY_1494
+1495,1495,1495,1495,1495,1495,1495,1495,R-HSA-983169,Class I MHC mediated antigen processing & presentation,REACTOME,pathway,PATHWAY_1495
+1496,1496,1496,1496,1496,1496,1496,1496,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,REACTOME,pathway,PATHWAY_1496
+1497,1497,1497,1497,1497,1497,1497,1497,R-HSA-163685,Integration of energy metabolism,REACTOME,pathway,PATHWAY_1497
+1498,1498,1498,1498,1498,1498,1498,1498,R-HSA-202427,Phosphorylation of CD3 and TCR zeta chains,REACTOME,pathway,PATHWAY_1498
+1499,1499,1499,1499,1499,1499,1499,1499,R-HSA-3785653,Myoclonic epilepsy of Lafora,REACTOME,pathway,PATHWAY_1499
+1500,1500,1500,1500,1500,1500,1500,1500,R-HSA-9702590,gilteritinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_1500
+1501,1501,1501,1501,1501,1501,1501,1501,R-HSA-5696395,Formation of Incision Complex in GG-NER,REACTOME,pathway,PATHWAY_1501
+1502,1502,1502,1502,1502,1502,1502,1502,R-HSA-373753,Nephrin family interactions,REACTOME,pathway,PATHWAY_1502
+1503,1503,1503,1503,1503,1503,1503,1503,R-HSA-9670613,Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations,REACTOME,pathway,PATHWAY_1503
+1504,1504,1504,1504,1504,1504,1504,1504,R-HSA-9673202,Defective F9 variant does not activate FX,REACTOME,pathway,PATHWAY_1504
+1505,1505,1505,1505,1505,1505,1505,1505,R-HSA-194138,Signaling by VEGF,REACTOME,pathway,PATHWAY_1505
+1506,1506,1506,1506,1506,1506,1506,1506,R-HSA-162592,Integration of provirus,REACTOME,pathway,PATHWAY_1506
+1507,1507,1507,1507,1507,1507,1507,1507,R-HSA-190236,Signaling by FGFR,REACTOME,pathway,PATHWAY_1507
+1508,1508,1508,1508,1508,1508,1508,1508,R-HSA-1296346,Tandem pore domain potassium channels,REACTOME,pathway,PATHWAY_1508
+1509,1509,1509,1509,1509,1509,1509,1509,R-HSA-5173105,O-linked glycosylation,REACTOME,pathway,PATHWAY_1509
+1510,1510,1510,1510,1510,1510,1510,1510,R-HSA-1480926,O2/CO2 exchange in erythrocytes,REACTOME,pathway,PATHWAY_1510
+1511,1511,1511,1511,1511,1511,1511,1511,R-HSA-9842860,Regulation of endogenous retroelements,REACTOME,pathway,PATHWAY_1511
+1512,1512,1512,1512,1512,1512,1512,1512,R-HSA-9834752,Respiratory syncytial virus genome replication,REACTOME,pathway,PATHWAY_1512
+1513,1513,1513,1513,1513,1513,1513,1513,R-HSA-1630316,Glycosaminoglycan metabolism,REACTOME,pathway,PATHWAY_1513
+1514,1514,1514,1514,1514,1514,1514,1514,R-HSA-112399,IRS-mediated signalling,REACTOME,pathway,PATHWAY_1514
+1515,1515,1515,1515,1515,1515,1515,1515,R-HSA-1855156,IPs transport between ER lumen and nucleus,REACTOME,pathway,PATHWAY_1515
+1516,1516,1516,1516,1516,1516,1516,1516,R-HSA-4085377,SUMOylation of SUMOylation proteins,REACTOME,pathway,PATHWAY_1516
+1517,1517,1517,1517,1517,1517,1517,1517,R-HSA-2393930,Phosphate bond hydrolysis by NUDT proteins,REACTOME,pathway,PATHWAY_1517
+1518,1518,1518,1518,1518,1518,1518,1518,R-HSA-5602571,TRAF3 deficiency - HSE,REACTOME,pathway,PATHWAY_1518
+1519,1519,1519,1519,1519,1519,1519,1519,R-HSA-187687,Signalling to ERKs,REACTOME,pathway,PATHWAY_1519
+1520,1520,1520,1520,1520,1520,1520,1520,R-HSA-5619092,"Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH)",REACTOME,pathway,PATHWAY_1520
+1521,1521,1521,1521,1521,1521,1521,1521,R-HSA-8941332,RUNX2 regulates genes involved in cell migration,REACTOME,pathway,PATHWAY_1521
+1522,1522,1522,1522,1522,1522,1522,1522,R-HSA-9672387,Defective F8 accelerates dissociation of the A2 domain,REACTOME,pathway,PATHWAY_1522
+1523,1523,1523,1523,1523,1523,1523,1523,R-HSA-9704646,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,REACTOME,pathway,PATHWAY_1523
+1524,1524,1524,1524,1524,1524,1524,1524,R-HSA-9668250,Defective factor IX causes hemophilia B,REACTOME,pathway,PATHWAY_1524
+1525,1525,1525,1525,1525,1525,1525,1525,R-HSA-5221030,"TET1,2,3 and TDG demethylate DNA",REACTOME,pathway,PATHWAY_1525
+1526,1526,1526,1526,1526,1526,1526,1526,R-HSA-5609977,Defective GALE causes EDG,REACTOME,pathway,PATHWAY_1526
+1527,1527,1527,1527,1527,1527,1527,1527,R-HSA-3248023,Regulation by TREX1,REACTOME,pathway,PATHWAY_1527
+1528,1528,1528,1528,1528,1528,1528,1528,R-HSA-450520,HuR (ELAVL1) binds and stabilizes mRNA,REACTOME,pathway,PATHWAY_1528
+1529,1529,1529,1529,1529,1529,1529,1529,R-HSA-380095,Tachykinin receptors bind tachykinins,REACTOME,pathway,PATHWAY_1529
+1530,1530,1530,1530,1530,1530,1530,1530,R-HSA-1296041,Activation of G protein gated Potassium channels,REACTOME,pathway,PATHWAY_1530
+1531,1531,1531,1531,1531,1531,1531,1531,R-HSA-76042,RNA Polymerase II Transcription Initiation And Promoter Clearance,REACTOME,pathway,PATHWAY_1531
+1532,1532,1532,1532,1532,1532,1532,1532,R-HSA-3595172,Defective CHST3 causes SEDCJD,REACTOME,pathway,PATHWAY_1532
+1533,1533,1533,1533,1533,1533,1533,1533,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,REACTOME,pathway,PATHWAY_1533
+1534,1534,1534,1534,1534,1534,1534,1534,R-HSA-1483196,PI and PC transport between ER and Golgi membranes,REACTOME,pathway,PATHWAY_1534
+1535,1535,1535,1535,1535,1535,1535,1535,R-HSA-8877627,Vitamin E transport,REACTOME,pathway,PATHWAY_1535
+1536,1536,1536,1536,1536,1536,1536,1536,R-HSA-9026286,Biosynthesis of DPAn-3-derived protectins and resolvins,REACTOME,pathway,PATHWAY_1536
+1537,1537,1537,1537,1537,1537,1537,1537,R-HSA-9610379,HCMV Late Events,REACTOME,pathway,PATHWAY_1537
+1538,1538,1538,1538,1538,1538,1538,1538,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,REACTOME,pathway,PATHWAY_1538
+1539,1539,1539,1539,1539,1539,1539,1539,R-HSA-112315,Transmission across Chemical Synapses,REACTOME,pathway,PATHWAY_1539
+1540,1540,1540,1540,1540,1540,1540,1540,R-HSA-8939245,RUNX1 regulates transcription of genes involved in BCR signaling,REACTOME,pathway,PATHWAY_1540
+1541,1541,1541,1541,1541,1541,1541,1541,R-HSA-5260271,Diseases of Immune System,REACTOME,pathway,PATHWAY_1541
+1542,1542,1542,1542,1542,1542,1542,1542,R-HSA-5205647,Mitophagy,REACTOME,pathway,PATHWAY_1542
+1543,1543,1543,1543,1543,1543,1543,1543,R-HSA-112409,RAF-independent MAPK1/3 activation,REACTOME,pathway,PATHWAY_1543
+1544,1544,1544,1544,1544,1544,1544,1544,R-HSA-8956320,Nucleotide biosynthesis,REACTOME,pathway,PATHWAY_1544
+1545,1545,1545,1545,1545,1545,1545,1545,R-HSA-9697154,Disorders of Nervous System Development,REACTOME,pathway,PATHWAY_1545
+1546,1546,1546,1546,1546,1546,1546,1546,R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,REACTOME,pathway,PATHWAY_1546
+1547,1547,1547,1547,1547,1547,1547,1547,R-HSA-111448,Activation of NOXA and translocation to mitochondria,REACTOME,pathway,PATHWAY_1547
+1548,1548,1548,1548,1548,1548,1548,1548,R-HSA-77595,Processing of Intronless Pre-mRNAs,REACTOME,pathway,PATHWAY_1548
+1549,1549,1549,1549,1549,1549,1549,1549,R-HSA-8951936,RUNX3 regulates p14-ARF,REACTOME,pathway,PATHWAY_1549
+1550,1550,1550,1550,1550,1550,1550,1550,R-HSA-991365,Activation of GABAB receptors,REACTOME,pathway,PATHWAY_1550
+1551,1551,1551,1551,1551,1551,1551,1551,R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,REACTOME,pathway,PATHWAY_1551
+1552,1552,1552,1552,1552,1552,1552,1552,R-HSA-3928662,EPHB-mediated forward signaling,REACTOME,pathway,PATHWAY_1552
+1553,1553,1553,1553,1553,1553,1553,1553,R-HSA-9831926,Nephron development,REACTOME,pathway,PATHWAY_1553
+1554,1554,1554,1554,1554,1554,1554,1554,R-HSA-5619113,Defective SLC3A1 causes cystinuria (CSNU),REACTOME,pathway,PATHWAY_1554
+1555,1555,1555,1555,1555,1555,1555,1555,R-HSA-9656223,Signaling by RAF1 mutants,REACTOME,pathway,PATHWAY_1555
+1556,1556,1556,1556,1556,1556,1556,1556,R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,REACTOME,pathway,PATHWAY_1556
+1557,1557,1557,1557,1557,1557,1557,1557,R-HSA-5619085,Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1),REACTOME,pathway,PATHWAY_1557
+1558,1558,1558,1558,1558,1558,1558,1558,R-HSA-450321,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,REACTOME,pathway,PATHWAY_1558
+1559,1559,1559,1559,1559,1559,1559,1559,R-HSA-1650814,Collagen biosynthesis and modifying enzymes,REACTOME,pathway,PATHWAY_1559
+1560,1560,1560,1560,1560,1560,1560,1560,R-HSA-3858516,Glycogen storage disease type 0 (liver GYS2),REACTOME,pathway,PATHWAY_1560
+1561,1561,1561,1561,1561,1561,1561,1561,R-HSA-190704,Oligomerization of connexins into connexons,REACTOME,pathway,PATHWAY_1561
+1562,1562,1562,1562,1562,1562,1562,1562,R-HSA-964827,"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",REACTOME,pathway,PATHWAY_1562
+1563,1563,1563,1563,1563,1563,1563,1563,R-HSA-163615,PKA activation,REACTOME,pathway,PATHWAY_1563
+1564,1564,1564,1564,1564,1564,1564,1564,R-HSA-2024096,HS-GAG degradation,REACTOME,pathway,PATHWAY_1564
+1565,1565,1565,1565,1565,1565,1565,1565,R-HSA-4793950,Defective MAN1B1 causes MRT15,REACTOME,pathway,PATHWAY_1565
+1566,1566,1566,1566,1566,1566,1566,1566,R-HSA-5083629,"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2",REACTOME,pathway,PATHWAY_1566
+1567,1567,1567,1567,1567,1567,1567,1567,R-HSA-69610,p53-Independent DNA Damage Response,REACTOME,pathway,PATHWAY_1567
+1568,1568,1568,1568,1568,1568,1568,1568,R-HSA-9013695,NOTCH4 Intracellular Domain Regulates Transcription,REACTOME,pathway,PATHWAY_1568
+1569,1569,1569,1569,1569,1569,1569,1569,R-HSA-6807070,PTEN Regulation,REACTOME,pathway,PATHWAY_1569
+1570,1570,1570,1570,1570,1570,1570,1570,R-HSA-212436,Generic Transcription Pathway,REACTOME,pathway,PATHWAY_1570
+1571,1571,1571,1571,1571,1571,1571,1571,R-HSA-110328,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,REACTOME,pathway,PATHWAY_1571
+1572,1572,1572,1572,1572,1572,1572,1572,R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,REACTOME,pathway,PATHWAY_1572
+1573,1573,1573,1573,1573,1573,1573,1573,R-HSA-5660668,CLEC7A/inflammasome pathway,REACTOME,pathway,PATHWAY_1573
+1574,1574,1574,1574,1574,1574,1574,1574,R-HSA-5619054,"Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)",REACTOME,pathway,PATHWAY_1574
+1575,1575,1575,1575,1575,1575,1575,1575,R-HSA-205025,NADE modulates death signalling,REACTOME,pathway,PATHWAY_1575
+1576,1576,1576,1576,1576,1576,1576,1576,R-HSA-6782315,tRNA modification in the nucleus and cytosol,REACTOME,pathway,PATHWAY_1576
+1577,1577,1577,1577,1577,1577,1577,1577,R-HSA-418360,Platelet calcium homeostasis,REACTOME,pathway,PATHWAY_1577
+1578,1578,1578,1578,1578,1578,1578,1578,R-HSA-9687136,Aberrant regulation of mitotic exit in cancer due to RB1 defects,REACTOME,pathway,PATHWAY_1578
+1579,1579,1579,1579,1579,1579,1579,1579,R-HSA-5579031,Defective ACTH causes obesity and POMCD,REACTOME,pathway,PATHWAY_1579
+1580,1580,1580,1580,1580,1580,1580,1580,R-HSA-4655427,SUMOylation of DNA methylation proteins,REACTOME,pathway,PATHWAY_1580
+1581,1581,1581,1581,1581,1581,1581,1581,R-HSA-1855170,IPs transport between nucleus and cytosol,REACTOME,pathway,PATHWAY_1581
+1582,1582,1582,1582,1582,1582,1582,1582,R-HSA-9018678,Biosynthesis of specialized proresolving mediators (SPMs),REACTOME,pathway,PATHWAY_1582
+1583,1583,1583,1583,1583,1583,1583,1583,R-HSA-8866904,Negative regulation of activity of TFAP2 (AP-2) family transcription factors,REACTOME,pathway,PATHWAY_1583
+1584,1584,1584,1584,1584,1584,1584,1584,R-HSA-186797,Signaling by PDGF,REACTOME,pathway,PATHWAY_1584
+1585,1585,1585,1585,1585,1585,1585,1585,R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,REACTOME,pathway,PATHWAY_1585
+1586,1586,1586,1586,1586,1586,1586,1586,R-HSA-8985947,Interleukin-9 signaling,REACTOME,pathway,PATHWAY_1586
+1587,1587,1587,1587,1587,1587,1587,1587,R-HSA-1428517,Aerobic respiration and respiratory electron transport,REACTOME,pathway,PATHWAY_1587
+1588,1588,1588,1588,1588,1588,1588,1588,R-HSA-8963898,Plasma lipoprotein assembly,REACTOME,pathway,PATHWAY_1588
+1589,1589,1589,1589,1589,1589,1589,1589,R-HSA-5619094,Variant SLC6A14 may confer susceptibility towards obesity,REACTOME,pathway,PATHWAY_1589
+1590,1590,1590,1590,1590,1590,1590,1590,R-HSA-5627123,RHO GTPases activate PAKs,REACTOME,pathway,PATHWAY_1590
+1591,1591,1591,1591,1591,1591,1591,1591,R-HSA-204174,Regulation of pyruvate dehydrogenase (PDH) complex,REACTOME,pathway,PATHWAY_1591
+1592,1592,1592,1592,1592,1592,1592,1592,R-HSA-3656248,Defective HEXB causes GM2G2,REACTOME,pathway,PATHWAY_1592
+1593,1593,1593,1593,1593,1593,1593,1593,R-HSA-446193,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",REACTOME,pathway,PATHWAY_1593
+1594,1594,1594,1594,1594,1594,1594,1594,R-HSA-9823730,Formation of definitive endoderm,REACTOME,pathway,PATHWAY_1594
+1595,1595,1595,1595,1595,1595,1595,1595,R-HSA-2142670,Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),REACTOME,pathway,PATHWAY_1595
+1596,1596,1596,1596,1596,1596,1596,1596,R-HSA-9005895,Pervasive developmental disorders,REACTOME,pathway,PATHWAY_1596
+1597,1597,1597,1597,1597,1597,1597,1597,R-HSA-76002,"Platelet activation, signaling and aggregation",REACTOME,pathway,PATHWAY_1597
+1598,1598,1598,1598,1598,1598,1598,1598,R-HSA-3371453,Regulation of HSF1-mediated heat shock response,REACTOME,pathway,PATHWAY_1598
+1599,1599,1599,1599,1599,1599,1599,1599,R-HSA-977068,Termination of O-glycan biosynthesis,REACTOME,pathway,PATHWAY_1599
+1600,1600,1600,1600,1600,1600,1600,1600,R-HSA-5654689,PI-3K cascade:FGFR1,REACTOME,pathway,PATHWAY_1600
+1601,1601,1601,1601,1601,1601,1601,1601,R-HSA-3878781,Glycogen storage disease type IV (GBE1),REACTOME,pathway,PATHWAY_1601
+1602,1602,1602,1602,1602,1602,1602,1602,R-HSA-5632928,Defective Mismatch Repair Associated With MSH2,REACTOME,pathway,PATHWAY_1602
+1603,1603,1603,1603,1603,1603,1603,1603,R-HSA-9633012,Response of EIF2AK4 (GCN2) to amino acid deficiency,REACTOME,pathway,PATHWAY_1603
+1604,1604,1604,1604,1604,1604,1604,1604,R-HSA-73854,RNA Polymerase I Promoter Clearance,REACTOME,pathway,PATHWAY_1604
+1605,1605,1605,1605,1605,1605,1605,1605,R-HSA-72163,mRNA Splicing - Major Pathway,REACTOME,pathway,PATHWAY_1605
+1606,1606,1606,1606,1606,1606,1606,1606,R-HSA-168274,Export of Viral Ribonucleoproteins from Nucleus,REACTOME,pathway,PATHWAY_1606
+1607,1607,1607,1607,1607,1607,1607,1607,R-HSA-68867,Assembly of the pre-replicative complex,REACTOME,pathway,PATHWAY_1607
+1608,1608,1608,1608,1608,1608,1608,1608,R-HSA-9726840,SHOC2 M1731 mutant abolishes MRAS complex function,REACTOME,pathway,PATHWAY_1608
+1609,1609,1609,1609,1609,1609,1609,1609,R-HSA-72165,mRNA Splicing - Minor Pathway,REACTOME,pathway,PATHWAY_1609
+1610,1610,1610,1610,1610,1610,1610,1610,R-HSA-9717264,ASP-3026-resistant ALK mutants,REACTOME,pathway,PATHWAY_1610
+1611,1611,1611,1611,1611,1611,1611,1611,R-HSA-399710,Activation of AMPA receptors,REACTOME,pathway,PATHWAY_1611
+1612,1612,1612,1612,1612,1612,1612,1612,R-HSA-113501,Inhibition of replication initiation of damaged DNA by RB1/E2F1,REACTOME,pathway,PATHWAY_1612
+1613,1613,1613,1613,1613,1613,1613,1613,R-HSA-73857,RNA Polymerase II Transcription,REACTOME,pathway,PATHWAY_1613
+1614,1614,1614,1614,1614,1614,1614,1614,R-HSA-5619115,Disorders of transmembrane transporters,REACTOME,pathway,PATHWAY_1614
+1615,1615,1615,1615,1615,1615,1615,1615,R-HSA-422085,"Synthesis, secretion, and deacylation of Ghrelin",REACTOME,pathway,PATHWAY_1615
+1616,1616,1616,1616,1616,1616,1616,1616,R-HSA-196854,Metabolism of vitamins and cofactors,REACTOME,pathway,PATHWAY_1616
+1617,1617,1617,1617,1617,1617,1617,1617,R-HSA-9678110,Attachment and Entry,REACTOME,pathway,PATHWAY_1617
+1618,1618,1618,1618,1618,1618,1618,1618,R-HSA-72702,Ribosomal scanning and start codon recognition,REACTOME,pathway,PATHWAY_1618
+1619,1619,1619,1619,1619,1619,1619,1619,R-HSA-159763,Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,REACTOME,pathway,PATHWAY_1619
+1620,1620,1620,1620,1620,1620,1620,1620,R-HSA-8941333,RUNX2 regulates genes involved in differentiation of myeloid cells,REACTOME,pathway,PATHWAY_1620
+1621,1621,1621,1621,1621,1621,1621,1621,R-HSA-499943,Interconversion of nucleotide di- and triphosphates,REACTOME,pathway,PATHWAY_1621
+1622,1622,1622,1622,1622,1622,1622,1622,R-HSA-397014,Muscle contraction,REACTOME,pathway,PATHWAY_1622
+1623,1623,1623,1623,1623,1623,1623,1623,R-HSA-9856651,MITF-M-dependent gene expression,REACTOME,pathway,PATHWAY_1623
+1624,1624,1624,1624,1624,1624,1624,1624,R-HSA-9700645,ALK mutants bind TKIs,REACTOME,pathway,PATHWAY_1624
+1625,1625,1625,1625,1625,1625,1625,1625,R-HSA-5603029,IkBA variant leads to EDA-ID,REACTOME,pathway,PATHWAY_1625
+1626,1626,1626,1626,1626,1626,1626,1626,R-HSA-446210,Synthesis of UDP-N-acetyl-glucosamine,REACTOME,pathway,PATHWAY_1626
+1627,1627,1627,1627,1627,1627,1627,1627,R-HSA-917977,Transferrin endocytosis and recycling,REACTOME,pathway,PATHWAY_1627
+1628,1628,1628,1628,1628,1628,1628,1628,R-HSA-1250196,SHC1 events in ERBB2 signaling,REACTOME,pathway,PATHWAY_1628
+1629,1629,1629,1629,1629,1629,1629,1629,R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,REACTOME,pathway,PATHWAY_1629
+1630,1630,1630,1630,1630,1630,1630,1630,R-HSA-9772573,Late SARS-CoV-2 Infection Events,REACTOME,pathway,PATHWAY_1630
+1631,1631,1631,1631,1631,1631,1631,1631,R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,REACTOME,pathway,PATHWAY_1631
+1632,1632,1632,1632,1632,1632,1632,1632,R-HSA-140342,Apoptosis induced DNA fragmentation,REACTOME,pathway,PATHWAY_1632
+1633,1633,1633,1633,1633,1633,1633,1633,R-HSA-192814,vRNA Synthesis,REACTOME,pathway,PATHWAY_1633
+1634,1634,1634,1634,1634,1634,1634,1634,R-HSA-4549349,Defective ALG2 causes CDG-1i,REACTOME,pathway,PATHWAY_1634
+1635,1635,1635,1635,1635,1635,1635,1635,R-HSA-112303,Electric Transmission Across Gap Junctions,REACTOME,pathway,PATHWAY_1635
+1636,1636,1636,1636,1636,1636,1636,1636,R-HSA-4085011,"Defective GNE causes sialuria, NK and IBM2",REACTOME,pathway,PATHWAY_1636
+1637,1637,1637,1637,1637,1637,1637,1637,R-HSA-3301854,Nuclear Pore Complex (NPC) Disassembly,REACTOME,pathway,PATHWAY_1637
+1638,1638,1638,1638,1638,1638,1638,1638,R-HSA-176033,Interactions of Vpr with host cellular proteins,REACTOME,pathway,PATHWAY_1638
+1639,1639,1639,1639,1639,1639,1639,1639,R-HSA-69541,Stabilization of p53,REACTOME,pathway,PATHWAY_1639
+1640,1640,1640,1640,1640,1640,1640,1640,R-HSA-76046,RNA Polymerase III Transcription Initiation,REACTOME,pathway,PATHWAY_1640
+1641,1641,1641,1641,1641,1641,1641,1641,R-HSA-9840373,Cellular response to mitochondrial stress,REACTOME,pathway,PATHWAY_1641
+1642,1642,1642,1642,1642,1642,1642,1642,R-HSA-9648895,Response of EIF2AK1 (HRI) to heme deficiency,REACTOME,pathway,PATHWAY_1642
+1643,1643,1643,1643,1643,1643,1643,1643,R-HSA-4839744,Signaling by APC mutants,REACTOME,pathway,PATHWAY_1643
+1644,1644,1644,1644,1644,1644,1644,1644,R-HSA-5602680,MyD88 deficiency (TLR5),REACTOME,pathway,PATHWAY_1644
+1645,1645,1645,1645,1645,1645,1645,1645,R-HSA-211859,Biological oxidations,REACTOME,pathway,PATHWAY_1645
+1646,1646,1646,1646,1646,1646,1646,1646,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),REACTOME,pathway,PATHWAY_1646
+1647,1647,1647,1647,1647,1647,1647,1647,R-HSA-5674135,MAP2K and MAPK activation,REACTOME,pathway,PATHWAY_1647
+1648,1648,1648,1648,1648,1648,1648,1648,R-HSA-5638302,Signaling by Overexpressed Wild-Type EGFR in Cancer,REACTOME,pathway,PATHWAY_1648
+1649,1649,1649,1649,1649,1649,1649,1649,R-HSA-167152,Formation of HIV elongation complex in the absence of HIV Tat,REACTOME,pathway,PATHWAY_1649
+1650,1650,1650,1650,1650,1650,1650,1650,R-HSA-3359485,Defective CD320 causes MMATC,REACTOME,pathway,PATHWAY_1650
+1651,1651,1651,1651,1651,1651,1651,1651,R-HSA-937039,IRAK1 recruits IKK complex,REACTOME,pathway,PATHWAY_1651
+1652,1652,1652,1652,1652,1652,1652,1652,R-HSA-446107,Type I hemidesmosome assembly,REACTOME,pathway,PATHWAY_1652
+1653,1653,1653,1653,1653,1653,1653,1653,R-HSA-6803205,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,REACTOME,pathway,PATHWAY_1653
+1654,1654,1654,1654,1654,1654,1654,1654,R-HSA-9694271,Assembly of the SARS-CoV-2 Replication-Transcription Complex (RTC),REACTOME,pathway,PATHWAY_1654
+1655,1655,1655,1655,1655,1655,1655,1655,R-HSA-1296025,ATP sensitive Potassium channels,REACTOME,pathway,PATHWAY_1655
+1656,1656,1656,1656,1656,1656,1656,1656,R-HSA-3595174,"Defective CHST14 causes EDS, musculocontractural type",REACTOME,pathway,PATHWAY_1656
+1657,1657,1657,1657,1657,1657,1657,1657,R-HSA-111458,Formation of apoptosome,REACTOME,pathway,PATHWAY_1657
+1658,1658,1658,1658,1658,1658,1658,1658,R-HSA-6787639,GDP-fucose biosynthesis,REACTOME,pathway,PATHWAY_1658
+1659,1659,1659,1659,1659,1659,1659,1659,R-HSA-73930,Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,REACTOME,pathway,PATHWAY_1659
+1660,1660,1660,1660,1660,1660,1660,1660,R-HSA-9671793,Diseases of hemostasis,REACTOME,pathway,PATHWAY_1660
+1661,1661,1661,1661,1661,1661,1661,1661,R-HSA-351200,Interconversion of polyamines,REACTOME,pathway,PATHWAY_1661
+1662,1662,1662,1662,1662,1662,1662,1662,R-HSA-9734207,Nucleotide salvage defects,REACTOME,pathway,PATHWAY_1662
+1663,1663,1663,1663,1663,1663,1663,1663,R-HSA-166208,mTORC1-mediated signalling,REACTOME,pathway,PATHWAY_1663
+1664,1664,1664,1664,1664,1664,1664,1664,R-HSA-2730905,Role of LAT2/NTAL/LAB on calcium mobilization,REACTOME,pathway,PATHWAY_1664
+1665,1665,1665,1665,1665,1665,1665,1665,R-HSA-5632987,Defective Mismatch Repair Associated With PMS2,REACTOME,pathway,PATHWAY_1665
+1666,1666,1666,1666,1666,1666,1666,1666,R-HSA-72764,Eukaryotic Translation Termination,REACTOME,pathway,PATHWAY_1666
+1667,1667,1667,1667,1667,1667,1667,1667,R-HSA-428559,Proton-coupled neutral amino acid transporters,REACTOME,pathway,PATHWAY_1667
+1668,1668,1668,1668,1668,1668,1668,1668,R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,REACTOME,pathway,PATHWAY_1668
+1669,1669,1669,1669,1669,1669,1669,1669,R-HSA-164525,Plus-strand DNA synthesis,REACTOME,pathway,PATHWAY_1669
+1670,1670,1670,1670,1670,1670,1670,1670,R-HSA-9837999,Mitochondrial protein degradation,REACTOME,pathway,PATHWAY_1670
+1671,1671,1671,1671,1671,1671,1671,1671,R-HSA-201681,TCF dependent signaling in response to WNT,REACTOME,pathway,PATHWAY_1671
+1672,1672,1672,1672,1672,1672,1672,1672,R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,REACTOME,pathway,PATHWAY_1672
+1673,1673,1673,1673,1673,1673,1673,1673,R-HSA-447115,Interleukin-12 family signaling,REACTOME,pathway,PATHWAY_1673
+1674,1674,1674,1674,1674,1674,1674,1674,R-HSA-76071,RNA Polymerase III Transcription Initiation From Type 3 Promoter,REACTOME,pathway,PATHWAY_1674
+1675,1675,1675,1675,1675,1675,1675,1675,R-HSA-77286,mitochondrial fatty acid beta-oxidation of saturated fatty acids,REACTOME,pathway,PATHWAY_1675
+1676,1676,1676,1676,1676,1676,1676,1676,R-HSA-198745,Signalling to STAT3,REACTOME,pathway,PATHWAY_1676
+1677,1677,1677,1677,1677,1677,1677,1677,R-HSA-4755579,"Defective SRD5A3 causes SRD5A3-CDG, KHRZ",REACTOME,pathway,PATHWAY_1677
+1678,1678,1678,1678,1678,1678,1678,1678,R-HSA-5653890,Lactose synthesis,REACTOME,pathway,PATHWAY_1678
+1679,1679,1679,1679,1679,1679,1679,1679,R-HSA-5619078,Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C),REACTOME,pathway,PATHWAY_1679
+1680,1680,1680,1680,1680,1680,1680,1680,R-HSA-4720475,Defective ALG3 causes CDG-1d,REACTOME,pathway,PATHWAY_1680
+1681,1681,1681,1681,1681,1681,1681,1681,R-HSA-8939246,RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,REACTOME,pathway,PATHWAY_1681
+1682,1682,1682,1682,1682,1682,1682,1682,R-HSA-210744,Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,REACTOME,pathway,PATHWAY_1682
+1683,1683,1683,1683,1683,1683,1683,1683,R-HSA-2408552,Methylation of MeSeH for excretion,REACTOME,pathway,PATHWAY_1683
+1684,1684,1684,1684,1684,1684,1684,1684,R-HSA-389542,NADPH regeneration,REACTOME,pathway,PATHWAY_1684
+1685,1685,1685,1685,1685,1685,1685,1685,R-HSA-9758941,Gastrulation,REACTOME,pathway,PATHWAY_1685
+1686,1686,1686,1686,1686,1686,1686,1686,R-HSA-1299344,TWIK-related spinal cord K+ channel (TRESK),REACTOME,pathway,PATHWAY_1686
+1687,1687,1687,1687,1687,1687,1687,1687,R-HSA-5619104,Defective SLC12A1 causes Bartter syndrome 1 (BS1),REACTOME,pathway,PATHWAY_1687
+1688,1688,1688,1688,1688,1688,1688,1688,R-HSA-5633231,Defective ALG14 causes ALG14-CMS,REACTOME,pathway,PATHWAY_1688
+1689,1689,1689,1689,1689,1689,1689,1689,R-HSA-9730737,Alkylating DNA damage induced by chemotherapeutic drugs,REACTOME,pathway,PATHWAY_1689
+1690,1690,1690,1690,1690,1690,1690,1690,R-HSA-3772470,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,REACTOME,pathway,PATHWAY_1690
+1691,1691,1691,1691,1691,1691,1691,1691,R-HSA-3656244,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),REACTOME,pathway,PATHWAY_1691
+1692,1692,1692,1692,1692,1692,1692,1692,R-HSA-9664873,Pexophagy,REACTOME,pathway,PATHWAY_1692
+1693,1693,1693,1693,1693,1693,1693,1693,R-HSA-73843,5-Phosphoribose 1-diphosphate biosynthesis,REACTOME,pathway,PATHWAY_1693
+1694,1694,1694,1694,1694,1694,1694,1694,R-HSA-168268,Virus Assembly and Release,REACTOME,pathway,PATHWAY_1694
+1695,1695,1695,1695,1695,1695,1695,1695,R-HSA-3323169,Defects in biotin (Btn) metabolism,REACTOME,pathway,PATHWAY_1695
+1696,1696,1696,1696,1696,1696,1696,1696,R-HSA-5693607,Processing of DNA double-strand break ends,REACTOME,pathway,PATHWAY_1696
+1697,1697,1697,1697,1697,1697,1697,1697,R-HSA-9683683,Maturation of protein E,REACTOME,pathway,PATHWAY_1697
+1698,1698,1698,1698,1698,1698,1698,1698,R-HSA-9637679,Escape of Mtb from the phagocyte,REACTOME,pathway,PATHWAY_1698
+1699,1699,1699,1699,1699,1699,1699,1699,R-HSA-9679504,Translation of Replicase and Assembly of the Replication Transcription Complex,REACTOME,pathway,PATHWAY_1699
+1700,1700,1700,1700,1700,1700,1700,1700,R-HSA-2142850,Hyaluronan biosynthesis and export,REACTOME,pathway,PATHWAY_1700
+1701,1701,1701,1701,1701,1701,1701,1701,R-HSA-5619045,Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM),REACTOME,pathway,PATHWAY_1701
+1702,1702,1702,1702,1702,1702,1702,1702,R-HSA-171306,Packaging Of Telomere Ends,REACTOME,pathway,PATHWAY_1702
+1703,1703,1703,1703,1703,1703,1703,1703,R-HSA-444473,Formyl peptide receptors bind formyl peptides and many other ligands,REACTOME,pathway,PATHWAY_1703
+1704,1704,1704,1704,1704,1704,1704,1704,R-HSA-1462054,Alpha-defensins,REACTOME,pathway,PATHWAY_1704
+1705,1705,1705,1705,1705,1705,1705,1705,R-HSA-9648025,EML4 and NUDC in mitotic spindle formation,REACTOME,pathway,PATHWAY_1705
+1706,1706,1706,1706,1706,1706,1706,1706,R-HSA-9710421,Defective pyroptosis,REACTOME,pathway,PATHWAY_1706
+1707,1707,1707,1707,1707,1707,1707,1707,R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",REACTOME,pathway,PATHWAY_1707
+1708,1708,1708,1708,1708,1708,1708,1708,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,REACTOME,pathway,PATHWAY_1708
+1709,1709,1709,1709,1709,1709,1709,1709,R-HSA-3000171,Non-integrin membrane-ECM interactions,REACTOME,pathway,PATHWAY_1709
+1710,1710,1710,1710,1710,1710,1710,1710,R-HSA-74160,Gene expression (Transcription),REACTOME,pathway,PATHWAY_1710
+1711,1711,1711,1711,1711,1711,1711,1711,R-HSA-73980,RNA Polymerase III Transcription Termination,REACTOME,pathway,PATHWAY_1711
+1712,1712,1712,1712,1712,1712,1712,1712,R-HSA-6783984,Glycine degradation,REACTOME,pathway,PATHWAY_1712
+1713,1713,1713,1713,1713,1713,1713,1713,R-HSA-2871809,FCERI mediated Ca+2 mobilization,REACTOME,pathway,PATHWAY_1713
+1714,1714,1714,1714,1714,1714,1714,1714,R-HSA-5619507,Activation of HOX genes during differentiation,REACTOME,pathway,PATHWAY_1714
+1715,1715,1715,1715,1715,1715,1715,1715,R-HSA-2151209,Activation of PPARGC1A (PGC-1alpha) by phosphorylation,REACTOME,pathway,PATHWAY_1715
+1716,1716,1716,1716,1716,1716,1716,1716,R-HSA-5659996,RPIA deficiency: failed conversion of R5P to RU5P,REACTOME,pathway,PATHWAY_1716
+1717,1717,1717,1717,1717,1717,1717,1717,R-HSA-5662702,Melanin biosynthesis,REACTOME,pathway,PATHWAY_1717
+1718,1718,1718,1718,1718,1718,1718,1718,R-HSA-141430,Inactivation of APC/C via direct inhibition of the APC/C complex,REACTOME,pathway,PATHWAY_1718
+1719,1719,1719,1719,1719,1719,1719,1719,R-HSA-975578,Reactions specific to the complex N-glycan synthesis pathway,REACTOME,pathway,PATHWAY_1719
+1720,1720,1720,1720,1720,1720,1720,1720,R-HSA-9845621,Defective VWF cleavage by ADAMTS13 variant,REACTOME,pathway,PATHWAY_1720
+1721,1721,1721,1721,1721,1721,1721,1721,R-HSA-9632697,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4,REACTOME,pathway,PATHWAY_1721
+1722,1722,1722,1722,1722,1722,1722,1722,R-HSA-193807,Synthesis of bile acids and bile salts via 27-hydroxycholesterol,REACTOME,pathway,PATHWAY_1722
+1723,1723,1723,1723,1723,1723,1723,1723,R-HSA-9918454,Defective visual phototransduction due to ABCA4 loss of function,REACTOME,pathway,PATHWAY_1723
+1724,1724,1724,1724,1724,1724,1724,1724,R-HSA-391908,Prostanoid ligand receptors,REACTOME,pathway,PATHWAY_1724
+1725,1725,1725,1725,1725,1725,1725,1725,R-HSA-5619114,Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),REACTOME,pathway,PATHWAY_1725
+1726,1726,1726,1726,1726,1726,1726,1726,R-HSA-392023,Adrenaline signalling through Alpha-2 adrenergic receptor,REACTOME,pathway,PATHWAY_1726
+1727,1727,1727,1727,1727,1727,1727,1727,R-HSA-162589,Reverse Transcription of HIV RNA,REACTOME,pathway,PATHWAY_1727
+1728,1728,1728,1728,1728,1728,1728,1728,R-HSA-177135,Conjugation of benzoate with glycine,REACTOME,pathway,PATHWAY_1728
+1729,1729,1729,1729,1729,1729,1729,1729,R-HSA-5358749,CTNNB1 S37 mutants aren't phosphorylated,REACTOME,pathway,PATHWAY_1729
+1730,1730,1730,1730,1730,1730,1730,1730,R-HSA-8964011,HDL clearance,REACTOME,pathway,PATHWAY_1730
+1731,1731,1731,1731,1731,1731,1731,1731,R-HSA-9706377,FLT3 signaling by CBL mutants,REACTOME,pathway,PATHWAY_1731
+1732,1732,1732,1732,1732,1732,1732,1732,R-HSA-380972,Energy dependent regulation of mTOR by LKB1-AMPK,REACTOME,pathway,PATHWAY_1732
+1733,1733,1733,1733,1733,1733,1733,1733,R-HSA-4839748,Signaling by AMER1 mutants,REACTOME,pathway,PATHWAY_1733
+1734,1734,1734,1734,1734,1734,1734,1734,R-HSA-5675221,Negative regulation of MAPK pathway,REACTOME,pathway,PATHWAY_1734
+1735,1735,1735,1735,1735,1735,1735,1735,R-HSA-5628897,TP53 Regulates Metabolic Genes,REACTOME,pathway,PATHWAY_1735
+1736,1736,1736,1736,1736,1736,1736,1736,R-HSA-5619037,Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),REACTOME,pathway,PATHWAY_1736
+1737,1737,1737,1737,1737,1737,1737,1737,R-HSA-5578997,Defective AHCY causes HMAHCHD,REACTOME,pathway,PATHWAY_1737
+1738,1738,1738,1738,1738,1738,1738,1738,R-HSA-193993,Mineralocorticoid biosynthesis,REACTOME,pathway,PATHWAY_1738
+1739,1739,1739,1739,1739,1739,1739,1739,R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,REACTOME,pathway,PATHWAY_1739
+1740,1740,1740,1740,1740,1740,1740,1740,R-HSA-983705,Signaling by the B Cell Receptor (BCR),REACTOME,pathway,PATHWAY_1740
+1741,1741,1741,1741,1741,1741,1741,1741,R-HSA-9674519,Defective F8 sulfation at Y1699,REACTOME,pathway,PATHWAY_1741
+1742,1742,1742,1742,1742,1742,1742,1742,R-HSA-888568,GABA synthesis,REACTOME,pathway,PATHWAY_1742
+1743,1743,1743,1743,1743,1743,1743,1743,R-HSA-6788467,IL-6-type cytokine receptor ligand interactions,REACTOME,pathway,PATHWAY_1743
+1744,1744,1744,1744,1744,1744,1744,1744,R-HSA-2206285,MPS VI - Maroteaux-Lamy syndrome,REACTOME,pathway,PATHWAY_1744
+1745,1745,1745,1745,1745,1745,1745,1745,R-HSA-139853,Elevation of cytosolic Ca2+ levels,REACTOME,pathway,PATHWAY_1745
+1746,1746,1746,1746,1746,1746,1746,1746,R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,REACTOME,pathway,PATHWAY_1746
+1747,1747,1747,1747,1747,1747,1747,1747,R-HSA-2206290,MPS IV - Morquio syndrome A,REACTOME,pathway,PATHWAY_1747
+1748,1748,1748,1748,1748,1748,1748,1748,R-HSA-2262752,Cellular responses to stress,REACTOME,pathway,PATHWAY_1748
+1749,1749,1749,1749,1749,1749,1749,1749,R-HSA-8866423,VLDL assembly,REACTOME,pathway,PATHWAY_1749
+1750,1750,1750,1750,1750,1750,1750,1750,R-HSA-4615885,SUMOylation of DNA replication proteins,REACTOME,pathway,PATHWAY_1750
+1751,1751,1751,1751,1751,1751,1751,1751,R-HSA-9824446,Viral Infection Pathways,REACTOME,pathway,PATHWAY_1751
+1752,1752,1752,1752,1752,1752,1752,1752,R-HSA-397795,G-protein beta:gamma signalling,REACTOME,pathway,PATHWAY_1752
+1753,1753,1753,1753,1753,1753,1753,1753,R-HSA-389977,Post-chaperonin tubulin folding pathway,REACTOME,pathway,PATHWAY_1753
+1754,1754,1754,1754,1754,1754,1754,1754,R-HSA-9018519,Estrogen-dependent gene expression,REACTOME,pathway,PATHWAY_1754
+1755,1755,1755,1755,1755,1755,1755,1755,R-HSA-388841,Regulation of T cell activation by CD28 family,REACTOME,pathway,PATHWAY_1755
+1756,1756,1756,1756,1756,1756,1756,1756,R-HSA-5619108,Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS),REACTOME,pathway,PATHWAY_1756
+1757,1757,1757,1757,1757,1757,1757,1757,R-HSA-196299,Beta-catenin phosphorylation cascade,REACTOME,pathway,PATHWAY_1757
+1758,1758,1758,1758,1758,1758,1758,1758,R-HSA-2033515,t(4;14) translocations of FGFR3,REACTOME,pathway,PATHWAY_1758
+1759,1759,1759,1759,1759,1759,1759,1759,R-HSA-166665,Terminal pathway of complement,REACTOME,pathway,PATHWAY_1759
+1760,1760,1760,1760,1760,1760,1760,1760,R-HSA-9865881,Complex III assembly,REACTOME,pathway,PATHWAY_1760
+1761,1761,1761,1761,1761,1761,1761,1761,R-HSA-5632968,Defective Mismatch Repair Associated With MSH6,REACTOME,pathway,PATHWAY_1761
+1762,1762,1762,1762,1762,1762,1762,1762,R-HSA-9821002,Chromatin modifications during the maternal to zygotic transition (MZT),REACTOME,pathway,PATHWAY_1762
+1763,1763,1763,1763,1763,1763,1763,1763,R-HSA-75067,Processing of Capped Intronless Pre-mRNA,REACTOME,pathway,PATHWAY_1763
+1764,1764,1764,1764,1764,1764,1764,1764,R-HSA-997272,Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,REACTOME,pathway,PATHWAY_1764
+1765,1765,1765,1765,1765,1765,1765,1765,R-HSA-447038,NrCAM interactions,REACTOME,pathway,PATHWAY_1765
+1766,1766,1766,1766,1766,1766,1766,1766,R-HSA-1237044,Erythrocytes take up carbon dioxide and release oxygen,REACTOME,pathway,PATHWAY_1766
+1767,1767,1767,1767,1767,1767,1767,1767,R-HSA-9758890,Transport of RCbl within the body,REACTOME,pathway,PATHWAY_1767
+1768,1768,1768,1768,1768,1768,1768,1768,R-HSA-6781827,Transcription-Coupled Nucleotide Excision Repair (TC-NER),REACTOME,pathway,PATHWAY_1768
+1769,1769,1769,1769,1769,1769,1769,1769,R-HSA-68952,DNA replication initiation,REACTOME,pathway,PATHWAY_1769
+1770,1770,1770,1770,1770,1770,1770,1770,R-HSA-9918442,Defective visual phototransduction due to LRAT loss of function,REACTOME,pathway,PATHWAY_1770
+1771,1771,1771,1771,1771,1771,1771,1771,R-HSA-211728,Regulation of PAK-2p34 activity by PS-GAP/RHG10,REACTOME,pathway,PATHWAY_1771
+1772,1772,1772,1772,1772,1772,1772,1772,R-HSA-1632852,Macroautophagy,REACTOME,pathway,PATHWAY_1772
+1773,1773,1773,1773,1773,1773,1773,1773,R-HSA-9683686,Maturation of spike protein,REACTOME,pathway,PATHWAY_1773
+1774,1774,1774,1774,1774,1774,1774,1774,R-HSA-8851680,Butyrophilin (BTN) family interactions,REACTOME,pathway,PATHWAY_1774
+1775,1775,1775,1775,1775,1775,1775,1775,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,REACTOME,pathway,PATHWAY_1775
+1776,1776,1776,1776,1776,1776,1776,1776,R-HSA-202733,Cell surface interactions at the vascular wall,REACTOME,pathway,PATHWAY_1776
+1777,1777,1777,1777,1777,1777,1777,1777,R-HSA-5619089,Defective SLC6A5 causes hyperekplexia 3 (HKPX3),REACTOME,pathway,PATHWAY_1777
+1778,1778,1778,1778,1778,1778,1778,1778,R-HSA-69183,Processive synthesis on the lagging strand,REACTOME,pathway,PATHWAY_1778
+1779,1779,1779,1779,1779,1779,1779,1779,R-HSA-9608290,Defective MUTYH substrate processing,REACTOME,pathway,PATHWAY_1779
+1780,1780,1780,1780,1780,1780,1780,1780,R-HSA-9683610,Maturation of nucleoprotein,REACTOME,pathway,PATHWAY_1780
+1781,1781,1781,1781,1781,1781,1781,1781,R-HSA-380615,Serotonin clearance from the synaptic cleft,REACTOME,pathway,PATHWAY_1781
+1782,1782,1782,1782,1782,1782,1782,1782,R-HSA-167242,Abortive elongation of HIV-1 transcript in the absence of Tat,REACTOME,pathway,PATHWAY_1782
+1783,1783,1783,1783,1783,1783,1783,1783,R-HSA-9702998,linifanib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_1783
+1784,1784,1784,1784,1784,1784,1784,1784,R-HSA-9833110,RSV-host interactions,REACTOME,pathway,PATHWAY_1784
+1785,1785,1785,1785,1785,1785,1785,1785,R-HSA-9772572,Early SARS-CoV-2 Infection Events,REACTOME,pathway,PATHWAY_1785
+1786,1786,1786,1786,1786,1786,1786,1786,R-HSA-9673013,Diseases of Telomere Maintenance,REACTOME,pathway,PATHWAY_1786
+1787,1787,1787,1787,1787,1787,1787,1787,R-HSA-9913635,Strand-asynchronous mitochondrial DNA replication,REACTOME,pathway,PATHWAY_1787
+1788,1788,1788,1788,1788,1788,1788,1788,R-HSA-418890,Role of second messengers in netrin-1 signaling,REACTOME,pathway,PATHWAY_1788
+1789,1789,1789,1789,1789,1789,1789,1789,R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,REACTOME,pathway,PATHWAY_1789
+1790,1790,1790,1790,1790,1790,1790,1790,R-HSA-211999,CYP2E1 reactions,REACTOME,pathway,PATHWAY_1790
+1791,1791,1791,1791,1791,1791,1791,1791,R-HSA-5666185,RHO GTPases Activate Rhotekin and Rhophilins,REACTOME,pathway,PATHWAY_1791
+1792,1792,1792,1792,1792,1792,1792,1792,R-HSA-8876725,Protein methylation,REACTOME,pathway,PATHWAY_1792
+1793,1793,1793,1793,1793,1793,1793,1793,R-HSA-196108,Pregnenolone biosynthesis,REACTOME,pathway,PATHWAY_1793
+1794,1794,1794,1794,1794,1794,1794,1794,R-HSA-157118,Signaling by NOTCH,REACTOME,pathway,PATHWAY_1794
+1795,1795,1795,1795,1795,1795,1795,1795,R-HSA-5619088,"Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)",REACTOME,pathway,PATHWAY_1795
+1796,1796,1796,1796,1796,1796,1796,1796,R-HSA-1461973,Defensins,REACTOME,pathway,PATHWAY_1796
+1797,1797,1797,1797,1797,1797,1797,1797,R-HSA-8963901,Chylomicron remodeling,REACTOME,pathway,PATHWAY_1797
+1798,1798,1798,1798,1798,1798,1798,1798,R-HSA-9609690,HCMV Early Events,REACTOME,pathway,PATHWAY_1798
+1799,1799,1799,1799,1799,1799,1799,1799,R-HSA-203754,NOSIP mediated eNOS trafficking,REACTOME,pathway,PATHWAY_1799
+1800,1800,1800,1800,1800,1800,1800,1800,R-HSA-167200,Formation of HIV-1 elongation complex containing HIV-1 Tat,REACTOME,pathway,PATHWAY_1800
+1801,1801,1801,1801,1801,1801,1801,1801,R-HSA-9648002,RAS processing,REACTOME,pathway,PATHWAY_1801
+1802,1802,1802,1802,1802,1802,1802,1802,R-HSA-1483257,Phospholipid metabolism,REACTOME,pathway,PATHWAY_1802
+1803,1803,1803,1803,1803,1803,1803,1803,R-HSA-9029558,NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,REACTOME,pathway,PATHWAY_1803
+1804,1804,1804,1804,1804,1804,1804,1804,R-HSA-9649913,RAS GTPase cycle mutants,REACTOME,pathway,PATHWAY_1804
+1805,1805,1805,1805,1805,1805,1805,1805,R-HSA-9675132,Diseases of cellular response to stress,REACTOME,pathway,PATHWAY_1805
+1806,1806,1806,1806,1806,1806,1806,1806,R-HSA-4419969,Depolymerization of the Nuclear Lamina,REACTOME,pathway,PATHWAY_1806
+1807,1807,1807,1807,1807,1807,1807,1807,R-HSA-9660826,Purinergic signaling in leishmaniasis infection,REACTOME,pathway,PATHWAY_1807
+1808,1808,1808,1808,1808,1808,1808,1808,R-HSA-9609523,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,REACTOME,pathway,PATHWAY_1808
+1809,1809,1809,1809,1809,1809,1809,1809,R-HSA-1483249,Inositol phosphate metabolism,REACTOME,pathway,PATHWAY_1809
+1810,1810,1810,1810,1810,1810,1810,1810,R-HSA-180786,Extension of Telomeres,REACTOME,pathway,PATHWAY_1810
+1811,1811,1811,1811,1811,1811,1811,1811,R-HSA-199977,ER to Golgi Anterograde Transport,REACTOME,pathway,PATHWAY_1811
+1812,1812,1812,1812,1812,1812,1812,1812,R-HSA-2023837,Signaling by FGFR2 amplification mutants,REACTOME,pathway,PATHWAY_1812
+1813,1813,1813,1813,1813,1813,1813,1813,R-HSA-451307,Activation of Na-permeable kainate receptors,REACTOME,pathway,PATHWAY_1813
+1814,1814,1814,1814,1814,1814,1814,1814,R-HSA-5362517,Signaling by Retinoic Acid,REACTOME,pathway,PATHWAY_1814
+1815,1815,1815,1815,1815,1815,1815,1815,R-HSA-70895,Branched-chain amino acid catabolism,REACTOME,pathway,PATHWAY_1815
+1816,1816,1816,1816,1816,1816,1816,1816,R-HSA-6807062,Cholesterol biosynthesis via lathosterol,REACTOME,pathway,PATHWAY_1816
+1817,1817,1817,1817,1817,1817,1817,1817,R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,REACTOME,pathway,PATHWAY_1817
+1818,1818,1818,1818,1818,1818,1818,1818,R-HSA-5632927,Defective Mismatch Repair Associated With MSH3,REACTOME,pathway,PATHWAY_1818
+1819,1819,1819,1819,1819,1819,1819,1819,R-HSA-5620912,Anchoring of the basal body to the plasma membrane,REACTOME,pathway,PATHWAY_1819
+1820,1820,1820,1820,1820,1820,1820,1820,R-HSA-8963676,Intestinal absorption,REACTOME,pathway,PATHWAY_1820
+1821,1821,1821,1821,1821,1821,1821,1821,R-HSA-9675136,Diseases of DNA Double-Strand Break Repair,REACTOME,pathway,PATHWAY_1821
+1822,1822,1822,1822,1822,1822,1822,1822,R-HSA-9820965,"Respiratory syncytial virus (RSV) genome replication, transcription and translation",REACTOME,pathway,PATHWAY_1822
+1823,1823,1823,1823,1823,1823,1823,1823,R-HSA-975110,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,REACTOME,pathway,PATHWAY_1823
+1824,1824,1824,1824,1824,1824,1824,1824,R-HSA-9020956,Interleukin-27 signaling,REACTOME,pathway,PATHWAY_1824
+1825,1825,1825,1825,1825,1825,1825,1825,R-HSA-173107,Binding and entry of HIV virion,REACTOME,pathway,PATHWAY_1825
+1826,1826,1826,1826,1826,1826,1826,1826,R-HSA-5683826,Surfactant metabolism,REACTOME,pathway,PATHWAY_1826
+1827,1827,1827,1827,1827,1827,1827,1827,R-HSA-6783310,Fanconi Anemia Pathway,REACTOME,pathway,PATHWAY_1827
+1828,1828,1828,1828,1828,1828,1828,1828,R-HSA-189451,Heme biosynthesis,REACTOME,pathway,PATHWAY_1828
+1829,1829,1829,1829,1829,1829,1829,1829,R-HSA-189483,Heme degradation,REACTOME,pathway,PATHWAY_1829
+1830,1830,1830,1830,1830,1830,1830,1830,R-HSA-9663199,Defective DNA double strand break response due to BRCA1 loss of function,REACTOME,pathway,PATHWAY_1830
+1831,1831,1831,1831,1831,1831,1831,1831,R-HSA-5655291,Signaling by FGFR4 in disease,REACTOME,pathway,PATHWAY_1831
+1832,1832,1832,1832,1832,1832,1832,1832,R-HSA-5467333,APC truncation mutants are not K63 polyubiquitinated,REACTOME,pathway,PATHWAY_1832
+1833,1833,1833,1833,1833,1833,1833,1833,R-HSA-5689877,Josephin domain DUBs,REACTOME,pathway,PATHWAY_1833
+1834,1834,1834,1834,1834,1834,1834,1834,R-HSA-9824585,Regulation of MITF-M-dependent genes involved in pigmentation,REACTOME,pathway,PATHWAY_1834
+1835,1835,1835,1835,1835,1835,1835,1835,R-HSA-199991,Membrane Trafficking,REACTOME,pathway,PATHWAY_1835
+1836,1836,1836,1836,1836,1836,1836,1836,R-HSA-9634635,Estrogen-stimulated signaling through PRKCZ,REACTOME,pathway,PATHWAY_1836
+1837,1837,1837,1837,1837,1837,1837,1837,R-HSA-179409,APC-Cdc20 mediated degradation of Nek2A,REACTOME,pathway,PATHWAY_1837
+1838,1838,1838,1838,1838,1838,1838,1838,R-HSA-5619097,Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH),REACTOME,pathway,PATHWAY_1838
+1839,1839,1839,1839,1839,1839,1839,1839,R-HSA-5635838,Activation of SMO,REACTOME,pathway,PATHWAY_1839
+1840,1840,1840,1840,1840,1840,1840,1840,R-HSA-164940,Nef mediated downregulation of MHC class I complex cell surface expression,REACTOME,pathway,PATHWAY_1840
+1841,1841,1841,1841,1841,1841,1841,1841,R-HSA-2206280,MPS IX - Natowicz syndrome,REACTOME,pathway,PATHWAY_1841
+1842,1842,1842,1842,1842,1842,1842,1842,R-HSA-9856649,Transcriptional and post-translational regulation of MITF-M expression and activity,REACTOME,pathway,PATHWAY_1842
+1843,1843,1843,1843,1843,1843,1843,1843,R-HSA-73614,Pyrimidine salvage,REACTOME,pathway,PATHWAY_1843
+1844,1844,1844,1844,1844,1844,1844,1844,R-HSA-171007,p38MAPK events,REACTOME,pathway,PATHWAY_1844
+1845,1845,1845,1845,1845,1845,1845,1845,R-HSA-73776,RNA Polymerase II Promoter Escape,REACTOME,pathway,PATHWAY_1845
+1846,1846,1846,1846,1846,1846,1846,1846,R-HSA-6804758,Regulation of TP53 Activity through Acetylation,REACTOME,pathway,PATHWAY_1846
+1847,1847,1847,1847,1847,1847,1847,1847,R-HSA-9005891,Loss of function of MECP2 in Rett syndrome,REACTOME,pathway,PATHWAY_1847
+1848,1848,1848,1848,1848,1848,1848,1848,R-HSA-9674415,Drug resistance of PDGFR mutants,REACTOME,pathway,PATHWAY_1848
+1849,1849,1849,1849,1849,1849,1849,1849,R-HSA-5655302,Signaling by FGFR1 in disease,REACTOME,pathway,PATHWAY_1849
+1850,1850,1850,1850,1850,1850,1850,1850,R-HSA-5654227,Phospholipase C-mediated cascade; FGFR3,REACTOME,pathway,PATHWAY_1850
+1851,1851,1851,1851,1851,1851,1851,1851,R-HSA-9762292,Regulation of CDH11 function,REACTOME,pathway,PATHWAY_1851
+1852,1852,1852,1852,1852,1852,1852,1852,R-HSA-774815,Nucleosome assembly,REACTOME,pathway,PATHWAY_1852
+1853,1853,1853,1853,1853,1853,1853,1853,R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,REACTOME,pathway,PATHWAY_1853
+1854,1854,1854,1854,1854,1854,1854,1854,R-HSA-162909,Host Interactions of HIV factors,REACTOME,pathway,PATHWAY_1854
+1855,1855,1855,1855,1855,1855,1855,1855,R-HSA-5579011,Defective CYP2U1 causes SPG56,REACTOME,pathway,PATHWAY_1855
+1856,1856,1856,1856,1856,1856,1856,1856,R-HSA-435354,Zinc transporters,REACTOME,pathway,PATHWAY_1856
+1857,1857,1857,1857,1857,1857,1857,1857,R-HSA-5619063,Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS),REACTOME,pathway,PATHWAY_1857
+1858,1858,1858,1858,1858,1858,1858,1858,R-HSA-5687128,MAPK6/MAPK4 signaling,REACTOME,pathway,PATHWAY_1858
+1859,1859,1859,1859,1859,1859,1859,1859,R-HSA-8854691,Interleukin-20 family signaling,REACTOME,pathway,PATHWAY_1859
+1860,1860,1860,1860,1860,1860,1860,1860,R-HSA-418886,Netrin mediated repulsion signals,REACTOME,pathway,PATHWAY_1860
+1861,1861,1861,1861,1861,1861,1861,1861,R-HSA-5654699,SHC-mediated cascade:FGFR2,REACTOME,pathway,PATHWAY_1861
+1862,1862,1862,1862,1862,1862,1862,1862,R-HSA-196757,Metabolism of folate and pterines,REACTOME,pathway,PATHWAY_1862
+1863,1863,1863,1863,1863,1863,1863,1863,R-HSA-77108,Utilization of Ketone Bodies,REACTOME,pathway,PATHWAY_1863
+1864,1864,1864,1864,1864,1864,1864,1864,R-HSA-5655253,Signaling by FGFR2 in disease,REACTOME,pathway,PATHWAY_1864
+1865,1865,1865,1865,1865,1865,1865,1865,R-HSA-5624958,ARL13B-mediated ciliary trafficking of INPP5E,REACTOME,pathway,PATHWAY_1865
+1866,1866,1866,1866,1866,1866,1866,1866,R-HSA-3000178,ECM proteoglycans,REACTOME,pathway,PATHWAY_1866
+1867,1867,1867,1867,1867,1867,1867,1867,R-HSA-9759218,Cobalamin (Cbl) metabolism,REACTOME,pathway,PATHWAY_1867
+1868,1868,1868,1868,1868,1868,1868,1868,R-HSA-190371,FGFR3b ligand binding and activation,REACTOME,pathway,PATHWAY_1868
+1869,1869,1869,1869,1869,1869,1869,1869,R-HSA-210993,Tie2 Signaling,REACTOME,pathway,PATHWAY_1869
+1870,1870,1870,1870,1870,1870,1870,1870,R-HSA-6803544,Ion influx/efflux at host-pathogen interface,REACTOME,pathway,PATHWAY_1870
+1871,1871,1871,1871,1871,1871,1871,1871,R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,REACTOME,pathway,PATHWAY_1871
+1872,1872,1872,1872,1872,1872,1872,1872,R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,REACTOME,pathway,PATHWAY_1872
+1873,1873,1873,1873,1873,1873,1873,1873,R-HSA-975144,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,REACTOME,pathway,PATHWAY_1873
+1874,1874,1874,1874,1874,1874,1874,1874,R-HSA-2160456,Phenylketonuria,REACTOME,pathway,PATHWAY_1874
+1875,1875,1875,1875,1875,1875,1875,1875,R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,REACTOME,pathway,PATHWAY_1875
+1876,1876,1876,1876,1876,1876,1876,1876,R-HSA-217271,FMO oxidises nucleophiles,REACTOME,pathway,PATHWAY_1876
+1877,1877,1877,1877,1877,1877,1877,1877,R-HSA-204005,COPII-mediated vesicle transport,REACTOME,pathway,PATHWAY_1877
+1878,1878,1878,1878,1878,1878,1878,1878,R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,REACTOME,pathway,PATHWAY_1878
+1879,1879,1879,1879,1879,1879,1879,1879,R-HSA-3371568,Attenuation phase,REACTOME,pathway,PATHWAY_1879
+1880,1880,1880,1880,1880,1880,1880,1880,R-HSA-5617833,Cilium Assembly,REACTOME,pathway,PATHWAY_1880
+1881,1881,1881,1881,1881,1881,1881,1881,R-HSA-1660502,PIPs transport between early and late endosome membranes,REACTOME,pathway,PATHWAY_1881
+1882,1882,1882,1882,1882,1882,1882,1882,R-HSA-9752946,Expression and translocation of olfactory receptors,REACTOME,pathway,PATHWAY_1882
+1883,1883,1883,1883,1883,1883,1883,1883,R-HSA-9839389,TGFBR3 regulates TGF-beta signaling,REACTOME,pathway,PATHWAY_1883
+1884,1884,1884,1884,1884,1884,1884,1884,R-HSA-8964058,HDL remodeling,REACTOME,pathway,PATHWAY_1884
+1885,1885,1885,1885,1885,1885,1885,1885,R-HSA-5690714,CD22 mediated BCR regulation,REACTOME,pathway,PATHWAY_1885
+1886,1886,1886,1886,1886,1886,1886,1886,R-HSA-5579030,Defective CYP19A1 causes AEXS,REACTOME,pathway,PATHWAY_1886
+1887,1887,1887,1887,1887,1887,1887,1887,R-HSA-418217,G beta:gamma signalling through PLC beta,REACTOME,pathway,PATHWAY_1887
+1888,1888,1888,1888,1888,1888,1888,1888,R-HSA-8955332,Carboxyterminal post-translational modifications of tubulin,REACTOME,pathway,PATHWAY_1888
+1889,1889,1889,1889,1889,1889,1889,1889,R-HSA-5654219,Phospholipase C-mediated cascade: FGFR1,REACTOME,pathway,PATHWAY_1889
+1890,1890,1890,1890,1890,1890,1890,1890,R-HSA-1483213,Synthesis of PE,REACTOME,pathway,PATHWAY_1890
+1891,1891,1891,1891,1891,1891,1891,1891,R-HSA-190374,FGFR1c and Klotho ligand binding and activation,REACTOME,pathway,PATHWAY_1891
+1892,1892,1892,1892,1892,1892,1892,1892,R-HSA-3065679,SUMO is proteolytically processed,REACTOME,pathway,PATHWAY_1892
+1893,1893,1893,1893,1893,1893,1893,1893,R-HSA-180910,Vpr-mediated nuclear import of PICs,REACTOME,pathway,PATHWAY_1893
+1894,1894,1894,1894,1894,1894,1894,1894,R-HSA-1296061,HCN channels,REACTOME,pathway,PATHWAY_1894
+1895,1895,1895,1895,1895,1895,1895,1895,R-HSA-381119,Unfolded Protein Response (UPR),REACTOME,pathway,PATHWAY_1895
+1896,1896,1896,1896,1896,1896,1896,1896,R-HSA-9636467,Blockage of phagosome acidification,REACTOME,pathway,PATHWAY_1896
+1897,1897,1897,1897,1897,1897,1897,1897,R-HSA-5578749,Transcriptional regulation by small RNAs,REACTOME,pathway,PATHWAY_1897
+1898,1898,1898,1898,1898,1898,1898,1898,R-HSA-5654704,SHC-mediated cascade:FGFR3,REACTOME,pathway,PATHWAY_1898
+1899,1899,1899,1899,1899,1899,1899,1899,R-HSA-9820952,Respiratory Syncytial Virus Infection Pathway,REACTOME,pathway,PATHWAY_1899
+1900,1900,1900,1900,1900,1900,1900,1900,R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,REACTOME,pathway,PATHWAY_1900
+1901,1901,1901,1901,1901,1901,1901,1901,R-HSA-5579029,Metabolic disorders of biological oxidation enzymes,REACTOME,pathway,PATHWAY_1901
+1902,1902,1902,1902,1902,1902,1902,1902,R-HSA-69242,S Phase,REACTOME,pathway,PATHWAY_1902
+1903,1903,1903,1903,1903,1903,1903,1903,R-HSA-5358346,Hedgehog ligand biogenesis,REACTOME,pathway,PATHWAY_1903
+1904,1904,1904,1904,1904,1904,1904,1904,R-HSA-5658471,Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),REACTOME,pathway,PATHWAY_1904
+1905,1905,1905,1905,1905,1905,1905,1905,R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,REACTOME,pathway,PATHWAY_1905
+1906,1906,1906,1906,1906,1906,1906,1906,R-HSA-8849470,PTK6 Regulates Cell Cycle,REACTOME,pathway,PATHWAY_1906
+1907,1907,1907,1907,1907,1907,1907,1907,R-HSA-6791226,Major pathway of rRNA processing in the nucleolus and cytosol,REACTOME,pathway,PATHWAY_1907
+1908,1908,1908,1908,1908,1908,1908,1908,R-HSA-418594,G alpha (i) signalling events,REACTOME,pathway,PATHWAY_1908
+1909,1909,1909,1909,1909,1909,1909,1909,R-HSA-8963896,HDL assembly,REACTOME,pathway,PATHWAY_1909
+1910,1910,1910,1910,1910,1910,1910,1910,R-HSA-5652084,Fructose metabolism,REACTOME,pathway,PATHWAY_1910
+1911,1911,1911,1911,1911,1911,1911,1911,R-HSA-5654695,PI-3K cascade:FGFR2,REACTOME,pathway,PATHWAY_1911
+1912,1912,1912,1912,1912,1912,1912,1912,R-HSA-9665737,Drug resistance in ERBB2 TMD/JMD mutants,REACTOME,pathway,PATHWAY_1912
+1913,1913,1913,1913,1913,1913,1913,1913,R-HSA-5674499,Negative feedback regulation of MAPK pathway,REACTOME,pathway,PATHWAY_1913
+1914,1914,1914,1914,1914,1914,1914,1914,R-HSA-5603027,IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR),REACTOME,pathway,PATHWAY_1914
+1915,1915,1915,1915,1915,1915,1915,1915,R-HSA-3000471,Scavenging by Class B Receptors,REACTOME,pathway,PATHWAY_1915
+1916,1916,1916,1916,1916,1916,1916,1916,R-HSA-4755583,Defective DOLK causes DOLK-CDG,REACTOME,pathway,PATHWAY_1916
+1917,1917,1917,1917,1917,1917,1917,1917,R-HSA-164516,Minus-strand DNA synthesis,REACTOME,pathway,PATHWAY_1917
+1918,1918,1918,1918,1918,1918,1918,1918,R-HSA-3656532,TGFBR1 KD Mutants in Cancer,REACTOME,pathway,PATHWAY_1918
+1919,1919,1919,1919,1919,1919,1919,1919,R-HSA-5357786,TNFR1-induced proapoptotic signaling,REACTOME,pathway,PATHWAY_1919
+1920,1920,1920,1920,1920,1920,1920,1920,R-HSA-9717319,brigatinib-resistant ALK mutants,REACTOME,pathway,PATHWAY_1920
+1921,1921,1921,1921,1921,1921,1921,1921,R-HSA-77350,Beta oxidation of hexanoyl-CoA to butanoyl-CoA,REACTOME,pathway,PATHWAY_1921
+1922,1922,1922,1922,1922,1922,1922,1922,R-HSA-8937144,Aryl hydrocarbon receptor signalling,REACTOME,pathway,PATHWAY_1922
+1923,1923,1923,1923,1923,1923,1923,1923,R-HSA-9673221,Defective F9 activation,REACTOME,pathway,PATHWAY_1923
+1924,1924,1924,1924,1924,1924,1924,1924,R-HSA-6814848,Glycerophospholipid catabolism,REACTOME,pathway,PATHWAY_1924
+1925,1925,1925,1925,1925,1925,1925,1925,R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,REACTOME,pathway,PATHWAY_1925
+1926,1926,1926,1926,1926,1926,1926,1926,R-HSA-9918438,Defective visual phototransduction due to RDH5 loss of function,REACTOME,pathway,PATHWAY_1926
+1927,1927,1927,1927,1927,1927,1927,1927,R-HSA-9709275,Impaired BRCA2 translocation to the nucleus,REACTOME,pathway,PATHWAY_1927
+1928,1928,1928,1928,1928,1928,1928,1928,R-HSA-5653656,Vesicle-mediated transport,REACTOME,pathway,PATHWAY_1928
+1929,1929,1929,1929,1929,1929,1929,1929,R-HSA-8852405,Signaling by MST1,REACTOME,pathway,PATHWAY_1929
+1930,1930,1930,1930,1930,1930,1930,1930,R-HSA-1474151,"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",REACTOME,pathway,PATHWAY_1930
+1931,1931,1931,1931,1931,1931,1931,1931,R-HSA-180689,APOBEC3G mediated resistance to HIV-1 infection,REACTOME,pathway,PATHWAY_1931
+1932,1932,1932,1932,1932,1932,1932,1932,R-HSA-3215018,Processing and activation of SUMO,REACTOME,pathway,PATHWAY_1932
+1933,1933,1933,1933,1933,1933,1933,1933,R-HSA-5654706,FRS-mediated FGFR3 signaling,REACTOME,pathway,PATHWAY_1933
+1934,1934,1934,1934,1934,1934,1934,1934,R-HSA-2979096,NOTCH2 Activation and Transmission of Signal to the Nucleus,REACTOME,pathway,PATHWAY_1934
+1935,1935,1935,1935,1935,1935,1935,1935,R-HSA-191859,snRNP Assembly,REACTOME,pathway,PATHWAY_1935
+1936,1936,1936,1936,1936,1936,1936,1936,R-HSA-71387,Metabolism of carbohydrates,REACTOME,pathway,PATHWAY_1936
+1937,1937,1937,1937,1937,1937,1937,1937,R-HSA-5579022,Defective GGT1 causes GLUTH,REACTOME,pathway,PATHWAY_1937
+1938,1938,1938,1938,1938,1938,1938,1938,R-HSA-168288,Fusion of the Influenza Virion to the Host Cell Endosome,REACTOME,pathway,PATHWAY_1938
+1939,1939,1939,1939,1939,1939,1939,1939,R-HSA-5467345,Deletions in the AXIN1 gene destabilize the destruction complex,REACTOME,pathway,PATHWAY_1939
+1940,1940,1940,1940,1940,1940,1940,1940,R-HSA-9734091,Drug-mediated inhibition of MET activation,REACTOME,pathway,PATHWAY_1940
+1941,1941,1941,1941,1941,1941,1941,1941,R-HSA-2206302,MPS I - Hurler syndrome,REACTOME,pathway,PATHWAY_1941
+1942,1942,1942,1942,1942,1942,1942,1942,R-HSA-9034864,Activated NTRK3 signals through RAS,REACTOME,pathway,PATHWAY_1942
+1943,1943,1943,1943,1943,1943,1943,1943,R-HSA-72202,Transport of Mature Transcript to Cytoplasm,REACTOME,pathway,PATHWAY_1943
+1944,1944,1944,1944,1944,1944,1944,1944,R-HSA-5619049,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),REACTOME,pathway,PATHWAY_1944
+1945,1945,1945,1945,1945,1945,1945,1945,R-HSA-5678420,"Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome",REACTOME,pathway,PATHWAY_1945
+1946,1946,1946,1946,1946,1946,1946,1946,R-HSA-195258,RHO GTPase Effectors,REACTOME,pathway,PATHWAY_1946
+1947,1947,1947,1947,1947,1947,1947,1947,R-HSA-9823587,Defects of platelet adhesion to exposed collagen,REACTOME,pathway,PATHWAY_1947
+1948,1948,1948,1948,1948,1948,1948,1948,R-HSA-9725554,Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin,REACTOME,pathway,PATHWAY_1948
+1949,1949,1949,1949,1949,1949,1949,1949,R-HSA-5578775,Ion homeostasis,REACTOME,pathway,PATHWAY_1949
+1950,1950,1950,1950,1950,1950,1950,1950,R-HSA-170145,Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes,REACTOME,pathway,PATHWAY_1950
+1951,1951,1951,1951,1951,1951,1951,1951,R-HSA-9673768,Signaling by membrane-tethered fusions of PDGFRA or PDGFRB,REACTOME,pathway,PATHWAY_1951
+1952,1952,1952,1952,1952,1952,1952,1952,R-HSA-70171,Glycolysis,REACTOME,pathway,PATHWAY_1952
+1953,1953,1953,1953,1953,1953,1953,1953,R-HSA-8963691,Phenylalanine and tyrosine metabolism,REACTOME,pathway,PATHWAY_1953
+1954,1954,1954,1954,1954,1954,1954,1954,R-HSA-5654700,FRS-mediated FGFR2 signaling,REACTOME,pathway,PATHWAY_1954
+1955,1955,1955,1955,1955,1955,1955,1955,R-HSA-190828,Gap junction trafficking,REACTOME,pathway,PATHWAY_1955
+1956,1956,1956,1956,1956,1956,1956,1956,R-HSA-5637815,Signaling by Ligand-Responsive EGFR Variants in Cancer,REACTOME,pathway,PATHWAY_1956
+1957,1957,1957,1957,1957,1957,1957,1957,R-HSA-9717207,"Sensory perception of sweet, bitter, and umami (glutamate) taste",REACTOME,pathway,PATHWAY_1957
+1958,1958,1958,1958,1958,1958,1958,1958,R-HSA-8863795,Downregulation of ERBB2 signaling,REACTOME,pathway,PATHWAY_1958
+1959,1959,1959,1959,1959,1959,1959,1959,R-HSA-77042,Formation of editosomes by ADAR proteins,REACTOME,pathway,PATHWAY_1959
+1960,1960,1960,1960,1960,1960,1960,1960,R-HSA-1482801,Acyl chain remodelling of PS,REACTOME,pathway,PATHWAY_1960
+1961,1961,1961,1961,1961,1961,1961,1961,R-HSA-1566977,Fibronectin matrix formation,REACTOME,pathway,PATHWAY_1961
+1962,1962,1962,1962,1962,1962,1962,1962,R-HSA-9865114,Maple Syrup Urine Disease,REACTOME,pathway,PATHWAY_1962
+1963,1963,1963,1963,1963,1963,1963,1963,R-HSA-5609974,Defective PGM1 causes PGM1-CDG,REACTOME,pathway,PATHWAY_1963
+1964,1964,1964,1964,1964,1964,1964,1964,R-HSA-5368598,Negative regulation of TCF-dependent signaling by DVL-interacting proteins,REACTOME,pathway,PATHWAY_1964
+1965,1965,1965,1965,1965,1965,1965,1965,R-HSA-5687583,Defective SLC34A2 causes PALM,REACTOME,pathway,PATHWAY_1965
+1966,1966,1966,1966,1966,1966,1966,1966,R-HSA-69620,Cell Cycle Checkpoints,REACTOME,pathway,PATHWAY_1966
+1967,1967,1967,1967,1967,1967,1967,1967,R-HSA-2243919,Crosslinking of collagen fibrils,REACTOME,pathway,PATHWAY_1967
+1968,1968,1968,1968,1968,1968,1968,1968,R-HSA-6791055,"TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P",REACTOME,pathway,PATHWAY_1968
+1969,1969,1969,1969,1969,1969,1969,1969,R-HSA-109606,Intrinsic Pathway for Apoptosis,REACTOME,pathway,PATHWAY_1969
+1970,1970,1970,1970,1970,1970,1970,1970,R-HSA-193144,Estrogen biosynthesis,REACTOME,pathway,PATHWAY_1970
+1971,1971,1971,1971,1971,1971,1971,1971,R-HSA-5658034,HHAT G278V doesn't palmitoylate Hh-Np,REACTOME,pathway,PATHWAY_1971
+1972,1972,1972,1972,1972,1972,1972,1972,R-HSA-9708296,"tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis",REACTOME,pathway,PATHWAY_1972
+1973,1973,1973,1973,1973,1973,1973,1973,R-HSA-418555,G alpha (s) signalling events,REACTOME,pathway,PATHWAY_1973
+1974,1974,1974,1974,1974,1974,1974,1974,R-HSA-6806667,Metabolism of fat-soluble vitamins,REACTOME,pathway,PATHWAY_1974
+1975,1975,1975,1975,1975,1975,1975,1975,R-HSA-3359475,"Defective MMAA causes MMA, cblA type",REACTOME,pathway,PATHWAY_1975
+1976,1976,1976,1976,1976,1976,1976,1976,R-HSA-210990,PECAM1 interactions,REACTOME,pathway,PATHWAY_1976
+1977,1977,1977,1977,1977,1977,1977,1977,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,REACTOME,pathway,PATHWAY_1977
+1978,1978,1978,1978,1978,1978,1978,1978,R-HSA-389359,CD28 dependent Vav1 pathway,REACTOME,pathway,PATHWAY_1978
+1979,1979,1979,1979,1979,1979,1979,1979,R-HSA-383280,Nuclear Receptor transcription pathway,REACTOME,pathway,PATHWAY_1979
+1980,1980,1980,1980,1980,1980,1980,1980,R-HSA-162588,Budding and maturation of HIV virion,REACTOME,pathway,PATHWAY_1980
+1981,1981,1981,1981,1981,1981,1981,1981,R-HSA-5627083,RHO GTPases regulate CFTR trafficking,REACTOME,pathway,PATHWAY_1981
+1982,1982,1982,1982,1982,1982,1982,1982,R-HSA-167590,Nef Mediated CD4 Down-regulation,REACTOME,pathway,PATHWAY_1982
+1983,1983,1983,1983,1983,1983,1983,1983,R-HSA-1251985,Nuclear signaling by ERBB4,REACTOME,pathway,PATHWAY_1983
+1984,1984,1984,1984,1984,1984,1984,1984,R-HSA-9916722,3-hydroxyisobutyryl-CoA hydrolase deficiency,REACTOME,pathway,PATHWAY_1984
+1985,1985,1985,1985,1985,1985,1985,1985,R-HSA-209822,Glycoprotein hormones,REACTOME,pathway,PATHWAY_1985
+1986,1986,1986,1986,1986,1986,1986,1986,R-HSA-75876,Synthesis of very long-chain fatty acyl-CoAs,REACTOME,pathway,PATHWAY_1986
+1987,1987,1987,1987,1987,1987,1987,1987,R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,REACTOME,pathway,PATHWAY_1987
+1988,1988,1988,1988,1988,1988,1988,1988,R-HSA-8951671,RUNX3 regulates YAP1-mediated transcription,REACTOME,pathway,PATHWAY_1988
+1989,1989,1989,1989,1989,1989,1989,1989,R-HSA-9665348,Signaling by ERBB2 ECD mutants,REACTOME,pathway,PATHWAY_1989
+1990,1990,1990,1990,1990,1990,1990,1990,R-HSA-5657560,Hereditary fructose intolerance,REACTOME,pathway,PATHWAY_1990
+1991,1991,1991,1991,1991,1991,1991,1991,R-HSA-5579032,Defective TBXAS1 causes GHDD,REACTOME,pathway,PATHWAY_1991
+1992,1992,1992,1992,1992,1992,1992,1992,R-HSA-9031528,NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,REACTOME,pathway,PATHWAY_1992
+1993,1993,1993,1993,1993,1993,1993,1993,R-HSA-5362798,Release of Hh-Np from the secreting cell,REACTOME,pathway,PATHWAY_1993
+1994,1994,1994,1994,1994,1994,1994,1994,R-HSA-9735786,Nucleotide catabolism defects,REACTOME,pathway,PATHWAY_1994
+1995,1995,1995,1995,1995,1995,1995,1995,R-HSA-9821993,Replacement of protamines by nucleosomes in the male pronucleus,REACTOME,pathway,PATHWAY_1995
+1996,1996,1996,1996,1996,1996,1996,1996,R-HSA-912631,Regulation of signaling by CBL,REACTOME,pathway,PATHWAY_1996
+1997,1997,1997,1997,1997,1997,1997,1997,R-HSA-1474290,Collagen formation,REACTOME,pathway,PATHWAY_1997
+1998,1998,1998,1998,1998,1998,1998,1998,R-HSA-5619111,Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1),REACTOME,pathway,PATHWAY_1998
+1999,1999,1999,1999,1999,1999,1999,1999,R-HSA-187024,NGF-independant TRKA activation,REACTOME,pathway,PATHWAY_1999
+2000,2000,2000,2000,2000,2000,2000,2000,R-HSA-416700,Other semaphorin interactions,REACTOME,pathway,PATHWAY_2000
+2001,2001,2001,2001,2001,2001,2001,2001,R-HSA-6805567,Keratinization,REACTOME,pathway,PATHWAY_2001
+2002,2002,2002,2002,2002,2002,2002,2002,R-HSA-9013957,TLR3-mediated TICAM1-dependent programmed cell death,REACTOME,pathway,PATHWAY_2002
+2003,2003,2003,2003,2003,2003,2003,2003,R-HSA-1369062,ABC transporters in lipid homeostasis,REACTOME,pathway,PATHWAY_2003
+2004,2004,2004,2004,2004,2004,2004,2004,R-HSA-168638,NOD1/2 Signaling Pathway,REACTOME,pathway,PATHWAY_2004
+2005,2005,2005,2005,2005,2005,2005,2005,R-HSA-5619084,ABC transporter disorders,REACTOME,pathway,PATHWAY_2005
+2006,2006,2006,2006,2006,2006,2006,2006,R-HSA-9605310,Defective Base Excision Repair Associated with MUTYH,REACTOME,pathway,PATHWAY_2006
+2007,2007,2007,2007,2007,2007,2007,2007,R-HSA-9674401,Sunitinib-resistant PDGFR mutants,REACTOME,pathway,PATHWAY_2007
+2008,2008,2008,2008,2008,2008,2008,2008,R-HSA-4641263,Regulation of FZD by ubiquitination,REACTOME,pathway,PATHWAY_2008
+2009,2009,2009,2009,2009,2009,2009,2009,R-HSA-156588,Glucuronidation,REACTOME,pathway,PATHWAY_2009
+2010,2010,2010,2010,2010,2010,2010,2010,R-HSA-391906,Leukotriene receptors,REACTOME,pathway,PATHWAY_2010
+2011,2011,2011,2011,2011,2011,2011,2011,R-HSA-9845614,Sphingolipid catabolism,REACTOME,pathway,PATHWAY_2011
+2012,2012,2012,2012,2012,2012,2012,2012,R-HSA-140875,Common Pathway of Fibrin Clot Formation,REACTOME,pathway,PATHWAY_2012
+2013,2013,2013,2013,2013,2013,2013,2013,R-HSA-8941326,RUNX2 regulates bone development,REACTOME,pathway,PATHWAY_2013
+2014,2014,2014,2014,2014,2014,2014,2014,R-HSA-9006931,Signaling by Nuclear Receptors,REACTOME,pathway,PATHWAY_2014
+2015,2015,2015,2015,2015,2015,2015,2015,R-HSA-2644603,Signaling by NOTCH1 in Cancer,REACTOME,pathway,PATHWAY_2015
+2016,2016,2016,2016,2016,2016,2016,2016,R-HSA-5626467,RHO GTPases activate IQGAPs,REACTOME,pathway,PATHWAY_2016
+2017,2017,2017,2017,2017,2017,2017,2017,R-HSA-5619042,Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN),REACTOME,pathway,PATHWAY_2017
+2018,2018,2018,2018,2018,2018,2018,2018,R-HSA-8939902,Regulation of RUNX2 expression and activity,REACTOME,pathway,PATHWAY_2018
+2019,2019,2019,2019,2019,2019,2019,2019,R-HSA-211958,Miscellaneous substrates,REACTOME,pathway,PATHWAY_2019
+2020,2020,2020,2020,2020,2020,2020,2020,R-HSA-156584,Cytosolic sulfonation of small molecules,REACTOME,pathway,PATHWAY_2020
+2021,2021,2021,2021,2021,2021,2021,2021,R-HSA-9912529,H139Hfs13* PPM1K causes a mild variant of  MSUD,REACTOME,pathway,PATHWAY_2021
+2022,2022,2022,2022,2022,2022,2022,2022,R-HSA-1234174,Cellular response to hypoxia,REACTOME,pathway,PATHWAY_2022
+2023,2023,2023,2023,2023,2023,2023,2023,R-HSA-425381,Bicarbonate transporters,REACTOME,pathway,PATHWAY_2023
+2024,2024,2024,2024,2024,2024,2024,2024,R-HSA-4085001,Sialic acid metabolism,REACTOME,pathway,PATHWAY_2024
+2025,2025,2025,2025,2025,2025,2025,2025,R-HSA-176034,Interactions of Tat with host cellular proteins,REACTOME,pathway,PATHWAY_2025
+2026,2026,2026,2026,2026,2026,2026,2026,R-HSA-9645135,STAT5 Activation,REACTOME,pathway,PATHWAY_2026
+2027,2027,2027,2027,2027,2027,2027,2027,R-HSA-9839383,TGFBR3 PTM regulation,REACTOME,pathway,PATHWAY_2027
+2028,2028,2028,2028,2028,2028,2028,2028,R-HSA-372708,p130Cas linkage to MAPK signaling for integrins,REACTOME,pathway,PATHWAY_2028
+2029,2029,2029,2029,2029,2029,2029,2029,R-HSA-5218920,VEGFR2 mediated vascular permeability,REACTOME,pathway,PATHWAY_2029
+2030,2030,2030,2030,2030,2030,2030,2030,R-HSA-168336,Uncoating of the Influenza Virion,REACTOME,pathway,PATHWAY_2030
+2031,2031,2031,2031,2031,2031,2031,2031,R-HSA-9007892,Interleukin-38 signaling,REACTOME,pathway,PATHWAY_2031
+2032,2032,2032,2032,2032,2032,2032,2032,R-HSA-9758881,Uptake of dietary cobalamins into enterocytes,REACTOME,pathway,PATHWAY_2032
+2033,2033,2033,2033,2033,2033,2033,2033,R-HSA-9662361,Sensory processing of sound by outer hair cells of the cochlea,REACTOME,pathway,PATHWAY_2033
+2034,2034,2034,2034,2034,2034,2034,2034,R-HSA-68875,Mitotic Prophase,REACTOME,pathway,PATHWAY_2034
+2035,2035,2035,2035,2035,2035,2035,2035,R-HSA-110313,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,REACTOME,pathway,PATHWAY_2035
+2036,2036,2036,2036,2036,2036,2036,2036,R-HSA-450604,KSRP (KHSRP) binds and destabilizes mRNA,REACTOME,pathway,PATHWAY_2036
+2037,2037,2037,2037,2037,2037,2037,2037,R-HSA-9823739,Formation of the anterior neural plate,REACTOME,pathway,PATHWAY_2037
+2038,2038,2038,2038,2038,2038,2038,2038,R-HSA-9645723,Diseases of programmed cell death,REACTOME,pathway,PATHWAY_2038
+2039,2039,2039,2039,2039,2039,2039,2039,R-HSA-9837092,FASTK family proteins regulate processing and stability of mitochondrial RNAs,REACTOME,pathway,PATHWAY_2039
+2040,2040,2040,2040,2040,2040,2040,2040,R-HSA-9664420,Killing mechanisms,REACTOME,pathway,PATHWAY_2040
+2041,2041,2041,2041,2041,2041,2041,2041,R-HSA-9013424,RHOV GTPase cycle,REACTOME,pathway,PATHWAY_2041
+2042,2042,2042,2042,2042,2042,2042,2042,R-HSA-5579010,Defective CYP24A1 causes HCAI,REACTOME,pathway,PATHWAY_2042
+2043,2043,2043,2043,2043,2043,2043,2043,R-HSA-2672351,Stimuli-sensing channels,REACTOME,pathway,PATHWAY_2043
+2044,2044,2044,2044,2044,2044,2044,2044,R-HSA-9664417,Leishmania phagocytosis,REACTOME,pathway,PATHWAY_2044
+2045,2045,2045,2045,2045,2045,2045,2045,R-HSA-9669926,Nilotinib-resistant KIT mutants,REACTOME,pathway,PATHWAY_2045
+2046,2046,2046,2046,2046,2046,2046,2046,R-HSA-169131,Inhibition of PKR,REACTOME,pathway,PATHWAY_2046
+2047,2047,2047,2047,2047,2047,2047,2047,R-HSA-5694530,Cargo concentration in the ER,REACTOME,pathway,PATHWAY_2047
+2048,2048,2048,2048,2048,2048,2048,2048,R-HSA-9706019,RHOBTB3 ATPase cycle,REACTOME,pathway,PATHWAY_2048
+2049,2049,2049,2049,2049,2049,2049,2049,R-HSA-2474795,Diseases associated with visual transduction,REACTOME,pathway,PATHWAY_2049
+2050,2050,2050,2050,2050,2050,2050,2050,R-HSA-1430728,Metabolism,REACTOME,pathway,PATHWAY_2050
+2051,2051,2051,2051,2051,2051,2051,2051,R-HSA-77305,Beta oxidation of palmitoyl-CoA to myristoyl-CoA,REACTOME,pathway,PATHWAY_2051
+2052,2052,2052,2052,2052,2052,2052,2052,R-HSA-9634285,Constitutive Signaling by Overexpressed ERBB2,REACTOME,pathway,PATHWAY_2052
+2053,2053,2053,2053,2053,2053,2053,2053,R-HSA-351202,Metabolism of polyamines,REACTOME,pathway,PATHWAY_2053
+2054,2054,2054,2054,2054,2054,2054,2054,R-HSA-6806942,MET Receptor Activation,REACTOME,pathway,PATHWAY_2054
+2055,2055,2055,2055,2055,2055,2055,2055,R-HSA-9669935,Signaling by juxtamembrane domain KIT mutants,REACTOME,pathway,PATHWAY_2055
+2056,2056,2056,2056,2056,2056,2056,2056,R-HSA-9683701,Translation of Structural Proteins,REACTOME,pathway,PATHWAY_2056
+2057,2057,2057,2057,2057,2057,2057,2057,R-HSA-1660514,Synthesis of PIPs at the Golgi membrane,REACTOME,pathway,PATHWAY_2057
+2058,2058,2058,2058,2058,2058,2058,2058,R-HSA-9754119,Drug-mediated inhibition of CDK4/CDK6 activity,REACTOME,pathway,PATHWAY_2058
+2059,2059,2059,2059,2059,2059,2059,2059,R-HSA-1299308,Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),REACTOME,pathway,PATHWAY_2059
+2060,2060,2060,2060,2060,2060,2060,2060,R-HSA-193048,Androgen biosynthesis,REACTOME,pathway,PATHWAY_2060
+2061,2061,2061,2061,2061,2061,2061,2061,R-HSA-5579009,Defective CYP11B2 causes CMO-1 deficiency,REACTOME,pathway,PATHWAY_2061
+2062,2062,2062,2062,2062,2062,2062,2062,R-HSA-6782210,Gap-filling DNA repair synthesis and ligation in TC-NER,REACTOME,pathway,PATHWAY_2062
+2063,2063,2063,2063,2063,2063,2063,2063,R-HSA-450294,MAP kinase activation,REACTOME,pathway,PATHWAY_2063
+2064,2064,2064,2064,2064,2064,2064,2064,R-HSA-9824443,Parasitic Infection Pathways,REACTOME,pathway,PATHWAY_2064
+2065,2065,2065,2065,2065,2065,2065,2065,R-HSA-5619058,"Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)",REACTOME,pathway,PATHWAY_2065
+2066,2066,2066,2066,2066,2066,2066,2066,R-HSA-69166,Removal of the Flap Intermediate,REACTOME,pathway,PATHWAY_2066
+2067,2067,2067,2067,2067,2067,2067,2067,R-HSA-168271,Transport of Ribonucleoproteins into the Host Nucleus,REACTOME,pathway,PATHWAY_2067
+2068,2068,2068,2068,2068,2068,2068,2068,R-HSA-9733709,Cardiogenesis,REACTOME,pathway,PATHWAY_2068
+2069,2069,2069,2069,2069,2069,2069,2069,R-HSA-8943723,Regulation of PTEN mRNA translation,REACTOME,pathway,PATHWAY_2069
+2070,2070,2070,2070,2070,2070,2070,2070,R-HSA-9026357,NTF4 activates NTRK2 (TRKB) signaling,REACTOME,pathway,PATHWAY_2070
+2071,2071,2071,2071,2071,2071,2071,2071,R-HSA-2586552,Signaling by Leptin,REACTOME,pathway,PATHWAY_2071
+2072,2072,2072,2072,2072,2072,2072,2072,R-HSA-2173791,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),REACTOME,pathway,PATHWAY_2072
+2073,2073,2073,2073,2073,2073,2073,2073,R-HSA-2978092,Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,REACTOME,pathway,PATHWAY_2073
+2074,2074,2074,2074,2074,2074,2074,2074,R-HSA-629587,Highly sodium permeable postsynaptic acetylcholine nicotinic receptors,REACTOME,pathway,PATHWAY_2074
+2075,2075,2075,2075,2075,2075,2075,2075,R-HSA-9693928,Defective RIPK1-mediated regulated necrosis,REACTOME,pathway,PATHWAY_2075
+2076,2076,2076,2076,2076,2076,2076,2076,R-HSA-622327,Postsynaptic nicotinic acetylcholine receptors,REACTOME,pathway,PATHWAY_2076
+2077,2077,2077,2077,2077,2077,2077,2077,R-HSA-5263617,Metabolism of ingested MeSeO2H into MeSeH,REACTOME,pathway,PATHWAY_2077
+2078,2078,2078,2078,2078,2078,2078,2078,R-HSA-5213460,RIPK1-mediated regulated necrosis,REACTOME,pathway,PATHWAY_2078
+2079,2079,2079,2079,2079,2079,2079,2079,R-HSA-8948751,Regulation of PTEN stability and activity,REACTOME,pathway,PATHWAY_2079
+2080,2080,2080,2080,2080,2080,2080,2080,R-HSA-9672395,Defective F8 binding to the cell membrane,REACTOME,pathway,PATHWAY_2080
+2081,2081,2081,2081,2081,2081,2081,2081,R-HSA-209968,Thyroxine biosynthesis,REACTOME,pathway,PATHWAY_2081
+2082,2082,2082,2082,2082,2082,2082,2082,R-HSA-111997,CaM pathway,REACTOME,pathway,PATHWAY_2082
+2083,2083,2083,2083,2083,2083,2083,2083,R-HSA-68616,Assembly of the ORC complex at the origin of replication,REACTOME,pathway,PATHWAY_2083
+2084,2084,2084,2084,2084,2084,2084,2084,R-HSA-156590,Glutathione conjugation,REACTOME,pathway,PATHWAY_2084
+2085,2085,2085,2085,2085,2085,2085,2085,R-HSA-9020591,Interleukin-12 signaling,REACTOME,pathway,PATHWAY_2085
+2086,2086,2086,2086,2086,2086,2086,2086,R-HSA-451326,Activation of kainate receptors upon glutamate binding,REACTOME,pathway,PATHWAY_2086
+2087,2087,2087,2087,2087,2087,2087,2087,R-HSA-167021,PLC-gamma1 signalling,REACTOME,pathway,PATHWAY_2087
+2088,2088,2088,2088,2088,2088,2088,2088,R-HSA-4687000,Defective MPDU1 causes CDG-1f,REACTOME,pathway,PATHWAY_2088
+2089,2089,2089,2089,2089,2089,2089,2089,R-HSA-9665686,Signaling by ERBB2 TMD/JMD mutants,REACTOME,pathway,PATHWAY_2089
+2090,2090,2090,2090,2090,2090,2090,2090,R-HSA-156580,Phase II - Conjugation of compounds,REACTOME,pathway,PATHWAY_2090
+2091,2091,2091,2091,2091,2091,2091,2091,R-HSA-3296469,Defects in cobalamin (B12) metabolism,REACTOME,pathway,PATHWAY_2091
+2092,2092,2092,2092,2092,2092,2092,2092,R-HSA-975871,MyD88 cascade initiated on plasma membrane,REACTOME,pathway,PATHWAY_2092
+2093,2093,2093,2093,2093,2093,2093,2093,R-HSA-202670,ERKs are inactivated,REACTOME,pathway,PATHWAY_2093
+2094,2094,2094,2094,2094,2094,2094,2094,R-HSA-416993,Trafficking of GluR2-containing AMPA receptors,REACTOME,pathway,PATHWAY_2094
+2095,2095,2095,2095,2095,2095,2095,2095,R-HSA-9755088,Ribavirin ADME,REACTOME,pathway,PATHWAY_2095
+2096,2096,2096,2096,2096,2096,2096,2096,R-HSA-5684264,MAP3K8 (TPL2)-dependent MAPK1/3 activation,REACTOME,pathway,PATHWAY_2096
+2097,2097,2097,2097,2097,2097,2097,2097,R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,REACTOME,pathway,PATHWAY_2097
+2098,2098,2098,2098,2098,2098,2098,2098,R-HSA-198203,PI3K/AKT activation,REACTOME,pathway,PATHWAY_2098
+2099,2099,2099,2099,2099,2099,2099,2099,R-HSA-75153,Apoptotic execution phase,REACTOME,pathway,PATHWAY_2099
+2100,2100,2100,2100,2100,2100,2100,2100,R-HSA-9839373,Signaling by TGFBR3,REACTOME,pathway,PATHWAY_2100
+2101,2101,2101,2101,2101,2101,2101,2101,R-HSA-8953854,Metabolism of RNA,REACTOME,pathway,PATHWAY_2101
+2102,2102,2102,2102,2102,2102,2102,2102,R-HSA-6806003,Regulation of TP53 Expression and Degradation,REACTOME,pathway,PATHWAY_2102
+2103,2103,2103,2103,2103,2103,2103,2103,R-HSA-5688426,Deubiquitination,REACTOME,pathway,PATHWAY_2103
+2104,2104,2104,2104,2104,2104,2104,2104,R-HSA-5579012,Defective MAOA causes BRUNS,REACTOME,pathway,PATHWAY_2104
+2105,2105,2105,2105,2105,2105,2105,2105,R-HSA-9735763,Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine,REACTOME,pathway,PATHWAY_2105
+2106,2106,2106,2106,2106,2106,2106,2106,R-HSA-2022857,Keratan sulfate degradation,REACTOME,pathway,PATHWAY_2106
+2107,2107,2107,2107,2107,2107,2107,2107,R-HSA-8963899,Plasma lipoprotein remodeling,REACTOME,pathway,PATHWAY_2107
+2108,2108,2108,2108,2108,2108,2108,2108,R-HSA-1855167,Synthesis of pyrophosphates in the cytosol,REACTOME,pathway,PATHWAY_2108
+2109,2109,2109,2109,2109,2109,2109,2109,R-HSA-2206308,MPS IV - Morquio syndrome B,REACTOME,pathway,PATHWAY_2109
+2110,2110,2110,2110,2110,2110,2110,2110,R-HSA-170834,Signaling by TGF-beta Receptor Complex,REACTOME,pathway,PATHWAY_2110
+2111,2111,2111,2111,2111,2111,2111,2111,R-HSA-174417,Telomere C-strand (Lagging Strand) Synthesis,REACTOME,pathway,PATHWAY_2111
+2112,2112,2112,2112,2112,2112,2112,2112,R-HSA-9027277,Erythropoietin activates Phospholipase C gamma (PLCG),REACTOME,pathway,PATHWAY_2112
+2113,2113,2113,2113,2113,2113,2113,2113,R-HSA-5576892,Phase 0 - rapid depolarisation,REACTOME,pathway,PATHWAY_2113
+2114,2114,2114,2114,2114,2114,2114,2114,R-HSA-9669936,Sorafenib-resistant KIT mutants,REACTOME,pathway,PATHWAY_2114
+2115,2115,2115,2115,2115,2115,2115,2115,R-HSA-3560783,"Defective B4GALT7 causes EDS, progeroid type",REACTOME,pathway,PATHWAY_2115
+2116,2116,2116,2116,2116,2116,2116,2116,R-HSA-1614635,Sulfur amino acid metabolism,REACTOME,pathway,PATHWAY_2116
+2117,2117,2117,2117,2117,2117,2117,2117,R-HSA-9840309,Glycosphingolipid biosynthesis,REACTOME,pathway,PATHWAY_2117
+2118,2118,2118,2118,2118,2118,2118,2118,R-HSA-9763198,Impaired BRCA2 binding to SEM1 (DSS1),REACTOME,pathway,PATHWAY_2118
+2119,2119,2119,2119,2119,2119,2119,2119,R-HSA-1296072,Voltage gated Potassium channels,REACTOME,pathway,PATHWAY_2119
+2120,2120,2120,2120,2120,2120,2120,2120,R-HSA-164939,Nef mediated downregulation of CD28 cell surface expression,REACTOME,pathway,PATHWAY_2120
+2121,2121,2121,2121,2121,2121,2121,2121,R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,REACTOME,pathway,PATHWAY_2121
+2122,2122,2122,2122,2122,2122,2122,2122,R-HSA-193704,p75 NTR receptor-mediated signalling,REACTOME,pathway,PATHWAY_2122
+2123,2123,2123,2123,2123,2123,2123,2123,R-HSA-77310,Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,REACTOME,pathway,PATHWAY_2123
+2124,2124,2124,2124,2124,2124,2124,2124,R-HSA-611105,Respiratory electron transport,REACTOME,pathway,PATHWAY_2124
+2125,2125,2125,2125,2125,2125,2125,2125,R-HSA-917937,Iron uptake and transport,REACTOME,pathway,PATHWAY_2125
+2126,2126,2126,2126,2126,2126,2126,2126,R-HSA-9018682,Biosynthesis of maresins,REACTOME,pathway,PATHWAY_2126
+2127,2127,2127,2127,2127,2127,2127,2127,R-HSA-9665249,Resistance of ERBB2 KD mutants to afatinib,REACTOME,pathway,PATHWAY_2127
+2128,2128,2128,2128,2128,2128,2128,2128,R-HSA-909733,Interferon alpha/beta signaling,REACTOME,pathway,PATHWAY_2128
+2129,2129,2129,2129,2129,2129,2129,2129,R-HSA-376172,DSCAM interactions,REACTOME,pathway,PATHWAY_2129
+2130,2130,2130,2130,2130,2130,2130,2130,R-HSA-5658442,Regulation of RAS by GAPs,REACTOME,pathway,PATHWAY_2130
+2131,2131,2131,2131,2131,2131,2131,2131,R-HSA-9918436,Defective visual phototransduction due to OPN1MW loss of function,REACTOME,pathway,PATHWAY_2131
+2132,2132,2132,2132,2132,2132,2132,2132,R-HSA-381042,PERK regulates gene expression,REACTOME,pathway,PATHWAY_2132
+2133,2133,2133,2133,2133,2133,2133,2133,R-HSA-1980145,Signaling by NOTCH2,REACTOME,pathway,PATHWAY_2133
+2134,2134,2134,2134,2134,2134,2134,2134,R-HSA-8948747,Regulation of PTEN localization,REACTOME,pathway,PATHWAY_2134
+2135,2135,2135,2135,2135,2135,2135,2135,R-HSA-73933,Resolution of Abasic Sites (AP sites),REACTOME,pathway,PATHWAY_2135
+2136,2136,2136,2136,2136,2136,2136,2136,R-HSA-1300645,Acrosome Reaction and Sperm:Oocyte Membrane Binding,REACTOME,pathway,PATHWAY_2136
+2137,2137,2137,2137,2137,2137,2137,2137,R-HSA-9639775,Antimicrobial action and antimicrobial resistance in Mtb,REACTOME,pathway,PATHWAY_2137
+2138,2138,2138,2138,2138,2138,2138,2138,R-HSA-916853,Degradation of GABA,REACTOME,pathway,PATHWAY_2138
+2139,2139,2139,2139,2139,2139,2139,2139,R-HSA-975155,MyD88 dependent cascade initiated on endosome,REACTOME,pathway,PATHWAY_2139
+2140,2140,2140,2140,2140,2140,2140,2140,R-HSA-216083,Integrin cell surface interactions,REACTOME,pathway,PATHWAY_2140
+2141,2141,2141,2141,2141,2141,2141,2141,R-HSA-74217,Purine salvage,REACTOME,pathway,PATHWAY_2141
+2142,2142,2142,2142,2142,2142,2142,2142,R-HSA-8849471,"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",REACTOME,pathway,PATHWAY_2142
+2143,2143,2143,2143,2143,2143,2143,2143,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,REACTOME,pathway,PATHWAY_2143
+2144,2144,2144,2144,2144,2144,2144,2144,R-HSA-8983432,Interleukin-15 signaling,REACTOME,pathway,PATHWAY_2144
+2145,2145,2145,2145,2145,2145,2145,2145,R-HSA-5419276,Mitochondrial translation termination,REACTOME,pathway,PATHWAY_2145
+2146,2146,2146,2146,2146,2146,2146,2146,R-HSA-420597,Nectin/Necl  trans heterodimerization,REACTOME,pathway,PATHWAY_2146
+2147,2147,2147,2147,2147,2147,2147,2147,R-HSA-1222387,Tolerance of reactive oxygen produced by macrophages,REACTOME,pathway,PATHWAY_2147
+2148,2148,2148,2148,2148,2148,2148,2148,R-HSA-5684045,Defective ABCD1 causes ALD,REACTOME,pathway,PATHWAY_2148
+2149,2149,2149,2149,2149,2149,2149,2149,R-HSA-9857377,Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy,REACTOME,pathway,PATHWAY_2149
+2150,2150,2150,2150,2150,2150,2150,2150,R-HSA-8943724,Regulation of PTEN gene transcription,REACTOME,pathway,PATHWAY_2150
+2151,2151,2151,2151,2151,2151,2151,2151,R-HSA-9617629,Regulation of FOXO transcriptional activity by acetylation,REACTOME,pathway,PATHWAY_2151
+2152,2152,2152,2152,2152,2152,2152,2152,R-HSA-9845576,Glycosphingolipid transport,REACTOME,pathway,PATHWAY_2152
+2153,2153,2153,2153,2153,2153,2153,2153,R-HSA-9010553,Regulation of expression of SLITs and ROBOs,REACTOME,pathway,PATHWAY_2153
+2154,2154,2154,2154,2154,2154,2154,2154,R-HSA-9637698,Phagocyte cell death caused by cytosolic Mtb,REACTOME,pathway,PATHWAY_2154
+2155,2155,2155,2155,2155,2155,2155,2155,R-HSA-9672383,Defective factor IX causes thrombophilia,REACTOME,pathway,PATHWAY_2155
+2156,2156,2156,2156,2156,2156,2156,2156,R-HSA-9660537,Signaling by MRAS-complex mutants,REACTOME,pathway,PATHWAY_2156
+2157,2157,2157,2157,2157,2157,2157,2157,R-HSA-8942233,Intestinal infectious diseases,REACTOME,pathway,PATHWAY_2157
+2158,2158,2158,2158,2158,2158,2158,2158,R-HSA-4608870,Asymmetric localization of PCP proteins,REACTOME,pathway,PATHWAY_2158
+2159,2159,2159,2159,2159,2159,2159,2159,R-HSA-75896,Plasmalogen biosynthesis,REACTOME,pathway,PATHWAY_2159
+2160,2160,2160,2160,2160,2160,2160,2160,R-HSA-381771,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",REACTOME,pathway,PATHWAY_2160
+2161,2161,2161,2161,2161,2161,2161,2161,R-HSA-203927,MicroRNA (miRNA) biogenesis,REACTOME,pathway,PATHWAY_2161
+2162,2162,2162,2162,2162,2162,2162,2162,R-HSA-5673000,RAF activation,REACTOME,pathway,PATHWAY_2162
+2163,2163,2163,2163,2163,2163,2163,2163,R-HSA-9834899,Specification of the neural plate border,REACTOME,pathway,PATHWAY_2163
+2164,2164,2164,2164,2164,2164,2164,2164,R-HSA-9696270,RND2 GTPase cycle,REACTOME,pathway,PATHWAY_2164
+2165,2165,2165,2165,2165,2165,2165,2165,R-HSA-5619072,Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M),REACTOME,pathway,PATHWAY_2165
+2166,2166,2166,2166,2166,2166,2166,2166,R-HSA-9663891,Selective autophagy,REACTOME,pathway,PATHWAY_2166
+2167,2167,2167,2167,2167,2167,2167,2167,R-HSA-9013149,RAC1 GTPase cycle,REACTOME,pathway,PATHWAY_2167
+2168,2168,2168,2168,2168,2168,2168,2168,R-HSA-9630221,Defective NTHL1 substrate processing,REACTOME,pathway,PATHWAY_2168
+2169,2169,2169,2169,2169,2169,2169,2169,R-HSA-195253,Degradation of beta-catenin by the destruction complex,REACTOME,pathway,PATHWAY_2169
+2170,2170,2170,2170,2170,2170,2170,2170,R-HSA-1660661,Sphingolipid de novo biosynthesis,REACTOME,pathway,PATHWAY_2170
+2171,2171,2171,2171,2171,2171,2171,2171,R-HSA-5619070,Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),REACTOME,pathway,PATHWAY_2171
+2172,2172,2172,2172,2172,2172,2172,2172,R-HSA-5688399,Defective ABCA3 causes SMDP3,REACTOME,pathway,PATHWAY_2172
+2173,2173,2173,2173,2173,2173,2173,2173,R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),REACTOME,pathway,PATHWAY_2173
+2174,2174,2174,2174,2174,2174,2174,2174,R-HSA-6809583,Retinoid metabolism disease events,REACTOME,pathway,PATHWAY_2174
+2175,2175,2175,2175,2175,2175,2175,2175,R-HSA-9665245,Resistance of ERBB2 KD mutants to tesevatinib,REACTOME,pathway,PATHWAY_2175
+2176,2176,2176,2176,2176,2176,2176,2176,R-HSA-4641262,Disassembly of the destruction complex and recruitment of AXIN to the membrane,REACTOME,pathway,PATHWAY_2176
+2177,2177,2177,2177,2177,2177,2177,2177,R-HSA-5621575,CD209 (DC-SIGN) signaling,REACTOME,pathway,PATHWAY_2177
+2178,2178,2178,2178,2178,2178,2178,2178,R-HSA-5654727,Negative regulation of FGFR2 signaling,REACTOME,pathway,PATHWAY_2178
+2179,2179,2179,2179,2179,2179,2179,2179,R-HSA-112307,Transmission across Electrical Synapses ,REACTOME,pathway,PATHWAY_2179
+2180,2180,2180,2180,2180,2180,2180,2180,R-HSA-9664323,FCGR3A-mediated IL10 synthesis,REACTOME,pathway,PATHWAY_2180
+2181,2181,2181,2181,2181,2181,2181,2181,R-HSA-3560792,Defective SLC26A2 causes chondrodysplasias,REACTOME,pathway,PATHWAY_2181
+2182,2182,2182,2182,2182,2182,2182,2182,R-HSA-5654738,Signaling by FGFR2,REACTOME,pathway,PATHWAY_2182
+2183,2183,2183,2183,2183,2183,2183,2183,R-HSA-3282872,Severe congenital neutropenia type 4 (G6PC3),REACTOME,pathway,PATHWAY_2183
+2184,2184,2184,2184,2184,2184,2184,2184,R-HSA-193697,p75NTR regulates axonogenesis,REACTOME,pathway,PATHWAY_2184
+2185,2185,2185,2185,2185,2185,2185,2185,R-HSA-168298,Release,REACTOME,pathway,PATHWAY_2185
+2186,2186,2186,2186,2186,2186,2186,2186,R-HSA-8964041,LDL remodeling,REACTOME,pathway,PATHWAY_2186
+2187,2187,2187,2187,2187,2187,2187,2187,R-HSA-69895,Transcriptional  activation of  cell cycle inhibitor p21 ,REACTOME,pathway,PATHWAY_2187
+2188,2188,2188,2188,2188,2188,2188,2188,R-HSA-877300,Interferon gamma signaling,REACTOME,pathway,PATHWAY_2188
+2189,2189,2189,2189,2189,2189,2189,2189,R-HSA-209543,p75NTR recruits signalling complexes,REACTOME,pathway,PATHWAY_2189
+2190,2190,2190,2190,2190,2190,2190,2190,R-HSA-2033514,FGFR3 mutant receptor activation,REACTOME,pathway,PATHWAY_2190
+2191,2191,2191,2191,2191,2191,2191,2191,R-HSA-182218,Nef Mediated CD8 Down-regulation,REACTOME,pathway,PATHWAY_2191
+2192,2192,2192,2192,2192,2192,2192,2192,R-HSA-4341670,Defective NEU1 causes sialidosis,REACTOME,pathway,PATHWAY_2192
+2193,2193,2193,2193,2193,2193,2193,2193,R-HSA-3214842,HDMs demethylate histones,REACTOME,pathway,PATHWAY_2193
+2194,2194,2194,2194,2194,2194,2194,2194,R-HSA-9634815,Transcriptional Regulation by NPAS4,REACTOME,pathway,PATHWAY_2194
+2195,2195,2195,2195,2195,2195,2195,2195,R-HSA-181430,Norepinephrine Neurotransmitter Release Cycle,REACTOME,pathway,PATHWAY_2195
+2196,2196,2196,2196,2196,2196,2196,2196,R-HSA-211981,Xenobiotics,REACTOME,pathway,PATHWAY_2196
+2197,2197,2197,2197,2197,2197,2197,2197,R-HSA-5632681,Ligand-receptor interactions,REACTOME,pathway,PATHWAY_2197
+2198,2198,2198,2198,2198,2198,2198,2198,R-HSA-9615933,Postmitotic nuclear pore complex (NPC) reformation,REACTOME,pathway,PATHWAY_2198
+2199,2199,2199,2199,2199,2199,2199,2199,R-HSA-8978934,Metabolism of cofactors,REACTOME,pathway,PATHWAY_2199
+2200,2200,2200,2200,2200,2200,2200,2200,R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,REACTOME,pathway,PATHWAY_2200
+2201,2201,2201,2201,2201,2201,2201,2201,R-HSA-354192,Integrin signaling,REACTOME,pathway,PATHWAY_2201
+2202,2202,2202,2202,2202,2202,2202,2202,R-HSA-9646399,Aggrephagy,REACTOME,pathway,PATHWAY_2202
+2203,2203,2203,2203,2203,2203,2203,2203,R-HSA-9012546,Interleukin-18 signaling,REACTOME,pathway,PATHWAY_2203
+2204,2204,2204,2204,2204,2204,2204,2204,R-HSA-5689901,Metalloprotease DUBs,REACTOME,pathway,PATHWAY_2204
+2205,2205,2205,2205,2205,2205,2205,2205,R-HSA-9033241,Peroxisomal protein import,REACTOME,pathway,PATHWAY_2205
+2206,2206,2206,2206,2206,2206,2206,2206,R-HSA-2555396,Mitotic Metaphase and Anaphase,REACTOME,pathway,PATHWAY_2206
+2207,2207,2207,2207,2207,2207,2207,2207,R-HSA-9725370,Signaling by ALK fusions and activated point mutants,REACTOME,pathway,PATHWAY_2207
+2208,2208,2208,2208,2208,2208,2208,2208,R-HSA-5619083,"Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)",REACTOME,pathway,PATHWAY_2208
+2209,2209,2209,2209,2209,2209,2209,2209,R-HSA-2173788,Downregulation of TGF-beta receptor signaling,REACTOME,pathway,PATHWAY_2209
+2210,2210,2210,2210,2210,2210,2210,2210,R-HSA-8978868,Fatty acid metabolism,REACTOME,pathway,PATHWAY_2210
+2211,2211,2211,2211,2211,2211,2211,2211,R-HSA-354194,GRB2:SOS provides linkage to MAPK signaling for Integrins ,REACTOME,pathway,PATHWAY_2211
+2212,2212,2212,2212,2212,2212,2212,2212,R-HSA-166020,Transfer of LPS from LBP carrier to CD14,REACTOME,pathway,PATHWAY_2212
+2213,2213,2213,2213,2213,2213,2213,2213,R-HSA-166187,Mitochondrial Uncoupling,REACTOME,pathway,PATHWAY_2213
+2214,2214,2214,2214,2214,2214,2214,2214,R-HSA-70326,Glucose metabolism,REACTOME,pathway,PATHWAY_2214
+2215,2215,2215,2215,2215,2215,2215,2215,R-HSA-194306,Neurophilin interactions with VEGF and VEGFR,REACTOME,pathway,PATHWAY_2215
+2216,2216,2216,2216,2216,2216,2216,2216,R-HSA-9630791,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4,REACTOME,pathway,PATHWAY_2216
+2217,2217,2217,2217,2217,2217,2217,2217,R-HSA-9619229,Activation of RAC1 downstream of NMDARs,REACTOME,pathway,PATHWAY_2217
+2218,2218,2218,2218,2218,2218,2218,2218,R-HSA-5576890,Phase 3 - rapid repolarisation,REACTOME,pathway,PATHWAY_2218
+2219,2219,2219,2219,2219,2219,2219,2219,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),REACTOME,pathway,PATHWAY_2219
+2220,2220,2220,2220,2220,2220,2220,2220,R-HSA-5619040,Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1),REACTOME,pathway,PATHWAY_2220
+2221,2221,2221,2221,2221,2221,2221,2221,R-HSA-392851,Prostacyclin signalling through prostacyclin receptor,REACTOME,pathway,PATHWAY_2221
+2222,2222,2222,2222,2222,2222,2222,2222,R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC,REACTOME,pathway,PATHWAY_2222
+2223,2223,2223,2223,2223,2223,2223,2223,R-HSA-6814122,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,REACTOME,pathway,PATHWAY_2223
+2224,2224,2224,2224,2224,2224,2224,2224,R-HSA-5602498,MyD88 deficiency (TLR2/4),REACTOME,pathway,PATHWAY_2224
+2225,2225,2225,2225,2225,2225,2225,2225,R-HSA-1483191,Synthesis of PC,REACTOME,pathway,PATHWAY_2225
+2226,2226,2226,2226,2226,2226,2226,2226,R-HSA-9013425,RHOT1 GTPase cycle,REACTOME,pathway,PATHWAY_2226
+2227,2227,2227,2227,2227,2227,2227,2227,R-HSA-111453,BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,REACTOME,pathway,PATHWAY_2227
+2228,2228,2228,2228,2228,2228,2228,2228,R-HSA-3656253,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",REACTOME,pathway,PATHWAY_2228
+2229,2229,2229,2229,2229,2229,2229,2229,R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,REACTOME,pathway,PATHWAY_2229
+2230,2230,2230,2230,2230,2230,2230,2230,R-HSA-9670439,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",REACTOME,pathway,PATHWAY_2230
+2231,2231,2231,2231,2231,2231,2231,2231,R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,REACTOME,pathway,PATHWAY_2231
+2232,2232,2232,2232,2232,2232,2232,2232,R-HSA-3000170,Syndecan interactions,REACTOME,pathway,PATHWAY_2232
+2233,2233,2233,2233,2233,2233,2233,2233,R-HSA-444257,RSK activation,REACTOME,pathway,PATHWAY_2233
+2234,2234,2234,2234,2234,2234,2234,2234,R-HSA-159231,Transport of Mature mRNA Derived from an Intronless Transcript,REACTOME,pathway,PATHWAY_2234
+2235,2235,2235,2235,2235,2235,2235,2235,R-HSA-9683673,Maturation of protein 3a,REACTOME,pathway,PATHWAY_2235
+2236,2236,2236,2236,2236,2236,2236,2236,R-HSA-1222538,Tolerance by Mtb to nitric oxide produced by macrophages,REACTOME,pathway,PATHWAY_2236
+2237,2237,2237,2237,2237,2237,2237,2237,R-HSA-2022377,Metabolism of Angiotensinogen to Angiotensins,REACTOME,pathway,PATHWAY_2237
+2238,2238,2238,2238,2238,2238,2238,2238,R-HSA-9705683,SARS-CoV-2-host interactions,REACTOME,pathway,PATHWAY_2238
+2239,2239,2239,2239,2239,2239,2239,2239,R-HSA-5654688,SHC-mediated cascade:FGFR1,REACTOME,pathway,PATHWAY_2239
+2240,2240,2240,2240,2240,2240,2240,2240,R-HSA-9833576,CDH11 homotypic and heterotypic interactions,REACTOME,pathway,PATHWAY_2240
+2241,2241,2241,2241,2241,2241,2241,2241,R-HSA-1810476,RIP-mediated NFkB activation via ZBP1,REACTOME,pathway,PATHWAY_2241
+2242,2242,2242,2242,2242,2242,2242,2242,R-HSA-8851907,MET activates PI3K/AKT signaling,REACTOME,pathway,PATHWAY_2242
+2243,2243,2243,2243,2243,2243,2243,2243,R-HSA-2660826,Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,REACTOME,pathway,PATHWAY_2243
+2244,2244,2244,2244,2244,2244,2244,2244,R-HSA-5579027,Defective CYP27B1 causes VDDR1B,REACTOME,pathway,PATHWAY_2244
+2245,2245,2245,2245,2245,2245,2245,2245,R-HSA-176974,Unwinding of DNA,REACTOME,pathway,PATHWAY_2245
+2246,2246,2246,2246,2246,2246,2246,2246,R-HSA-9623433,NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,REACTOME,pathway,PATHWAY_2246
+2247,2247,2247,2247,2247,2247,2247,2247,R-HSA-111465,Apoptotic cleavage of cellular proteins,REACTOME,pathway,PATHWAY_2247
+2248,2248,2248,2248,2248,2248,2248,2248,R-HSA-9636383,Prevention of phagosomal-lysosomal fusion,REACTOME,pathway,PATHWAY_2248
+2249,2249,2249,2249,2249,2249,2249,2249,R-HSA-71240,Tryptophan catabolism,REACTOME,pathway,PATHWAY_2249
+2250,2250,2250,2250,2250,2250,2250,2250,R-HSA-9907570,Loss-of-function mutations in DLD cause MSUD3/DLDD,REACTOME,pathway,PATHWAY_2250
+2251,2251,2251,2251,2251,2251,2251,2251,R-HSA-3214841,PKMTs methylate histone lysines,REACTOME,pathway,PATHWAY_2251
+2252,2252,2252,2252,2252,2252,2252,2252,R-HSA-5676594,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,REACTOME,pathway,PATHWAY_2252
+2253,2253,2253,2253,2253,2253,2253,2253,R-HSA-5689880,Ub-specific processing proteases,REACTOME,pathway,PATHWAY_2253
+2254,2254,2254,2254,2254,2254,2254,2254,R-HSA-9711097,Cellular response to starvation,REACTOME,pathway,PATHWAY_2254
+2255,2255,2255,2255,2255,2255,2255,2255,R-HSA-9700649,Drug resistance of ALK mutants,REACTOME,pathway,PATHWAY_2255
+2256,2256,2256,2256,2256,2256,2256,2256,R-HSA-9818025,NFE2L2 regulating TCA cycle genes,REACTOME,pathway,PATHWAY_2256
+2257,2257,2257,2257,2257,2257,2257,2257,R-HSA-5685939,HDR through MMEJ (alt-NHEJ),REACTOME,pathway,PATHWAY_2257
+2258,2258,2258,2258,2258,2258,2258,2258,R-HSA-2028269,Signaling by Hippo,REACTOME,pathway,PATHWAY_2258
+2259,2259,2259,2259,2259,2259,2259,2259,R-HSA-1663150,The activation of arylsulfatases,REACTOME,pathway,PATHWAY_2259
+2260,2260,2260,2260,2260,2260,2260,2260,R-HSA-5656364,Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM),REACTOME,pathway,PATHWAY_2260
+2261,2261,2261,2261,2261,2261,2261,2261,R-HSA-5624138,Trafficking of myristoylated proteins to the cilium,REACTOME,pathway,PATHWAY_2261
+2262,2262,2262,2262,2262,2262,2262,2262,R-HSA-8939242,RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,REACTOME,pathway,PATHWAY_2262
+2263,2263,2263,2263,2263,2263,2263,2263,R-HSA-6790901,rRNA modification in the nucleus and cytosol,REACTOME,pathway,PATHWAY_2263
+2264,2264,2264,2264,2264,2264,2264,2264,R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,REACTOME,pathway,PATHWAY_2264
+2265,2265,2265,2265,2265,2265,2265,2265,R-HSA-69200,Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,REACTOME,pathway,PATHWAY_2265
+2266,2266,2266,2266,2266,2266,2266,2266,R-HSA-69190,DNA strand elongation,REACTOME,pathway,PATHWAY_2266
+2267,2267,2267,2267,2267,2267,2267,2267,R-HSA-8868766,rRNA processing in the mitochondrion,REACTOME,pathway,PATHWAY_2267
+2268,2268,2268,2268,2268,2268,2268,2268,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,REACTOME,pathway,PATHWAY_2268
+2269,2269,2269,2269,2269,2269,2269,2269,R-HSA-400253,Circadian Clock,REACTOME,pathway,PATHWAY_2269
+2270,2270,2270,2270,2270,2270,2270,2270,R-HSA-1660517,Synthesis of PIPs at the late endosome membrane,REACTOME,pathway,PATHWAY_2270
+2271,2271,2271,2271,2271,2271,2271,2271,R-HSA-1169408,ISG15 antiviral mechanism,REACTOME,pathway,PATHWAY_2271
+2272,2272,2272,2272,2272,2272,2272,2272,R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,REACTOME,pathway,PATHWAY_2272
+2273,2273,2273,2273,2273,2273,2273,2273,R-HSA-9694635,Translation of Structural Proteins,REACTOME,pathway,PATHWAY_2273
+2274,2274,2274,2274,2274,2274,2274,2274,R-HSA-9917777,Epigenetic regulation by WDR5-containing histone modifying complexes,REACTOME,pathway,PATHWAY_2274
+2275,2275,2275,2275,2275,2275,2275,2275,R-HSA-5579000,Defective CYP1B1 causes Glaucoma,REACTOME,pathway,PATHWAY_2275
+2276,2276,2276,2276,2276,2276,2276,2276,R-HSA-6784531,tRNA processing in the nucleus,REACTOME,pathway,PATHWAY_2276
+2277,2277,2277,2277,2277,2277,2277,2277,R-HSA-112311,Neurotransmitter clearance,REACTOME,pathway,PATHWAY_2277
+2278,2278,2278,2278,2278,2278,2278,2278,R-HSA-1299361,TWIK-related alkaline pH activated K+ channel (TALK),REACTOME,pathway,PATHWAY_2278
+2279,2279,2279,2279,2279,2279,2279,2279,R-HSA-1839122,Signaling by activated point mutants of FGFR1,REACTOME,pathway,PATHWAY_2279
+2280,2280,2280,2280,2280,2280,2280,2280,R-HSA-9844594,Transcriptional regulation of brown and beige adipocyte differentiation by EBF2,REACTOME,pathway,PATHWAY_2280
+2281,2281,2281,2281,2281,2281,2281,2281,R-HSA-212165,Epigenetic regulation of gene expression,REACTOME,pathway,PATHWAY_2281
+2282,2282,2282,2282,2282,2282,2282,2282,R-HSA-425407,SLC-mediated transmembrane transport,REACTOME,pathway,PATHWAY_2282
+2283,2283,2283,2283,2283,2283,2283,2283,R-HSA-1638091,Heparan sulfate/heparin (HS-GAG) metabolism,REACTOME,pathway,PATHWAY_2283
+2284,2284,2284,2284,2284,2284,2284,2284,R-HSA-5339700,Signaling by TCF7L2 mutants,REACTOME,pathway,PATHWAY_2284
+2285,2285,2285,2285,2285,2285,2285,2285,R-HSA-1912399,Pre-NOTCH Processing in the Endoplasmic Reticulum,REACTOME,pathway,PATHWAY_2285
+2286,2286,2286,2286,2286,2286,2286,2286,R-HSA-977347,Serine biosynthesis,REACTOME,pathway,PATHWAY_2286
+2287,2287,2287,2287,2287,2287,2287,2287,R-HSA-4549380,Defective ALG1 causes CDG-1k,REACTOME,pathway,PATHWAY_2287
+2288,2288,2288,2288,2288,2288,2288,2288,R-HSA-390247,Beta-oxidation of very long chain fatty acids,REACTOME,pathway,PATHWAY_2288
+2289,2289,2289,2289,2289,2289,2289,2289,R-HSA-399954,Sema3A PAK dependent Axon repulsion,REACTOME,pathway,PATHWAY_2289
+2290,2290,2290,2290,2290,2290,2290,2290,R-HSA-75094,Formation of the Editosome,REACTOME,pathway,PATHWAY_2290
+2291,2291,2291,2291,2291,2291,2291,2291,R-HSA-5619101,Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),REACTOME,pathway,PATHWAY_2291
+2292,2292,2292,2292,2292,2292,2292,2292,R-HSA-2855086,Ficolins bind to repetitive carbohydrate structures on the target cell surface,REACTOME,pathway,PATHWAY_2292
+2293,2293,2293,2293,2293,2293,2293,2293,R-HSA-9701193,Defective homologous recombination repair (HRR) due to PALB2 loss of function,REACTOME,pathway,PATHWAY_2293
+2294,2294,2294,2294,2294,2294,2294,2294,R-HSA-71384,Ethanol oxidation,REACTOME,pathway,PATHWAY_2294
+2295,2295,2295,2295,2295,2295,2295,2295,R-HSA-438064,Post NMDA receptor activation events,REACTOME,pathway,PATHWAY_2295
+2296,2296,2296,2296,2296,2296,2296,2296,R-HSA-937041,IKK complex recruitment mediated by RIP1,REACTOME,pathway,PATHWAY_2296
+2297,2297,2297,2297,2297,2297,2297,2297,R-HSA-5250958,Toxicity of botulinum toxin type B (botB),REACTOME,pathway,PATHWAY_2297
+2298,2298,2298,2298,2298,2298,2298,2298,R-HSA-5619068,Defective SLC2A10 causes arterial tortuosity syndrome (ATS),REACTOME,pathway,PATHWAY_2298
+2299,2299,2299,2299,2299,2299,2299,2299,R-HSA-2162123,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),REACTOME,pathway,PATHWAY_2299
+2300,2300,2300,2300,2300,2300,2300,2300,R-HSA-8875513,MET interacts with TNS proteins,REACTOME,pathway,PATHWAY_2300
+2301,2301,2301,2301,2301,2301,2301,2301,R-HSA-3371378,Regulation by c-FLIP,REACTOME,pathway,PATHWAY_2301
+2302,2302,2302,2302,2302,2302,2302,2302,R-HSA-964739,N-glycan trimming and elongation in the cis-Golgi,REACTOME,pathway,PATHWAY_2302
+2303,2303,2303,2303,2303,2303,2303,2303,R-HSA-9927354,Co-stimulation by ICOS,REACTOME,pathway,PATHWAY_2303
+2304,2304,2304,2304,2304,2304,2304,2304,R-HSA-5693548,Sensing of DNA Double Strand Breaks,REACTOME,pathway,PATHWAY_2304
+2305,2305,2305,2305,2305,2305,2305,2305,R-HSA-9027604,Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives,REACTOME,pathway,PATHWAY_2305
+2306,2306,2306,2306,2306,2306,2306,2306,R-HSA-9013423,RAC3 GTPase cycle,REACTOME,pathway,PATHWAY_2306
+2307,2307,2307,2307,2307,2307,2307,2307,R-HSA-2980767,"Activation of NIMA Kinases NEK9, NEK6, NEK7",REACTOME,pathway,PATHWAY_2307
+2308,2308,2308,2308,2308,2308,2308,2308,R-HSA-427359,SIRT1 negatively regulates rRNA expression,REACTOME,pathway,PATHWAY_2308
+2309,2309,2309,2309,2309,2309,2309,2309,R-HSA-195399,VEGF binds to VEGFR leading to receptor dimerization,REACTOME,pathway,PATHWAY_2309
+2310,2310,2310,2310,2310,2310,2310,2310,R-HSA-2485179,Activation of the phototransduction cascade,REACTOME,pathway,PATHWAY_2310
+2311,2311,2311,2311,2311,2311,2311,2311,R-HSA-5660724,Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),REACTOME,pathway,PATHWAY_2311
+2312,2312,2312,2312,2312,2312,2312,2312,R-HSA-75953,RNA Polymerase II Transcription Initiation,REACTOME,pathway,PATHWAY_2312
+2313,2313,2313,2313,2313,2313,2313,2313,R-HSA-9680187,Signaling by extracellular domain mutants of KIT,REACTOME,pathway,PATHWAY_2313
+2314,2314,2314,2314,2314,2314,2314,2314,R-HSA-9845620,Enhanced binding of GP1BA variant to VWF multimer:collagen ,REACTOME,pathway,PATHWAY_2314
+2315,2315,2315,2315,2315,2315,2315,2315,R-HSA-5683329,Defective ABCD4 causes MAHCJ,REACTOME,pathway,PATHWAY_2315
+2316,2316,2316,2316,2316,2316,2316,2316,R-HSA-375281,Hormone ligand-binding receptors,REACTOME,pathway,PATHWAY_2316
+2317,2317,2317,2317,2317,2317,2317,2317,R-HSA-9013407,RHOH GTPase cycle,REACTOME,pathway,PATHWAY_2317
+2318,2318,2318,2318,2318,2318,2318,2318,R-HSA-5654710,PI-3K cascade:FGFR3,REACTOME,pathway,PATHWAY_2318
+2319,2319,2319,2319,2319,2319,2319,2319,R-HSA-9711123,Cellular response to chemical stress,REACTOME,pathway,PATHWAY_2319
+2320,2320,2320,2320,2320,2320,2320,2320,R-HSA-174430,Telomere C-strand synthesis initiation,REACTOME,pathway,PATHWAY_2320
+2321,2321,2321,2321,2321,2321,2321,2321,R-HSA-8953750,Transcriptional Regulation by E2F6,REACTOME,pathway,PATHWAY_2321
+2322,2322,2322,2322,2322,2322,2322,2322,R-HSA-379726,Mitochondrial tRNA aminoacylation,REACTOME,pathway,PATHWAY_2322
+2323,2323,2323,2323,2323,2323,2323,2323,R-HSA-5693579,Homologous DNA Pairing and Strand Exchange,REACTOME,pathway,PATHWAY_2323
+2324,2324,2324,2324,2324,2324,2324,2324,R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,REACTOME,pathway,PATHWAY_2324
+2325,2325,2325,2325,2325,2325,2325,2325,R-HSA-433137,"Sodium-coupled sulphate, di- and tri-carboxylate transporters",REACTOME,pathway,PATHWAY_2325
+2326,2326,2326,2326,2326,2326,2326,2326,R-HSA-5676590,NIK-->noncanonical NF-kB signaling,REACTOME,pathway,PATHWAY_2326
+2327,2327,2327,2327,2327,2327,2327,2327,R-HSA-1299503,TWIK related potassium channel (TREK),REACTOME,pathway,PATHWAY_2327
+2328,2328,2328,2328,2328,2328,2328,2328,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,REACTOME,pathway,PATHWAY_2328
+2329,2329,2329,2329,2329,2329,2329,2329,R-HSA-9732724,IFNG signaling activates MAPKs,REACTOME,pathway,PATHWAY_2329
+2330,2330,2330,2330,2330,2330,2330,2330,R-HSA-416550,Sema4D mediated inhibition of cell attachment and migration,REACTOME,pathway,PATHWAY_2330
+2331,2331,2331,2331,2331,2331,2331,2331,R-HSA-5218900,CASP8 activity is inhibited,REACTOME,pathway,PATHWAY_2331
+2332,2332,2332,2332,2332,2332,2332,2332,R-HSA-9684325,Maturation of replicase proteins,REACTOME,pathway,PATHWAY_2332
+2333,2333,2333,2333,2333,2333,2333,2333,R-HSA-1222499,Latent infection - Other responses of Mtb to phagocytosis,REACTOME,pathway,PATHWAY_2333
+2334,2334,2334,2334,2334,2334,2334,2334,R-HSA-419037,NCAM1 interactions,REACTOME,pathway,PATHWAY_2334
+2335,2335,2335,2335,2335,2335,2335,2335,R-HSA-446728,Cell junction organization,REACTOME,pathway,PATHWAY_2335
+2336,2336,2336,2336,2336,2336,2336,2336,R-HSA-9020702,Interleukin-1 signaling,REACTOME,pathway,PATHWAY_2336
+2337,2337,2337,2337,2337,2337,2337,2337,R-HSA-420092,Glucagon-type ligand receptors,REACTOME,pathway,PATHWAY_2337
+2338,2338,2338,2338,2338,2338,2338,2338,R-HSA-180292,GAB1 signalosome,REACTOME,pathway,PATHWAY_2338
+2339,2339,2339,2339,2339,2339,2339,2339,R-HSA-451927,Interleukin-2 family signaling,REACTOME,pathway,PATHWAY_2339
+2340,2340,2340,2340,2340,2340,2340,2340,R-HSA-190373,FGFR1c ligand binding and activation,REACTOME,pathway,PATHWAY_2340
+2341,2341,2341,2341,2341,2341,2341,2341,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,REACTOME,pathway,PATHWAY_2341
+2342,2342,2342,2342,2342,2342,2342,2342,R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,REACTOME,pathway,PATHWAY_2342
+2343,2343,2343,2343,2343,2343,2343,2343,R-HSA-400508,"Incretin synthesis, secretion, and inactivation",REACTOME,pathway,PATHWAY_2343
+2344,2344,2344,2344,2344,2344,2344,2344,R-HSA-5083628,"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",REACTOME,pathway,PATHWAY_2344
+2345,2345,2345,2345,2345,2345,2345,2345,R-HSA-6781823,Formation of TC-NER Pre-Incision Complex,REACTOME,pathway,PATHWAY_2345
+2346,2346,2346,2346,2346,2346,2346,2346,R-HSA-70263,Gluconeogenesis,REACTOME,pathway,PATHWAY_2346
+2347,2347,2347,2347,2347,2347,2347,2347,R-HSA-9707587,Regulation of HMOX1 expression and activity,REACTOME,pathway,PATHWAY_2347
+2348,2348,2348,2348,2348,2348,2348,2348,R-HSA-9630747,Diseases of Cellular Senescence,REACTOME,pathway,PATHWAY_2348
+2349,2349,2349,2349,2349,2349,2349,2349,R-HSA-9007101,Rab regulation of trafficking,REACTOME,pathway,PATHWAY_2349
+2350,2350,2350,2350,2350,2350,2350,2350,R-HSA-5358508,Mismatch Repair,REACTOME,pathway,PATHWAY_2350
+2351,2351,2351,2351,2351,2351,2351,2351,R-HSA-196025,Formation of annular gap junctions,REACTOME,pathway,PATHWAY_2351
+2352,2352,2352,2352,2352,2352,2352,2352,R-HSA-3359478,Defective MUT causes MMAM,REACTOME,pathway,PATHWAY_2352
+2353,2353,2353,2353,2353,2353,2353,2353,R-HSA-2682334,EPH-Ephrin signaling,REACTOME,pathway,PATHWAY_2353
+2354,2354,2354,2354,2354,2354,2354,2354,R-HSA-9679506,SARS-CoV Infections,REACTOME,pathway,PATHWAY_2354
+2355,2355,2355,2355,2355,2355,2355,2355,R-HSA-5083636,Defective GALNT12 causes CRCS1,REACTOME,pathway,PATHWAY_2355
+2356,2356,2356,2356,2356,2356,2356,2356,R-HSA-1253288,Downregulation of ERBB4 signaling,REACTOME,pathway,PATHWAY_2356
+2357,2357,2357,2357,2357,2357,2357,2357,R-HSA-3656234,Defective HEXA causes GM2G1,REACTOME,pathway,PATHWAY_2357
+2358,2358,2358,2358,2358,2358,2358,2358,R-HSA-430116,GP1b-IX-V activation signalling,REACTOME,pathway,PATHWAY_2358
+2359,2359,2359,2359,2359,2359,2359,2359,R-HSA-5218859,Regulated Necrosis,REACTOME,pathway,PATHWAY_2359
+2360,2360,2360,2360,2360,2360,2360,2360,R-HSA-156902,Peptide chain elongation,REACTOME,pathway,PATHWAY_2360
+2361,2361,2361,2361,2361,2361,2361,2361,R-HSA-9657050,Defective OGG1 Localization,REACTOME,pathway,PATHWAY_2361
+2362,2362,2362,2362,2362,2362,2362,2362,R-HSA-9674428,PDGFR mutants bind TKIs,REACTOME,pathway,PATHWAY_2362
+2363,2363,2363,2363,2363,2363,2363,2363,R-HSA-157858,Gap junction trafficking and regulation,REACTOME,pathway,PATHWAY_2363
+2364,2364,2364,2364,2364,2364,2364,2364,R-HSA-9699150,Defective DNA double strand break response due to BARD1 loss of function,REACTOME,pathway,PATHWAY_2364
+2365,2365,2365,2365,2365,2365,2365,2365,R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,REACTOME,pathway,PATHWAY_2365
+2366,2366,2366,2366,2366,2366,2366,2366,R-HSA-9754678,SARS-CoV-2 modulates host translation machinery,REACTOME,pathway,PATHWAY_2366
+2367,2367,2367,2367,2367,2367,2367,2367,R-HSA-375165,NCAM signaling for neurite out-growth,REACTOME,pathway,PATHWAY_2367
+2368,2368,2368,2368,2368,2368,2368,2368,R-HSA-877312,Regulation of IFNG signaling,REACTOME,pathway,PATHWAY_2368
+2369,2369,2369,2369,2369,2369,2369,2369,R-HSA-2426168,Activation of gene expression by SREBF (SREBP),REACTOME,pathway,PATHWAY_2369
+2370,2370,2370,2370,2370,2370,2370,2370,R-HSA-9603798,Class I peroxisomal membrane protein import,REACTOME,pathway,PATHWAY_2370
+2371,2371,2371,2371,2371,2371,2371,2371,R-HSA-2424491,DAP12 signaling,REACTOME,pathway,PATHWAY_2371
+2372,2372,2372,2372,2372,2372,2372,2372,R-HSA-164944,Nef and signal transduction,REACTOME,pathway,PATHWAY_2372
+2373,2373,2373,2373,2373,2373,2373,2373,R-HSA-9726842,Gain-of-function MRAS complexes activate RAF signaling,REACTOME,pathway,PATHWAY_2373
+2374,2374,2374,2374,2374,2374,2374,2374,R-HSA-5602415,UNC93B1 deficiency - HSE,REACTOME,pathway,PATHWAY_2374
+2375,2375,2375,2375,2375,2375,2375,2375,R-HSA-190370,FGFR1b ligand binding and activation,REACTOME,pathway,PATHWAY_2375
+2376,2376,2376,2376,2376,2376,2376,2376,R-HSA-9846298,Defective binding of VWF variant to GPIb:IX:V,REACTOME,pathway,PATHWAY_2376
+2377,2377,2377,2377,2377,2377,2377,2377,R-HSA-69278,"Cell Cycle, Mitotic",REACTOME,pathway,PATHWAY_2377
+2378,2378,2378,2378,2378,2378,2378,2378,R-HSA-727802,Transport of nucleotide sugars,REACTOME,pathway,PATHWAY_2378
+2379,2379,2379,2379,2379,2379,2379,2379,R-HSA-77285,Beta oxidation of myristoyl-CoA to lauroyl-CoA,REACTOME,pathway,PATHWAY_2379
+2380,2380,2380,2380,2380,2380,2380,2380,R-HSA-3134975,Regulation of innate immune responses to cytosolic DNA,REACTOME,pathway,PATHWAY_2380
+2381,2381,2381,2381,2381,2381,2381,2381,R-HSA-180897,Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,REACTOME,pathway,PATHWAY_2381
+2382,2382,2382,2382,2382,2382,2382,2382,R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds",REACTOME,pathway,PATHWAY_2382
+2383,2383,2383,2383,2383,2383,2383,2383,R-HSA-114516,Disinhibition of SNARE formation,REACTOME,pathway,PATHWAY_2383
+2384,2384,2384,2384,2384,2384,2384,2384,R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,REACTOME,pathway,PATHWAY_2384
+2385,2385,2385,2385,2385,2385,2385,2385,R-HSA-1855184,IPs transport between cytosol and ER lumen,REACTOME,pathway,PATHWAY_2385
+2386,2386,2386,2386,2386,2386,2386,2386,R-HSA-5545483,Defective Mismatch Repair Associated With MLH1,REACTOME,pathway,PATHWAY_2386
+2387,2387,2387,2387,2387,2387,2387,2387,R-HSA-5676934,Protein repair,REACTOME,pathway,PATHWAY_2387
+2388,2388,2388,2388,2388,2388,2388,2388,R-HSA-373755,Semaphorin interactions,REACTOME,pathway,PATHWAY_2388
+2389,2389,2389,2389,2389,2389,2389,2389,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,REACTOME,pathway,PATHWAY_2389
+2390,2390,2390,2390,2390,2390,2390,2390,R-HSA-391251,Protein folding,REACTOME,pathway,PATHWAY_2390
+2391,2391,2391,2391,2391,2391,2391,2391,R-HSA-71064,Lysine catabolism,REACTOME,pathway,PATHWAY_2391
+2392,2392,2392,2392,2392,2392,2392,2392,R-HSA-193639,p75NTR signals via NF-kB,REACTOME,pathway,PATHWAY_2392
+2393,2393,2393,2393,2393,2393,2393,2393,R-HSA-8964540,Alanine metabolism,REACTOME,pathway,PATHWAY_2393
+2394,2394,2394,2394,2394,2394,2394,2394,R-HSA-381038,XBP1(S) activates chaperone genes,REACTOME,pathway,PATHWAY_2394
+2395,2395,2395,2395,2395,2395,2395,2395,R-HSA-9656249,Defective Base Excision Repair Associated with OGG1,REACTOME,pathway,PATHWAY_2395
+2396,2396,2396,2396,2396,2396,2396,2396,R-HSA-9672397,Defective F8 secretion,REACTOME,pathway,PATHWAY_2396
+2397,2397,2397,2397,2397,2397,2397,2397,R-HSA-5619073,Defective GCK causes maturity-onset diabetes of the young 2 (MODY2),REACTOME,pathway,PATHWAY_2397
+2398,2398,2398,2398,2398,2398,2398,2398,R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,REACTOME,pathway,PATHWAY_2398
+2399,2399,2399,2399,2399,2399,2399,2399,R-HSA-9006335,Signaling by Erythropoietin,REACTOME,pathway,PATHWAY_2399
+2400,2400,2400,2400,2400,2400,2400,2400,R-HSA-6791462,"TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P",REACTOME,pathway,PATHWAY_2400
+2401,2401,2401,2401,2401,2401,2401,2401,R-HSA-76066,RNA Polymerase III Transcription Initiation From Type 2 Promoter,REACTOME,pathway,PATHWAY_2401
+2402,2402,2402,2402,2402,2402,2402,2402,R-HSA-5619102,SLC transporter disorders,REACTOME,pathway,PATHWAY_2402
+2403,2403,2403,2403,2403,2403,2403,2403,R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,REACTOME,pathway,PATHWAY_2403
+2404,2404,2404,2404,2404,2404,2404,2404,R-HSA-9022692,Regulation of MECP2 expression and activity,REACTOME,pathway,PATHWAY_2404
+2405,2405,2405,2405,2405,2405,2405,2405,R-HSA-8854521,Interaction between PHLDA1 and AURKA,REACTOME,pathway,PATHWAY_2405
+2406,2406,2406,2406,2406,2406,2406,2406,R-HSA-453274,Mitotic G2-G2/M phases,REACTOME,pathway,PATHWAY_2406
+2407,2407,2407,2407,2407,2407,2407,2407,R-HSA-177162,Conjugation of phenylacetate with glutamine,REACTOME,pathway,PATHWAY_2407
+2408,2408,2408,2408,2408,2408,2408,2408,R-HSA-453279,Mitotic G1 phase and G1/S transition,REACTOME,pathway,PATHWAY_2408
+2409,2409,2409,2409,2409,2409,2409,2409,R-HSA-420029,Tight junction interactions,REACTOME,pathway,PATHWAY_2409
+2410,2410,2410,2410,2410,2410,2410,2410,R-HSA-5696397,Gap-filling DNA repair synthesis and ligation in GG-NER,REACTOME,pathway,PATHWAY_2410
+2411,2411,2411,2411,2411,2411,2411,2411,R-HSA-74749,Signal attenuation,REACTOME,pathway,PATHWAY_2411
+2412,2412,2412,2412,2412,2412,2412,2412,R-HSA-9764260,Regulation of Expression and Function of Type II Classical Cadherins,REACTOME,pathway,PATHWAY_2412
+2413,2413,2413,2413,2413,2413,2413,2413,R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,REACTOME,pathway,PATHWAY_2413
+2414,2414,2414,2414,2414,2414,2414,2414,R-HSA-9762114,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,REACTOME,pathway,PATHWAY_2414
+2415,2415,2415,2415,2415,2415,2415,2415,R-HSA-964975,Vitamin B6 activation to pyridoxal phosphate,REACTOME,pathway,PATHWAY_2415
+2416,2416,2416,2416,2416,2416,2416,2416,R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,REACTOME,pathway,PATHWAY_2416
+2417,2417,2417,2417,2417,2417,2417,2417,R-HSA-8979227,Triglyceride metabolism,REACTOME,pathway,PATHWAY_2417
+2418,2418,2418,2418,2418,2418,2418,2418,R-HSA-6799198,Complex I biogenesis,REACTOME,pathway,PATHWAY_2418
+2419,2419,2419,2419,2419,2419,2419,2419,R-HSA-112040,G-protein mediated events,REACTOME,pathway,PATHWAY_2419
+2420,2420,2420,2420,2420,2420,2420,2420,R-HSA-2142700,Biosynthesis of Lipoxins (LX),REACTOME,pathway,PATHWAY_2420
+2421,2421,2421,2421,2421,2421,2421,2421,R-HSA-2299718,Condensation of Prophase Chromosomes,REACTOME,pathway,PATHWAY_2421
+2422,2422,2422,2422,2422,2422,2422,2422,R-HSA-9023661,Biosynthesis of E-series 18(R)-resolvins,REACTOME,pathway,PATHWAY_2422
+2423,2423,2423,2423,2423,2423,2423,2423,R-HSA-9028731,Activated NTRK2 signals through FRS2 and FRS3,REACTOME,pathway,PATHWAY_2423
+2424,2424,2424,2424,2424,2424,2424,2424,R-HSA-8939211,ESR-mediated signaling,REACTOME,pathway,PATHWAY_2424
+2425,2425,2425,2425,2425,2425,2425,2425,R-HSA-8851708,Signaling by FGFR2 IIIa TM,REACTOME,pathway,PATHWAY_2425
+2426,2426,2426,2426,2426,2426,2426,2426,R-HSA-5578998,Defective OPLAH causes OPLAHD,REACTOME,pathway,PATHWAY_2426
+2427,2427,2427,2427,2427,2427,2427,2427,R-HSA-9025094,Biosynthesis of DPAn-3 SPMs,REACTOME,pathway,PATHWAY_2427
+2428,2428,2428,2428,2428,2428,2428,2428,R-HSA-9652282,Drug-mediated inhibition of ERBB2 signaling,REACTOME,pathway,PATHWAY_2428
+2429,2429,2429,2429,2429,2429,2429,2429,R-HSA-9709957,Sensory Perception,REACTOME,pathway,PATHWAY_2429
+2430,2430,2430,2430,2430,2430,2430,2430,R-HSA-169893,Prolonged ERK activation events,REACTOME,pathway,PATHWAY_2430
+2431,2431,2431,2431,2431,2431,2431,2431,R-HSA-912446,Meiotic recombination,REACTOME,pathway,PATHWAY_2431
+2432,2432,2432,2432,2432,2432,2432,2432,R-HSA-189200,Cellular hexose transport,REACTOME,pathway,PATHWAY_2432
+2433,2433,2433,2433,2433,2433,2433,2433,R-HSA-9734281,Defective HPRT1 disrupts guanine and hypoxanthine salvage,REACTOME,pathway,PATHWAY_2433
+2434,2434,2434,2434,2434,2434,2434,2434,R-HSA-209952,Peptide hormone biosynthesis,REACTOME,pathway,PATHWAY_2434
+2435,2435,2435,2435,2435,2435,2435,2435,R-HSA-8963684,Tyrosine catabolism,REACTOME,pathway,PATHWAY_2435
+2436,2436,2436,2436,2436,2436,2436,2436,R-HSA-9679191,Potential therapeutics for SARS,REACTOME,pathway,PATHWAY_2436
+2437,2437,2437,2437,2437,2437,2437,2437,R-HSA-9694322,Virion Assembly and Release,REACTOME,pathway,PATHWAY_2437
+2438,2438,2438,2438,2438,2438,2438,2438,R-HSA-5654221,Phospholipase C-mediated cascade; FGFR2,REACTOME,pathway,PATHWAY_2438
+2439,2439,2439,2439,2439,2439,2439,2439,R-HSA-380108,Chemokine receptors bind chemokines,REACTOME,pathway,PATHWAY_2439
+2440,2440,2440,2440,2440,2440,2440,2440,R-HSA-2470946,Cohesin Loading onto Chromatin,REACTOME,pathway,PATHWAY_2440
+2441,2441,2441,2441,2441,2441,2441,2441,R-HSA-69563,p53-Dependent G1 DNA Damage Response,REACTOME,pathway,PATHWAY_2441
+2442,2442,2442,2442,2442,2442,2442,2442,R-HSA-111461,Cytochrome c-mediated apoptotic response,REACTOME,pathway,PATHWAY_2442
+2443,2443,2443,2443,2443,2443,2443,2443,R-HSA-168330,Viral RNP Complexes in the Host Cell Nucleus,REACTOME,pathway,PATHWAY_2443
+2444,2444,2444,2444,2444,2444,2444,2444,R-HSA-9636667,Manipulation of host energy metabolism,REACTOME,pathway,PATHWAY_2444
+2445,2445,2445,2445,2445,2445,2445,2445,R-HSA-3906995,Diseases associated with O-glycosylation of proteins,REACTOME,pathway,PATHWAY_2445
+2446,2446,2446,2446,2446,2446,2446,2446,R-HSA-9020265,Biosynthesis of aspirin-triggered D-series resolvins,REACTOME,pathway,PATHWAY_2446
+2447,2447,2447,2447,2447,2447,2447,2447,R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,REACTOME,pathway,PATHWAY_2447
+2448,2448,2448,2448,2448,2448,2448,2448,R-HSA-5619053,Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP),REACTOME,pathway,PATHWAY_2448
+2449,2449,2449,2449,2449,2449,2449,2449,R-HSA-3656243,Defective ST3GAL3 causes MCT12 and EIEE15,REACTOME,pathway,PATHWAY_2449
+2450,2450,2450,2450,2450,2450,2450,2450,R-HSA-749476,RNA Polymerase III Abortive And Retractive Initiation,REACTOME,pathway,PATHWAY_2450
+2451,2451,2451,2451,2451,2451,2451,2451,R-HSA-9913351,Formation of the dystrophin-glycoprotein complex (DGC),REACTOME,pathway,PATHWAY_2451
+2452,2452,2452,2452,2452,2452,2452,2452,R-HSA-429947,Deadenylation of mRNA,REACTOME,pathway,PATHWAY_2452
+2453,2453,2453,2453,2453,2453,2453,2453,R-HSA-9036866,Expression and Processing of Neurotrophins,REACTOME,pathway,PATHWAY_2453
+2454,2454,2454,2454,2454,2454,2454,2454,R-HSA-9673770,Signaling by PDGFRA extracellular domain mutants,REACTOME,pathway,PATHWAY_2454
+2455,2455,2455,2455,2455,2455,2455,2455,R-HSA-68962,Activation of the pre-replicative complex,REACTOME,pathway,PATHWAY_2455
+2456,2456,2456,2456,2456,2456,2456,2456,R-HSA-1474165,Reproduction,REACTOME,pathway,PATHWAY_2456
+2457,2457,2457,2457,2457,2457,2457,2457,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),REACTOME,pathway,PATHWAY_2457
+2458,2458,2458,2458,2458,2458,2458,2458,R-HSA-8964315,G beta:gamma signalling through BTK,REACTOME,pathway,PATHWAY_2458
+2459,2459,2459,2459,2459,2459,2459,2459,R-HSA-75893,TNF signaling,REACTOME,pathway,PATHWAY_2459
+2460,2460,2460,2460,2460,2460,2460,2460,R-HSA-5654741,Signaling by FGFR3,REACTOME,pathway,PATHWAY_2460
+2461,2461,2461,2461,2461,2461,2461,2461,R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,REACTOME,pathway,PATHWAY_2461
+2462,2462,2462,2462,2462,2462,2462,2462,R-HSA-8850843,Phosphate bond hydrolysis by NTPDase proteins,REACTOME,pathway,PATHWAY_2462
+2463,2463,2463,2463,2463,2463,2463,2463,R-HSA-9664565,Signaling by ERBB2 KD Mutants,REACTOME,pathway,PATHWAY_2463
+2464,2464,2464,2464,2464,2464,2464,2464,R-HSA-211935,Fatty acids,REACTOME,pathway,PATHWAY_2464
+2465,2465,2465,2465,2465,2465,2465,2465,R-HSA-3899300,SUMOylation of transcription cofactors,REACTOME,pathway,PATHWAY_2465
+2466,2466,2466,2466,2466,2466,2466,2466,R-HSA-1855229,IP6 and IP7 transport between cytosol and nucleus,REACTOME,pathway,PATHWAY_2466
+2467,2467,2467,2467,2467,2467,2467,2467,R-HSA-70221,Glycogen breakdown (glycogenolysis),REACTOME,pathway,PATHWAY_2467
+2468,2468,2468,2468,2468,2468,2468,2468,R-HSA-5654732,Negative regulation of FGFR3 signaling,REACTOME,pathway,PATHWAY_2468
+2469,2469,2469,2469,2469,2469,2469,2469,R-HSA-8848584,Wax and plasmalogen biosynthesis,REACTOME,pathway,PATHWAY_2469
+2470,2470,2470,2470,2470,2470,2470,2470,R-HSA-68911,G2 Phase,REACTOME,pathway,PATHWAY_2470
+2471,2471,2471,2471,2471,2471,2471,2471,R-HSA-190872,Transport of connexons to the plasma membrane,REACTOME,pathway,PATHWAY_2471
+2472,2472,2472,2472,2472,2472,2472,2472,R-HSA-1433617,Regulation of signaling by NODAL,REACTOME,pathway,PATHWAY_2472
+2473,2473,2473,2473,2473,2473,2473,2473,R-HSA-1483255,PI Metabolism,REACTOME,pathway,PATHWAY_2473
+2474,2474,2474,2474,2474,2474,2474,2474,R-HSA-171319,Telomere Extension By Telomerase,REACTOME,pathway,PATHWAY_2474
+2475,2475,2475,2475,2475,2475,2475,2475,R-HSA-425986,Sodium/Proton exchangers,REACTOME,pathway,PATHWAY_2475
+2476,2476,2476,2476,2476,2476,2476,2476,R-HSA-5637812,Signaling by EGFRvIII in Cancer,REACTOME,pathway,PATHWAY_2476
+2477,2477,2477,2477,2477,2477,2477,2477,R-HSA-390666,Serotonin receptors,REACTOME,pathway,PATHWAY_2477
+2478,2478,2478,2478,2478,2478,2478,2478,R-HSA-5205685,PINK1-PRKN Mediated Mitophagy,REACTOME,pathway,PATHWAY_2478
+2479,2479,2479,2479,2479,2479,2479,2479,R-HSA-2408550,Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,REACTOME,pathway,PATHWAY_2479
+2480,2480,2480,2480,2480,2480,2480,2480,R-HSA-4793952,Defective MGAT2 causes CDG-2a,REACTOME,pathway,PATHWAY_2480
+2481,2481,2481,2481,2481,2481,2481,2481,R-HSA-9674396,Imatinib-resistant PDGFR mutants,REACTOME,pathway,PATHWAY_2481
+2482,2482,2482,2482,2482,2482,2482,2482,R-HSA-9702518,STAT5 activation downstream of FLT3 ITD mutants,REACTOME,pathway,PATHWAY_2482
+2483,2483,2483,2483,2483,2483,2483,2483,R-HSA-5661270,Formation of xylulose-5-phosphate,REACTOME,pathway,PATHWAY_2483
+2484,2484,2484,2484,2484,2484,2484,2484,R-HSA-442982,Ras activation upon Ca2+ influx through NMDA receptor,REACTOME,pathway,PATHWAY_2484
+2485,2485,2485,2485,2485,2485,2485,2485,R-HSA-3928664,Ephrin signaling,REACTOME,pathway,PATHWAY_2485
+2486,2486,2486,2486,2486,2486,2486,2486,R-HSA-210746,Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,REACTOME,pathway,PATHWAY_2486
+2487,2487,2487,2487,2487,2487,2487,2487,R-HSA-983231,Factors involved in megakaryocyte development and platelet production,REACTOME,pathway,PATHWAY_2487
+2488,2488,2488,2488,2488,2488,2488,2488,R-HSA-9768759,Regulation of NPAS4 gene expression,REACTOME,pathway,PATHWAY_2488
+2489,2489,2489,2489,2489,2489,2489,2489,R-HSA-434316,Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,REACTOME,pathway,PATHWAY_2489
+2490,2490,2490,2490,2490,2490,2490,2490,R-HSA-180336,SHC1 events in EGFR signaling,REACTOME,pathway,PATHWAY_2490
+2491,2491,2491,2491,2491,2491,2491,2491,R-HSA-165158,Activation of AKT2,REACTOME,pathway,PATHWAY_2491
+2492,2492,2492,2492,2492,2492,2492,2492,R-HSA-6783783,Interleukin-10 signaling,REACTOME,pathway,PATHWAY_2492
+2493,2493,2493,2493,2493,2493,2493,2493,R-HSA-1296067,Potassium transport channels,REACTOME,pathway,PATHWAY_2493
+2494,2494,2494,2494,2494,2494,2494,2494,R-HSA-163210,Formation of ATP by chemiosmotic coupling,REACTOME,pathway,PATHWAY_2494
+2495,2495,2495,2495,2495,2495,2495,2495,R-HSA-5663084,Diseases of carbohydrate metabolism,REACTOME,pathway,PATHWAY_2495
+2496,2496,2496,2496,2496,2496,2496,2496,R-HSA-2534343,Interaction With Cumulus Cells And The Zona Pellucida,REACTOME,pathway,PATHWAY_2496
+2497,2497,2497,2497,2497,2497,2497,2497,R-HSA-5654726,Negative regulation of FGFR1 signaling,REACTOME,pathway,PATHWAY_2497
+2498,2498,2498,2498,2498,2498,2498,2498,R-HSA-975576,N-glycan antennae elongation in the medial/trans-Golgi,REACTOME,pathway,PATHWAY_2498
+2499,2499,2499,2499,2499,2499,2499,2499,R-HSA-5607763,CLEC7A (Dectin-1) induces NFAT activation,REACTOME,pathway,PATHWAY_2499
+2500,2500,2500,2500,2500,2500,2500,2500,R-HSA-8869496,TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,REACTOME,pathway,PATHWAY_2500
+2501,2501,2501,2501,2501,2501,2501,2501,R-HSA-422356,Regulation of insulin secretion,REACTOME,pathway,PATHWAY_2501
+2502,2502,2502,2502,2502,2502,2502,2502,R-HSA-71291,Metabolism of amino acids and derivatives,REACTOME,pathway,PATHWAY_2502
+2503,2503,2503,2503,2503,2503,2503,2503,R-HSA-77588,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,REACTOME,pathway,PATHWAY_2503
+2504,2504,2504,2504,2504,2504,2504,2504,R-HSA-9635486,Infection with Mycobacterium tuberculosis,REACTOME,pathway,PATHWAY_2504
+2505,2505,2505,2505,2505,2505,2505,2505,R-HSA-73887,Death Receptor Signaling,REACTOME,pathway,PATHWAY_2505
+2506,2506,2506,2506,2506,2506,2506,2506,R-HSA-1839124,FGFR1 mutant receptor activation,REACTOME,pathway,PATHWAY_2506
+2507,2507,2507,2507,2507,2507,2507,2507,R-HSA-433692,Proton-coupled monocarboxylate transport,REACTOME,pathway,PATHWAY_2507
+2508,2508,2508,2508,2508,2508,2508,2508,R-HSA-112411,MAPK1 (ERK2) activation,REACTOME,pathway,PATHWAY_2508
+2509,2509,2509,2509,2509,2509,2509,2509,R-HSA-9717326,crizotinib-resistant ALK mutants,REACTOME,pathway,PATHWAY_2509
+2510,2510,2510,2510,2510,2510,2510,2510,R-HSA-1660662,Glycosphingolipid metabolism,REACTOME,pathway,PATHWAY_2510
+2511,2511,2511,2511,2511,2511,2511,2511,R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,REACTOME,pathway,PATHWAY_2511
+2512,2512,2512,2512,2512,2512,2512,2512,R-HSA-392499,Metabolism of proteins,REACTOME,pathway,PATHWAY_2512
+2513,2513,2513,2513,2513,2513,2513,2513,R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,REACTOME,pathway,PATHWAY_2513
+2514,2514,2514,2514,2514,2514,2514,2514,R-HSA-9669937,Drug resistance of KIT mutants,REACTOME,pathway,PATHWAY_2514
+2515,2515,2515,2515,2515,2515,2515,2515,R-HSA-8856828,Clathrin-mediated endocytosis,REACTOME,pathway,PATHWAY_2515
+2516,2516,2516,2516,2516,2516,2516,2516,R-HSA-5578768,Physiological factors,REACTOME,pathway,PATHWAY_2516
+2517,2517,2517,2517,2517,2517,2517,2517,R-HSA-5660686,Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),REACTOME,pathway,PATHWAY_2517
+2518,2518,2518,2518,2518,2518,2518,2518,R-HSA-2468052,Establishment of Sister Chromatid Cohesion,REACTOME,pathway,PATHWAY_2518
+2519,2519,2519,2519,2519,2519,2519,2519,R-HSA-9027284,Erythropoietin activates RAS,REACTOME,pathway,PATHWAY_2519
+2520,2520,2520,2520,2520,2520,2520,2520,R-HSA-9758274,Regulation of NF-kappa B signaling,REACTOME,pathway,PATHWAY_2520
+2521,2521,2521,2521,2521,2521,2521,2521,R-HSA-9669934,Sunitinib-resistant KIT mutants,REACTOME,pathway,PATHWAY_2521
+2522,2522,2522,2522,2522,2522,2522,2522,R-HSA-1980143,Signaling by NOTCH1,REACTOME,pathway,PATHWAY_2522
+2523,2523,2523,2523,2523,2523,2523,2523,R-HSA-9649948,Signaling downstream of RAS mutants,REACTOME,pathway,PATHWAY_2523
+2524,2524,2524,2524,2524,2524,2524,2524,R-HSA-388479,Vasopressin-like receptors,REACTOME,pathway,PATHWAY_2524
+2525,2525,2525,2525,2525,2525,2525,2525,R-HSA-5619061,Defective SLC33A1 causes spastic paraplegia 42 (SPG42),REACTOME,pathway,PATHWAY_2525
+2526,2526,2526,2526,2526,2526,2526,2526,R-HSA-203615,eNOS activation,REACTOME,pathway,PATHWAY_2526
+2527,2527,2527,2527,2527,2527,2527,2527,R-HSA-9632974,NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ,REACTOME,pathway,PATHWAY_2527
+2528,2528,2528,2528,2528,2528,2528,2528,R-HSA-9832991,Formation of the posterior neural plate,REACTOME,pathway,PATHWAY_2528
+2529,2529,2529,2529,2529,2529,2529,2529,R-HSA-9915355,Beta-ketothiolase deficiency,REACTOME,pathway,PATHWAY_2529
+2530,2530,2530,2530,2530,2530,2530,2530,R-HSA-8934593,Regulation of RUNX1 Expression and Activity,REACTOME,pathway,PATHWAY_2530
+2531,2531,2531,2531,2531,2531,2531,2531,R-HSA-9690406,Transcriptional regulation of testis differentiation,REACTOME,pathway,PATHWAY_2531
+2532,2532,2532,2532,2532,2532,2532,2532,R-HSA-8985586,SLIT2:ROBO1 increases RHOA activity,REACTOME,pathway,PATHWAY_2532
+2533,2533,2533,2533,2533,2533,2533,2533,R-HSA-1839120,Signaling by FGFR1 amplification mutants,REACTOME,pathway,PATHWAY_2533
+2534,2534,2534,2534,2534,2534,2534,2534,R-HSA-190241,FGFR2 ligand binding and activation,REACTOME,pathway,PATHWAY_2534
+2535,2535,2535,2535,2535,2535,2535,2535,R-HSA-8956321,Nucleotide salvage,REACTOME,pathway,PATHWAY_2535
+2536,2536,2536,2536,2536,2536,2536,2536,R-HSA-176412,Phosphorylation of the APC/C,REACTOME,pathway,PATHWAY_2536
+2537,2537,2537,2537,2537,2537,2537,2537,R-HSA-111464,SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ,REACTOME,pathway,PATHWAY_2537
+2538,2538,2538,2538,2538,2538,2538,2538,R-HSA-445144,Signal transduction by L1,REACTOME,pathway,PATHWAY_2538
+2539,2539,2539,2539,2539,2539,2539,2539,R-HSA-5619096,Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1),REACTOME,pathway,PATHWAY_2539
+2540,2540,2540,2540,2540,2540,2540,2540,R-HSA-191273,Cholesterol biosynthesis,REACTOME,pathway,PATHWAY_2540
+2541,2541,2541,2541,2541,2541,2541,2541,R-HSA-9755779,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,REACTOME,pathway,PATHWAY_2541
+2542,2542,2542,2542,2542,2542,2542,2542,R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,REACTOME,pathway,PATHWAY_2542
+2543,2543,2543,2543,2543,2543,2543,2543,R-HSA-1296065,Inwardly rectifying K+ channels,REACTOME,pathway,PATHWAY_2543
+2544,2544,2544,2544,2544,2544,2544,2544,R-HSA-8874081,MET activates PTK2 signaling,REACTOME,pathway,PATHWAY_2544
+2545,2545,2545,2545,2545,2545,2545,2545,R-HSA-5250992,Toxicity of botulinum toxin type E (botE),REACTOME,pathway,PATHWAY_2545
+2546,2546,2546,2546,2546,2546,2546,2546,R-HSA-4793953,Defective B4GALT1 causes CDG-2d,REACTOME,pathway,PATHWAY_2546
+2547,2547,2547,2547,2547,2547,2547,2547,R-HSA-9661070,Defective translocation of RB1 mutants to the nucleus,REACTOME,pathway,PATHWAY_2547
+2548,2548,2548,2548,2548,2548,2548,2548,R-HSA-5663220,RHO GTPases Activate Formins,REACTOME,pathway,PATHWAY_2548
+2549,2549,2549,2549,2549,2549,2549,2549,R-HSA-9031525,NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ,REACTOME,pathway,PATHWAY_2549
+2550,2550,2550,2550,2550,2550,2550,2550,R-HSA-1181150,Signaling by NODAL,REACTOME,pathway,PATHWAY_2550
+2551,2551,2551,2551,2551,2551,2551,2551,R-HSA-9657689,Defective SERPING1 causes hereditary angioedema,REACTOME,pathway,PATHWAY_2551
+2552,2552,2552,2552,2552,2552,2552,2552,R-HSA-9627069,Regulation of the apoptosome activity,REACTOME,pathway,PATHWAY_2552
+2553,2553,2553,2553,2553,2553,2553,2553,R-HSA-2559580,Oxidative Stress Induced Senescence,REACTOME,pathway,PATHWAY_2553
+2554,2554,2554,2554,2554,2554,2554,2554,R-HSA-8866910,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,REACTOME,pathway,PATHWAY_2554
+2555,2555,2555,2555,2555,2555,2555,2555,R-HSA-3238698,WNT ligand biogenesis and trafficking,REACTOME,pathway,PATHWAY_2555
+2556,2556,2556,2556,2556,2556,2556,2556,R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,REACTOME,pathway,PATHWAY_2556
+2557,2557,2557,2557,2557,2557,2557,2557,R-HSA-9734767,Developmental Cell Lineages,REACTOME,pathway,PATHWAY_2557
+2558,2558,2558,2558,2558,2558,2558,2558,R-HSA-2892245,"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",REACTOME,pathway,PATHWAY_2558
+2559,2559,2559,2559,2559,2559,2559,2559,R-HSA-400042,"Adrenaline,noradrenaline inhibits insulin secretion",REACTOME,pathway,PATHWAY_2559
+2560,2560,2560,2560,2560,2560,2560,2560,R-HSA-112122,ALKBH2 mediated reversal of alkylation damage,REACTOME,pathway,PATHWAY_2560
+2561,2561,2561,2561,2561,2561,2561,2561,R-HSA-9716542,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",REACTOME,pathway,PATHWAY_2561
+2562,2562,2562,2562,2562,2562,2562,2562,R-HSA-5654716,Downstream signaling of activated FGFR4,REACTOME,pathway,PATHWAY_2562
+2563,2563,2563,2563,2563,2563,2563,2563,R-HSA-8853659,RET signaling,REACTOME,pathway,PATHWAY_2563
+2564,2564,2564,2564,2564,2564,2564,2564,R-HSA-416482,G alpha (12/13) signalling events,REACTOME,pathway,PATHWAY_2564
+2565,2565,2565,2565,2565,2565,2565,2565,R-HSA-3065678,"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",REACTOME,pathway,PATHWAY_2565
+2566,2566,2566,2566,2566,2566,2566,2566,R-HSA-199920,CREB phosphorylation,REACTOME,pathway,PATHWAY_2566
+2567,2567,2567,2567,2567,2567,2567,2567,R-HSA-9819196,Zygotic genome activation (ZGA),REACTOME,pathway,PATHWAY_2567
+2568,2568,2568,2568,2568,2568,2568,2568,R-HSA-168302,Budding,REACTOME,pathway,PATHWAY_2568
+2569,2569,2569,2569,2569,2569,2569,2569,R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,REACTOME,pathway,PATHWAY_2569
+2570,2570,2570,2570,2570,2570,2570,2570,R-HSA-1606341,IRF3 mediated activation of type 1 IFN,REACTOME,pathway,PATHWAY_2570
+2571,2571,2571,2571,2571,2571,2571,2571,R-HSA-399719,Trafficking of AMPA receptors,REACTOME,pathway,PATHWAY_2571
+2572,2572,2572,2572,2572,2572,2572,2572,R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),REACTOME,pathway,PATHWAY_2572
+2573,2573,2573,2573,2573,2573,2573,2573,R-HSA-111995,phospho-PLA2 pathway,REACTOME,pathway,PATHWAY_2573
+2574,2574,2574,2574,2574,2574,2574,2574,R-HSA-8873719,RAB geranylgeranylation,REACTOME,pathway,PATHWAY_2574
+2575,2575,2575,2575,2575,2575,2575,2575,R-HSA-113507,E2F-enabled inhibition of pre-replication complex formation,REACTOME,pathway,PATHWAY_2575
+2576,2576,2576,2576,2576,2576,2576,2576,R-HSA-427652,Sodium-coupled phosphate cotransporters,REACTOME,pathway,PATHWAY_2576
+2577,2577,2577,2577,2577,2577,2577,2577,R-HSA-2465910,MASTL Facilitates Mitotic Progression,REACTOME,pathway,PATHWAY_2577
+2578,2578,2578,2578,2578,2578,2578,2578,R-HSA-9673163,Oleoyl-phe metabolism,REACTOME,pathway,PATHWAY_2578
+2579,2579,2579,2579,2579,2579,2579,2579,R-HSA-9907900,Proteasome assembly,REACTOME,pathway,PATHWAY_2579
+2580,2580,2580,2580,2580,2580,2580,2580,R-HSA-9037628,Rhesus blood group biosynthesis,REACTOME,pathway,PATHWAY_2580
+2581,2581,2581,2581,2581,2581,2581,2581,R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,REACTOME,pathway,PATHWAY_2581
+2582,2582,2582,2582,2582,2582,2582,2582,R-HSA-5627117,RHO GTPases Activate ROCKs,REACTOME,pathway,PATHWAY_2582
+2583,2583,2583,2583,2583,2583,2583,2583,R-HSA-5579015,Defective CYP26B1 causes RHFCA,REACTOME,pathway,PATHWAY_2583
+2584,2584,2584,2584,2584,2584,2584,2584,R-HSA-9662834,CD163 mediating an anti-inflammatory response,REACTOME,pathway,PATHWAY_2584
+2585,2585,2585,2585,2585,2585,2585,2585,R-HSA-6807004,Negative regulation of MET activity,REACTOME,pathway,PATHWAY_2585
+2586,2586,2586,2586,2586,2586,2586,2586,R-HSA-9660821,ADORA2B mediated anti-inflammatory cytokines production,REACTOME,pathway,PATHWAY_2586
+2587,2587,2587,2587,2587,2587,2587,2587,R-HSA-9020958,Interleukin-21 signaling,REACTOME,pathway,PATHWAY_2587
+2588,2588,2588,2588,2588,2588,2588,2588,R-HSA-1369007,Mitochondrial ABC transporters,REACTOME,pathway,PATHWAY_2588
+2589,2589,2589,2589,2589,2589,2589,2589,R-HSA-2395516,Electron transport from NADPH to Ferredoxin,REACTOME,pathway,PATHWAY_2589
+2590,2590,2590,2590,2590,2590,2590,2590,R-HSA-156581,Methylation,REACTOME,pathway,PATHWAY_2590
+2591,2591,2591,2591,2591,2591,2591,2591,R-HSA-110357,Displacement of DNA glycosylase by APEX1,REACTOME,pathway,PATHWAY_2591
+2592,2592,2592,2592,2592,2592,2592,2592,R-HSA-4717374,Defective DPM1 causes DPM1-CDG,REACTOME,pathway,PATHWAY_2592
+2593,2593,2593,2593,2593,2593,2593,2593,R-HSA-6809371,Formation of the cornified envelope,REACTOME,pathway,PATHWAY_2593
+2594,2594,2594,2594,2594,2594,2594,2594,R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",REACTOME,pathway,PATHWAY_2594
+2595,2595,2595,2595,2595,2595,2595,2595,R-HSA-427389,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,REACTOME,pathway,PATHWAY_2595
+2596,2596,2596,2596,2596,2596,2596,2596,R-HSA-1268020,Mitochondrial protein import,REACTOME,pathway,PATHWAY_2596
+2597,2597,2597,2597,2597,2597,2597,2597,R-HSA-9730414,MITF-M-regulated melanocyte development,REACTOME,pathway,PATHWAY_2597
+2598,2598,2598,2598,2598,2598,2598,2598,R-HSA-5654736,Signaling by FGFR1,REACTOME,pathway,PATHWAY_2598
+2599,2599,2599,2599,2599,2599,2599,2599,R-HSA-8863678,Neurodegenerative Diseases,REACTOME,pathway,PATHWAY_2599
+2600,2600,2600,2600,2600,2600,2600,2600,R-HSA-2408508,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",REACTOME,pathway,PATHWAY_2600
+2601,2601,2601,2601,2601,2601,2601,2601,R-HSA-6803529,FGFR2 alternative splicing,REACTOME,pathway,PATHWAY_2601
+2602,2602,2602,2602,2602,2602,2602,2602,R-HSA-2142770,Synthesis of 15-eicosatetraenoic acid derivatives,REACTOME,pathway,PATHWAY_2602
+2603,2603,2603,2603,2603,2603,2603,2603,R-HSA-211945,Phase I - Functionalization of compounds,REACTOME,pathway,PATHWAY_2603
+2604,2604,2604,2604,2604,2604,2604,2604,R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,REACTOME,pathway,PATHWAY_2604
+2605,2605,2605,2605,2605,2605,2605,2605,R-HSA-9026762,Biosynthesis of maresin conjugates in tissue regeneration (MCTR),REACTOME,pathway,PATHWAY_2605
+2606,2606,2606,2606,2606,2606,2606,2606,R-HSA-5693532,DNA Double-Strand Break Repair,REACTOME,pathway,PATHWAY_2606
+2607,2607,2607,2607,2607,2607,2607,2607,R-HSA-5603041,IRAK4 deficiency (TLR2/4),REACTOME,pathway,PATHWAY_2607
+2608,2608,2608,2608,2608,2608,2608,2608,R-HSA-3000157,Laminin interactions,REACTOME,pathway,PATHWAY_2608
+2609,2609,2609,2609,2609,2609,2609,2609,R-HSA-72613,Eukaryotic Translation Initiation,REACTOME,pathway,PATHWAY_2609
+2610,2610,2610,2610,2610,2610,2610,2610,R-HSA-9855142,Cellular responses to mechanical stimuli,REACTOME,pathway,PATHWAY_2610
+2611,2611,2611,2611,2611,2611,2611,2611,R-HSA-9032759,NTRK2 activates RAC1,REACTOME,pathway,PATHWAY_2611
+2612,2612,2612,2612,2612,2612,2612,2612,R-HSA-432142,Platelet sensitization by LDL,REACTOME,pathway,PATHWAY_2612
+2613,2613,2613,2613,2613,2613,2613,2613,R-HSA-6804760,Regulation of TP53 Activity through Methylation,REACTOME,pathway,PATHWAY_2613
+2614,2614,2614,2614,2614,2614,2614,2614,R-HSA-9918449,Defective visual phototransduction due to STRA6 loss of function,REACTOME,pathway,PATHWAY_2614
+2615,2615,2615,2615,2615,2615,2615,2615,R-HSA-9682385,FLT3 signaling in disease,REACTOME,pathway,PATHWAY_2615
+2616,2616,2616,2616,2616,2616,2616,2616,R-HSA-9025106,Biosynthesis of DPAn-6 SPMs,REACTOME,pathway,PATHWAY_2616
+2617,2617,2617,2617,2617,2617,2617,2617,R-HSA-9608287,Defective MUTYH substrate binding,REACTOME,pathway,PATHWAY_2617
+2618,2618,2618,2618,2618,2618,2618,2618,R-HSA-5619067,Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA),REACTOME,pathway,PATHWAY_2618
+2619,2619,2619,2619,2619,2619,2619,2619,R-HSA-109581,Apoptosis,REACTOME,pathway,PATHWAY_2619
+2620,2620,2620,2620,2620,2620,2620,2620,R-HSA-166166,MyD88-independent TLR4 cascade ,REACTOME,pathway,PATHWAY_2620
+2621,2621,2621,2621,2621,2621,2621,2621,R-HSA-181429,Serotonin Neurotransmitter Release Cycle,REACTOME,pathway,PATHWAY_2621
+2622,2622,2622,2622,2622,2622,2622,2622,R-HSA-8963693,Aspartate and asparagine metabolism,REACTOME,pathway,PATHWAY_2622
+2623,2623,2623,2623,2623,2623,2623,2623,R-HSA-9753512,Signaling by RAS GTPase mutants,REACTOME,pathway,PATHWAY_2623
+2624,2624,2624,2624,2624,2624,2624,2624,R-HSA-3560796,Defective PAPSS2 causes SEMD-PA,REACTOME,pathway,PATHWAY_2624
+2625,2625,2625,2625,2625,2625,2625,2625,R-HSA-69306,DNA Replication,REACTOME,pathway,PATHWAY_2625
+2626,2626,2626,2626,2626,2626,2626,2626,R-HSA-72172,mRNA Splicing,REACTOME,pathway,PATHWAY_2626
+2627,2627,2627,2627,2627,2627,2627,2627,R-HSA-5358606,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),REACTOME,pathway,PATHWAY_2627
+2628,2628,2628,2628,2628,2628,2628,2628,R-HSA-162906,HIV Infection,REACTOME,pathway,PATHWAY_2628
+2629,2629,2629,2629,2629,2629,2629,2629,R-HSA-110381,Resolution of AP sites via the single-nucleotide replacement pathway,REACTOME,pathway,PATHWAY_2629
+2630,2630,2630,2630,2630,2630,2630,2630,R-HSA-196783,Coenzyme A biosynthesis,REACTOME,pathway,PATHWAY_2630
+2631,2631,2631,2631,2631,2631,2631,2631,R-HSA-9645460,Alpha-protein kinase 1 signaling pathway,REACTOME,pathway,PATHWAY_2631
+2632,2632,2632,2632,2632,2632,2632,2632,R-HSA-5579007,Defective ACY1 causes encephalopathy,REACTOME,pathway,PATHWAY_2632
+2633,2633,2633,2633,2633,2633,2633,2633,R-HSA-4720489,Defective ALG12 causes CDG-1g,REACTOME,pathway,PATHWAY_2633
+2634,2634,2634,2634,2634,2634,2634,2634,R-HSA-5083627,Defective LARGE causes MDDGA6 and MDDGB6,REACTOME,pathway,PATHWAY_2634
+2635,2635,2635,2635,2635,2635,2635,2635,R-HSA-9679509,Virion Assembly and Release,REACTOME,pathway,PATHWAY_2635
+2636,2636,2636,2636,2636,2636,2636,2636,R-HSA-3359474,Defective MMACHC causes MAHCC,REACTOME,pathway,PATHWAY_2636
+2637,2637,2637,2637,2637,2637,2637,2637,R-HSA-163316,Mitochondrial transcription termination,REACTOME,pathway,PATHWAY_2637
+2638,2638,2638,2638,2638,2638,2638,2638,R-HSA-162599,Late Phase of HIV Life Cycle,REACTOME,pathway,PATHWAY_2638
+2639,2639,2639,2639,2639,2639,2639,2639,R-HSA-167160,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,REACTOME,pathway,PATHWAY_2639
+2640,2640,2640,2640,2640,2640,2640,2640,R-HSA-4791275,Signaling by WNT in cancer,REACTOME,pathway,PATHWAY_2640
+2641,2641,2641,2641,2641,2641,2641,2641,R-HSA-187037,Signaling by NTRK1 (TRKA),REACTOME,pathway,PATHWAY_2641
+2642,2642,2642,2642,2642,2642,2642,2642,R-HSA-167060,NGF processing,REACTOME,pathway,PATHWAY_2642
+2643,2643,2643,2643,2643,2643,2643,2643,R-HSA-9006115,Signaling by NTRK2 (TRKB),REACTOME,pathway,PATHWAY_2643
+2644,2644,2644,2644,2644,2644,2644,2644,R-HSA-9758920,Formation of lateral plate mesoderm,REACTOME,pathway,PATHWAY_2644
+2645,2645,2645,2645,2645,2645,2645,2645,R-HSA-888590,"GABA synthesis, release, reuptake and degradation",REACTOME,pathway,PATHWAY_2645
+2646,2646,2646,2646,2646,2646,2646,2646,R-HSA-166520,Signaling by NTRKs,REACTOME,pathway,PATHWAY_2646
+2647,2647,2647,2647,2647,2647,2647,2647,R-HSA-5545619,XAV939 stabilizes AXIN,REACTOME,pathway,PATHWAY_2647
+2648,2648,2648,2648,2648,2648,2648,2648,R-HSA-2142753,Arachidonate metabolism,REACTOME,pathway,PATHWAY_2648
+2649,2649,2649,2649,2649,2649,2649,2649,R-HSA-2161541,Abacavir metabolism,REACTOME,pathway,PATHWAY_2649
+2650,2650,2650,2650,2650,2650,2650,2650,R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,REACTOME,pathway,PATHWAY_2650
+2651,2651,2651,2651,2651,2651,2651,2651,R-HSA-159854,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",REACTOME,pathway,PATHWAY_2651
+2652,2652,2652,2652,2652,2652,2652,2652,R-HSA-68886,M Phase,REACTOME,pathway,PATHWAY_2652
+2653,2653,2653,2653,2653,2653,2653,2653,R-HSA-9706374,FLT3 signaling through SRC family kinases,REACTOME,pathway,PATHWAY_2653
+2654,2654,2654,2654,2654,2654,2654,2654,R-HSA-5619109,Defective SLC6A2 causes orthostatic intolerance (OI),REACTOME,pathway,PATHWAY_2654
+2655,2655,2655,2655,2655,2655,2655,2655,R-HSA-2142712,Synthesis of 12-eicosatetraenoic acid derivatives,REACTOME,pathway,PATHWAY_2655
+2656,2656,2656,2656,2656,2656,2656,2656,R-HSA-381753,Olfactory Signaling Pathway,REACTOME,pathway,PATHWAY_2656
+2657,2657,2657,2657,2657,2657,2657,2657,R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,REACTOME,pathway,PATHWAY_2657
+2658,2658,2658,2658,2658,2658,2658,2658,R-HSA-173736,Alternative complement activation,REACTOME,pathway,PATHWAY_2658
+2659,2659,2659,2659,2659,2659,2659,2659,R-HSA-2206281,Mucopolysaccharidoses,REACTOME,pathway,PATHWAY_2659
+2660,2660,2660,2660,2660,2660,2660,2660,R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,REACTOME,pathway,PATHWAY_2660
+2661,2661,2661,2661,2661,2661,2661,2661,R-HSA-448706,Interleukin-1 processing,REACTOME,pathway,PATHWAY_2661
+2662,2662,2662,2662,2662,2662,2662,2662,R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,REACTOME,pathway,PATHWAY_2662
+2663,2663,2663,2663,2663,2663,2663,2663,R-HSA-141333,Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,REACTOME,pathway,PATHWAY_2663
+2664,2664,2664,2664,2664,2664,2664,2664,R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,REACTOME,pathway,PATHWAY_2664
+2665,2665,2665,2665,2665,2665,2665,2665,R-HSA-5619087,Defective SLC12A3 causes Gitelman syndrome (GS),REACTOME,pathway,PATHWAY_2665
+2666,2666,2666,2666,2666,2666,2666,2666,R-HSA-9796292,Formation of axial mesoderm,REACTOME,pathway,PATHWAY_2666
+2667,2667,2667,2667,2667,2667,2667,2667,R-HSA-187706,Signalling to p38 via RIT and RIN,REACTOME,pathway,PATHWAY_2667
+2668,2668,2668,2668,2668,2668,2668,2668,R-HSA-9609646,HCMV Infection,REACTOME,pathway,PATHWAY_2668
+2669,2669,2669,2669,2669,2669,2669,2669,R-HSA-196819,Vitamin B1 (thiamin) metabolism,REACTOME,pathway,PATHWAY_2669
+2670,2670,2670,2670,2670,2670,2670,2670,R-HSA-8964208,Phenylalanine metabolism,REACTOME,pathway,PATHWAY_2670
+2671,2671,2671,2671,2671,2671,2671,2671,R-HSA-2022870,Chondroitin sulfate biosynthesis,REACTOME,pathway,PATHWAY_2671
+2672,2672,2672,2672,2672,2672,2672,2672,R-HSA-9662360,Sensory processing of sound by inner hair cells of the cochlea,REACTOME,pathway,PATHWAY_2672
+2673,2673,2673,2673,2673,2673,2673,2673,R-HSA-6807505,RNA polymerase II transcribes snRNA genes,REACTOME,pathway,PATHWAY_2673
+2674,2674,2674,2674,2674,2674,2674,2674,R-HSA-9843970,Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex,REACTOME,pathway,PATHWAY_2674
+2675,2675,2675,2675,2675,2675,2675,2675,R-HSA-5357956,TNFR1-induced NF-kappa-B signaling pathway,REACTOME,pathway,PATHWAY_2675
+2676,2676,2676,2676,2676,2676,2676,2676,R-HSA-1912408,Pre-NOTCH Transcription and Translation,REACTOME,pathway,PATHWAY_2676
+2677,2677,2677,2677,2677,2677,2677,2677,R-HSA-2142789,Ubiquinol biosynthesis,REACTOME,pathway,PATHWAY_2677
+2678,2678,2678,2678,2678,2678,2678,2678,R-HSA-5620924,Intraflagellar transport,REACTOME,pathway,PATHWAY_2678
+2679,2679,2679,2679,2679,2679,2679,2679,R-HSA-561048,Organic anion transport,REACTOME,pathway,PATHWAY_2679
+2680,2680,2680,2680,2680,2680,2680,2680,R-HSA-168316,Assembly of Viral Components at the Budding Site,REACTOME,pathway,PATHWAY_2680
+2681,2681,2681,2681,2681,2681,2681,2681,R-HSA-446219,Synthesis of substrates in N-glycan biosythesis,REACTOME,pathway,PATHWAY_2681
+2682,2682,2682,2682,2682,2682,2682,2682,R-HSA-912694,Regulation of IFNA/IFNB signaling,REACTOME,pathway,PATHWAY_2682
+2683,2683,2683,2683,2683,2683,2683,2683,R-HSA-9723907,Loss of Function of TP53 in Cancer,REACTOME,pathway,PATHWAY_2683
+2684,2684,2684,2684,2684,2684,2684,2684,R-HSA-428930,Thromboxane signalling through TP receptor,REACTOME,pathway,PATHWAY_2684
+2685,2685,2685,2685,2685,2685,2685,2685,R-HSA-168874,"Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus",REACTOME,pathway,PATHWAY_2685
+2686,2686,2686,2686,2686,2686,2686,2686,R-HSA-75102,C6 deamination of adenosine,REACTOME,pathway,PATHWAY_2686
+2687,2687,2687,2687,2687,2687,2687,2687,R-HSA-977444,GABA B receptor activation,REACTOME,pathway,PATHWAY_2687
+2688,2688,2688,2688,2688,2688,2688,2688,R-HSA-8939256,RUNX1 regulates transcription of genes involved in WNT signaling,REACTOME,pathway,PATHWAY_2688
+2689,2689,2689,2689,2689,2689,2689,2689,R-HSA-3371598,Defective BTD causes biotidinase deficiency,REACTOME,pathway,PATHWAY_2689
+2690,2690,2690,2690,2690,2690,2690,2690,R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",REACTOME,pathway,PATHWAY_2690
+2691,2691,2691,2691,2691,2691,2691,2691,R-HSA-3642279,TGFBR2 MSI Frameshift Mutants in Cancer,REACTOME,pathway,PATHWAY_2691
+2692,2692,2692,2692,2692,2692,2692,2692,R-HSA-9703465,Signaling by FLT3 fusion proteins,REACTOME,pathway,PATHWAY_2692
+2693,2693,2693,2693,2693,2693,2693,2693,R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,REACTOME,pathway,PATHWAY_2693
+2694,2694,2694,2694,2694,2694,2694,2694,R-HSA-9703009,tamatinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_2694
+2695,2695,2695,2695,2695,2695,2695,2695,R-HSA-9013409,RHOJ GTPase cycle,REACTOME,pathway,PATHWAY_2695
+2696,2696,2696,2696,2696,2696,2696,2696,R-HSA-2892247,"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",REACTOME,pathway,PATHWAY_2696
+2697,2697,2697,2697,2697,2697,2697,2697,R-HSA-9824878,"Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 ",REACTOME,pathway,PATHWAY_2697
+2698,2698,2698,2698,2698,2698,2698,2698,R-HSA-380612,Metabolism of serotonin,REACTOME,pathway,PATHWAY_2698
+2699,2699,2699,2699,2699,2699,2699,2699,R-HSA-192905,vRNP Assembly,REACTOME,pathway,PATHWAY_2699
+2700,2700,2700,2700,2700,2700,2700,2700,R-HSA-391160,Signal regulatory protein family interactions,REACTOME,pathway,PATHWAY_2700
+2701,2701,2701,2701,2701,2701,2701,2701,R-HSA-9679514,SARS-CoV-1 Genome Replication and Transcription,REACTOME,pathway,PATHWAY_2701
+2702,2702,2702,2702,2702,2702,2702,2702,R-HSA-8964572,Lipid particle organization,REACTOME,pathway,PATHWAY_2702
+2703,2703,2703,2703,2703,2703,2703,2703,R-HSA-9830364,Formation of the nephric duct,REACTOME,pathway,PATHWAY_2703
+2704,2704,2704,2704,2704,2704,2704,2704,R-HSA-5250941,Negative epigenetic regulation of rRNA expression,REACTOME,pathway,PATHWAY_2704
+2705,2705,2705,2705,2705,2705,2705,2705,R-HSA-2024101,CS/DS degradation,REACTOME,pathway,PATHWAY_2705
+2706,2706,2706,2706,2706,2706,2706,2706,R-HSA-174362,Transport and synthesis of PAPS,REACTOME,pathway,PATHWAY_2706
+2707,2707,2707,2707,2707,2707,2707,2707,R-HSA-913709,O-linked glycosylation of mucins,REACTOME,pathway,PATHWAY_2707
+2708,2708,2708,2708,2708,2708,2708,2708,R-HSA-69002,DNA Replication Pre-Initiation,REACTOME,pathway,PATHWAY_2708
+2709,2709,2709,2709,2709,2709,2709,2709,R-HSA-388396,GPCR downstream signalling,REACTOME,pathway,PATHWAY_2709
+2710,2710,2710,2710,2710,2710,2710,2710,R-HSA-5683371,Defective ABCB6 causes MCOPCB7,REACTOME,pathway,PATHWAY_2710
+2711,2711,2711,2711,2711,2711,2711,2711,R-HSA-389356,Co-stimulation by CD28,REACTOME,pathway,PATHWAY_2711
+2712,2712,2712,2712,2712,2712,2712,2712,R-HSA-70921,Histidine catabolism,REACTOME,pathway,PATHWAY_2712
+2713,2713,2713,2713,2713,2713,2713,2713,R-HSA-9818564,Epigenetic regulation of gene expression by MLL3 and MLL4 complexes,REACTOME,pathway,PATHWAY_2713
+2714,2714,2714,2714,2714,2714,2714,2714,R-HSA-9658195,Leishmania infection,REACTOME,pathway,PATHWAY_2714
+2715,2715,2715,2715,2715,2715,2715,2715,R-HSA-5579024,Defective MAT1A causes MATD,REACTOME,pathway,PATHWAY_2715
+2716,2716,2716,2716,2716,2716,2716,2716,R-HSA-141334,PAOs oxidise polyamines to amines,REACTOME,pathway,PATHWAY_2716
+2717,2717,2717,2717,2717,2717,2717,2717,R-HSA-72695,"Formation of the ternary complex, and subsequently, the 43S complex",REACTOME,pathway,PATHWAY_2717
+2718,2718,2718,2718,2718,2718,2718,2718,R-HSA-69205,G1/S-Specific Transcription,REACTOME,pathway,PATHWAY_2718
+2719,2719,2719,2719,2719,2719,2719,2719,R-HSA-9692916,SARS-CoV-1 activates/modulates innate immune responses,REACTOME,pathway,PATHWAY_2719
+2720,2720,2720,2720,2720,2720,2720,2720,R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,REACTOME,pathway,PATHWAY_2720
+2721,2721,2721,2721,2721,2721,2721,2721,R-HSA-72200,mRNA Editing: C to U Conversion,REACTOME,pathway,PATHWAY_2721
+2722,2722,2722,2722,2722,2722,2722,2722,R-HSA-390918,Peroxisomal lipid metabolism,REACTOME,pathway,PATHWAY_2722
+2723,2723,2723,2723,2723,2723,2723,2723,R-HSA-1482798,Acyl chain remodeling of CL,REACTOME,pathway,PATHWAY_2723
+2724,2724,2724,2724,2724,2724,2724,2724,R-HSA-1296071,Potassium Channels,REACTOME,pathway,PATHWAY_2724
+2725,2725,2725,2725,2725,2725,2725,2725,R-HSA-5693537,Resolution of D-Loop Structures,REACTOME,pathway,PATHWAY_2725
+2726,2726,2726,2726,2726,2726,2726,2726,R-HSA-442755,Activation of NMDA receptors and postsynaptic events,REACTOME,pathway,PATHWAY_2726
+2727,2727,2727,2727,2727,2727,2727,2727,R-HSA-167246,Tat-mediated elongation of the HIV-1 transcript,REACTOME,pathway,PATHWAY_2727
+2728,2728,2728,2728,2728,2728,2728,2728,R-HSA-5619077,Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D),REACTOME,pathway,PATHWAY_2728
+2729,2729,2729,2729,2729,2729,2729,2729,R-HSA-167172,Transcription of the HIV genome,REACTOME,pathway,PATHWAY_2729
+2730,2730,2730,2730,2730,2730,2730,2730,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,REACTOME,pathway,PATHWAY_2730
+2731,2731,2731,2731,2731,2731,2731,2731,R-HSA-8849468,PTK6 Regulates Proteins Involved in RNA Processing,REACTOME,pathway,PATHWAY_2731
+2732,2732,2732,2732,2732,2732,2732,2732,R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",REACTOME,pathway,PATHWAY_2732
+2733,2733,2733,2733,2733,2733,2733,2733,R-HSA-3270619,IRF3-mediated induction of type I IFN,REACTOME,pathway,PATHWAY_2733
+2734,2734,2734,2734,2734,2734,2734,2734,R-HSA-212300,PRC2 methylates histones and DNA,REACTOME,pathway,PATHWAY_2734
+2735,2735,2735,2735,2735,2735,2735,2735,R-HSA-9013026,RHOB GTPase cycle,REACTOME,pathway,PATHWAY_2735
+2736,2736,2736,2736,2736,2736,2736,2736,R-HSA-5682294,Defective ABCA12 causes ARCI4B,REACTOME,pathway,PATHWAY_2736
+2737,2737,2737,2737,2737,2737,2737,2737,R-HSA-3214815,HDACs deacetylate histones,REACTOME,pathway,PATHWAY_2737
+2738,2738,2738,2738,2738,2738,2738,2738,R-HSA-110320,Translesion Synthesis by POLH,REACTOME,pathway,PATHWAY_2738
+2739,2739,2739,2739,2739,2739,2739,2739,R-HSA-5657655,MGMT-mediated DNA damage reversal,REACTOME,pathway,PATHWAY_2739
+2740,2740,2740,2740,2740,2740,2740,2740,R-HSA-5083635,Defective B3GALTL causes PpS,REACTOME,pathway,PATHWAY_2740
+2741,2741,2741,2741,2741,2741,2741,2741,R-HSA-373756,SDK interactions,REACTOME,pathway,PATHWAY_2741
+2742,2742,2742,2742,2742,2742,2742,2742,R-HSA-432722,Golgi Associated Vesicle Biogenesis,REACTOME,pathway,PATHWAY_2742
+2743,2743,2743,2743,2743,2743,2743,2743,R-HSA-9613829,Chaperone Mediated Autophagy,REACTOME,pathway,PATHWAY_2743
+2744,2744,2744,2744,2744,2744,2744,2744,R-HSA-3359471,"Defective MMAB causes MMA, cblB type",REACTOME,pathway,PATHWAY_2744
+2745,2745,2745,2745,2745,2745,2745,2745,R-HSA-4420097,VEGFA-VEGFR2 Pathway,REACTOME,pathway,PATHWAY_2745
+2746,2746,2746,2746,2746,2746,2746,2746,R-HSA-9768778,Regulation of NPAS4 mRNA translation,REACTOME,pathway,PATHWAY_2746
+2747,2747,2747,2747,2747,2747,2747,2747,R-HSA-901042,Calnexin/calreticulin cycle,REACTOME,pathway,PATHWAY_2747
+2748,2748,2748,2748,2748,2748,2748,2748,R-HSA-446203,Asparagine N-linked glycosylation,REACTOME,pathway,PATHWAY_2748
+2749,2749,2749,2749,2749,2749,2749,2749,R-HSA-445095,Interaction between L1 and Ankyrins,REACTOME,pathway,PATHWAY_2749
+2750,2750,2750,2750,2750,2750,2750,2750,R-HSA-9018896,Biosynthesis of E-series 18(S)-resolvins,REACTOME,pathway,PATHWAY_2750